Master keyword index to volumes 386–410 (2000)

European Journal of Pharmacology www.elsevier.nlrlocaterejphar

Master keyword index to volumes 386–410 ž2000/ A-192621 Endothelin-1; Endothelin ETA -receptor; Endothelin ETB -receptor; PD 155080; Endotoxaemia; Septic shock ŽWanecek, M. Ž386. 235.

Acetylcholine X Monosodium glutamate; Smooth muscle; Adenosine-5 -triphosphate; Bradykinin; Angiotensin II ŽSukhanov, S.N. Ž386. 247.

A-85380 Nicotinic acetylcholine receptor; Molecular model; Epibatidine; ABT-594; Analgesia; Antinociception ŽMeyer, M.D. Ž393. 171.

Choline; Cortex, medial prefrontal; Norepinephrine; Serotonin ŽHedou, G. Ž390. 127.

Abecarnil Radiotelemetry; Withdrawal, precipitated ŽElliot, E.E. Ž394. 237. Abnormal behavior Personality; Genes; Neurotransmission; Polymorphism; Temperament ŽEbstein, R.P. Ž410. 205. ABT-594 Nicotinic acetylcholine receptor; Molecular model; Epibatidine; A-85380; Analgesia; Antinociception ŽMeyer, M.D. Ž393. 171. Abuse liability Cyclo-oxygenase inhibitor; Nimesulide; Conditioned place preference ŽFattore, L. Ž406. 75. Acamprosate Ethanol; Spermine; NMDA receptor; Primary cultured neuron; Patchclamp, whole-cell ŽPopp, R.L. Ž394. 221.

Cholinergic; Glutamate; Interaction; Motivation; Behaviour ŽAura, J. Ž390. 313. Nicotinic acetylcholine receptor; Choline; Agonist; Partial; Co-agonist; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209. Dopamine; GABA Ž g-aminobutyric acid.; Substantia nigra; Striatum; P. Ž399. 151. Antimuscarinic drug; L-Dopa ŽIzurieta-Sanchez, ´ Hippocampus; HU 210; Microdialysis; Cortex, prefrontal; SR 141716A; WIN 55, 212-2 ŽAcquas, E. Ž401. 179. Nerve growth factor ŽNGF.; Dopamine receptor; Cognition; Extrapyramidal symptom ŽOzaki, T. Ž402. 39. Neuroinflammation; Forebrain basal; Caspase; Non-steroidal anti-inflammatory drug; ŽRat. ŽWenk, G.L. Ž402. 77. Airway epithelium; Smooth muscle, airway; Nitric oxide ŽNO.; Indomethacin; Airway segment ŽMcParland, B.E. Ž402. 151.

ACEA-1021 Cocaine; Motor activity; Conditioning; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; Memantine; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303.

Vagus nerve; C-fiber; Cholinergic nerve; Neurokinin-A ŽMatsumoto, K. Ž403. 157.

Morphine; Antinociception; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r579; MRZ 2r576 ŽBelozertseva, I.V. Ž396. 77.

Acetylcholine receptor Conotoxin; Neuronal nicotinic receptor; Chromaffin cell; Nicotinic receptor antagonist; Catecholamine release ŽBroxton, N. Ž390. 229.

Aceclofenac X Osteoarthritis; Rheumatoid arthritis; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 1; Pro-matrix metalloproteinase 3; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429.

Sox protein; Sp1; Transcriptional regulation; hnRNP K ŽMelnikova, I.N. Ž393. 75. Ligand-gated ion channel; RNA blot; In situ hybridization; Peripheral nervous system; Neural development ŽErkman, L. Ž393. 97.

Acetaldehyde Ethanol; Hepatocyte; MAPK Žmitogen-activated protein kinase.; Angiotensin II ŽWeng, Y.-I. Ž398. 323.

Nicotinic receptor; a-Bungarotoxin; Ciliary ganglion; Sciatic nerve; Neuronal ŽRoth, A.L. Ž393. 105.

Acetic acid-induced writhing FR122047; Cyclooxygenase-1; Formalin test ŽOchi, T. Ž391. 49.

Neuron; Property; Ligand binding domain; Pharmacological; Physiological ŽCurtis, L. Ž393. 155.

Acetophenone analogue Choleretic; Cholesterol; Lithogenic index; Phloacetophenone; Ž Curcuma comosa. ŽPiyachaturawat, P. Ž387. 221.

Epilepsy; Mutation ŽSteinlein, O.K. Ž393. 243.

Acetycholine Cannabinoid; Glutamate; Learning; Short-term memory ŽHan, C.J. Ž403. 87.

Acetylcholine release Stomach; Histamine H 3 receptor; Pertussis toxin ŽYokotani, K. Ž392. 23. Trachea; Tachykinin NK 2 receptor; wbAla8 xNeurokinin A-Ž4–10.; SR 48968 ŽD’Agostino, G. Ž396. 29.

2

Master keyword index to Õolumes 386–410 (2000)

Ca2q channel blocker; Thapsigargin; Stimulus pattern; Neuromuscular junction ŽCorreia-de-Sa, ´ P. Ž406. 355. Acetylcholinesterase Alzheimer’s disease; Parkinson’s disease; a 3 subunit; a4 subunit; a7 subunit; b-Amyloidosis; Tobacco exposure ŽPerry, E. Ž393. 215. Žy.-Huperzine A; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Learning; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65. Acidosis ATP; P2X receptor; pH; Purine; Mesenteric arterial bed; Vasoconstriction ŽRalevic, V. Ž406. 99. Aciflourfen Benzodiazepine receptor, mitochondrial; d-Aminolaevulinic acid; Protoporphyrin IX; Zinc protoporphyrin IX; Protoporphyrinogen oxidase ŽMesenholler, M. Ž406. 171. ¨ Aconitum alkaloid Hippocampus; Electrophysiology; Epileptiform activity; Naq current ŽAmeri, A. Ž386. 187. ACTH (adrenocorticotropic hormone) MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Peptide–receptor interaction; Avoidance; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. ACTH (adrenocorticotropin) Neonatal; Neuroprotection; Magnocellular basal nucleus; Cholinergic neuron; Glia ŽHorvath, K.M. Ž405. 33. Corticosterone; CRH Žcorticotropin-releasing hormone.; Coping; Social; Maternal behavior ŽLevine, S. Ž405. 149. Actin polymerization TA-993; Platelet; Glycoprotein IIbrIIIa receptor; ADP; Ca2q, intracellular ŽKatoh, M. Ž399. 91. Action potential Metoprolol; Ramipril; Myocardial infarction; Papillary muscle ŽWagner, K.-D. Ž388. 263. Anaesthetic volatile; Arrhythmia; K AT P channel; Myocyte; Patch clamp ŽTerrenoire, C. Ž390. 95. Action potential duration Antiarrhythmic drug; Reperfusion arrhythmia; Vma x ŽBaczko, ´ I. Ž404. 181. Activation Nicotine; Cholinergic; Tobacco; Addiction; Ventral tegmental area ŽDani, J.A. Ž393. 31. Nicotinic acetylcholine receptor; Pharmacological comparison; Subunit null mutation; Binding ŽWhiteaker, P. Ž393. 123. Active avoidance, mice Ca2q channel antagonist; Amlodipine; Memory enhancement; Maze learning; Chronic drug administration ŽQuartermain, D. Ž399. 57. Active sensitisation Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; Methacholine; 5-HT; Bronchoconstriction; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469.

Activity D9 -Tetrahydrocannabinol; Cannabinoid; Biphasic effect; Movement ŽSanudo-Pena, ˜ ˜ M.C. Ž391. 269. Acute lung injury Selectin; Sialyl Lewis X; Lipopolysaccharide ŽHayashi, H. Ž392. 109. Acute tolerance Clozapine, intravenous; Clozapine, oral; Pharmacodynamics; Pharmacokinetics; Pharmacokinetic–pharmacodynamic modeling; Potency, relative ŽSun, L. Ž398. 225. ( R )-ACX Sulfonylurea compound; Insulin releasing effect; Hypoglycemic effect ŽSeri, K. Ž389. 253. Adaptation Restraint stress; D-Amphetamine; Conditioned place preference; Dopamine D1 receptor; Dopamine D 2 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127. Addiction Nicotine; Activation; Cholinergic; Tobacco; Ventral tegmental area ŽDani, J.A. Ž393. 31. Dependence; Dopamine; Nicotine; Nucleus accumbens; Prefrontal cortex ŽDi Chiara, G. Ž393. 295. Endogenous opoid; Reward; Brain stimulation reward; Self-administration; Sexual behaviour; Social behaviour ŽVan Ree, J.M. Ž405. 89. Opioid system, endogenous; Gene polymorphism; Single nucleotide polymorphism; Pharmacogenetics; Physiogenetics ŽLaForge, K.S. Ž410. 249. Opiate; Heroin; Genetic; Pharmacogenomics; Candidate gene ŽLichtermann, D. Ž410. 269. Adenine nucleotide Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. [3 H]Adenosine Adenosine uptake; Mitochondrion; Testis, rat; Benzodiazepine receptor ligand, mitochondrial ŽJimenez, A. Ž398. 31. ´ Adenosine ATP; Mesentery, hamster; Prejunctional neuromodulation; Purine receptor; Sympathetic neurotransmission ŽRalevic, V. Ž387. 287. Methamphetamine; Sensitization; Adenosine A 1 receptor; Adenosine A 2A receptor ŽShimazoe, T. Ž388. 249. Smooth muscle, vascular; Kq channel, Ca2q-dependent ŽLi, G. Ž394. 35. Opioid; Striatum ŽHalimi, G. Ž398. 217. Neuropeptide FF; Morphine; Spinal cord; Antinociception ŽGouarderes, ` C. Ž406. 391. Phosphatidylinositol-3-kinase; Wortmannin; Methacholine; 5-HT; Bronchoconstriction; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469. Chloroadenosine; Interneuron; Hippocampus; Afterhyperpolarization ŽLi, H. Ž407. 237.

Master keyword index to Õolumes 386–410 (2000)

3

Adenosine kinase; Adenosine deaminase; Formalin; Microdialysis; Pain; Inflammation ŽLiu, X.J. Ž408. 143.

Locomotion; Dopamine receptor; Caffeine; In situ hybridization; Autoradiography ŽHalldner, L. Ž406. 345.

Purine; ATP; Nucleotide; Hippocampus; Suramin; Long-term potentiation ŽO’Kane, E.M. Ž409. 159.

Adenosine receptor agonist Myocardial infarction; Protection, delayed; ŽMinipig. ŽMeng, H. Ž387. 101.

Neonate; Cardiac myocyte; Ca2q current, L-type; ATP; Purinoceptor ŽSuto, F. Ž409. 213. Adenosine A 1 receptor Paw oedema; Adenosine A 2 receptor; Adenosine A 3 receptor; Plethysmometry; ŽRat. ŽSawynok, J. Ž386. 253. Methamphetamine; Sensitization; Adenosine; Adenosine A 2A receptor ŽShimazoe, T. Ž388. 249. ATP; FRTL-5 thyroid cell; Protein kinase C; Signal transduction ŽVainio, M. Ž390. 43. Oedema; Adenosine A 2B receptor; Mast cell ŽSawynok, J. Ž395. 47. Adenosine A 2 receptor Paw oedema; Adenosine A 1 receptor; Adenosine A 3 receptor; Plethysmometry; ŽRat. ŽSawynok, J. Ž386. 253. Adenosine A 2A receptor Methamphetamine; Sensitization; Adenosine; Adenosine A 1 receptor ŽShimazoe, T. Ž388. 249. SCH 58261; ZM 241385; CGS 21680; Motor activity; Knockout, mouse ŽEl Yacoubi, M. Ž401. 63.

Basal ganglia disorder; Dystonia; Movement disorders ŽRichter, A. Ž404. 299. X

Adenosine-5 -triphosphate Monosodium glutamate; Smooth muscle; Acetylcholine; Bradykinin; Angiotensin II ŽSukhanov, S.N. Ž386. 247. Adenosine uptake w3 HxAdenosine; Mitochondrion; Testis, rat; Benzodiazepine receptor ligand, mitochondrial ŽJimenez, A. Ž398. 31. ´ Adenylate cyclase Zaldaride maleate; Calmodulin; Guanylate cyclase; Ion secretion ŽAikawa, N. Ž394. 233. Dopamine receptor; Receptor fragment; COS-7 cell ŽScarselli, M. Ž397. 291. Adenylyl cyclase G protein-coupled receptor; Dopamine; Palmitoylation; Phosphorylation; Desensitization ŽJin, H. Ž386. 305. NS-105; Glutamate receptor, metabotropic; Antisense oligodeoxynucleotide, knockdown; Primary neuronal culture ŽHirouchi, M. Ž387. 9.

Adenosine A 2B receptor Oedema; Adenosine A 1 receptor; Mast cell ŽSawynok, J. Ž395. 47.

Adhesion Fractalkine; Chemokine; Chemotaxis; Umbilical vein, human; Endothelial cell ŽChapman, G.A. Ž392. 189.

Adenosine A 3 receptor Paw oedema; Adenosine A 1 receptor; Adenosine A 2 receptor; Plethysmometry; ŽRat. ŽSawynok, J. Ž386. 253.

Nitric oxide ŽNO.; Nitric oxide-releasing compound; E-Selectin; ICAM-1; Lipopolysaccharide ŽKosonen, O. Ž394. 149.

Adenosine A 1 receptor antagonist Dysmotility; Ischemia–reperfusion; Colon; RT-PCR Žreverse transcription-polymerase chain reaction.; ŽRat. ŽKadowaki, M. Ž409. 319. Adenosine A 2A receptor antagonist KF17837 ŽŽ E .-1,3-dipropyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; KW-6002 ŽŽ E .-1,3-diethyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; Parkinson’s disease; 6-Hydroxydopamine ŽKoga, K. Ž408. 249. Adenosine deaminase Adenosine receptor; Colon adenocarcinoma; HT29 cell; Epithelial differentiation ŽLelievre, V. Ž391. 21. ` Adenosine; Adenosine kinase; Formalin; Microdialysis; Pain; Inflammation ŽLiu, X.J. Ž408. 143. Adenosine kinase Adenosine; Adenosine deaminase; Formalin; Microdialysis; Pain; Inflammation ŽLiu, X.J. Ž408. 143.

Adipocyte, white Monoamine oxidase; Hydrogen peroxide; Cell metabolism ŽRaimondi, L. Ž395. 177. Adipose tissue Ethanol withdrawal; Hormone-sensitive lipase, cAMP; Phosphodiesterase ŽShih, M.-F. Ž409. 223. ADP TA-993; Platelet; Glycoprotein IIbrIIIa receptor; Actin polymerization; Ca2q, intracellular ŽKatoh, M. Ž399. 91. Adrenaline Disopyramide; Cibenzoline; Pilsicainide; QTc; ŽDog. ŽMiyamoto, S. Ž400. 263. mCPP Ž m-chlorophenylpiperazine.; Glucagon; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2C r2B receptor ŽYamada, J. Ž406. 153. Adrenal medulla Phospholipase C; Histamine; Chromaffin cell; Ca2q; Inositol phospholipid ŽRoberts-Thomson, E.L. Ž398. 199.

Adenosine receptor Colon adenocarcinoma; HT29 cell; Adenosine deaminase; Epithelial differentiation ŽLelievre, V. Ž391. 21. `

Adrenoceptor Ca2q; Tyrosine kinase; Inositol phosphate; Fura-2 ŽBerts, A. Ž389. 35.

ATP; Hippocampal slice; Electrical signal; Optical recording ŽSato, K. Ž399. 123.

Urethra; Nitric oxide ŽNO.; Nitrergic nerve; ŽRabbit. ŽSeshita, H. Ž400. 271.

4

Master keyword index to Õolumes 386–410 (2000)

b 3 -Adrenoceptor; Cly channel; Kq channel; Ionic secretion; Colon, rat ŽSchultheiss, G. Ž403. 251.

FR140423; Antinociception; Noradrenergic system; Spinal cord; ŽMouse. ŽOchi, T. Ž400. 199.

cAMP-dependent protein kinase; Dopamine; Loop of Henle; ŽMouse. ŽHiguchi, E. Ž408. 107.

a 2B -Adrenoceptor Gastroprotection; Clonidine; Opioid receptor ŽGyires, K. Ž396. 131.

Saphenous vein; In vivo; 5-HT receptor; ŽRabbit. ŽVayssettes-Courchay, C. Ž408. 277.

b-Adrenoceptor Muscarinic acetylcholine receptor; Radioligand binding ŽManukhin, B.N. Ž386. 279.

a 1A -Adrenoceptor ŽChang, R.S.L. Ž409. 301. a 2 Adrenoceptor Opioid receptor subtype; Xylazine; DAMGO; DPDPE; Tyr-W-MIF-1; U50,488 ŽWare, T.D. Ž389. 181. a-Adrenoceptor Rabies virus; NG108-15 cell; Ca2q current; Muscarinic receptor; Patch clamp, Whole-cell ŽIwata, M. Ž404. 79. Nicotine; Anxiety; Elevated plus-maze; ŽMouse. ŽZarrindast, M.-R. Ž407. 145. a 1-Adrenoceptor Receptor phosphorylation; Protein kinase C; Phosphatidylinositol 3kinase; G protein receptor kinases; Desensitization ŽGarcıa-Sainz, J.A. ´ ´ Ž389. 1. a 1L -Adrenoceptor; JTH-601; Prostate; ŽDog. ŽSuzuki, Y. Ž394. 123. GEPR Žgenetically epilepsy-prone rat.; Electroshock; Convulsion; bAdrenoceptor; Receptor regulation ŽSeo, D.O. Ž396. 53. Immunosuppressant; Cyclosporine; Nitric oxide ŽNO.; C6 glioma cell ŽIkesue, H. Ž407. 221. a 1a -Adrenoceptor a 1b -Adrenoceptor; a 1d -Adrenoceptor; Rabbit; Molecular cloning; Pharmacology; Tissue distribution ŽPiao, H. Ž396. 9. a 1A -Adrenoceptor Adrenoceptor ŽChang, R.S.L. Ž409. 301. a 1b -Adrenoceptor a 1a -Adrenoceptor; a 1d-Adrenoceptor; Rabbit; Molecular cloning; Pharmacology; Tissue distribution ŽPiao, H. Ž396. 9. a 1d -Adrenoceptor a 1a -Adrenoceptor; a 1b-Adrenoceptor; Rabbit; Molecular cloning; Pharmacology; Tissue distribution ŽPiao, H. Ž396. 9.

GEPR Žgenetically epilepsy-prone rat.; Electroshock; Convulsion; a 1 Adrenoceptor; Receptor regulation ŽSeo, D.O. Ž396. 53. Age; Endothelium; Isoprenaline; Relaxation; Kq channel ŽVan der Zypp, A. Ž397. 129. b-Adrenoceptor, atypical; Endothelium; Nitric oxide ŽNO.; Guanylyl cyclase; Smooth muscle, vascular ŽBrawley, L. Ž398. 285. Kq channel, Ca2q-activated; Large conductance; Detrusor muscle; Protein kinase A ŽKobayashi, H. Ž404. 231. b 2 -Adrenoceptor Gs protein, coupling; Neutrophil; Depression, major; Anxiety; Antidepressant, tricyclic ŽGurguis, G.N.M. Ž386. 135. Salmeterol; Benzalkonium chloride; Mast cell; G-protein; Asthma ŽSeebeck, J. Ž397. 19. Urinary incontinence; ATP-sensitive Kq channel; Detrusor muscle; Clenbuterol ŽHudman, D. Ž397. 169. b 3 -Adrenoceptor b-Adrenoceptor, atypical; Duodenum, guinea pig; Carteolol; Partial agonist; Bupranolol ŽHorinouchi, T. Ž403. 133. Adrenoceptor; Cly channel; Kq channel; Ionic secretion; Colon, rat ŽSchultheiss, G. Ž403. 251. b-Adrenoceptor activation Choroidal blood flow; Laser-Doppler flowmetry; Sympathetic vasodilation; b-Adrenoceptor antagonist; L-NAME Ž N G -nitro-L-arginine methyl ester.; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227. ß3-adrenoceptor agonist Obesity ŽForrest, M.J. Ž407. 175.

a 1L -Adrenoceptor a 1-Adrenoceptor; JTH-601; Prostate; ŽDog. ŽSuzuki, Y. Ž394. 123.

b 2 -Adrenoceptor agonist Nitric oxide ŽNO.; Smooth muscle; cGMP; cAMP; Iberiotoxin ŽVaali, K. Ž399. 75.

a 2-Adrenoceptor Electrophysiology; Antidepressant; 5-HT1A receptor; Tyramine; Norepinephrine transporter; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. 211. ´

b 3 -Adrenoceptor agonists Thermogenesis; Pyruvate-oxidation; Glucose metabolism; Soleus muscle, isolated ŽBoard, M. Ž406. 33.

Atipamezole; Ageing; Memory; Cholinergic system; Noradrenergic system ŽHaapalinna, A. Ž387. 141.

a 1A -Adrenoceptor antagonist Prostate; Adrenoceptor subtype ŽChang, R.S.L. Ž409. 301.

w35 SxGTPgS binding; Brain, human; 5-HT1A receptor; m-Opioid receptor; G-protein ŽGonzalez-Maeso, J. Ž390. 25. ´ Myometrium Žporcine.; Clonidine; Ca2q, intracellular; cAMP; Ca2q sensitivity ŽKitazawa, T. Ž390. 185. Agonist, Inverse; G protein-coupled receptor; RX821002; MK-912; GTP; Rauwolscine ŽMurrin, L.C. Ž398. 185. Signal transduction; G protein; G protein coupled receptor; Second messenger; 5-HT receptor; 5-HT1A receptor ŽHappe, H.K. Ž399. 17.

a 2-Adrenoceptor antagonist Focal cerebral ischemia; Recovery; Sensorimotor functions; ŽRat. ŽJolkkonen, J. Ž400. 211. b-Adrenoceptor antagonist Choroidal blood flow; Laser-Doppler flowmetry; Sympathetic vasodilation; b-Adrenoceptor activation; L-NAME Ž N G -nitro-L-arginine methyl ester.; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227. Myocardial ischemia; Antioxidant ŽGao, F. Ž406. 109.

Master keyword index to Õolumes 386–410 (2000)

5

b-Adrenoceptor, atypical b-Adrenoceptor; Endothelium; Nitric oxide ŽNO.; Guanylyl cyclase; Smooth muscle, vascular ŽBrawley, L. Ž398. 285.

Affinity Intrinsic activity; Efficacy; GppŽNH.p shift; 5-HT1A receptor ligand; S-14506; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97.

b 3 -Adrenoceptor; Duodenum, guinea pig; Carteolol; Partial agonist; Bupranolol ŽHorinouchi, T. Ž403. 133.

Afterhyperpolarization Adenosine; Chloroadenosine; Interneuron; Hippocampus ŽLi, H. Ž407. 237.

a-Adrenoceptors Stroke-prone spontaneously hypertensive rats ŽSHRSP.; Pulmonary artery; Nitric oxide ŽNO.; Endothelium ŽMatsuda, K. Ž392. 61. b-Adrenoceptor stimulation Coronary blood flow; Coronary vasodilatation; Coronary vasodilator tone ŽFernandez, N. Ž387. 93. ´ Adrenoceptor subtype a 1A -Adrenoceptor antagonist; Prostate ŽChang, R.S.L. Ž409. 301. a 1-Adrenoceptor subtype Nasal mucosa vasculature; Noradrenaline; NS-49; Vasoconstrictor response ŽTanimitsu, N. Ž387. 73. Methoxamine; Cirazoline; P7480; Mesenteric artery, rat; BMY 7378 ŽHussain, M.B. Ž395. 69. b-Adrenoceptor, subtype Detrusor; Cardiovascular system; ŽFerret. ŽTakeda, H. Ž403. 147. b-Adrenoceptor turnover Amiodarone; Triiodothyronine; Cardiomyocyte ŽVassy, R. Ž408. 227. Adrenomedullin Okadaic acid; ERK Žextracellular signal-related kinase.; JNK Žjun amino-terminal kinase.; P38 MAPK ŽP38 mitogen-activated protein kinase. ŽParameswaran, N. Ž388. 133. Papillary muscle; Contractility; cAMP ŽIhara, T. Ž390. 167. Amylin; Calcitonin gene-related peptide ŽCGRP.; Calcitonin receptor-like receptor; Myocardial contraction; Receptor associated modifying protein ŽRAMP. ŽSaetrum Opgaard, O. Ž397. 373. Inflammation; Eye; CGRP Žcalcitonin gene-related peptide.; Nitric oxide ŽNO. ŽClementi, G. Ž400. 321. Pneumocyte Žtype II.; Phosphatidylcholine secretion; Surfactant; Protein kinase C ŽOkumura, M. Ž403. 189. Myocyte; Papillary muscle; Heart, isolated; Ca2q transient; ŽRat. ŽStangl, V. Ž408. 83. Lenticulostriate artery, human; RT-PCR; CGRP Žcalcitonin gene-related peptide.; CRLR Žcalcitonin receptor-like receptor.; RAMP Žreceptor activity-modifying protein. ŽSams, A. Ž408. 183. Aerosol Cannabinoid; D9-THC Ž D9-tetrahydrocannabinol.; SR 141716A; Antinociception; Marijuana, medical; Nebulizer ŽLichtman, A.H. Ž399. 141.

v-Agatoxin IVA-sensitive Ca 2H channel a-Eudesmol; Glutamate release; Synaptosome; Microdialysis; Focal ischemia ŽAsakura, K. Ž394. 57. Age b-Adrenoceptor; Endothelium; Isoprenaline; Relaxation; Kq channel ŽVan der Zypp, A. Ž397. 129. Ageing a 2 -Adrenoceptor; Atipamezole; Memory; Cholinergic system; Noradrenergic system ŽHaapalinna, A. Ž387. 141. Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Nicotinic agent; Schizophrenia; Dementia; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Stress; Glucocorticoid; Cytokine; Alzheimer’s disease ŽAngelucci, L. Ž405. 139. Aggregation Polymorphonuclear leukocyte; Rho kinase; p160ROCK; Superoxide production ŽKawaguchi, A. Ž403. 203. Aggressive behavior Hypothalamo-pituitary-adrenal axis; Monoamine; Pertussis toxin; ŽMouse. ŽKim, D.-H. Ž409. 67. Aging Nitric oxide ŽNO.; cGMP-dependent protein kinase; Naq,Kq-ATPase; Trachea, rat ŽScavone, C. Ž388. 1. Vanadyl sulfate; Insulin action; Insulin release; Islet, isolated ŽDe Tata, V. Ž398. 169. Agonist Clenbuterol; Contractile response ŽHudman, D. Ž392. 79. Nicotinic acetylcholine receptor; Acetylcholine; Choline; Partial; Coagonist; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209. Agonist binding mGlu 1 receptor, Arg 78 ; Glutamic acid; Quisqualic acid; Mutagenesis ŽJensen, A.A. Ž397. 247. Agonist coupling GABA A receptor subtype; Brain regional heterogeneity; w35 SxTBPS binding; Taurine; b-Alanine; Muscimol; 4-PIOL; 5-Ž4-piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233. Agonist, inverse a 2 -Adrenoceptor; G protein-coupled receptor; RX821002; MK-912; GTP; Rauwolscine ŽMurrin, L.C. Ž398. 185.

Affective disorder Behaviour; Autonomic response; Endocrine response; Anxiety; Posttraumatic stress disorder ŽPTSD.; ŽRat. ŽStam, R. Ž405. 217.

AH-1058 Ca2q channel blocker; Ventricular arrhythmia ŽTakahara, A. Ž398. 107.

Afferent Cannabinoid; Capsaicin; Neuron; Pain; Receptor; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39.

Air pouch Leukotriene B 4 ; Leukocyte infiltration; Collagen-induced arthritis; Interleukin-1; LY293111Na ŽKuwabara, K. Ž402. 275.

6

Master keyword index to Õolumes 386–410 (2000)

Air pouch, mouse Ditriazines; Nitric oxide ŽNO.; Eicosanoid; Macrophage; Neutrophil; Carrageenan paw oedema ŽRioja, I. Ž397. 207.

Alcoholism Alcohol; Opioid receptor; Genetics; Quantitative trait locus ŽTown, T. Ž410. 243.

Airway Bronchodilation; Rho-associated coiled coil-forming protein kinase; Rho; Smooth muscle ŽNakahara, T. Ž389. 103.

Alcohol withdrawal, human Delirium tremens; Volume and fluid regulation; ANP Žatrial natriuretic peptide. secretion; Withdrawal hyperexcitability, mouse; NMDA Ž Nmethyl-D-aspartate. seizure; Glutamate ŽKovacs, ´ G.L. Ž405. 103.

Prostaglandin; Leukotriene; Neuromediator; Endothelin; ŽMouse. ŽRichter, M. Ž389. 225. Airway eosinophil infiltration Glaucine; Phosphodiesterase 4 inhibitor; Sensitized, guinea pig; Airway hyperreactivity; Airway microvascular leakage ŽPons, R. Ž397. 187. Airway epithelial cell Thapsigargin; Ca2q-ATPase inhibitor; Ca2q store, EpDRF Žepitheliumdependent relaxing factor.; ŽGuinea pig. ŽTakahashi, N. Ž410. 61. Airway epithelium Acetylcholine; Smooth muscle, airway; Nitric oxide ŽNO.; Indomethacin; Airway segment ŽMcParland, B.E. Ž402. 151. Airway hyperreactivity Glaucine; Phosphodiesterase 4 inhibitor; Sensitized, guinea pig; Airway eosinophil infiltration; Airway microvascular leakage ŽPons, R. Ž397. 187. Airway hyperresponsiveness JTE-522; Cyclooxygenase-2; Prostaglandin E 2 ; Thromboxane A 2 ; U46619; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267. TA-270; Asthmatic response; Bronchoalveolar eosinophilia ŽAoki, Y. Ž409. 325. Airway microvascular leakage Glaucine; Phosphodiesterase 4 inhibitor; Sensitized, guinea pig; Airway hyperreactivity; Airway eosinophil infiltration ŽPons, R. Ž397. 187. Airway segment Acetylcholine; Airway epithelium; Smooth muscle, airway; Nitric oxide ŽNO.; Indomethacin ŽMcParland, B.E. Ž402. 151. [b Ala8 ]Neurokinin A-(4–10) Trachea; Acetylcholine release; Tachykinin NK 2 receptor; SR 48968 ŽD’Agostino, G. Ž396. 29. b-Alanine GABA A receptor subtype; Brain regional heterogeneity; w35 SxTBPS binding; Agonist coupling; Taurine; Muscimol; 4-PIOL; 5-Ž4-piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233. Alanine aminotransferase Concanavalin A; Apoptosis; Interferon-g; Soyasapogenol A; Tumor necrosis factor-a ŽTNF-a . ŽKuzuhara, H. Ž391. 175. Alcohol Opioid receptor; Genetics; Alcoholism; Quantitative trait locus ŽTown, T. Ž410. 243. Alcohol consumption Neutral endopeptidase; Enkephalinase; Enkephalin; Knockout mouse; Angiotensin-converting enzyme; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327.

Aldose reductase Autonomic neuropathy; Diabetes; Non-adrenergic non-cholinergic; Gastric fundus, rat; Streptozotocin ŽJenkinson, K.M. Ž401. 251. Aldosterone Ouabain; Naq; Ca2q; NaŽq. –KŽq. –exchanging ATPase ŽYingst, D.R. Ž406. 49. Alkaline Endothelin-1; Basilar artery; 5-HT Ž5-hydroxytryptamine, serotonin.; Hypocapnia; Isocapnia ŽZuccarello, M. Ž407. 191. Allergic conjunctivitis Vascular permeability; Histamine H 1 receptors; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽNakahara, H. Ž409. 313. Allergic dermatitis Phosphodiesterase 4 inhibitor; RPR 73401; Ear swelling test, mouse; Interleukin-4 ŽEhinger, A.M. Ž392. 93. Allodynia Endothelin; Streptozotocin; Diabetic neuropathy ŽJarvis, M.F. Ž388. 29. Antinociception; Diuresis; Dynorphin; k-Opioid receptors; Sedation ŽKo, M.C.H. Ž402. 69. Allodynia, tactile Diabetic, rat; Allodynia, thermal; Tachykinin receptor antagonist ŽCoudore-Civiale, M.-A. Ž401. 47. ´ Allodynia, thermal Diabetic, rat; Allodynia, tactile; Tachykinin receptor antagonist ŽCoudore-Civiale, M.-A. Ž401. 47. ´ Allosteric modulation Nicotinic acetylcholine receptor; Alzheimer’s disease; Galanthamine; Cholinergic deficit ŽMaelicke, A. Ž393. 165. Allosteric modulator Mutagenesis; Catecholamine ŽSchetz, J.A. Ž388. R5. AMPA receptor; S18986-1; Hippocampus; Noradrenaline release ŽLockhart, B. Ž401. 145. Almotriptan 5-HT1B r1D receptor agonist; Migraine; Preclinical study ŽGras, J. Ž410. 43. Cardiovascular safety; 5-HT1B r1D receptor agonist; Migraine ŽGras, J. Ž410. 53. Alzheimer disease Amyloid precursor protein ŽAPP.; Platelet; Diagnosis ŽDi Luca, M. Ž405. 277. Alzheimer’s disease Cholinergic system; Cholinesterase inhibitor; Cerebral metabolism; Nucleus basalis, rat ŽBassant, M.-H. Ž387. 151.

Master keyword index to Õolumes 386–410 (2000) Cholinergic; Exocytosis; Neuromuscular junction; Oocyte; Synaptic vesicle; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7. Lithium chloride; b-Amyloid; Bcl-2 ŽWei, H. Ž392. 117. Nicotinic acetylcholine receptor; Allosteric modulation; Galanthamine; Cholinergic deficit ŽMaelicke, A. Ž393. 165. Parkinson’s disease; a 3 subunit; a4 subunit; a7 subunit; b-Amyloidosis; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215. Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨ Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Learning; Memory; Free radical ŽWang, L.M. Ž398. 65. Stress; Glucocorticoid; Cytokine; Ageing ŽAngelucci, L. Ž405. 139. Microglia; NSAIDs; Aspirin; Interferon-g ŽOgawa, O. Ž408. 137. Vitamin E; Atherosclerosis; Apolipoprotein E ŽPeroutka, S.J. Ž410. 161. Ambroxol Guanylate cyclase; Nitric oxide ŽNO. ŽSeverina, I.S. Ž407. 61. Amino acid Dopamine; Guanidinoethyl sulfonate; Microdialysis; ŽRat. ŽOlive, M.F. Ž409. 291. 3-Aminobenzamide Glioma; PolyŽADP–ribose. polymerase; Nitrosoureas ŽWinter, S. Ž398. 177. g-Aminobutyric acid Gabapentin; Substantia nigra reticulata; Microdialysis ŽTimmerman, W. Ž398. 53. g-Aminobutyric acid (GABA) Dopamine; Microdialysis; Cocaine; g-Vinyl GABA Žvigabatrin.; gAminobutyric acid ŽGABA. reuptake inhibitor ŽGerasimov, M.R. Ž395. 129. Diazepam; Progesterone; Kq channel; Coronary ŽJacob, M.K. Ž403. 209. g-Aminobutyric acid (GABA) reuptake inhibitor g-Aminobutyric acid ŽGABA.; Dopamine; Microdialysis; Cocaine; gVinyl GABA Žvigabatrin. ŽGerasimov, M.R. Ž395. 129. Aminoglycoside Ototoxicity; NMDA receptor; Dizocilpine ŽHarvey, S.C. Ž387. 1. Aminoguanidine Concanavalin A; Hepatitis ŽOkamoto, T. Ž396. 125. Diabetes; Nitric oxide ŽNO.; Morphine; Antinociception ŽGrover, V.S. Ž399. 161.

7

d-Aminolaevulinic acid Benzodiazepine receptor, mitochondrial; Protoporphyrin IX; Zinc protoporphyrin IX; Aciflourfen; Protoporphyrinogen oxidase ŽMesenholler, M. ¨ Ž406. 171. Aminopeptidase P Bradykinin; Bradykinin B 2 receptor; Carboxypeptidase; Neutral endopeptidase; Angiotensin I converting enzyme; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317. 4-Aminopyridine 3-Nitropropionic acid; Mitochondrial toxin; Seizure; GABA Ž g-aminobutyric acid.; Electroconvulsion ŽHaberek, G. Ž403. 229. 3,4-Diaminopyridine; Apamin; Passive avoidance; ŽMouse. ŽInan, S.Y. Ž407. 159. Amiodarone b-Adrenoceptor turnover; Triiodothyronine; Cardiomyocyte ŽVassy, R. Ž408. 227. Amitriptyline Caffeine; Thermal hyperalgesia; Neuropathic pain ŽEsser, M.J. Ž399. 131. Antidepressant; Tetrodotoxin-sensitive; Tetrodotoxin-resistant; Naq channel; Dorsal root ganglion ŽSong, J.-H. Ž401. 297. Conditioned place preference; Antidepressant; 5-HT Ž5-hyroxytryptamine, serotonin. reuptake inhibitor, selective ŽSubhan, F. Ž408. 257. Amlodipine Ca2q channel antagonist; Memory enhancement; Maze learning; Active avoidance, mice; Chronic drug administration ŽQuartermain, D. Ž399. 57. AMP579 Coronary artery endothelium; Neutrophil degranulation; Neutrophil adherence; Superoxide anion ŽNakamura, M. Ž397. 197. AMPA ( a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid) AMPA receptor modulator; Cortex; Hippocampus ŽBlack, M.D. Ž394. 85. AMPA ( a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) Epilepsy; Riluzole; Audiogenic seizure; GlycinerNMDA receptor; DBAr2 mouse ŽDe Sarro, G. Ž408. 25. AMPA receptor Cocaine; Convulsion; Toxicity; Kainate receptor; NMDA receptor ŽPouw, B. Ž386. 181. Cortical neurone, cultured; Chloral hydrate; Trichloroethanol; Ca2q concentration, intracellular; Fura-2 microfluorimetry ŽFischer, W. Ž394. 41. Analgesia; NMDA receptor; Morphine; Spinal cord; ŽRat. ŽNishiyama, T. Ž395. 203. Purkinje cell; GYKI 53784; Aniracetam; Cyclothiazide; 1-BCP; BDP-12 ŽKapus, G. Ž397. 43.

Anti-Fas antibody; Hepatitis ŽOkamoto, T. Ž403. 277.

S18986-1; Hippocampus; Noradrenaline release; Allosteric modulator ŽLockhart, B. Ž401. 145.

Endotoxic shock; Nitric oxide ŽNO.; ŽRat. ŽErol, A. Ž408. 175.

Object recognition; Memory; S 18986-1; ŽRat. ŽLebrun, C. Ž401. 205.

( RS )-2-Amino-3-(3-hydroxy-1,2,5-thiadiazol-4-yl)propionic acid EAAT; TDPA; EAAT2 inhibitor, selective ŽBrauner-Osborne, H. Ž406. ¨ 41.

AMPA receptor modulator AMPA Ž a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid.; Cortex; Hippocampus ŽBlack, M.D. Ž394. 85.

8

Master keyword index to Õolumes 386–410 (2000)

Amphetamine Psychostimulants sensitization; Cocaine; Nucleus accumbens shell; Nucleus accumbens core ŽCadoni, C. Ž388. 69. Dopamine release; Protein kinase C; Phorbol ester; Cocaine; Transport, reverse ŽCowell, R.M. Ž389. 59. Neurotoxicity; Cytochrome oxidase; Histochemistry; Energy metabolism ŽBurrows, K.B. Ž398. 11. D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; SR 141716; Operant behavior; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251. Cocaine; Dorsal horn; Hyperalgesia ŽOhsawa, M. Ž399. 165. Glutamate receptor, metabotropic; LY379268; Motor activity; Stereotypy ŽCartmell, J. Ž400. 221. Psychostimulant; Dopamine trasporter ŽFleckenstein, A.E. Ž406. 1. D-Amphetamine

Restraint stress; Adaptation; Conditioned place preference; Dopamine D1 receptor; Dopamine D 2 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127. Amphibian w3 HxNaloxone; Antinociception; Opioid receptor ŽNewman, L.C. Ž397. 255. Amrinone Ischaemia; Reperfusion injury; ŽRat. ŽRechtman, M.P. Ž402. 255. Amtolmetin guacyl Antisecretion; Gastroprotection; Capsaicin; CGRP Žcalcitonin gene-related peptide. ŽTubaro, E. Ž387. 233. Amygdala Anxiety; Stress; Noradrenaline; Hypothalamus; Locus coeruleus; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397. Amygdaloid nucleus, central Stressful stimuli; Neuropeptide; c-fos; Paraventricular nucleus; Supraoptic nucleus ŽPalkovits, M. Ž405. 161. Amylin Adrenomedullin; Calcitonin gene-related peptide ŽCGRP.; Calcitonin receptor-like receptor; Myocardial contraction; Receptor associated modifying protein ŽRAMP. ŽSaetrum Opgaard, O. Ž397. 373. Amylin, Amylin-(8-37) Osteoblast, Human; CGRP Žcalcitonin gene-related peptide.; CGRP-Ž837.; Proliferation; cAMP ŽVilla, I. Ž409. 273. b-Amyloid Lithium chloride; Bcl-2; Alzheimer’s disease ŽWei, H. Ž392. 117.

Amyloid precursor protein Alzheimer’s disease; Amyloid-b peptide; Plaque; Tau; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨ Amyloid precursor protein (APP) Alzheimer disease; Platelet; Diagnosis ŽDi Luca, M. Ž405. 277. Amyotrophic lateral sclerosis (ALS) Motor neuron; Apoptosis; Cell culture; Tissue culture; Neurodegenerative disease ŽBar, ¨ P.R. Ž405. 285. Anabolic steroid Pregnenolone sulfate; Ethylestrenol; Passive avoidance behavior; Memory; Non-linear dynamics; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177. Anaesthetic GABA Ž g-aminobutyric acid.; Benzodiazepine; Optic nerve; Propofol ŽEmpson, R.M. Ž401. 339. Anaesthetic volatile Action potential; Arrhythmia; K AT P channel; Myocyte; Patch clamp ŽTerrenoire, C. Ž390. 95. Analgesia Crotalus durissus terrificus venom; Opioid receptor; Nitric oxide ŽNO. ŽPicolo, G. Ž391. 55. Nicotinic acetylcholine receptor; Molecular model; Epibatidine; ABT-594; A-85380; Antinociception ŽMeyer, M.D. Ž393. 171. NMDA receptor; AMPA receptor; Morphine; Spinal cord; ŽRat. ŽNishiyama, T. Ž395. 203. Melatonin; Central nervous system; Naloxone ŽYu, C.-X. Ž403. 49. Antinociception; Pain; Neuropeptide FF; Spinal cord; Supraspinal ŽAltier, N. Ž407. 245. Anandamide Cannabinoid CB1 receptor; D9-Tetrahydrocannabinol; CP 55,940; SR 141716A; SR 144528; Sympathetic neurotransmission ŽLay, L. Ž391. 151. Food intake; Diet restriction; Cognitive function; Hippocampus; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147. Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Palmitoylethanolamide; 2Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. D9-Tetrahydrocannabinol; Ž R .-Methanandamide; SR 141716; Amphetamine; Operant behavior; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251.

Amyloid-b peptide Alzheimer’s disease; Amyloid precursor protein; Plaque; Tau; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨

Ca2q channel; Skeletal muscle ŽOz, M. Ž404. 13.

b-Amyloidosis Alzheimer’s disease; Parkinson’s disease; a 3 subunit; a4 subunit; a7 subunit; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215.

Cannabinoid; Fatty acid ethanolamides; High-performance liquid chromatography; Mass spectrometry; Anandamide transport ŽGiuffrida, A. Ž408. 161.

Cannabinoid receptor; Vanilloid receptor; Capsaicin; Anti-nociception; Behavior; ŽMouse. ŽDi Marzo, V. Ž406. 363.

Master keyword index to Õolumes 386–410 (2000) Anandamide transport Cannabinoid; Anandamide; Fatty acid ethanolamides; High-performance liquid chromatography; Mass spectrometry ŽGiuffrida, A. Ž408. 161. Anaphylactic shock PAF Žplatelet-activating factor.; PAF acetylhydrolase ŽFukuda, Y. Ž390. 203. Anaphylaxis, passive cutaneous Scratching behavior; Immunoglobulin E; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Anatoxin-a Nicotinic receptor, presynaptic; Glutamate receptor antagonist; Nicotine; Immunogold electron microscopy; Synaptosome ŽWonnacott, S. Ž393. 51. Androgen Th1rTh2; Immune function; Prenatal; Estrogen; Autoimmunity ŽMartin, J.T. Ž405. 251. Aromatase inhibitor; Breast carcinoma; Oestrogen ŽPalma, C. Ž409. 93. Anesthetic GABA A receptor; Propofol; Locus coeruleus ŽChen, C.-L. Ž386. 201. Anesthetic; volatile; Kq channel; Ca2q-activated; Xenopus oocyte ŽNamba, T. Ž395. 95. Angiogenesis S-nitrosocaptopril; Captopril; Nitric oxide ŽNO.; Capillary endothelium; Chorioallantoic membrane; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137. Endothelial cell; Ca2q influx; Proliferation ŽKawasaki, J. Ž398. 19. Heparin; Intragastric administration; Gastric ulcer healing; Nitric oxide ŽNO. synthase, Constitutive; Proliferation; Regeneration ŽLi, Y. Ž399. 205. Chymase; Mast cell; Compound 48r80; Granuloma ŽMuramatsu, M. Ž402. 181. Angiogenesis inhibition Dienogest; Steroid, synthetic; Angiostatic therapy; Angiogenic disease ŽNakamura, M. Ž386. 33. Angiogenic disease Dienogest; Steroid, synthetic; Angiogenesis inhibition; Angiostatic therapy ŽNakamura, M. Ž386. 33. Angiostatic therapy Dienogest; Steroid, synthetic; Angiogenesis inhibition; Angiogenic disease ŽNakamura, M. Ž386. 33. Angiotensin MAP Žmitogen-activated protein. kinase; Endothelin; Aorta; Spontaneously hypertensive rat ŽSHR.; DOCA-salt hypertensive rat ŽKubo, T. Ž400. 231. Endothelium; Nitric oxide ŽNO.; Diabetes mellitus ŽPieper, G.M. Ž403. 129. Nonpeptide angiotensin receptor agonist; DuP 532; PD123,319; ŽFeline. ŽDe Witt, B.J. Ž404. 213. Preconditioning; Ischaemia; Prazosin; Colchicine ŽSharma, A. Ž406. 85.

9

Fetal, sheep; AT1 receptor; AT2 receptor; Cardiovascular; Cortisol ŽHegarty, B.D. Ž406. 439. Angiotensin-converting enzyme; Angiotensinogen; Angiotensin AT1 receptor; Polymorphism; Renin ŽDanser, A.H.J. Ž410. 303. Angiotensin AT1 receptor Angiotensin; Angiotensin-converting enzyme; Angiotensinogen; Polymorphism; Renin ŽDanser, A.H.J. Ž410. 303. Angiotensin AT2 receptor Losartan; PD 123319; Kinin; Nitric oxide ŽNO. synthase; Cyclooxygenase; Footshock ŽIsrael, A. Ž394. 103. Angiotensin AT1 receptor antagonist Nitric oxide synthase inhibition; Myocardial infarct; Angiotensin II cardiac ŽVerhagen, A.M.G. Ž400. 239. Angiotensin-converting enzyme Neutral endopeptidase; Enkephalinase; Enkephalin; Knockout mouse; Alcohol consumption; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327. Angiotensin-converting enzyme inhibitor; Endothelial cells, cultured; Umbilical veins, human; Nitric oxide ŽNO.; Platelet aggregation ŽPersson, K. Ž406. 15. Gene polymorphism; Susceptibility; Cardiovascular disease; Angiotensinogen; Angiotensin II type 1 receptor ŽWang, J.-G. Ž410. 289. Angiotensin; Angiotensinogen; Angiotensin AT1 receptor; Polymorphism; Renin ŽDanser, A.H.J. Ž410. 303. Angiotensin-converting enzyme inhibitor Bradykinin; Ischemia; Reperfusion; Ventricular function, dog ŽHosoya, K. Ž390. 157. Trandolapril; Cholesterol-fed, rabbit; Aorta; Coronary artery; Mesenteric, 5th branch ŽSanz, M. Ž397. 359. Diabetes; Nephropathy; Urinary albumin excretion; Immunohistochemistry ŽKatoh, M. Ž398. 381. Angiotensin-converting enzyme; Endothelial cells, cultured; Umbilical veins, human; Nitric oxide ŽNO.; Platelet aggregation ŽPersson, K. Ž406. 15. Angiotensin I converting enzyme Bradykinin; Bradykinin B 2 receptor; Carboxypeptidase; Neutral endopeptidase; Aminopeptidase P; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317. Angiotensin I-converting enzyme Carotid artery, rat; Endothelial injury; Angiotensin I-converting enzyme inhibitor; Vasoconstriction ŽLemay, J. Ž394. 301. Angiotensin I-converting enzyme inhibitor Carotid artery, rat; Endothelial injury; Angiotensin I-converting enzyme; Vasoconstriction ŽLemay, J. Ž394. 301. Angiotensin II X Monosodium glutamate; Smooth muscle; Adenosine-5 -triphosphate; Acetylcholine; Bradykinin ŽSukhanov, S.N. Ž386. 247. Angiotensin II type 1 receptor; Ca2q, cytosolic; Mesothelial cell; Pleura ŽKuwahara, M. Ž388. 21.

10

Master keyword index to Õolumes 386–410 (2000)

MAP Žmitogen activated protein. kinase; Mechanical stress; Aorta; Losartan ŽKubo, T. Ž391. 281. Cyclosporine A; Naq; Enalapril; Valsartan; Vascular response ŽLassila, M. Ž398. 99. Ethanol; Acetaldehyde; Hepatocyte; MAPK Žmitogen-activated protein kinase. ŽWeng, Y.-I. Ž398. 323.

ANP (atrial natriuretic peptide) Ethanol tolerance; Ethanol dependence; Withdrawal; NMDA Ž N-methylD-aspartate.; Antiserum against atrial natriuretic peptide ŽKovacs, ´ G.L. Ž401. 343. Histamine; Pre-eclampsia; Nitric oxide ŽNO.; Endothelium; ŽHuman. ŽSuzuki, Y. Ž410. 7.

Taurine; Cell size; Fetal gene expression; Growth factor gene expression; Protein kinase C ŽAzuma, M. Ž403. 181.

ANP (atrial natriuretic peptide) secretion Alcohol withdrawal, human; Delirium tremens; Volume and fluid regulation; Withdrawal hyperexcitability, mouse; NMDA Ž N-methyl-D-aspartate. seizure; Glutamate ŽKovacs, ´ G.L. Ž405. 103.

Angiotensin II cardiac Nitric oxide synthase inhibition; Myocardial infarct; Angiotensin AT1 receptor antagonist ŽVerhagen, A.M.G. Ž400. 239.

Antagonism Dmt–Tic; Inverse agonism ŽLabarre, M. Ž406. R1.

Angiotensin II type 1 receptor Angiotensin II; Ca2q, cytosolic; Mesothelial cell; Pleura ŽKuwahara, M. Ž388. 21. Gene polymorphism; Susceptibility; Cardiovascular disease; Angiotensin-converting enzyme; Angiotensinogen ŽWang, J.-G. Ž410. 289. Angiotensin II type 2 receptor Lipopolysaccharide; Cytokine; Nitric oxide ŽNO.; Cyclic GMP; Cardiac fibroblast ŽTamura, M. Ž386. 289. Angiotensinogen Gene polymorphism; Susceptibility; Cardiovascular disease; Angiotensin-converting enzyme; Angiotensin II type 1 receptor ŽWang, J.-G. Ž410. 289. Angiotensin; Angiotensin-converting enzyme; Angiotensin AT1 receptor; Polymorphism; Renin ŽDanser, A.H.J. Ž410. 303. 1,5-Anhydro-D-fructose Insulin secretion; Glucose elimination; Glucagon-like peptide-1; ŽMouse. ŽAhren, ´ B. Ž397. 219. Animal model Depression; CRF Žcorticotropin-releasing factor.; Bed nucleus of the stria terminalis ŽStout, S.C. Ž401. 39. Asthma; NANC Žnon-adrenergic–non-cholinergic. nerve, excitatory; Neuropeptide; ŽHuman. ŽKraneveld, A.D. Ž405. 113. Anionic secretion P2Y receptor; Sweat gland; Hyperhidrosis; Ca2q, intracellular; Ussing chamber ŽBovell, D.L. Ž403. 45. Aniracetam AMPA receptor; Purkinje cell; GYKI 53784; Cyclothiazide; 1-BCP; BDP-12 ŽKapus, G. Ž397. 43. Annexin V Nitric oxide ŽNO.; Hydrogen peroxide; Apoptosis; Neuroblastoma; PC12; NO donor ŽTerwel, D. Ž400. 19. Anococcygeus, mouse Forskolin; Nitrergic; Nitric oxide ŽNO.; Papaverine; Sildenafil; Sodium nitroprusside ŽFrith, D. Ž400. 305. Anorexia Melanocortin; Feeding; Central nervous system; Behavior; Body weight homeostasis; Obesity ŽVergoni, A.V. Ž405. 25.

Bradykinin B 2 receptor; FR173657; FR190997; MEN 11270; Non-peptide ŽMeini, S. Ž409. 185. Antagonism, insurmountable Vas deferens, rat; Bradykinin; Bradykinin receptor; Hoe 140 ŽAsghar, A.U.R. Ž398. 131. Antagonist Bradykinin B 2 receptor; Vessel, isolated; ŽHuman.; ŽPig.; ŽRabbit. ŽRizzi, C. Ž386. 25. X ATP receptor; Oocyte; Voltage clamp; Whole cell; NF279 Ž8,8 ŽcarbonylbisŽimino-4, 1-phenylenecarbonylimino-4, 1-phenylenecarbonyl imino..bisŽ1,3,5-naphthalenetrisulfonic acid.. ŽKlapperstuck, M. Ž387. ¨ 245.

Glutamate; Receptor; Metabotropic; 2-Methyl-6-Žphenylethynyl.-pyridine ŽMPEP. ŽSpooren, W.P.J.M. Ž406. 403. Antagonist activity S-0139; Endothelin receptor subtype; Blood vessel, rabbit; Blood vessel, canine ŽIwasaki, T. Ž400. 255. Antagonist, competitive Nicotinic acetylcholine receptor; Photoaffinity labeling; Antagonist, noncompetitive; 5-HT Ž5-hydroxytryptamine, serotonin. ŽBlanton, M.P. Ž389. 155. Antagonist, noncompetitive Nicotinic acetylcholine receptor; Photoaffinity labeling; Antagonist, competitive; 5-HT Ž5-hydroxytryptamine, serotonin. ŽBlanton, M.P. Ž389. 155. Anthelmintic resistance Patch-clamp; Parasitic nematode; Nicotinic receptor ŽRobertson, A.P. Ž394. 1. Antiarrhythmic Class I; Myocardial ischaemia; Arrhythmia; Proarrhythmia ŽBarrett, T.D. Ž398. 365. Antiarrhythmic agent, Class III Kq current, Delayed rectifier; Sinoatrial node; Atrioventricular node ŽSato, N. Ž404. 281. Antiarrhythmic drug Inward rectifier Kq channel; Maxi-Kq channel; Smooth muscle; ŽBovine. ŽNakahara, T. Ž402. 143. Reperfusion arrhythmia; Action potential duration; Vma x ŽBaczko, ´ I. Ž404. 181.

Master keyword index to Õolumes 386–410 (2000) Antibradycardic agent MF 10058; Muscarinic M 2 receptor antagonist; Cardioselective muscarinic receptor antagonist; Sick sinus syndrome; Bradycardia ŽLamperti, G. Ž406. 93. Anticonvulsant Retigabine; Entorhinal cortex; Spike frequency habituation; EPSP Žexcitatory postsynaptic potential.; IPSP Žinhibitory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165. Epilepsy; Topiramate; Carbamazepine; Phenytoin; Valproate; Felbamate; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. GYKI 52466; 2,3-Benzodiazepine; Epilepsy; Hippocampus; Brain slice; Epileptiform bursting ŽMarinelli, S. Ž391. 75. Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Anticonvulsant drug Movement disorder; Nootropic drug; Epilepsy ŽLoscher, W. Ž391. 251. ¨ Antidepressant DHPG ŽŽ RS .-3,5-dihydroxyphenylglycine.; Glutamate receptor, metabotropic, group I; Hippocampus; Imipramine ŽZahorodna, A. Ž386. 173. Electrophysiology; 5-HT1A receptor; a 2 -Adrenoceptor; Tyramine; Norepinephrine transporter; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. 211. ´

11

Antidepressant drug Imipramine; Lithium chloride; Locomotor activity; Mania ŽD’Aquila, P.S. Ž395. 157. Desipramine; Grooming; Locomotor activity; Mesolimbic dopamine system; Open field; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43. Dopamine; Depression; Mania; Mesolimbic dopamine system ŽD’Aquila, P.S. Ž405. 365. Antidepressant, tricyclic b 2 -Adrenoceptor; Gs protein, coupling; Neutrophil; Depression, major; Anxiety ŽGurguis, G.N.M. Ž386. 135. Antidromic stimulation Vagal afferent; Somatostatin; Capsaicin; Mustard oil; Anti-inflammatory effect ŽThan, ´ M. Ž399. 251. Anti-emesis Cisplatin; ŽCat. ŽRudd, J.A. Ž391. 145. Antiepileptic drug ´ ˛der, Topiramate; Electroshock, maximal; Drug interaction; Seizure ŽSwia M. Ž399. 35. Vigabatrin; Epileptic activity; Temporal lobe epilepsy; Pharmacoresistant; Brain slice ŽMusshoff, U. Ž401. 167. Neurotoxicity; Neuroprotection; Apoptosis ŽAmbrosio, A.F. Ž406. 191. ´

35

G-protein; w SxGTPgS autoradiography; 5-HT1 A receptor; GABA B receptor; Anxiolytic ŽSim-Selley, L.J. Ž389. 147. NMDA receptor; Glycine; DSP-4; Norepinephrine; Desipramine ŽHarkin, A. Ž389. 187. Microdialysis; Serotonin Ž5-hydroxytryptamine, 5-HT.; Selective serotonin Ž5-hydroxytryptamine, 5-HT. reuptake inhibitor; Venlafaxine; YM992 ŽHatanaka, K.-i. Ž395. 23. Norepinephrine; 5-HT2A receptor antagonist; Microdialysis; YM992; Venlafaxine ŽHatanaka, K.-i. Ž395. 31. Sibutramine; Desmethylsibutramine; Didemethylsibutramine; Food intake; Obesity; Locomotor activity ŽGlick, S.D. Ž397. 93. q

Amitriptyline; Tetrodotoxin-sensitive; Tetrodotoxin-resistant; Na nel; Dorsal root ganglion ŽSong, J.-H. Ž401. 297.

chan-

Melatonin; Forced-swim test; Sex difference; Depression ŽBrotto, L.A. Ž402. 87. Mineralocorticoid receptor; Glucocorticoid receptor; Hypothalamic–pituitary–adrenocortical axis; Stress; Major depression ŽReul, J.M.H.M. Ž405. 235. Mechanism of action; Monoamine; Neuropeptide; Intracellular signaling; Transcription factor ŽVetulani, J. Ž405. 351.

Anti-Fas antibody Aminoguanidine; Hepatitis ŽOkamoto, T. Ž403. 277. Anti-hyperalgesia Dopaminergic agent; Carrageenan; Dopamine D1 receptor; Dopamine D 2 receptor; Hypoalgesia ŽGao, X. Ž406. 53. Anti-implantation activity Apigenin; Luteolin; Estrogenic activity ŽHiremath, S.P. Ž391. 193. Anti-inflammation Diarylheptanoid; Leukocyte adhesion molecule; Vascular endothelial cell; 5-Lipoxygenase ŽYamazaki, R. Ž404. 375. Anti-inflammatory activity Verbascosaponin A; Verbascosaponin; Scropolioside A; Scrovalentinoside; Ž Scrophularia auriculata ssp. pseudoauriculata. ŽGiner, R.-M. Ž389. 243. Anti-inflammatory effect Cynaropicrin; TNF-a Žtumor necrosis factor-a .; Nitric oxide ŽNO. release; Lymphocyte proliferation; Immunosuppressive effect ŽCho, J.Y. Ž398. 399. Vagal afferent; Somatostatin; Capsaicin; Mustard oil; Antidromic stimulation ŽThan, ´ M. Ž399. 251.

Conditioned place preference; Amitriptyline; 5-HT Ž5-hyroxytryptamine, serotonin. reuptake inhibitor, selective ŽSubhan, F. Ž408. 257.

Anti-inflammatory steroid Carrageenin-induced pleurisy, rat; Dexamethasone; Prostaglandin H synthase-2 Žcyclooxygenase-2.; Phospholipase A 2 ŽKawamura, M. Ž400. 127.

Forced swim test; 5-HT4 receptor; SB 204070A; Fluoxetine ŽCryan, J.F. Ž409. 295.

Anti-muscarinic action Heart; Mitoxantrone; ŽGuinea pig. ŽChugun, A. Ž407. 183.

12

Master keyword index to Õolumes 386–410 (2000)

Antimuscarinic drug Dopamine; Acetylcholine; GABA Ž g-aminobutyric acid.; Substantia nigra; Striatum; L-Dopa ŽIzurieta-Sanchez, P. Ž399. 151. ´ Antinociception d-Opioid receptor; m-Opioid receptor; m-Opioid receptor-knockout mice; G protein; Opioid drug ŽHosohata, Y. Ž388. 241. Endomorphin-1; Endomorphin-2; Diabetes; d-Opioid receptor; m-Opioid receptor ŽKamei, J. Ž391. 91. Pain; Sex difference; Gonadectomy, adult; b-Endorphin ŽKrzanowska, E.K. Ž392. 157.

Analgesia; Pain; Neuropeptide FF; Spinal cord; Supraspinal ŽAltier, N. Ž407. 245. Morphine; Zn2q; Intrathecal; Tolerance; Dependence ŽLarson, A.A. Ž407. 267. FR140423; Serotonergic system; 5-HT2A receptor; 5-HT3 receptor; Spinal cord; ŽMice. ŽOchi, T. Ž409. 167. Anti-nociception Cannabinoid receptor; Vanilloid receptor; Anandamide; Capsaicin; Behavior; ŽMouse. ŽDi Marzo, V. Ž406. 363.

G protein g 2 subunit; DPDPE ŽcwD-Pen2 ,D-Pen 5 xenkephalin. ŽHosohata, K. Ž392. R9.

Antinociceptive action k-Opioid receptor agonist; TRK-820; k-Opioid receptor subtype ŽEndoh, T. Ž387. 133.

Nicotinic acetylcholine receptor; Molecular model; Epibatidine; ABT-594; A-85380; Analgesia ŽMeyer, M.D. Ž393. 171.

Antinociceptive tolerance Morphine; TRK-820; U-50,488H; ŽMouse. ŽTsuji, M. Ž394. 91.

Locomotor activity; Straub tail; Morphine; SC17599; ŽMouse. ŽHoushyar, H. Ž395. 121.

Antioxidant Glutathione; Sleep deprivation; Melatonin; Hypothalamus ŽD’Almeida, V. Ž390. 299.

Opioid; Dizocilpine ŽMK-801.; NMDA receptor; Metabotropic glutamate receptor; Ž S .-4CPG ŽŽ S .-4-carboxyphenylglycine. ŽSuzuki, T. Ž396. 23.

Ischemia–reperfusion injury; Picroliv; Liver ŽSingh, A.K. Ž395. 229.

Morphine; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r579; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77.

Streptozotocin-induced diabetic mouse; Corpus cavernosum; Nitric oxide ŽNO.; Vitamin E; Sodium selenate; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93.

Amphibian; w3 HxNaloxone; Opioid receptor ŽNewman, L.C. Ž397. 255.

Diabetic retinopathy; Glutathione; Lipid peroxidation; Superoxide dismutase ŽObrosova, I.G. Ž398. 139.

Cannabinoid; Intrahecal; Intraventricular; Structure–activity relationship; Tetrahydrocannabinol ŽWiley, J.L. Ž397. 319.

Oxidative stress; Free radical; Cortical culture; Propofol; Vitamin E ŽBoland, A. Ž404. 21.

Cannabinoid; D9-THC Ž D9-tetrahydrocannabinol.; SR 141716A; Marijuana, medical; Aerosol; Nebulizer ŽLichtman, A.H. Ž399. 141.

Myocardial ischemia; b-Adrenoceptor antagonist ŽGao, F. Ž406. 109.

Diabetes; Nitric oxide ŽNO.; Aminoguanidine; Morphine ŽGrover, V.S. Ž399. 161.

Liver, rat; Ischemia–reperfusion; Protective effect; ATP; Bile flow; Glutathione ŽSettaf, A. Ž406. 281.

cGMP; Sodium nitroprusside; Kq channel ŽSoares, A.C. Ž400. 67.

Tyrosine hydroxylase; Haloperidol; Substantia nigra; Immunohistochemistry; ŽRat. ŽBesret, L. Ž408. 35.

Nigella satiÕa oil; Thymoquinone; Opioid system; Formalin test ŽAbdelFattah, A.-F.M. Ž400. 89. FR140423; Noradrenergic system; a 2-Adrenoceptor; Spinal cord; ŽMouse. ŽOchi, T. Ž400. 199. m-Opioid receptor; G-protein; Ponsrmedulla; Diabetes ŽOhsawa, M. Ž401. 55. Opioid; Diabetes mellitus; G-protein; m-Opioid receptor; d-Opioid receptor ŽPieper, G.M. Ž401. 375. Allodynia; Diuresis; Dynorphin; k-Opioid receptors; Sedation ŽKo, M.C.H. Ž402. 69.

Antiplatelet vasodilating agent Streptozotocin-diabetic, rat; Cilostazol; Phosphodiesterase inhibitor ŽYamamoto, Y. Ž409. 1. Antipsychotic Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5-HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57. Muscarinic receptor; Olanzapine; Clozapine; Binding ŽBymaster, F.P. Ž390. 245.

Sarpogrelate; 5-HT2A receptor antagonist; Formalin test; ŽRat. ŽObata, H. Ž404. 95.

Neuroleptic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2 -like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143.

Nicotine; CaM kinase II; Ca2q channels; Intrathecal; ŽMice. ŽDamaj, M.I. Ž404. 103.

Kq channel; Calcium; Calmodulin; Patch clamp; Dequalinium ŽDreixler, J.C. Ž401. 1.

Neuropeptide FF; Morphine; Adenosine; Spinal cord ŽGouarderes, C. ` Ž406. 391.

Dopamine receptor; Pharmacogenetics; Polymorphism; Mutation; Schizophrenia ŽWong, A.H.C. Ž410. 183.

Master keyword index to Õolumes 386–410 (2000) Antipsychotic agent Kq channel; Pimozide; HERG Žhuman ether-a-go-go-related gene.; Arrhythmia ŽKang, J. Ž392. 137.

13

Blood pressure; Glutamate; Heart rate; Kindling; Long-term potentiation; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265. Plus-maze; Opiate; Benzodiazepine; Naloxone ŽBelzung, C. Ž394. 289.

Antipsychotic drug 5-HT1A receptor; GTPgw35 Sx; Brain, human; Clozapine; Quetiapine ŽElliott, J. Ž386. 313. Risperidone; Microdialysis; Schizophrenia; Electrophysiology; Noradrenergic system ŽNasif, F.J. Ž394. 67. Antisecretion Amtolmetin guacyl; Gastroprotection; Capsaicin; CGRP Žcalcitonin gene-related peptide. ŽTubaro, E. Ž387. 233. Antisense Methylene methylimino linkage; Platelet-derived growth factor A-chain; Spontaneously hypertensive rat ŽSHR.; Smooth muscle cell, vascular ŽKishioka, H. Ž392. 129.

Stress; 5-HT1A receptor; Tachycardia; Hyperthermia; Radiotelemetry ŽBouwknecht, J.A. Ž400. 59. 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1. Behaviour; Autonomic response; Endocrine response; Affective disorder; Post-traumatic stress disorder ŽPTSD.; ŽRat. ŽStam, R. Ž405. 217. Stress; Noradrenaline; Hypothalamus; Amygdala; Locus coeruleus; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397.

CRF Žcorticotropin-releasing factor.; Urocortin; CRF receptor; Stress; Behaviour; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Conditioned fear stress; Freezing behavior; Monoamine oxidase inhibitor ŽMaki, Y. Ž406. 411.

Antisense oligodeoxynucleotide, knockdown NS-105; Glutamate receptor, metabotropic; Adenylyl cyclase; Primary neuronal culture ŽHirouchi, M. Ž387. 9.

Nicotine; Elevated plus-maze; a-Adrenoceptor; ŽMouse. ŽZarrindast, M.R. Ž407. 145.

Antisense oligodeoxynucleotide NaqrCa2q exchange; Ca2q pump; Ca2q concentration, Intracellular; Thapsigargin ŽNakao, M. Ž387. 273. Antisense oligonucleotide CGRP receptor, porcine, cloned; G protein-coupled receptor kinase; Homologous desensitization; CGRP Žcalcitonin gene-related peptide.; Ro 32-0432 ŽAiyar, N. Ž403. 1. Antiserum against atrial natriuretic peptide Ethanol tolerance; Ethanol dependence; Withdrawal; NMDA Ž N-methylD-aspartate.; ANP Žatrial natriuretic peptide. ŽKovacs, ´ G.L. Ž401. 343. Antithrombin consumption Hemophilia A; Blood coagulation control; Thrombin–antithrombin complex; Factor Xarantithrombin complex; Protein SV-IV ŽDi Micco, B. Ž391. 1. Antithrombotic Coagulation factor Xa; Thrombin; Heparin; ŽIn vivo. ŽHeran, C. Ž389. 201. Antitumour Ehrlich ascites tumour; Myelopoiesis; MAPA Žmagnesium ammonium phospholinoleate-palmitoleate anhydride.; CFU-GM Žcolony-forming unit-granulocyte-macrophage. ŽJusto, G.Z. Ž388. 219. Anti-tussive drug Cough reflex; ATP-sensitive Kq channel; Moguisteine ŽMorita, K. Ž395. 161. Anxiety b 2 -Adrenoceptor; Gs protein, coupling; Neutrophil; Depression, major; Antidepressant, tricyclic ŽGurguis, G.N.M. Ž386. 135.

MDMA ŽŽ".-3,4-Methylenedioxymethamphetamine.; Ecstasy; Odor, cat; Social interaction; Ultrasonic vocalization ŽMorley, K.C. Ž408. 41. Nitric oxide ŽNO.; NMDA Ž N-methyl-D-aspartate.; Motor behavior; Ultrasonic vocalization; ŽRat. ŽPodhorna, J. Ž408. 265. Fluvoxamine; Diazepam; Conditioned fear stress; Defensive freezing behavior; ŽMouse. ŽMiyamoto, J. Ž409. 81. Anxiolytic G-protein; w35 SxGTPgS autoradiography; 5-HT1 A receptor; GABA B receptor; Antidepressant ŽSim-Selley, L.J. Ž389. 147. Anxiolytic drug Anxiety; Stress; Noradrenaline; Hypothalamus; Amygdala; Locus coeruleus; Benzodiazepines; Opioid agent ŽTanaka, M. Ž405. 397. Aorta Flavonoid; Dioclein; Endothelium; Vasorelaxation; Nitric oxide ŽNO. ŽLemos, V.S. Ž386. 41. Somatostatin; Mesenteric artery; Ca2q ŽRuiz, E. Ž388. 255. Angiotensin II; MAP Žmitogen activated protein. kinase; Mechanical stress; Losartan ŽKubo, T. Ž391. 281. Thapsigargin; Nitric oxide ŽNO.; Endothelium; Kq channel; Relaxation; ŽRat. ŽHuang, Y. Ž392. 51. Streptozotocin-diabetes; Endothelium-dependent relaxation; Endotheliumindependent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163. Trandolapril; Angiotensin-converting enzyme inhibitor; Cholesterol-fed, rabbit; Coronary artery; Mesenteric, 5th branch ŽSanz, M. Ž397. 359.

Depression; 5-HT2C receptor; ŽRat. ŽKennett, G. Ž387. 197. Nicotine; 5-HT1A receptor; Phobia; Septum, lateral; Hippocampus, dorsal ŽFile, S.E. Ž393. 231.

MAP Žmitogen-activated protein. kinase; Angiotensin; Endothelin; Spontaneously hypertensive rat ŽSHR.; DOCA-salt hypertensive rat ŽKubo, T. Ž400. 231.

14

Master keyword index to Õolumes 386–410 (2000)

Guanylyl cyclase, soluble; Superoxide anion; Renin–angiotensin system; Hypertension ŽJacke, K. Ž403. 27.

CTGF Žconnective tissue growth factor.; TGF-b Žtransforming growth factor b .; Caspase; Atherosclerosis ŽHishikawa, K. Ž392. 19.

Organophosphate; Diisopropyl-flurophosphate; Phentolamine; Norepinephrine; ŽRat. ŽLim, S.L. Ž404. 353.

Non-steroidal anti-inflammatory drug ŽNSAID.; Ulcer; Colon cancer; Pentose phosphate pathway ŽPorter, S.N. Ž397. 1.

Aorta, rabbit Polygodial; Relaxation; Pulmonary artery, rabbit; Pulmonary artery, guinea-pig; Nitric oxide ŽNO. ŽAndre, ´ E. Ž386. 47.

NOR3; Nitric oxide ŽNO.; Nitric oxide ŽNO. donor; DAF-2 Ž4,5-diaminofluorescein.; Ascorbic acid ŽYamamoto, T. Ž397. 25.

Aorta, rat UTP contraction; Smooth muscle; Vascular; Protein kinase C; Ca2q ŽLopez, C. Ž391. 299. ´ CP-060S; Ca2q channel, L-type voltage-dependent; Ca2q, Cytosolic ŽSato, K. Ž400. 225. Aortic endothelial cell, bovine Lipopolysaccharide, bacterial; Bradykinin receptor; Microphysiometer; FR173657 ŽBentley, K.R. Ž402. 11. AP-1 (activator protein-1) Opioid peptide; Electrophoretic mobility shift assay; Transcriptional regulation; Uterus, rat; Hypothalamus, rat ŽOszter, A. Ž395. 103. Hyperalgesia; Complete Freund adjuvant; NF-kB Žnuclear factor kappa B.; Octamer factor; NO Žnitric oxide. synthase, neuronal ŽChan, C.-F. Ž402. 61. Apamin PACAP Žpituitary adenylate cyclase-activating peptide.; VIP Žvasoactive intestinal peptide.; Suramin; PACAP-Ž6–38.; VIP-Ž10–28.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217. 4-Aminopyridine; 3,4-Diaminopyridine; Passive avoidance; ŽMouse. ŽInan, S.Y. Ž407. 159. Apigenin Luteolin; Anti-implantation activity; Estrogenic activity ŽHiremath, S.P. Ž391. 193. Apolipoprotein E Vitamin E; Atherosclerosis; Alzheimer’s disease ŽPeroutka, S.J. Ž410. 161. Apomorphine Dopamine; N-propyl analog; Microdialysis; Bioavailability; Striatum ŽRodenhuis, N. Ž387. 39. Scopolamine; Muscarinic acetylcholine receptor; Prepulse inhibition; Startle; Phencyclidine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105. Prepulse inhibition; Phencyclidine; s1 Receptor ligand; MS-377 ŽYamada, S. Ž402. 251. Histamine; Licking behavior; ŽRat. ŽFarzin, D. Ž404. 169. Apoptosis Ca2q; Nifedipine; Cardiomyocyte ŽRabkin, S.W. Ž388. 209. Chloromethyl ketone; Stroke; Focal ischemia; Serine protease inhibitor; Nitric oxide ŽNO. ŽLeBlanc, M.H. Ž390. 249. Alanine aminotransferase; Concanavalin A; Interferon-g; Soyasapogenol A; Tumor necrosis factor-a ŽTNF-a . ŽKuzuhara, H. Ž391. 175.

Nitric oxide ŽNO.; Hydrogen peroxide; Neuroblastoma; PC12; NO donor; Annexin V ŽTerwel, D. Ž400. 19. Cardiac ischemia; Infarct; Caspase inhibitor; Reperfusion injury ŽHuang, J.-Q. Ž402. 139. Amyotrophic lateral sclerosis ŽALS.; Motor neuron; Cell culture; Tissue culture; Neurodegenerative disease ŽBar, ¨ P.R. Ž405. 285. Antiepileptic drug; Neurotoxicity; Neuroprotection ŽAmbrosio, A.F. Ž406. ´ 191. Eosinophil; Fluticasone propionate; Budesonide; Beclomethasone ŽZhang, X. Ž406. 325. CV-2619; NGF Žnerve growth factor.; Astrocyte ŽTakuma, K. Ž406. 333. Smooth muscle cell, vascular; p53; Gadd45; Troglitazone; Pioglitazone ŽOkura, T. Ž407. 227. Cryptolepine; Neocryptolepine; Plant alkaloid; Topoisomerase II; Cytotoxicity ŽDassonneville, L. Ž409. 9. Droloxifene; Luteal cell; c-myc; bax; bcl-2; mRNA ŽLeng, Y. Ž409. 123. Apoptosis inhibitory protein Neutrophil; Caspase; Transcription factor; NF-kB Žnuclear factor-kB.; TNF-a Žtumor necrosis factor-a . ŽNiwa, M. Ž407. 211. Aquaretic effect Vasopressin V2 receptor antagonist; SR121463 ŽLacour, C. Ž394. 131. Arachidonic acid Cytosolic phospholipase A 2 ; S-Nitroso-cysteine; cGMP; PC12 cell ŽThang, S.H. Ž395. 183. Cardiomyocyte; Ca2q channel; Phospholipase A 2 ; Mepacrine ŽXiao, Y.-F. Ž399. 107. Arachidonic acid cascade Valproate; Platelet; Brain microvessel, rat ŽSzupera, Z. Ž387. 205. Arachidonic acid metabolite Cytokine; Bronchial hyperresponsiveness; Bronchial asthma ŽNakatani, Y. Ž392. 175. 2-Arachidonylglycerol Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; Palmitoylethanolamide; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. Arginine Glutamine; Endothelin; Endotoxin; Nitro-arginine ŽMitchell, J.A. Ž389. 209. Cyclosporin A; Osteopenia; Pyridinoline; ŽRat. ŽFiore, C.E. Ž408. 323.

Master keyword index to Õolumes 386–410 (2000) L-arginine

Renal failure; Gentamicin; Nitric oxide ŽNO.; L-NAME Ž N v -nitro-Larginine methyl ester.; ŽRat. ŽCan, C. Ž390. 327. [Arg 8 ]vasopressin Prostanoid; Smooth muscle cell; Cell proliferation ŽNagano, K. Ž389. 25. Aromatase inhibitor Breast carcinoma; Oestrogen; Androgen ŽPalma, C. Ž409. 93. Aromatic L-amino acid decarboxylase Methamphetamine; 3-Nitropropionic acid; Neurotoxicity; Dopamine; 5HT, 5-Hydroxytryptamine; Motor behaviour ŽEradiri, O.L. Ž386. 217. Arrhythmia Anaesthetic volatile; Action potential; K AT P channel; Myocyte; Patch clamp ŽTerrenoire, C. Ž390. 95. Kq channel; Pimozide; HERG Žhuman ether-a-go-go-related gene.; Antipsychotic agent ŽKang, J. Ž392. 137. Sodium–hydrogen exchanger; Myocardial infarct size ŽGumina, R.J. Ž396. 119. I K.ATP ; Glibenclamide; HMR1883; Sulfonylurea; Cardiac ischemia; Dispersion; Sulfonylurea ŽDhein, S. Ž398. 273. Antiarrhythmic; Class I; Myocardial ischaemia; Proarrhythmia ŽBarrett, T.D. Ž398. 365.

15

Articular chondrocyte, rabbit X Osteoarthritis; Rheumatoid arthritis; Aceclofenac; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 1; Pro-matrix metalloproteinase 3 ŽAkimoto, H. Ž401. 429. Ascorbic acid Apoptosis; NOR3; Nitric oxide ŽNO.; Nitric oxide ŽNO. donor; DAF-2 Ž4,5-diaminofluorescein. ŽYamamoto, T. Ž397. 25. Clozapine; Haloperidol; Ritanserin; Ethanol; Microdialysis; ŽRat. ŽLiu, W. Ž398. 333. Aspirin Dipyridamole; Nitric oxide ŽNO.; Platelet; Polymorphonuclear leukocyte ŽDe La Cruz, J.P. Ž397. 35. Alzheimer’s disease; Microglia; NSAIDs; Interferon-g ŽOgawa, O. Ž408. 137. Association 5-HT2A receptor; Transmission disequilibrium; Genome screening; Dopamine; Estrogen b receptor; Leptin ŽHinney, A. Ž410. 147. Smoking; Genetic polymorphism; Neurotransmitter; Linkage ŽArinami, T. Ž410. 215. Associative memory mechanism Vasopressin; Norepinephrine; Neuromodulation; Hippocampus ŽBrinton, R.D. Ž405. 73.

TY-12533; NaqrHq exchanger; Ischemia; Reperfusion; Myocardial infarction ŽAihara, K. Ž404. 221.

Asthma Salmeterol; Benzalkonium chloride; Mast cell; G-protein; b 2-Adrenoceptor ŽSeebeck, J. Ž397. 19.

K AT P channel; Hypertension; Myocardial ischemia; Reperfusion ŽLee, Y.-M. Ž397. 151.

TEI-9874; Immunoglobulin E ŽNonaka, T. Ž402. 287.

Arterial baroreceptor Autonomic nervous system; Propofol ŽXu, H. Ž387. 79. Arterial contraction Sarcoplasmic reticulum; Ca2q-ATPase, Sarcoplasmic reticulum; Ca2q uptake function; Superficial buffer barrier hypothesis; Ca2q influx; Ca2q channel, L-type ŽNomura, Y. Ž404. 315.

Leukotriene; Thromboxane; YM158 ŽArakida, Y. Ž403. 169. NANC Žnon-adrenergic–non-cholinergic. nerve, excitatory; Neuropeptide; Animal model; ŽHuman. ŽKraneveld, A.D. Ž405. 113. Asthmatic response TA-270; Bronchoalveolar eosinophilia; Airway hyperresponsiveness ŽAoki, Y. Ž409. 325.

Arterial pressure Spectral analysis; Valsartan; Catecholamine; Isoprenaline ŽBlanc, J. Ž394. 311.

Astrocyte Ca2q reperfusion; T-588; NGF Žnerve growth factor.; PD98059; MAP Žmitogen-activated protein. kinase ŽTakuma, K. Ž399. 1.

Arterial thrombosis Thromboxane A 2 ; Z-335; Cilostazol ŽTanaka, T. Ž401. 413.

CV-2619; NGF Žnerve growth factor.; Apoptosis ŽTakuma, K. Ž406. 333.

Arteriole FITC-dextran; Permeability; Nitric oxide ŽNO.; Platelet-activating factor ŽPAF.; Nitric oxide synthase ŽNOS. inhibitor; Microcirculation ŽKlabunde, R.E. Ž404. 387. Artery Rabbit; Phosphoinositide; Peptide; Phospholipase C; Urotensin II ŽOpgaard, O.S. Ž406. 265. Arthritis Phosphodiesterase 4; Hyperalgesia; Oedema; TNF-a Žtumor necrosis factor-a .; Rolipram ŽFrancischi, J.N. Ž399. 243. Y-39041; TNF-a ŽTumor necrosis factor-a .; Interleukin-10; Lipopolysaccharide ŽHisadome, M. Ž409. 331.

Ca2q; LDH Žlactate dehydrogenase.; Mitochondrion; MTT; Naq,KqATPase; Ouabain ŽTakahashi, S. Ž408. 127. a subunit GABA A rbenzodiazepine receptor; Hippocampus; Olfactory bulb; Ligand affinity; Receptor heterogeneity ŽLameh, J. Ž400. 167. a 3 subunit Alzheimer’s disease; Parkinson’s disease; a4 subunit; a7 subunit; bAmyloidosis; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215. a 4 subunit Alzheimer’s disease; Parkinson’s disease; a 3 subunit; a7 subunit; bAmyloidosis; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215.

16

Master keyword index to Õolumes 386–410 (2000)

a 7 subunit Alzheimer’s disease; Parkinson’s disease; a 3 subunit; a4 subunit; bAmyloidosis; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215. Ataxia, cerebellar 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HIAA Ž5-hydroxyindole-3acetic acid.; 5-Hydroxytryptophol; Dopamine; Noradrenaline ŽReader, T.A. Ž398. 41. Atherosclerosis Endothelin-converting enzyme; Endothelin; Cholesterol; Lipid peroxide; ŽRabbit. ŽMitani, H. Ž387. 313. Nitrate; Nitric oxide ŽNO. synthase; Nitric oxide ŽNO.; L-NIL Ž N-iminoethyl-L-lysine.; ŽRabbit. ŽBehr-Roussel, D. Ž388. 275. Endothelin; TNF Žtumor necrosis factor. receptor; Endothelial cell; Epithelial cell; Inflammation ŽLees, D.M. Ž390. 89. CTGF Žconnective tissue growth factor.; TGF-b Žtransforming growth factor b .; Apoptosis; Caspase ŽHishikawa, K. Ž392. 19. Differentiation; Protein kinase C; Gene expression; a-tropomyosin; ŽRat. ŽHirano, K. Ž406. 209. Vitamin E; Alzheimer’s disease; Apolipoprotein E ŽPeroutka, S.J. Ž410. 161. Atipamezole a 2-Adrenoceptor; Ageing; Memory; Cholinergic system; Noradrenergic system ŽHaapalinna, A. Ž387. 141. ATP Vas deferens; Ectonucleotidase; Purinergic ŽTennant, J.P. Ž387. 107. Adenosine; Mesentery, hamster; Prejunctional neuromodulation; Purine receptor; Sympathetic neurotransmission ŽRalevic, V. Ž387. 287. Adenosine A 1 receptor; FRTL-5 thyroid cell; Protein kinase C; Signal transduction ŽVainio, M. Ž390. 43. Ecto-nucleotidase; Dipyridamole; Ecto-ATPase; Superior cervical ganglion, rat; UTP ŽConnolly, G.P. Ž397. 271. Hippocampal slice; Electrical signal; Optical recording; Adenosine receptor ŽSato, K. Ž399. 123. Acidosis; P2X receptor; pH; Purine; Mesenteric arterial bed; Vasoconstriction ŽRalevic, V. Ž406. 99.

ATP–MgCl 2 Mitochondrial energy metabolism; Mitochondrial enzyme; Lipid peroxidation; Hepatic ischemiarreperfusion ŽJeong, C. Ž403. 243. ATP receptor X Oocyte; Antagonist; Voltage clamp; Whole cell; NF279 Ž8,8 -ŽcarbonylbisŽimino-4, 1-phenylenecarbonylimino-4, 1-phenylenecarbonylimino.. bisŽ1,3,5-naphthalenetrisulfonic acid.. ŽKlapperstuck, ¨ M. Ž387. 245. Enteric neuron; Submucosal neuron; Ca2q; Receptor; P2X receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´ ATP-sensitive K H channel Cough reflex; Moguisteine; Anti-tussive drug ŽMorita, K. Ž395. 161. Urinary incontinence; b 2 -Adrenoceptor; Detrusor muscle; Clenbuterol ŽHudman, D. Ž397. 169. ATP-sensitive, K H channels Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79. AT1 receptor Fetal, sheep; Angiotensin; AT2 receptor; Cardiovascular; Cortisol ŽHegarty, B.D. Ž406. 439. AT2 receptor Fetal, sheep; Angiotensin; AT1 receptor; Cardiovascular; Cortisol ŽHegarty, B.D. Ž406. 439. Atrioventricular node Kq current, Delayed rectifier; Sinoatrial node; Antiarrhythmic agent, Class III ŽSato, N. Ž404. 281. Atrium cAMP; Pituitary adenylate cyclase activating polypeptide ŽPACAP. ŽCui, X. Ž402. 129. Atrium, right YM-31636; 5-HT3 receptor agonist; Colon, distal; ŽGuinea pig. ŽIto, H. Ž409. 195. a-tropomyosin Differentiation; Protein kinase C; Atherosclerosis; Gene expression; ŽRat. ŽHirano, K. Ž406. 209. Attention Nicotine; Learning; Memory ŽLevin, E.D. Ž393. 141. Nicotine; Mecamylamine; Cognition ŽStolerman, I.P. Ž393. 147.

Liver, rat; Ischemia–reperfusion; Protective effect; Bile flow; Glutathione; Antioxidant ŽSettaf, A. Ž406. 281. P2 purinoceptors; Feeding behaviour ŽKittner, H. Ž406. R13. Purine; Adenosine; Nucleotide; Hippocampus; Suramin; Long-term potentiation ŽO’Kane, E.M. Ž409. 159. Neonate; Cardiac myocyte; Ca2q current, L-type; Adenosine; Purinoceptor ŽSuto, F. Ž409. 213. Hormonal control; Endothelial receptor, luminal; Purinoceptor; Endothelial mediator; Cardiac function control ŽZenteno-Savin, T. Ž410. 15.

Attractor Anabolic steroid; Pregnenolone sulfate; Ethylestrenol; Passive avoidance behavior; Memory; Non-linear dynamics; Chaos theory ŽIsaacson, R.L. Ž405. 177. Audiogenic seizure Epilepsy; Topiramate; Carbamazepine; Phenytoin; Valproate; Felbamate; Anticonvulsant; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; DBAr2 mouse ŽDe Sarro, G. Ž394. 275.

Master keyword index to Õolumes 386–410 (2000)

17

Epilepsy; Riluzole; AMPA Ž a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.; GlycinerNMDA receptor; DBAr2 mouse ŽDe Sarro, G. Ž408. 25.

b-amyloid Chemokine; N-methyl-D-aspartate ŽNMDA.; Cortical culture; Neuroprotection ŽBruno, V. Ž399. 117.

Autoimmunity Androgen; Th1rTh2; Immune function; Prenatal; Estrogen ŽMartin, J.T. Ž405. 251.

Barbiturate Movement disorder; Dystonia; Paroxysmal choreoathetosis; GABA Ž gaminobutyric acid. ŽRichter, A. Ž397. 343.

Autonomic dysfunction Nicotinic receptor; Nicotinic receptor subunit; Bladder; Knockout mice ŽDe Biasi, M. Ž393. 137.

Baroreflex Quinpirole; Renal sympathetic nerve activity; Rabbit, conscious ŽVan den Buuse, M. Ž388. 85.

Autonomic nervous system Arterial baroreceptor; Propofol ŽXu, H. Ž387. 79.

Basal ganglia Glutamate receptor, metabotropic; Excitatory amino acid; Caudoputamen; Nucleus accumbens; Drug of abuse ŽMao, L. Ž404. 289.

Stress; Behaviour ŽNijsen, M.J.M.A. Ž389. 89. Corticotropin-releasing factor ŽCRF.; Vasopressin; Learning; Memory ŽCroiset, G. Ž405. 225.

Basal ganglia disorder Adenosine receptor agonist; Dystonia; Movement disorders ŽRichter, A. Ž404. 299.

Autonomic neuropathy Aldose reductase; Diabetes; Non-adrenergic non-cholinergic; Gastric fundus, rat; Streptozotocin ŽJenkinson, K.M. Ž401. 251.

Basilar artery Hypocapnic constriction; Endothelin-1; Nitric oxide ŽNO. ŽZuccarello, M. Ž401. 213.

Autonomic response Behaviour; Endocrine response; Anxiety; Affective disorder; Post-traumatic stress disorder ŽPTSD.; ŽRat. ŽStam, R. Ž405. 217.

Endothelin-1; 5-HT Ž5-hydroxytryptamine, serotonin.; Hypocapnia; Isocapnia; Alkaline ŽZuccarello, M. Ž407. 191.

Autoradiography Adenosine receptor; Locomotion; Dopamine receptor; Caffeine; In situ hybridization ŽHalldner, L. Ž406. 345. Aversion Dorsal periaqueductal gray; m-Opioid receptor; k-Opioid receptor; CTOP; Nor-binaltorphimine; Elevated plus-maze ŽNobre, M.J. Ž404. 145. Avoidance ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Peptide– receptor interaction; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. Axial stretch Circumferential stretch; Impedance planimetry; Coronary artery, large; Tone; Ca2q-channel, voltage-gated; ŽPig. ŽTanko, ´ L.B. Ž387. 303.

Basolateral amygdala Synaptic g-aminobutyric acid ŽGABA. transmission; 5-HT1A receptors; Presynaptic modulation; Dissociated neuron and tandospirone ŽKishimoto, K. Ž407. 257. Bathocuproine Neocuproine; Corpus cavernosum; S-Nitrosoglutathione; Non-adrenergic non-cholinergic ŽNANC. nerve; Nitrergic relaxation ŽGoc ¨ ¸men, C. Ž406. 293. bax Droloxifene; Luteal cell; Apoptosis; c-myc; bcl-2; mRNA ŽLeng, Y. Ž409. 123. BAY K 8644 Clonidine; GABA Ž g-aminobutyric acid.; Ca2q channel, L-type; Limbic system; Septum, Epilepsy ŽBaran, H. Ž401. 31.

Ba 2H Cell death; Cytotoxicity; Cytoprotection; Chromaffin cell; Ca2q channel antagonist ŽCano-Abad, M.F. Ž402. 19.

BAY K8644 Generalized absence epilepsy; Ca2q channel; WAGrRij rat; Spike-wave discharge; Nimodipine; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381.

Baclofen GABA Ž g-aminobutyric acid.; Esophageal sphincter relaxation, transient, lower; Tolerance ŽLehmann, A. Ž403. 163.

BAY u9773 Pulmonary artery, porcine; Leukotriene; Contraction; CysLT receptor; ICI 204,219 ŽBack, ¨ M. Ž401. 381.

Imipramine; Ligation; Hot-plate test; ŽMouse. ŽZarrindast, M.-R. Ž407. 65.

Pulmonary artery, human; Contraction; Cysteinyl–leukotriene receptor; Prostacyclin; MK 571 ŽBack, ¨ M. Ž401. 389.

Cocaine; Methamphetamine; Drug-discrimination; ŽRat. ŽMunzar, P. Ž408. 169.

Bcl-2 Lithium chloride; b-Amyloid; Alzheimer’s disease ŽWei, H. Ž392. 117.

b-adrenergic stimulation Lipopolysaccharide; Vascular hyporeactivity; Ventricular myocyte; Ca2q transient; Nitric oxide ŽNO. ŽShan, Q. Ž406. 257.

bcl-2 Droloxifene; Luteal cell; Apoptosis; c-myc; bax; mRNA ŽLeng, Y. Ž409. 123.

Bafilomycin A 1 a-Fluoromethylhistidine; Histidine decarboxylase; Reserpine; Vacuolartype ATPase; Vesicular monoamine transporter ŽLindstrom, ¨ E. Ž387. 19.

1-BCP AMPA receptor; Purkinje cell; GYKI 53784; Aniracetam; Cyclothiazide; BDP-12 ŽKapus, G. Ž397. 43.

18

Master keyword index to Õolumes 386–410 (2000)

BDP-12 AMPA receptor; Purkinje cell; GYKI 53784; Aniracetam; Cyclothiazide; 1-BCP ŽKapus, G. Ž397. 43. Beclomethasone Apoptosis; Eosinophil; Fluticasone propionate; Budesonide ŽZhang, X. Ž406. 325. Bed nucleus of the stria terminalis Animal model; Depression; CRF Žcorticotropin-releasing factor. ŽStout, S.C. Ž401. 39. Behavior Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57. Melanocortin; Feeding; Central nervous system; Body weight homeostasis; Anorexia; Obesity ŽVergoni, A.V. Ž405. 25. Cannabinoid receptor; Vanilloid receptor; Anandamide; Capsaicin; Antinociception; ŽMouse. ŽDi Marzo, V. Ž406. 363. Behavioral dependence THC Žtetrahydrocannabinol.; Dependence; Withdrawal; Operant behavior; SR141716A; ŽRat. ŽBeardsley, P.M. Ž387. 47. Behavioral tolerance Dopamine D1 receptor; 6-Hydroxydopamine; Turning behavior ŽCasas, M. Ž396. 93. Behaviour Stress; Autonomic nervous system ŽNijsen, M.J.M.A. Ž389. 89. Acetylcholine; Cholinergic; Glutamate; Interaction; Motivation ŽAura, J. Ž390. 313. CRF Žcorticotropin-releasing factor.; Urocortin; CRF receptor; Antisense; Stress; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Benzodiazepine Anxiety; Plus-maze; Opiate; Naloxone ŽBelzung, C. Ž394. 289. GABA Ž g-aminobutyric acid.; Anaesthetic; Optic nerve; Propofol ŽEmpson, R.M. Ž401. 339. Zolpidem; Drug discrimination ŽRowlett, J.K. Ž406. R9. Dopamine; Licking behaviour; Bout structure; Palatability ŽHiggs, S. Ž409. 73. Benzodiazepine receptor Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Benzodiazepine receptor ligand, mitochondrial w3 HxAdenosine; Adenosine uptake; Mitochondrion; Testis, rat ŽJimenez, ´ A. Ž398. 31. Benzodiazepine receptor, mitochondrial d-Aminolaevulinic acid; Protoporphyrin IX; Zinc protoporphyrin IX; Aciflourfen; Protoporphyrinogen oxidase ŽMesenholler, M. Ž406. 171. ¨ Benzodiazepine receptor, peripheral Paw oedema; Pleurisy ŽTorres, S.R. Ž408. 199. Benzodiazepines Anxiety; Stress; Noradrenaline; Hypothalamus; Amygdala; Locus coeruleus; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397. Berberine Nitric oxide ŽNO.; Kq channel; Ca2q channel; Vasorelaxation; Proliferation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187. Betulinic acid Ca2q; Ca2q store; Fura-2; MDCK cell; Thapsigargin ŽChou, K.-J. Ž408. 99.

Autonomic response; Endocrine response; Anxiety; Affective disorder; Post-traumatic stress disorder ŽPTSD.; ŽRat. ŽStam, R. Ž405. 217.

BeWo cells P-Glycoprotein; Placenta; Blood–placental barrier; Drug disposition ŽUshigome, F. Ž408. 1.

Phencyclidine; Nitric oxide ŽNO.; N G -nitro-L-arginine methyl ester; c-fos; ŽRat. ŽBujas-Bobanovic, M. Ž409. 57.

BHA (3-t-butyl-4-hydroxyanisole) Hindered phenol; Ca2q homeostasis ŽFusi, F. Ž394. 109.

Behavioural tolerance Cannabinoid; Brain; Energetic metabolism; Cannabinoid CB1 receptorspecific antagonist ŽCosta, B. Ž395. 1.

BIBN4096BS Calcitonin gene-related peptide ŽCGRP.; CGRP Ž8-38.; CGRP receptor subtypes; Left atrium, rat; Vas deferens, rat ŽWu, D. Ž400. 313.

Benazoline Imidazoline I 2 receptor ligand; Idazoxan; RX821002; Metrazoline; Tracizoline; Food intake; Water intake ŽPolidori, C. Ž392. 41.

Bicuculline 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT3 receptor; glycine receptor; GABA A ; Nicotinic acetylcholine receptor ŽSun, H. Ž391. 243.

Benserazide Leptin; 5-HTP Ž5-Hydroxytryptophan.; 5-HT Ž5-hydroxytryptamine, serotonin.; ŽMouse. ŽYamada, J. Ž406. 159.

Bifunctional inhibitor Thrombin; Platelet aggregation; Coagulation; Shear ŽTaka, T. Ž406. 181.

Benzalkonium chloride Salmeterol; Mast cell; G-protein; b 2 -Adrenoceptor; Asthma ŽSeebeck, J. Ž397. 19.

Big-endothelin-1 Chronic hypoxia; Lung; Endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101.

2,3-Benzodiazepine GYKI 52466; Anticonvulsant; Epilepsy; Hippocampus; Brain slice; Epileptiform bursting ŽMarinelli, S. Ž391. 75.

BIIE0246 Neuropeptide Y; Neuropeptide Y Y2 receptor; Hippocampus ŽWeiser, T. Ž404. 133.

Master keyword index to Õolumes 386–410 (2000)

19

Bile flow Liver, rat; Ischemia–reperfusion; Protective effect; ATP; Glutathione; Antioxidant ŽSettaf, A. Ž406. 281.

Bladder Nicotinic receptor; Nicotinic receptor subunit; Autonomic dysfunction; Knockout mice ŽDe Biasi, M. Ž393. 137.

Binding Muscarinic receptor; Olanzapine; Clozapine; Antipsychotic ŽBymaster, F.P. Ž390. 245.

Blood–brain barrier Brain edema; Cerebral ischemia–reperfusion; Histamine; Intracellular histamine binding site; DPPE Ž N,N-diethyl-2-w4-Žphenylmethyl.phenoxyxethanamine. ŽDeli, M.A. Ž387. 63.

Nicotinic acetylcholine receptor; Pharmacological comparison; Subunit null mutation; Activation ŽWhiteaker, P. Ž393. 123.

P-Glycoprotein; Bioflavonoid; Vincristine; Protein kinase C ŽMitsunaga, Y. Ž395. 193.

Norbinaltorphimine; k-Opioid receptor ŽJones, R.M. Ž396. 49. Cholecystokinin; SR146131; wCa2q x i ; Phosphoinositide turnover; ŽHuman. ŽSchaeffer, P. Ž397. 303. Binding affinity Muscarinic receptor subtype; Ileum, avian; Functional affinity ŽDarroch, S. Ž402. 161.

Blood coagulation control Hemophilia A; Antithrombin consumption; Thrombin–antithrombin complex; Factor Xarantithrombin complex; Protein SV-IV ŽDi Micco, B. Ž391. 1. Blood flow Nerve conduction; Kq channel opener; Naq, Kq ATPase; Oxidative stress; Glutathione; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335.

Binding, in vivo Dopamine; Dopamine D 2 receptor, extrastriatal; w123 IxEpidepride; SPECT ŽSingle photon emission computed tomography.; a-Methyl-para-tyrosine; Schizophrenia ŽFujita, M. Ž387. 179.

Blood–placental barrier P-Glycoprotein; Placenta; BeWo cells; Drug disposition ŽUshigome, F. Ž408. 1.

Binding site CCK 1 receptor; Modelling; SR 27897; SR 146131 ŽGouldson, P. Ž400. 185.

Blood pressure Anxiety; Glutamate; Heart rate; Kindling; Long-term potentiation; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

s Binding site MS-377; Radiolabeled ligand binding; Brain membrane, rat ŽKarasawa, J.-i. Ž400. 51.

Endothelin receptor antagonist; Nicotine; Thromboxane; ŽRat. ŽTanusSantos, J.E. Ž396. 33.

Bioavailability Apomorphine; Dopamine; N-propyl analog; Microdialysis; Striatum ŽRodenhuis, N. Ž387. 39. Dopamine receptor agonist; Microdialysis; Striatum; Bioisosteric replacement; Thiophene analog ŽRodenhuis, N. Ž394. 255. Bioflavonoid P-Glycoprotein; Blood–brain barrier; Vincristine; Protein kinase C ŽMitsunaga, Y. Ž395. 193. Bioisosteric replacement Dopamine receptor agonist; Microdialysis; Bioavailability; Striatum; Thiophene analog ŽRodenhuis, N. Ž394. 255. Biological effect Gastrin-releasing peptide; Bombesin, synthetic glycine-extended form; Gastrin-releasing peptiderbombesin receptor antagonist; ŽIn vitro. ŽOiry, C. Ž403. 17.

Opiate; Dependence, acute; Gender difference; Cardiovascular system; Heart rate; Rat, spinal ŽCruz, S.L. Ž397. 121. Cocaine; Potentiation; Noradrenaline; Contractility; Chlorisondamine ŽSabra, R. Ž397. 139. Endothelin-1; Bradykinin; Enalapril; Losartan; ŽRat. ŽTanus-Santos, J.E. Ž397. 367. Quinpirole; Spinal cord transection; Intrathecal domperidone; Dopamine D 2 receptor, spinal; Conscious, rat ŽLahlou, S. Ž408. 51. Oestrogen receptor modulator; Oestrogen; Nitric oxide ŽNO.; Vasopressin; Enzyme regulation ŽPavo, ´ ´ I. Ž410. 101. Blood vessel Nicotine; Nicotinic receptor, Non-neuronal; Lung; Skin ŽConti-Fine, B.M. Ž393. 279. Nitric oxide ŽNO.; S-Nitrosothiol; Organic nitrate; Tolerance ŽMiller, M.R. Ž403. 111.

Biphasic effect D9-Tetrahydrocannabinol; Activity; Cannabinoid; Movement ŽSanudo˜ Pena, ˜ M.C. Ž391. 269.

Nitric oxide ŽNO.; S-Nitrosothiol; Organic nitrate; Tolerance ŽMiller, M.R. Ž408. 335.

Bipolar disorder Schizophrenia; Depression; Memory; Synaptic plasticity; Ventricle enlargement; Neurocognitive impairment ŽVawter, M.P. Ž405. 385.

Blood vessel, canine S-0139; Endothelin receptor subtype; Antagonist activity; Blood vessel, rabbit ŽIwasaki, T. Ž400. 255.

Biscoclaurine alkaloid ŽPDGF. Platelet-derived growth factor; ŽTGF-b . Transforming growth factor-b; Mesangial cell, rat ŽHayama, M. Ž390. 37.

Blood vessel, rabbit S-0139; Endothelin receptor subtype; Antagonist activity; Blood vessel, canine ŽIwasaki, T. Ž400. 255.

Master keyword index to Õolumes 386–410 (2000)

20

B-lymphocyte wMet 5 xenkephalin; Gender; T-lymphocyte; Proliferation; Opioid receptor ŽGabrilovac, J. Ž392. 101. BMY 7378 a 1-Adrenoceptor subtype; Methoxamine; Cirazoline; P7480; Mesenteric artery, rat ŽHussain, M.B. Ž395. 69. Body weight homeostasis Melanocortin; Feeding; Central nervous system; Behavior; Anorexia; Obesity ŽVergoni, A.V. Ž405. 25. Body weight, rat Cannabinoid; HU 210; Ingestive behaviour ŽGiuliani, D. Ž391. 275. Bombesin FLIPR ŽFluorescent imaging plate reader.; Chinese hamster ovary ŽBrough, S.J. Ž409. 259. Bombesin, synthetic glycine-extended form Gastrin-releasing peptide; Biological effect; Gastrin-releasing peptiderbombesin receptor antagonist; ŽIn vitro. ŽOiry, C. Ž403. 17. Bone Nitric oxide ŽNO.; Nitric oxide ŽNO. synthases; Vanadium; Growth; Osteoblast differentiation; Cytotoxicity ŽCortizo, A.M. Ž400. 279. Bout structure Benzodiazepine; Dopamine; Licking behaviour; Palatability ŽHiggs, S. Ž409. 73. BP 897 Dopamine; D3 receptor; Microphysiometry; Radioligand binding ŽWood, M.D. Ž407. 47. BQ-788 Endothelin ETA receptor; Endothelin ETB receptor; Splanchnic nerve stimulation; FR139317 ŽHosokawa, A. Ž397. 55. Endothelin-1; FR139317; Phosphoramidon; Transmural electrical stimulation ŽNagayama, T. Ž406. 69. Bradycardia MF 10058; Muscarinic M 2 receptor antagonist; Cardioselective muscarinic receptor antagonist; Antibradycardic agent; Sick sinus syndrome ŽLamperti, G. Ž406. 93. 3

[ H]Bradykinin Bradykinin B1 receptor; Bradykinin B 2 receptor; Regulation; w3 HxdesArg 10 -kallidin; WI-38 cell; Cytokine ŽPhagoo, S.B. Ž397. 237. Bradykinin X Monosodium glutamate; Smooth muscle; Adenosine-5 -triphosphate; Ž Ž . . Acetylcholine; Angiotensin II Sukhanov, S.N. 386 247 Thermal hyperalgesia; Protein kinase C; Phorbol-12, 13-dibutyrate; Calphostin C; Diabetes; ŽMouse. ŽKamei, J. Ž390. 113. Angiotensin-converting enzyme inhibitor; Ischemia; Reperfusion; Ventricular function, dog ŽHosoya, K. Ž390. 157. 10

Des-Arg -kallidin; FLIPR Žfluorometric imaging plate reader.; Ca Non-competitive antagonism; CHO cells ŽSimpson, P.B. Ž392. 1.

2q

;

Interleukin-1b; Prostaglandin E 2 ; Ca2q mobilization; Gingival fibroblast, human ŽNakao, S. Ž395. 247. Blood pressure; Endothelin-1; Enalapril; Losartan; ŽRat. ŽTanus-Santos, J.E. Ž397. 367.

Vas deferens, rat; Bradykinin receptor; Hoe 140; Antagonism, insurmountable ŽAsghar, A.U.R. Ž398. 131. Bradykinin B 2 receptor; Carboxypeptidase; Neutral endopeptidase; Angiotensin I converting enzyme; Aminopeptidase P; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317. Purinergic neuromodulation; Endothelium; Prostanoid ŽThapaliya, S. Ž408. 313. Inflammation; Neurogenic; Phorbol ester; Protein kinase C; Triterpenoid ŽHuguet, A.-I. Ž410. 69. Bradykinin B 1 receptor Bradykinin B 2 receptor; Regulation; w3 Hxdes-Arg 10 -kallidin; w3 HxBradykinin; WI-38 cell; Cytokine ŽPhagoo, S.B. Ž397. 237. Umbilical vein, human; Retinoid ŽSardi, S.P. Ž407. 313. Bradykinin B 2 receptor Antagonist; Vessel, isolated; ŽHuman.; ŽPig.; ŽRabbit. ŽRizzi, C. Ž386. 25. Bradykinin receptor antagonist; Cystitis; MEN 11270; Urinary bladder, human; Urinary bladder, rat ŽMeini, S. Ž388. 177. Bradykinin B1 receptor; Regulation; w3 Hxdes-Arg 10 -kallidin; w3 HxBradykinin; WI-38 cell; Cytokine ŽPhagoo, S.B. Ž397. 237. Bradykinin; Carboxypeptidase; Neutral endopeptidase; Angiotensin I converting enzyme; Aminopeptidase P; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317. Antagonism; FR173657; FR190997; MEN 11270; Non-peptide ŽMeini, S. Ž409. 185. Bradykinin B 2 receptor antagonist Kallikrein secretion; Kq; Diuresis; Natriuresis; FR173657 ŽSuzuki, T. Ž399. 223. Bradykinin receptor Vas deferens, rat; Bradykinin; Hoe 140; Antagonism, insurmountable ŽAsghar, A.U.R. Ž398. 131. Lipopolysaccharide, bacterial; Microphysiometer; Aortic endothelial cell, bovine; FR173657 ŽBentley, K.R. Ž402. 11. Bradykinin receptor antagonist Bradykinin B 2 receptor; Cystitis; MEN 11270; Urinary bladder, human; Urinary bladder, rat ŽMeini, S. Ž388. 177. Brain Donepezil hydrochloride; E2020; Tacrine; Cholinesterase inhibitor; Peripheral tissue; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. Kynurenine; 3-Hydroxyanthranilic acid; Inhibitor; Plasma; ŽRat. ŽFornstedt-Wallin, B. Ž386. 15. SP1 Žstimulatory protein-1. gene transcription factor; NF-kB Žnuclear factor-kB. gene transcription factor; Ethanol tolerance; Ethanol dependence ŽMittal, N. Ž386. 113. Cerebral ischemia; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-L-arginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Erythropoietin; Subarachnoid hemorrhage ŽBuemi, M. Ž392. 31.

Master keyword index to Õolumes 386–410 (2000) Cannabinoid; Behavioural tolerance; Energetic metabolism; Cannabinoid CB1 receptor-specific antagonist ŽCosta, B. Ž395. 1. Galanin; Galanin-Ž1–15.; Galanin receptor; Galanin receptor antagonist; Cardiovascular; Neuropeptide ŽNarvaez, ´ J.A. Ž399. 197. Brain edema Blood–brain barrier; Cerebral ischemia–reperfusion; Histamine; Intracellular histamine binding site; DPPE Ž N,N-diethyl-2-w4-Žphenylmethyl.phenoxyxethanamine. ŽDeli, M.A. Ž387. 63.

21

Bronchial asthma Cytokine; Bronchial hyperresponsiveness; Arachidonic acid metabolite ŽNakatani, Y. Ž392. 175. Bronchial hyperresponsiveness Cytokine; Bronchial asthma; Arachidonic acid metabolite ŽNakatani, Y. Ž392. 175. Ozone; Haemoxygenase; Carbon monoxide ŽCO.; Neutrophil ŽHisada, T. Ž399. 229.

Brain, human 5-HT1A receptor; GTPgw35 Sx; Antipsychotic drug; Clozapine; Quetiapine ŽElliott, J. Ž386. 313.

Bronchoalveolar eosinophilia TA-270; Asthmatic response; Airway hyperresponsiveness ŽAoki, Y. Ž409. 325.

w35 SxGTPgS binding; a 2 -Adrenoceptor; 5-HT1A receptor; m-Opioid receptor; G-protein ŽGonzalez-Maeso, J. Ž390. 25. ´

Bronchoalveolar lavage Phosphodiesterase inhibitor; Matrix metalloproteinase; Tissue remodelling; ŽMouse. ŽBelleguic, C. Ž404. 369.

Brain injury Erythropoietin; Cerebral ischemia; Neuronal death delayed; Nitric oxide ŽNO. ŽCalapai, G. Ž401. 349. Brain ischemia Erythropoietin; Subarachnoid hemorrhage ŽAlafaci, C. Ž406. 219. Brain melanocortin system ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Peptide–receptor interaction; Avoidance; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. Brain membrane, rat MS-377; s Binding site; Radiolabeled ligand binding ŽKarasawa, J.-i. Ž400. 51. Brain microvessel, rat Valproate; Arachidonic acid cascade; Platelet ŽSzupera, Z. Ž387. 205. Brain phospholipase A 2 Catecholamines, plasma; Sympatho-adrenomedullary outflow, central; Melittin; Mepacrine ŽYokotani, K. Ž398. 341. Brain regional heterogeneity GABA A receptor subtype; w35 SxTBPS binding; Agonist coupling; Taurine; b-Alanine; Muscimol; 4-PIOL; 5-Ž4-piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233.

Bronchoconstriction Chronic hypoxia; Lung; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; Methacholine; 5-HT; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469. Bronchodilation Airway; Rho-associated coiled coil-forming protein kinase; Rho; Smooth muscle ŽNakahara, T. Ž389. 103. Bronchodilator Rho-kinase; Y-27632 ŽIizuka, K. Ž406. 273. Bronchus, human, isolated Phorbol 12,13-diacetate; Theophylline; Caffeine ŽSarria, ´ B. Ž399. 65. Brown Norway, rat Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; Methacholine; 5-HT; Bronchoconstriction; Active sensitisation; Ovalbumin ŽTigani, B. Ž406. 469. Brush border membrane 5-HT Ž5-hydroxytryptamine, serotonin. transport; 5-HT receptor; Jejunum, rabbit ŽAlcalde, A.I. Ž403. 9.

Brain slice GYKI 52466; 2,3-Benzodiazepine; Anticonvulsant; Epilepsy; Hippocampus; Epileptiform bursting ŽMarinelli, S. Ž391. 75.

Brush border membrane vesicle E3040; Urate uptake; ŽRat. ŽYamada, H. Ž406. 45.

Antiepileptic drug; Vigabatrin; Epileptic activity; Temporal lobe epilepsy; Pharmacoresistant ŽMusshoff, U. Ž401. 167.

b 3 subunit a-Conotoxin MII; Conus; Nicotinic acetylcholine receptor, human ŽMcIntosh, J.M. Ž393. 205.

Brain stimulation reward Endogenous opoid; Addiction; Reward; Self-administration; Sexual behaviour; Social behaviour ŽVan Ree, J.M. Ž405. 89.

Budesonide Apoptosis; Eosinophil; Fluticasone propionate; Beclomethasone ŽZhang, X. Ž406. 325.

Branched chain amino acid Encephalomyocarditis virus; Glucose intolerance; Insulitis ŽUtsugi, T. Ž398. 409.

Bumetanide Loop-diuretic; Frusemide; Cardiomyocyte; Contraction ŽKelso, E. Ž400. 43.

Breast carcinoma Aromatase inhibitor; Oestrogen; Androgen ŽPalma, C. Ž409. 93.

a-Bungarotoxin Nicotinic acetylcholine receptor subtype; Epibatidine ŽVailati, S. Ž393. 23.

BRL 49653 Thiazolidinedione; Troglitazone; Rosiglitazone; K AT P current; Glibenclamide; Kq channel ŽMishra, S.K. Ž386. 121.

Nicotinic receptor; Acetylcholine receptor; Ciliary ganglion; Sciatic nerve; Neuronal ŽRoth, A.L. Ž393. 105.

22

Master keyword index to Õolumes 386–410 (2000)

Bupranolol b-Adrenoceptor, atypical; b 3 -Adrenoceptor; Duodenum, guinea pig; Carteolol; Partial agonist ŽHorinouchi, T. Ž403. 133.

Ca 2H-ATPase inhibitor Thapsigargin; Ca2q store, EpDRF Žepithelium-dependent relaxing factor.; Airway epithelial cell; ŽGuinea pig. ŽTakahashi, N. Ž410. 61.

Buprenorphine Respiration; Methoclocinnamox; Opioid receptor agonist; Opioid receptor antagonist; ŽRhesus monkey. ŽKishioka, S. Ž391. 289.

Ca 2H-ATPase, Sarcoplasmic reticulum Sarcoplasmic reticulum; Ca2q uptake function; Superficial buffer barrier hypothesis; Ca2q influx; Ca2q channel, L-type; Arterial contraction ŽNomura, Y. Ž404. 315.

2,3-Butanedione monoxime Ca2i q transient; Fura 2-acetoxymethyl ŽAM. ester; Long-term culture; Contractility; Ultrastructure; ŽGuinea pig. ŽHorackova, M. Ž404. 247.

Ca 2H channel Hippocampal neuron; Veratridine; Swelling; Death; Naq channel ŽOkuyama, K. Ž398. 209.

g-Butyrobetaine hydroxylase inhibitor Heart failure; Survival rate; Ventricular remodeling; Cardiac functional adaptability; High-energy phosphate ŽHayashi, Y. Ž395. 217.

Cardiomyocyte; Phospholipase A 2 ; Arachidonic acid; Mepacrine ŽXiao, Y.-F. Ž399. 107.

Ca 2H Apoptosis; Nifedipine; Cardiomyocyte ŽRabkin, S.W. Ž388. 209.

Berberine; Nitric oxide ŽNO.; Kq channel; Vasorelaxation; Proliferation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187.

cAMP; Fluid secretion; Calcein; Multidrug resistance protein ŽSugita, M. Ž388. 227.

Anandamide; Skeletal muscle ŽOz, M. Ž404. 13.

Somatostatin; Aorta; Mesenteric artery ŽRuiz, E. Ž388. 255. Tyrosine kinase; Adrenoceptor; Inositol phosphate; Fura-2 ŽBerts, A. Ž389. 35. UTP contraction; Aorta, rat; Smooth muscle; Vascular; Protein kinase C ŽLopez, C. Ž391. 299. ´ Des-Arg 10 -kallidin; FLIPR Žfluorometric imaging plate reader.; Bradykinin; Non-competitive antagonism; CHO cells ŽSimpson, P.B. Ž392. 1. Phospholipase C; Histamine; Chromaffin cell; Inositol phospholipid; Adrenal medulla ŽRoberts-Thomson, E.L. Ž398. 199. Kq channel; Calmodulin; Patch clamp; Antipsychotic; Dequalinium ŽDreixler, J.C. Ž401. 1. Ouabain; Naq; Aldosterone; NaŽq. –KŽq. –exchanging ATPase ŽYingst, D.R. Ž406. 49. Thiazide; Methyclothiazide; Endothelium; Spontaneously hypertensive, rat ŽSHR.; Hypertension ŽColas, B. Ž408. 63. Betulinic acid; Ca2q store; Fura-2; MDCK cell; Thapsigargin ŽChou, K.-J. Ž408. 99. Astrocyte; LDH Žlactate dehydrogenase.; Mitochondrion; MTT; Naq,Kq-ATPase; Ouabain ŽTakahashi, S. Ž408. 127.

8-OH-DPAT; 5-HT1A receptor; Naq channel; Neuroprotection; Ischemia ŽMelena, J. Ž406. 319. Generalized absence epilepsy; WAGrRij rat; Spike-wave discharge; Nimodipine; BAY K8644; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381. Recombinant; HEK293 cell; Pharmacology ŽMcNaughton, N.C.L. Ž407. 53. Ca 2H channel antagonist Amlodipine; Memory enhancement; Maze learning; Active avoidance, mice; Chronic drug administration ŽQuartermain, D. Ž399. 57. Cerebral ischaemia model; Naq channel antagonist; Electrophysiology ŽCampbell, C.A. Ž401. 419. Ba2q; Cell death; Cytotoxicity; Cytoprotection; Chromaffin cell ŽCanoAbad, M.F. Ž402. 19. Ca 2H channel blocker Respiration; Opioid; Rhesus monkey ŽKishioka, S. Ž397. 85. AH-1058; Ventricular arrhythmia ŽTakahara, A. Ž398. 107. Herbal drug; Sesquiterpene; Smooth muscle ŽIrie, K. Ž403. 235. Thapsigargin; Stimulus pattern; Acetylcholine release; Neuromuscular junction ŽCorreia-de-Sa, ´ P. Ž406. 355.

Enteric neuron; Submucosal neuron; ATP receptor; Receptor; P2X receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´

Ca 2H channel, L-type Clonidine; BAY K 8644; GABA Ž g-aminobutyric acid.; Limbic system; Septum, Epilepsy ŽBaran, H. Ž401. 31.

[Ca 2H ]i Cholecystokinin; SR146131; Phosphoinositide turnover; Binding; ŽHuman. ŽSchaeffer, P. Ž397. 303.

Sarcoplasmic reticulum; Ca2q-ATPase, Sarcoplasmic reticulum; Ca2q uptake function; Superficial buffer barrier hypothesis; Ca2q influx; Arterial contraction ŽNomura, Y. Ž404. 315.

Ca 2H-activated Anesthetic; volatile; Kq channel; Xenopus oocyte ŽNamba, T. Ž395. 95.

Sarcoplasmic reticulum; Superficial buffer barrier hypothesis; Ca2q-induced Ca2q release channels; Ca2q movement; Ca2q influx ŽAsano, M. Ž404. 327.

Ca 2H-ATPase Oligomycin; Naq,Kq-ATPase; Naq occlusion; Chimeric ATPase ŽHomareda, H. Ž400. 177.

Ventricular cardiomyocyte, rat; Contractile function; Nitric oxide ŽNO.; Myoglobin ŽVulcu, S.D. Ž406. 247.

Master keyword index to Õolumes 386–410 (2000) Ca 2H channel, L-type voltage-dependent CP-060S; Aorta, rat; Ca2q, Cytosolic ŽSato, K. Ž400. 225. Ca2q channel, neuronal Cerebral ischaemia; Neuroprotection ŽHicks, C.A. Ž408. 241. Ca 2H channel, N-type v-Conotoxin GVIA; v-Conotoxin MVIIA; v-Conotoxin MVIIC; Vas deferens; Intestine; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuineapig. ŽSanger, G.J. Ž388. 89. Ca 2H channels Nicotine; Antinociception; CaM kinase II; Intrathecal; ŽMice. ŽDamaj, M.I. Ž404. 103. Ca 2H-channel, voltage-gated Circumferential stretch; Axial stretch; Impedance planimetry; Coronary artery, large; Tone; ŽPig. ŽTanko, ´ L.B. Ž387. 303.

23

Ca 2H entry, capacitative Ca2q store, internal; Fura-2; Cation channel, non-selective; Tyrosine kinase ŽOhta, T. Ž387. 211. Ca 2H, Extracellular Muscarinic receptor; Gallbladder; Receptor heterogeneity; Radioligand binding; Kinetics; Ca2q, Intracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Ca 2H homeostasis Hindered phenol; BHA Ž3-t-butyl-4-hydroxyanisole. ŽFusi, F. Ž394. 109. Ca 2H-induced Ca 2H release channels Sarcoplasmic reticulum; Superficial buffer barrier hypothesis; Ca2q movement; Ca2q influx; Ca2q channel, L-type ŽAsano, M. Ž404. 327. Ca 2H influx Endothelial cell; Angiogenesis; Proliferation ŽKawasaki, J. Ž398. 19.

Ca 2H-channel, voltage-sensitive S-Nitrosothiol; Nitric oxide ŽNO.; EDRF Žendothelium-derived relaxing factor.; Vasodilation ŽTravis, M.D. Ž408. 289.

Sarcoplasmic reticulum; Ca2q-ATPase, Sarcoplasmic reticulum; Ca2q uptake function; Superficial buffer barrier hypothesis; Ca2q channel, L-type; Arterial contraction ŽNomura, Y. Ž404. 315.

Ca 2H concentration Sphingomyelinase; Smooth muscle, Aortic, rat; Intracellular, free ŽZheng, T. Ž391. 127.

Sarcoplasmic reticulum; Superficial buffer barrier hypothesis; Ca2q-induced Ca2q release channels; Ca2q movement; Ca2q channel, L-type ŽAsano, M. Ž404. 327.

Ca 2H concentration, Intracellular Antisense oligodeoxynucleotide; NaqrCa2q exchange; Ca2q pump; Thapsigargin ŽNakao, M. Ž387. 273.

Ca 2H, intracellular Tyrosine kinase; Damnacanthal; Dermal fibroblast ŽAoki, K. Ž387. 119.

Ca 2H concentration, intracellular AMPA receptor; Cortical neurone, cultured; Chloral hydrate; Trichloroethanol; Fura-2 microfluorimetry ŽFischer, W. Ž394. 41. 2H

Ca current NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Patch clamp; Ca2q current, Capacitative; Ca2q release-activated current; Jurkat cell; pH Modulation ŽLi, J.H. Ž394. 171. Mibefradil; Sinus node cell ŽProtas, L. Ž401. 27. Rabies virus; NG108-15 cell; a-Adrenoceptor; Muscarinic receptor; Patch clamp, Whole-cell ŽIwata, M. Ž404. 79. Ca 2H current, Capacitative NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Patch clamp; Ca2q current; Ca2q release-activated current; Jurkat cell; pH Modulation ŽLi, J.H. Ž394. 171. 2H

current, L-type Ca Neonate; Cardiac myocyte; Adenosine; ATP; Purinoceptor ŽSuto, F. Ž409. 213.

Myometrium Žporcine.; a 2 -Adrenoceptor; Clonidine; cAMP; Ca2q sensitivity ŽKitazawa, T. Ž390. 185. TA-993; Platelet; Glycoprotein IIbrIIIa receptor; ADP; Actin polymerization ŽKatoh, M. Ž399. 91. P2Y receptor; Sweat gland; Anionic secretion; Hyperhidrosis; Ussing chamber ŽBovell, D.L. Ž403. 45. Ca 2H, Intracellular Muscarinic receptor; Gallbladder; Receptor heterogeneity; Radioligand binding; Kinetics; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Ca 2H mobilisation Muscarinic receptor; Sphingosine 1-phosphate; Dimethylsphingosine; InsŽ1,4,5.P3 ; SH-SY5Y neuroblastoma cell ŽYoung, K.W. Ž402. 55. Ca 2H mobilization Bradykinin; Interleukin-1b; Prostaglandin E 2 ; Gingival fibroblast, human ŽNakao, S. Ž395. 247.

Ca , cytosolic Angiotensin II; Angiotensin II type 1 receptor; Mesothelial cell; Pleura ŽKuwahara, M. Ž388. 21.

Ca 2H movement Sarcoplasmic reticulum; Superficial buffer barrier hypothesis; Ca2q-induced Ca2q release channels; Ca2q influx; Ca2q channel, L-type ŽAsano, M. Ž404. 327.

Neuromedin B receptor antagonist, nonpeptide; c-fos mRNA; Focal adhesion kinase; Proliferation ŽMoody, T.W. Ž409. 133.

[Ca 2H ]i oscillation Rebamipide; CCK 1 receptor; Pancreatic acinar cell ŽMoon, S.J. Ž388. 17.

Ca 2H, Cytosolic CP-060S; Aorta, rat; Ca2q channel, L-type voltage-dependent ŽSato, K. Ž400. 225.

Ca 2H overload l-cis-Diltiazem; d-cis-Diltiazem; Patch-clamp; Whole-cell; Naq current; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217.

Ca 2H, cytosolic-free Neutrophils, rat; p38 Mitogen-activated protein kinase; Tyrosine kinase; Protein kinase C; Phospholipase C ŽChang, L.-C. Ž390. 61.

Ca 2H pump Antisense oligodeoxynucleotide; NaqrCa2q exchange; Ca2q concentration, Intracellular; Thapsigargin ŽNakao, M. Ž387. 273.

2H

24

Master keyword index to Õolumes 386–410 (2000)

Ca 2H release-activated current NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Patch clamp; Ca2q current; Ca2q current, Capacitative; Jurkat cell; pH Modulation ŽLi, J.H. Ž394. 171. Ca 2H reperfusion T-588; NGF Žnerve growth factor.; PD98059; MAP Žmitogen-activated protein. kinase; Astrocyte ŽTakuma, K. Ž399. 1.

Caffeine Ryanodine receptor; Skinned fiber; Dichlorobenzamil; Phenamil ŽPonte, C.G. Ž391. 11. Bronchus, human, isolated; Phorbol 12,13-diacetate; Theophylline ŽSarria, ´ B. Ž399. 65. Amitriptyline; Thermal hyperalgesia; Neuropathic pain ŽEsser, M.J. Ž399. 131.

Ca 2H-responsiveness Ca2q-sensitizer; Myocardial contractility; End-systolic elastance; Stunning ŽDe Zeeuw, S. Ž403. 99.

Adenosine receptor; Locomotion; Dopamine receptor; In situ hybridization; Autoradiography ŽHalldner, L. Ž406. 345.

Ca 2H sensitivity Myometrium Žporcine.; a 2 -Adrenoceptor; Clonidine; Ca2q, intracellular; cAMP ŽKitazawa, T. Ž390. 185.

Caged compound GABA Ž g-aminobutyrate.; Synaptic inhibition; Hippocampus; Granule cell; GABA A receptor ŽMolnar, ´ P. Ž391. 255.

Ca 2H sensitizer Myocardial oxygen consumption; Diastolic function, regional; Systolic shortening, regional; Systemic haemodynamics ŽSoei, L.K. Ž386. 55.

Calcein Calcium ion; cAMP; Fluid secretion; Multidrug resistance protein ŽSugita, M. Ž388. 227.

Ca 2H-sensitizer Ca2q-responsiveness; Myocardial contractility; End-systolic elastance; Stunning ŽDe Zeeuw, S. Ž403. 99. Inotropic agent; Hemodynamics; Heart failure; Excitation–contraction coupling; Diastolic dysfunction ŽJanssen, P.M.L. Ž404. 191. Ca 2H signalling InsP3 receptor; Paxilline; Mycotoxin ŽLongland, C.L. Ž408. 219. Ca 2H store Betulinic acid; Ca2q; Fura-2; MDCK cell; Thapsigargin ŽChou, K.-J. Ž408. 99. Ca 2H store, EpDRF (epithelium-dependent relaxing factor) Thapsigargin; Ca2q-ATPase inhibitor; Airway epithelial cell; ŽGuinea pig. ŽTakahashi, N. Ž410. 61. Ca 2H store, internal Ca2q entry, capacitative; Fura-2; Cation channel, non-selective; Tyrosine kinase ŽOhta, T. Ž387. 211. [Ca 2H ]i transient Endothelin-1; Cardiac muscle; Protein kinase C ŽIzumi, M. Ž396. 109. Ca 2H transient Positive inotropic effect; Ventricular muscle, dog; Myofibrillar Ca2q sensitivity; cAMP; Levosimendan ŽTakahashi, R. Ž400. 103. Lipopolysaccharide; Vascular hyporeactivity; Ventricular myocyte; badrenergic stimulation; Nitric oxide ŽNO. ŽShan, Q. Ž406. 257. Ca 2i H transient 2,3-Butanedione monoxime; Fura 2-acetoxymethyl ŽAM. ester; Long-term culture; Contractility; Ultrastructure; ŽGuinea pig. ŽHorackova, M. Ž404. 247. Adrenomedullin; Myocyte; Papillary muscle; Heart, isolated; ŽRat. ŽStangl, V. Ž408. 83. Ca 2H uptake function Sarcoplasmic reticulum; Ca2q-ATPase, Sarcoplasmic reticulum; Superficial buffer barrier hypothesis; Ca2q influx; Ca2q channel, L-type; Arterial contraction ŽNomura, Y. Ž404. 315.

Calcein-AM Multidrug resistance; P-glycoprotein; MRP1 Žmultidrug resistance-associated protein.; Daunorubicin; Inhibitor; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207. Calcineurin Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Calcitonin gene-related peptide (CGRP) Amylin; Adrenomedullin; Calcitonin receptor-like receptor; Myocardial contraction; Receptor associated modifying protein ŽRAMP . ŽSaetrum Opgaard, O. Ž397. 373. BIBN4096BS; CGRP Ž8-38.; CGRP receptor subtypes; Left atrium, rat; Vas deferens, rat ŽWu, D. Ž400. 313. Calcitonin receptor-like receptor Amylin; Adrenomedullin; Calcitonin gene-related peptide ŽCGRP.; Myocardial contraction; Receptor associated modifying protein ŽRAMP. ŽSaetrum Opgaard, O. Ž397. 373. Calmodulin Zaldaride maleate; Adenylate cyclase; Guanylate cyclase; Ion secretion ŽAikawa, N. Ž394. 233. Kq channel; Calcium; Patch clamp; Antipsychotic; Dequalinium ŽDreixler, J.C. Ž401. 1. Calmodulin antagonist Mechanosensitive channel; Stretch receptor; Voltage clamp ŽLin, J.-H. Ž397. 11. Calphostin C Bradykinin; Thermal hyperalgesia; Protein kinase C; Phorbol-12, 13-dibutyrate; Diabetes; ŽMouse. ŽKamei, J. Ž390. 113. CaM kinase II Nicotine; Antinociception; Ca2q channels; Intrathecal; ŽMice. ŽDamaj, M.I. Ž404. 103. cAMP HCL-31D, platelet aggregation; Thromboxane B 2 ; Phosphoinositide breakdown ŽChou, T.-C. Ž387. 125.

Master keyword index to Õolumes 386–410 (2000) Thromboxane A 2 ; TP receptor; Forskolin; Mammary artery, internal; Saphenous vein ŽCracowski, J.-L. Ž387. 295. Calcium ion; Fluid secretion; Calcein; Multidrug resistance protein ŽSugita, M. Ž388. 227. Receptor expression; Ligand binding; mRNA detection ŽDautzenberg, F.M. Ž390. 51. Adrenomedullin; Papillary muscle; Contractility ŽIhara, T. Ž390. 167. Myometrium Žporcine.; a 2 -Adrenoceptor; Clonidine; Ca2q, intracellular; Ca2q sensitivity ŽKitazawa, T. Ž390. 185. Nitric oxide ŽNO.; b 2-Adrenoceptor agonist; Smooth muscle; cGMP; Iberiotoxin ŽVaali, K. Ž399. 75. Positive inotropic effect; Ventricular muscle, dog; Ca2q transient; Myofibrillar Ca2q sensitivity; Levosimendan ŽTakahashi, R. Ž400. 103. Mesenteric artery, rat; Levcromakalim; Forskolin; Protein kinase A; K AT P channels ŽOmar, R. Ž401. 85. Cannabinoid CB 2 receptor; WIN55212; Palmitoylethanolamide; Nitric oxide ŽNO.; RAW264.7; Macrophage ŽRoss, R.A. Ž401. 121. Atrium; Pituitary adenylate cyclase activating polypeptide ŽPACAP. ŽCui, X. Ž402. 129. 5-HT Ž5-Hydroxytryptamine, serotonin.; Endothelial cell, rat; Protein kinase C; w3 HxPhorbol 12,13-dibutyrate binding; Trypsin-treated protein kinase C activity; cGMP ŽLee, H.-Z. Ž403. 195. Epithelial Naq channel; Urinary bladder ŽBurton, T.J. Ž404. 273. Phosphodiesterase; Pulmonary circulation; cGMP; ŽPharmacology.; ŽCat. ŽDe Witt, B.J. Ž406. 233. Osteoblast, Human; CGRP Žcalcitonin gene-related peptide.; CGRP-Ž837.; Amylin, Amylin-Ž8-37.; Proliferation ŽVilla, I. Ž409. 273. cAMP accumulation m-Opioid receptor; Orphanin FQrnociceptin ŽMandyam, C.D. Ž402. 205.

25

HU 210; Ingestive behaviour; Body weight, rat ŽGiuliani, D. Ž391. 275. Behavioural tolerance; Brain; Energetic metabolism; Cannabinoid CB1 receptor-specific antagonist ŽCosta, B. Ž395. 1. Capsaicin; Neuron; Afferent; Pain; Receptor; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39. Antinociception; Intrahecal; Intraventricular; Structure–activity relationship; Tetrahydrocannabinol ŽWiley, J.L. Ž397. 319. D9-THC Ž D9 -tetrahydrocannabinol.; SR 141716A; Antinociception; Marijuana, medical; Aerosol; Nebulizer ŽLichtman, A.H. Ž399. 141. Acetycholine; Glutamate; Learning; Short-term memory ŽHan, C.J. Ž403. 87. Radial-arm maze; SR141716A; Working memory ŽLichtman, A.H. Ž404. 175. Anandamide; Fatty acid ethanolamides; High-performance liquid chromatography; Mass spectrometry; Anandamide transport ŽGiuffrida, A. Ž408. 161. Cannabinoid CB 1 receptor D9-Tetrahydrocannabinol; CP 55,940; Anandamide; SR 141716A; SR 144528; Sympathetic neurotransmission ŽLay, L. Ž391. 151. Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. Cannabinoid CB 2 receptor Cannabinoid CB1 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. WIN55212; Palmitoylethanolamide; Nitric oxide ŽNO.; RAW264.7; Macrophage; cAMP ŽRoss, R.A. Ž401. 121.

5-HT receptor; Vasoconstriction ŽBou, J. Ž410. 33.

Cannabinoid CB 1 receptor-specific antagonist Cannabinoid; Behavioural tolerance; Brain; Energetic metabolism ŽCosta, B. Ž395. 1.

cAMP-dependent protein kinase m-Opioid receptor; Tolerance; Desensitization; Morphine; N-Ž2aminoethyl.-5-isoquinolinesulfonamide ŽH8. ŽWang, Z. Ž389. 165.

Cannabinoid receptor Knockout mouse; D9 Tetrahydrocannabinol; Macrophage ŽBuckley, N.E. Ž396. 141.

Adrenoceptor; Dopamine; Loop of Henle; ŽMouse. ŽHiguchi, E. Ž408. 107.

SR 144528; WIN 55212-2; Mutagenesis; Ligand docking; Molecular model ŽGouldson, P. Ž401. 17.

cAMP phosphodiesterase Insulin; Primary culture of hepatocyte; Tyrosine phosphorylation; Microtubule; Wortmannin; Herbimycin A ŽIshibashi, K. Ž409. 109.

Vanilloid receptor; Anandamide; Capsaicin; Anti-nociception; Behavior; ŽMouse. ŽDi Marzo, V. Ž406. 363.

cAMP response element Melatonin receptor; Luciferase; Reporter gene assay; HEK293 cell ŽConway, S. Ž390. 15.

Cannabinoid receptor agonist WIN 55212-2; Cannabinoid receptor antagonist; SR14716A; Ileum; Electrical field stimulation; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207.

Candidate gene Opiate; Heroin; Addiction; Genetic; Pharmacogenomics ŽLichtermann, D. Ž410. 269.

Cannabinoid receptor antagonist Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Hyperalgesia; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85.

Cannabinoid D9-Tetrahydrocannabinol; Activity; Biphasic effect; Movement ŽSanudo˜ Pena, ˜ M.C. Ž391. 269.

Cannabinoid receptor agonist; WIN 55212-2; SR14716A; Ileum; Electrical field stimulation; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207.

26

Master keyword index to Õolumes 386–410 (2000)

Capillary endothelium Angiogenesis; S-nitrosocaptopril; Captopril; Nitric oxide ŽNO.; Chorioallantoic membrane; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137.

Cardiac action potential Fluoroquinolones; Sparfloxacin; Moxifloxacin; Grepafloxacin; Ciprofloxacin; Purkinje fibre; ŽCanine. ŽPatmore, L. Ž406. 449.

Capsaicin Amtolmetin guacyl; Antisecretion; Gastroprotection; CGRP Žcalcitonin gene-related peptide. ŽTubaro, E. Ž387. 233.

Cardiac fibroblast Lipopolysaccharide; Angiotensin II type 2 receptor; Cytokine; Nitric oxide ŽNO.; Cyclic GMP ŽTamura, M. Ž386. 289.

X X Myenteric neuron; PPADS ŽPyridoxal-phosphate-6-azophenyl-2 ,4 -disulphonic acid.; VIP ŽVasoactive intestinal polypeptide.; PACAP ŽPituitary adenylate cyclase activating peptide.; NO ŽNitric oxide.; Small intestine ŽBartho, ´ L. Ž392. 183.

Cannabinoid; Neuron; Afferent; Pain; Receptor; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39. Vagal afferent; Somatostatin; Mustard oil; Antidromic stimulation; Antiinflammatory effect ŽThan, ´ M. Ž399. 251. Cannabinoid receptor; Vanilloid receptor; Anandamide; Anti-nociception; Behavior; ŽMouse. ŽDi Marzo, V. Ž406. 363. Nociception; Pain; Ricinoleic acid; Substance P; Tachykinin; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Captopril Angiogenesis; S-nitrosocaptopril; Nitric oxide ŽNO.; Capillary endothelium; Chorioallantoic membrane; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137.

Cardiac functional adaptability g-Butyrobetaine hydroxylase inhibitor; Heart failure; Survival rate; Ventricular remodeling; High-energy phosphate ŽHayashi, Y. Ž395. 217. Cardiac function control Hormonal control; Endothelial receptor, luminal; ATP; Purinoceptor; Endothelial mediator ŽZenteno-Savin, T. Ž410. 15. Cardiac hypertrophy Diabetes; Hyperglycaemia; Peroxisome proliferator-activated receptor g ŽBell, D. Ž390. 237. Nandrolone decanoate; Deca durabolin; Cocaine; Radiotelemetry; ECG Želectrocardiogram.; Noradrenaline ŽPhillis, B.D. Ž398. 263. Cardiac ischemia I K.ATP ; Glibenclamide; HMR1883; Sulfonylurea; Dispersion; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273. Apoptosis; Infarct; Caspase inhibitor; Reperfusion injury ŽHuang, J.-Q. Ž402. 139.

Carbachol Mesenteric artery, rat; Endothelium; Levcromakalim; Hyperpolarisation; 18a-Glycyrrhetinic acid ŽWhite, R. Ž397. 279.

Cardiac muscle Endothelin-1; wCa2q x i transient; Protein kinase C ŽIzumi, M. Ž396. 109.

Nonvascular smooth muscle; Mitogen-activated protein kinase; Contraction; Prostaglandin F2 a ŽYousufzai, S.Y.K. Ž407. 17.

Cardiac myocyte Neonate; Ca2q current, L-type; Adenosine; ATP; Purinoceptor ŽSuto, F. Ž409. 213.

Carbamazepine Epilepsy; Topiramate; Phenytoin; Valproate; Felbamate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163.

Cardiomyocyte Apoptosis; Ca2q; Nifedipine ŽRabkin, S.W. Ž388. 209.

Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275.

Ca2q channel; Phospholipase A 2 ; Arachidonic acid; Mepacrine ŽXiao, Y.-F. Ž399. 107. Loop-diuretic; Bumetanide; Frusemide; Contraction ŽKelso, E. Ž400. 43.

Carbohydrate Indolocarbazole; Cell membrane; Cellular uptake; Rebeccamycin ŽGoossens, J.-F. Ž389. 141.

Amiodarone; b-Adrenoceptor turnover; Triiodothyronine ŽVassy, R. Ž408. 227.

b-Carboline alkaloid Inflammation; Nitric oxide ŽNO.; Inducible NO synthase; NF-kB Žnuclear factor-kB. ŽLee, B.G. Ž406. 301.

Cardioselective muscarinic receptor antagonist MF 10058; Muscarinic M 2 receptor antagonist; Antibradycardic agent; Sick sinus syndrome; Bradycardia ŽLamperti, G. Ž406. 93.

Carbon monoxide (CO) Nitric oxide ŽNO.; Hydrogen peroxide; Corpus cavernosa; Urethra relaxation ŽNaseem, K.M. Ž387. 329.

Cardiovascular Galanin; Galanin-Ž1–15.; Galanin receptor; Galanin receptor antagonist; Neuropeptide; Brain ŽNarvaez, ´ J.A. Ž399. 197.

Ozone; Haemoxygenase; Neutrophil; Bronchial hyperresponsiveness ŽHisada, T. Ž399. 229.

Fetal, sheep; Angiotensin; AT1 receptor; AT2 receptor; Cortisol ŽHegarty, B.D. Ž406. 439.

Carboxyl terminal tail d-Opioid receptor; Down-regulation ŽOkura, T. Ž387. R11.

Cardiovascular disease Gene polymorphism; Susceptibility; Angiotensin-converting enzyme; Angiotensinogen; Angiotensin II type 1 receptor ŽWang, J.-G. Ž410. 289.

Carboxypeptidase Bradykinin; Bradykinin B 2 receptor; Neutral endopeptidase; Angiotensin I converting enzyme; Aminopeptidase P; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317.

Cardiovascular regulation Paraventricular nucleus; Excitatory amino acid; Central; Microinjection; ŽRat. ŽGoren, M.Z. Ž388. 77. ¨

Master keyword index to Õolumes 386–410 (2000) Cardiovascular safety 5-HT1B r1D receptor agonist; Migraine; Almotriptan ŽGras, J. Ž410. 53. Cardiovascular system Opiate; Dependence, acute; Gender difference; Blood pressure; Heart rate; Rat, spinal ŽCruz, S.L. Ž397. 121. b-Adrenoceptor, subtype; Detrusor; ŽFerret. ŽTakeda, H. Ž403. 147. Carnitine palmitoyltransferase Etomoxir; SDZ CPI 975; Hypertrophy ŽYotsumoto, T. Ž398. 297. Carnitine palmitoyltransferase I inhibition Heart, Rat; Contractile function; Etomoxir; Hypertrophy; Infarct size ŽGunther, J. Ž406. 123. ¨ Carotid artery Endothelium; Diabetes; Nitric oxide ŽNO.; 5-HT Ž5-Hydroxytryptamine, serotonin. ŽMiranda, F.J. Ž401. 397. Hyperpolarization; Nitric oxide ŽNO.; Prostanoid; N v -nitro-L-arginine; ODQ Ž1 H-w1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Femoral artery ŽCrauwels, H.M. Ž404. 341. Carotid artery blood flow Eletriptan; Sumatriptan; Femoral artery blood flow; Neurogenic inflammation; Coronary artery diameter ŽGupta, P. Ž398. 73. Carotid artery, rat Endothelial injury; Angiotensin I-converting enzyme; Angiotensin I-converting enzyme inhibitor; Vasoconstriction ŽLemay, J. Ž394. 301. Carrageenan Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Superoxide dismutase; Tempol ŽCuzzocrea, S. Ž390. 209. Dopaminergic agent; Dopamine D1 receptor; Dopamine D 2 receptor; Anti-hyperalgesia; Hypoalgesia ŽGao, X. Ž406. 53. Carrageenan paw oedema Ditriazines; Nitric oxide ŽNO.; Eicosanoid; Macrophage; Neutrophil; Air pouch, mouse ŽRioja, I. Ž397. 207. Carrageenin-induced pleurisy, rat Anti-inflammatory steroid; Dexamethasone; Prostaglandin H synthase-2 Žcyclooxygenase-2.; Phospholipase A 2 ŽKawamura, M. Ž400. 127. CART (cocaine- and amphetamine-regulated transcript) TRH Žthyrotropin releasing hormone.; Dopamine; Norepinephrine; Synaptosome; Hypothalamus ŽBrunetti, L. Ž409. 103. Carteolol b-Adrenoceptor, atypical; b 3 -Adrenoceptor; Duodenum, guinea pig; Partial agonist; Bupranolol ŽHorinouchi, T. Ž403. 133. Caspase CTGF Žconnective tissue growth factor.; TGF-b Žtransforming growth factor b .; Apoptosis; Atherosclerosis ŽHishikawa, K. Ž392. 19.

27

Caspase inhibitor Apoptosis; Cardiac ischemia; Infarct; Reperfusion injury ŽHuang, J.-Q. Ž402. 139. Catalase Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Endothelium-independent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Superoxide dismutase ŽKarasu, C¸ . Ž392. 163. Catalepsy Dopamine D 2 receptor; Dopamine D 3 receptor; Haloperidol; Knock-out mice; SCH 23390 ŽBoulay, D. Ž391. 63. Neuroleptic; Antipsychotic; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2 -like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. Catecholamine Mutagenesis; Allosteric modulator ŽSchetz, J.A. Ž388. R5. Spectral analysis; Valsartan; Isoprenaline; Arterial pressure ŽBlanc, J. Ž394. 311. Self-administration; Epinephrine; Norepinephrine; Corticosterone; Yoking; Nicotine ŽDonny, E.C. Ž402. 231. Catecholamine, 5-hydroxytryptamine, serotonin (5-HT) Anandamide; Food intake; Diet restriction; Cognitive function; Hippocampus; Hypothalamus; Corticosterone ŽHao, S. Ž392. 147. Catecholamine release Conotoxin; Neuronal nicotinic receptor; Acetylcholine receptor; Chromaffin cell; Nicotinic receptor antagonist ŽBroxton, N. Ž390. 229. Catecholaminergic activity Morphine withdrawal; Ventricle, right; Yohimbine; Prazosin ŽMilanes, ´ M.V. Ž397. 311. Catecholamines, plasma Brain phospholipase A 2 ; Sympatho-adrenomedullary outflow, central; Melittin; Mepacrine ŽYokotani, K. Ž398. 341. Cation channel, non-selective Ca2q entry, capacitative; Ca2q store, internal; Fura-2; Tyrosine kinase ŽOhta, T. Ž387. 211. Cation, Divalent 5-HT3 receptor; Zn2q; Voltage-clamp, Whole-cell; Radioligand binding; Neuromodulation ŽHubbard, P.C. Ž394. 189. Caudoputamen Glutamate receptor, metabotropic; Excitatory amino acid; Nucleus accumbens; Basal ganglia; Drug of abuse ŽMao, L. Ž404. 289. C57BL mouse liver microsomal preparation Deprenyl metabolism; Cytochrome P450; Parkinson’s disease; N-dealkylation pathway ŽValoti, M. Ž391. 199.

Neuroinflammation; Forebrain basal; Acetylcholine; Non-steroidal antiinflammatory drug; ŽRat. ŽWenk, G.L. Ž402. 77.

C2C12 cell Glucose transporter isotype 4; Insulin resistance; YM-126414 ŽShimokawa, T. Ž410. 1.

Neutrophil; Apoptosis inhibitory protein; Transcription factor; NF-kB Žnuclear factor-kB.; TNF-a Žtumor necrosis factor-a . ŽNiwa, M. Ž407. 211.

CCK A receptor SR 27897B; L-365,260; Cholecystokinin; Dopamine; CCK B receptor ŽTieppo, C.A. Ž387. 189.

28

Master keyword index to Õolumes 386–410 (2000)

CCK B receptor SR 27897B; L-365,260; Cholecystokinin; Dopamine; CCK A receptor ŽTieppo, C.A. Ž387. 189.

Central nervous system Convulsion; Systemic toxicity ŽSugimoto, M. Ž401. 329. Melatonin; Analgesia; Naloxone ŽYu, C.-X. Ž403. 49.

CCK 1 receptor Rebamipide; wCa2q x i oscillation; Pancreatic acinar cell ŽMoon, S.J. Ž388. 17. Binding site; Modelling; SR 27897; SR 146131 ŽGouldson, P. Ž400. 185. CCK receptor antagonist Gastrin; Gastrin-binding protein ŽRorison, K.A. Ž388. 9. CCK 1 receptor antagonist Enkephalin catabolism, mixed inhibitors; Enkephalin, endogenous; Drug discrimination; Morphine; CI 988; RB 120 ŽHutcheson, D.M. Ž401. 197. CCK 2 receptor antagonist Fluoxetine; Conditioned place preference; Morphine; RB 120; CI 988 ŽSubhan, F. Ž390. 137. CCR1 Species selectivity; Molecule antagonist ŽLiang, M. Ž389. 41. Cell culture Vasopressin; Vasopressin V1A receptor; Vasopressin V2 receptor; Hypertrophy; Myocyte ŽNakamura, Y. Ž391. 39. Amyotrophic lateral sclerosis ŽALS.; Motor neuron; Apoptosis; Tissue culture; Neurodegenerative disease ŽBar, ¨ P.R. Ž405. 285. Cell cycle Suramin; Eriochrome Black T; Endothelial cell; Cyclin ŽLanger, I. Ž399. 85. Ribavirin; Ras; Raf-1; Heat shock; Extracellular signal-regulated protein kinase; GTP ŽVallee, ´ S. Ž404. 49.

Melanocortin; Feeding; Behavior; Body weight homeostasis; Anorexia; Obesity ŽVergoni, A.V. Ž405. 25.

´ Ž405. 297. Stem cell; Differentiation; Hematopoietic ŽMezey, E. TC-2559; Nicotinic receptor; Cognition ŽBencherif, M. Ž409. 45. Centralr r peripheral Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Cerebellum s Receptor; Glutamate release; GABA Ž g-aminobutyric acid. release; Synaptosome ŽGarrone, B. Ž400. 35. Cocaine; Norepinephrine; Purkinje cell; Microiontophoresis; Glutamate; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ s Receptor; Žq.Pentazocine; Haloperidol; GTPase; w35 SxGTPgS autoradiography ŽHong, W. Ž408. 117. Cerebral blood flow Morphine tolerance; Morphine dependence; Naloxone; Opiate withdrawal; Laser–Doppler flowmetry, ŽRat. ŽZamani, R. Ž408. 299. Cerebral blood flow, local Cerebral ischemia; Middle cerebral artery occlusion ŽTakamatsu, H. Ž398. 375.

Cell death Ba2q; Cytotoxicity; Cytoprotection; Chromaffin cell; Ca2q channel antagonist ŽCano-Abad, M.F. Ž402. 19.

Cerebral endothelial cell Dithiocarbamate; NF-kB Žnuclear factor-kB.; Zn2q; ŽBovine. ŽKim, C.H. Ž392. 133.

Cell membrane Indolocarbazole; Cellular uptake; Carbohydrate; Rebeccamycin ŽGoossens, J.-F. Ž389. 141.

Cerebral ischaemia Neuroprotection; Ca2q channel, neuronal ŽHicks, C.A. Ž408. 241.

Cell metabolism Monoamine oxidase; Hydrogen peroxide; Adipocyte, white ŽRaimondi, L. Ž395. 177. Cell proliferation wArg 8 xvasopressin; Prostanoid; Smooth muscle cell ŽNagano, K. Ž389. 25. Cell size Taurine; Angiotensin II; Fetal gene expression; Growth factor gene expression; Protein kinase C ŽAzuma, M. Ž403. 181. Cellular injury Protein kinase C; Phorbol ester; Oxidant ŽTepperman, B.L. Ž389. 131. Cellular uptake Indolocarbazole; Cell membrane; Carbohydrate; Rebeccamycin ŽGoossens, J.-F. Ž389. 141. Central Paraventricular nucleus; Excitatory amino acid; Cardiovascular regulation; Microinjection; ŽRat. ŽGoren, M.Z. Ž388. 77. ¨

Cerebral ischaemia model Ca2q channel antagonist; Naq channel antagonist; Electrophysiology ŽCampbell, C.A. Ž401. 419. Cerebral ischemia Brain; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-Larginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. 5-HT receptor; 8-OH-DPAT Ž8-hydroxy-2-Ždi-n-propylamino.tetralin.; Stereology; ŽRat. ŽTorup, L. Ž395. 137. g-Hydroxybutyrate; Hippocampus; Immunochemistry; Sensory–motor test; Spatial learning ŽVergoni, A.V. Ž397. 75. Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Morris water maze; Learning; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65. Middle cerebral artery occlusion; Cerebral blood flow, local ŽTakamatsu, H. Ž398. 375.

Master keyword index to Õolumes 386–410 (2000) Erythropoietin; Brain injury; Neuronal death delayed; Nitric oxide ŽNO. ŽCalapai, G. Ž401. 349. Cerebral ischemia, focal LY341122; Neuroprotection; Stroke; Oxygen radical; ŽRat. ŽHuh, P.W. Ž389. 79. Cerebral ischemia–reperfusion Blood–brain barrier; Brain edema; Histamine; Intracellular histamine binding site; DPPE Ž N,N-diethyl-2-w4-Žphenylmethyl.phenoxyxethanamine. ŽDeli, M.A. Ž387. 63.

29

CFU-GM (colony-forming unit-granulocyte-macrophage) Ehrlich ascites tumour; Antitumour; Myelopoiesis; MAPA Žmagnesium ammonium phospholinoleate-palmitoleate anhydride. ŽJusto, G.Z. Ž388. 219. C6 glioma cell Zolmitriptan; 5-HT1B receptor, human; Kq channel, Ca2q-dependent ŽLe Grand, B. Ž397. 297. Immunosuppressant; Cyclosporine; Nitric oxide ŽNO.; a 1 -Adrenoceptor ŽIkesue, H. Ž407. 221.

Cerebral metabolism Cholinergic system; Cholinesterase inhibitor; Alzheimer’s disease; Nucleus basalis, rat ŽBassant, M.-H. Ž387. 151.

cGMP Lipopolysaccharide; Angiotensin II type 2 receptor; Cytokine; Nitric oxide ŽNO.; Cardiac fibroblast ŽTamura, M. Ž386. 289.

Cerebral vasospasm Protein kinase C isoform; Subarachnoid hemorrhage ŽNishizawa, S. Ž398. 113.

Meloxicam; Nitric oxide ŽNO.; N G -L-nitro-arginine methyl ester ŽLNAME.; ODQ Ž1 H-Ž1,2,4.-oxadiazoloŽ4,2-a.quinoxalin-1-one. ŽAguirreBanuelos, P. Ž395. 9. ˜

Cerebrocortical neuronal culture Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29.

Arachidonic acid; Cytosolic phospholipase A 2 ; S-Nitroso-cysteine; PC12 cell ŽThang, S.H. Ž395. 183.

Cerebrovascular constriction Tamoxifen; Oxyhemoglobin; Protein kinase C ŽWickman, G. Ž390. 181.

Sodium nitroprusside; Kq channel; Antinociception ŽSoares, A.C. Ž400. 67.

Cetirizine Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73.

Morphine; Sildenafil; N G -L-nitro-arginine methyl ester ŽL-NAME.; ODQ Ž1 H-w1,2,4x-oxadiazolow4,3-axquinoxalin-1-one.; Naloxone ŽMixcoatlZecuatl, T. Ž400. 81.

C-fiber Vagus nerve; Cholinergic nerve; Acetylcholine; Neurokinin-A ŽMatsumoto, K. Ž403. 157. C-fibre Flexor reflex; Rostral ventromedial medulla; Wind-up; Spino-bulbo-spinal; Inhibitory feedback mechanism; Morphine ŽGozariu, M. Ž394. 75.

Nitric oxide ŽNO.; b 2-Adrenoceptor agonist; Smooth muscle; cAMP; Iberiotoxin ŽVaali, K. Ž399. 75.

Urinary bladder; Urethra; Nitric oxide ŽNO.; Smooth muscle ŽFujiwara, M. Ž401. 241. 5-HT Ž5-Hydroxytryptamine, serotonin.; Endothelial cell, rat; Protein kinase C; w3 HxPhorbol 12,13-dibutyrate binding; Trypsin-treated protein kinase C activity; cAMP ŽLee, H.-Z. Ž403. 195.

Cough; Substance P; Tachykinin; Citric acid ŽMoreaux, B. Ž408. 305.

Phosphodiesterase; Pulmonary circulation; cAMP; ŽPharmacology.; ŽCat. ŽDe Witt, B.J. Ž406. 233.

c-Fos Racemic-flurbiprofen; SŽq.-flurbifrofen; RŽy.-flurbifrofen; Noxious heat; Spinal dorsal horn ŽBuritova, J. Ž406. 59.

cGMP-dependent protein kinase Nitric oxide ŽNO.; Naq,Kq-ATPase; Aging; Trachea, rat ŽScavone, C. Ž388. 1.

c-fos Morphine withdrawal; Prostaglandin; Prostanoid EP3 receptor; m-Opioid receptor; Locus coeruleus ŽNakagawa, T. Ž390. 257.

CGRP-(8-38) Calcitonin gene-related peptide ŽCGRP.; BIBN4096BS; CGRP receptor subtypes; Left atrium, rat; Vas deferens, rat ŽWu, D. Ž400. 313.

c-jun; Cholecystokinin; MAP Žmitogen-activated protein., kinase; Hypotonic stress ŽMurai, A. Ž394. 27.

CGRP-(8-37) Osteoblast, Human; CGRP Žcalcitonin gene-related peptide.; Amylin, Amylin-Ž8-37.; Proliferation; cAMP ŽVilla, I. Ž409. 273.

zif268; 6-Hydroxydopamine; N-methyl-D-aspartate ŽNMDA.; L-3,4-dihydroxyphenylalanine ŽL-DOPA.; Striatum ŽAdams, A.C. Ž404. 303. Stressful stimuli; Neuropeptide; Paraventricular nucleus; Supraoptic nucleus; Amygdaloid nucleus, central ŽPalkovits, M. Ž405. 161. Phencyclidine; Nitric oxide ŽNO.; N G -nitro-L-arginine methyl ester; Behaviour; ŽRat. ŽBujas-Bobanovic, M. Ž409. 57.

CGRP (calcitonin gene-related peptide) Amtolmetin guacyl; Antisecretion; Gastroprotection; Capsaicin ŽTubaro, E. Ž387. 233. ERK Žextracellular signal-regulated kinase.; P38; Forskolin; HEK 293 cell ŽParameswaran, N. Ž389. 125. Vasodilation; Sensory nerve fibre; Migraine ŽOlivar, T. Ž395. 61.

c-fos mRNA Neuromedin B receptor antagonist, nonpeptide; Ca2q, cytosolic; Focal adhesion kinase; Proliferation ŽMoody, T.W. Ž409. 133.

Adrenomedullin; Inflammation; Eye; Nitric oxide ŽNO. ŽClementi, G. Ž400. 321.

30

Master keyword index to Õolumes 386–410 (2000)

CGRP receptor, porcine, cloned; G protein-coupled receptor kinase; Homologous desensitization; Ro 32-0432; Antisense oligonucleotide ŽAiyar, N. Ž403. 1.

Chimeric receptor Constitutively-active receptor; IP receptor; Partial agonist; Prostacyclin ŽWise, H. Ž386. 89.

Preconditioning; TNF-a Žtumor necrosis factor-a .; Glibenclamide; Heart, rat ŽPeng, J. Ž407. 303.

Chinese hamster ovary Bombesin; FLIPR ŽFluorescent imaging plate reader. ŽBrough, S.J. Ž409. 259.

Lenticulostriate artery, human; RT-PCR; Adrenomedullin; CRLR Žcalcitonin receptor-like receptor.; RAMP Žreceptor activity-modifying protein. ŽSams, A. Ž408. 183. Osteoblast, Human; CGRP-Ž8-37.; Amylin, Amylin-Ž8-37.; Proliferation; cAMP ŽVilla, I. Ž409. 273. CGRP receptor, porcine, cloned G protein-coupled receptor kinase; Homologous desensitization; CGRP Žcalcitonin gene-related peptide.; Ro 32-0432; Antisense oligonucleotide ŽAiyar, N. Ž403. 1. CGRP receptor subtypes Calcitonin gene-related peptide ŽCGRP.; BIBN4096BS; CGRP Ž8-38.; Left atrium, rat; Vas deferens, rat ŽWu, D. Ž400. 313. CGS 21680 Adenosine A 2A receptor; SCH 58261; ZM 241385; Motor activity; Knockout, mouse ŽEl Yacoubi, M. Ž401. 63.

Chloral hydrate AMPA receptor; Cortical neurone, cultured; Trichloroethanol; Ca2q concentration, intracellular; Fura-2 microfluorimetry ŽFischer, W. Ž394. 41. Chlorisondamine Cocaine; Potentiation; Noradrenaline; Blood pressure; Contractility ŽSabra, R. Ž397. 139. Chlormethiazole Clomethiazole; Spreading depression; Hippocampus; Hypoxia; Neuroprotection ŽStone, T.W. Ž399. 29. Chloroadenosine Adenosine; Interneuron; Hippocampus; Afterhyperpolarization ŽLi, H. Ž407. 237. Chlorogenic acid derivative Glucose production, hepatic; Glucose-6-phosphatase; Glucose, blood; Glycogenesis ŽHerling, A.W. Ž386. 75.

Chaos theory Anabolic steroid; Pregnenolone sulfate; Ethylestrenol; Passive avoidance behavior; Memory; Non-linear dynamics; Attractor ŽIsaacson, R.L. Ž405. 177.

7-Chlorokynurenate Excitotoxicity; Glycine B receptor; Neuroprotection ŽWu, H.-Q. Ž390. 267.

Charged residue Cholecystokinin CCK 1 receptor; Mutagenesis; SR 27897; SR 146131 ŽGouldson, P. Ž389. 115.

Chloromethyl ketone Stroke; Focal ischemia; Apoptosis; Serine protease inhibitor; Nitric oxide ŽNO. ŽLeBlanc, M.H. Ž390. 249.

Chemokine Fractalkine; Chemotaxis; Adhesion; Umbilical vein, human; Endothelial cell ŽChapman, G.A. Ž392. 189.

CHO cells Des-Arg 10 -kallidin; FLIPR Žfluorometric imaging plate reader.; Bradykinin; Ca2q; Non-competitive antagonism ŽSimpson, P.B. Ž392. 1.

N-methyl-D-aspartate ŽNMDA.; b-amyloid; Cortical culture; Neuroprotection ŽBruno, V. Ž399. 117.

Cholecystokinin SR 27897B; L-365,260; Dopamine; CCK A receptor; CCK B receptor ŽTieppo, C.A. Ž387. 189.

G-protein coupled receptor; Receptor coupling; HIV Žhuman immunodeficiency virus. ŽDi Salvo, J. Ž409. 143. Chemosensitivity Glioma; Telomerase; Penclomedine; p53 ŽVietor, M. Ž407. 27. Chemotaxis Fractalkine; Chemokine; Adhesion; Umbilical vein, human; Endothelial cell ŽChapman, G.A. Ž392. 189. Chick embryo Angiogenesis; S-nitrosocaptopril; Captopril; Nitric oxide ŽNO.; Capillary endothelium; Chorioallantoic membrane; Hemoglobin ŽJia, L. Ž391. 137. Chimera Dopamine transporter; Cocaine; Cocaine analog; Phosphorylation; Sitedirected mutagenesis ŽChen, N. Ž405. 329. Chimeric ATPase Oligomycin; Naq,Kq-ATPase; Ca2q-ATPase; Naq occlusion ŽHomareda, H. Ž400. 177.

c-fos; c-jun; MAP Žmitogen-activated protein., kinase; Hypotonic stress ŽMurai, A. Ž394. 27. SR146131; wCa2q x i ; Phosphoinositide turnover; Binding; ŽHuman. ŽSchaeffer, P. Ž397. 303. Cholecystokinin CCK 1 receptor Mutagenesis; Charged residue; SR 27897; SR 146131 ŽGouldson, P. Ž389. 115. Choleretic Acetophenone analogue; Cholesterol; Lithogenic index; Phloacetophenone; Ž Curcuma comosa. ŽPiyachaturawat, P. Ž387. 221. Cholesterol Acetophenone analogue; Choleretic; Lithogenic index; Phloacetophenone; Ž Curcuma comosa. ŽPiyachaturawat, P. Ž387. 221. Endothelin-converting enzyme; Endothelin; Atherosclerosis; Lipid peroxide; ŽRabbit. ŽMitani, H. Ž387. 313.

Master keyword index to Õolumes 386–410 (2000)

31

Cholesterol-fed, rabbit Trandolapril; Angiotensin-converting enzyme inhibitor; Aorta; Coronary artery; Mesenteric, 5th branch ŽSanz, M. Ž397. 359.

Žy.-Huperzine A; Acetylcholinesterase; Cerebral ischemia; Morris water maze; Learning; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65.

Choline Acetylcholine; Cortex, medial prefrontal; Norepinephrine; Serotonin ŽHedou, G. Ž390. 127.

Chondroitinase Dermatan; Chondroitin sulfate; Fibroblast; Proliferation ŽDenholm, E.M. Ž400. 145.

Hippocampus; Interneuron; Nicotinic receptor; Excitation; Methyllycaconitine; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59.

Chondroitin sulfate Dermatan; Fibroblast; Proliferation; Chondroitinase ŽDenholm, E.M. Ž400. 145.

Nicotinic acetylcholine receptor; Acetylcholine; Agonist; Partial; Coagonist; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209. Cholinergic Alzheimer’s disease; Exocytosis; Neuromuscular junction; Oocyte; Synaptic vesicle; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7. Acetylcholine; Glutamate; Interaction; Motivation; Behaviour ŽAura, J. Ž390. 313. Nicotine; Activation; Tobacco; Addiction; Ventral tegmental area ŽDani, J.A. Ž393. 31. Cholinergic deficit Nicotinic acetylcholine receptor; Allosteric modulation; Alzheimer’s disease; Galanthamine ŽMaelicke, A. Ž393. 165. Cholinergic nerve Vagus nerve; C-fiber; Acetylcholine; Neurokinin-A ŽMatsumoto, K. Ž403. 157. Cholinergic neuron Neonatal; ACTH Žadrenocorticotropin.; Neuroprotection; Magnocellular basal nucleus; Glia ŽHorvath, K.M. Ž405. 33. Cholinergic neurotransmission ¨ Experimental diabetes; Nitric oxide ŽNO. ŽOzdem, S.S. Ž387. 321. Cholinergic system a 2-Adrenoceptor; Atipamezole; Ageing; Memory; Noradrenergic system ŽHaapalinna, A. Ž387. 141. Cholinesterase inhibitor; Cerebral metabolism; Alzheimer’s disease; Nucleus basalis, rat ŽBassant, M.-H. Ž387. 151. Cholinesterase Donepezil hydrochloride ŽE2020.; Tacrine; Physostigmine; ENA-713; TAK-147; NIK-247; Cholinesterase inhibitor ŽKosasa, T. Ž389. 173. Cholinesterase inhibitor Donepezil hydrochloride; E2020; Tacrine; Brain; Peripheral tissue; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. Cholinergic system; Cerebral metabolism; Alzheimer’s disease; Nucleus basalis, rat ŽBassant, M.-H. Ž387. 151.

Chorioallantoic membrane Angiogenesis; S-nitrosocaptopril; Captopril; Nitric oxide ŽNO.; Capillary endothelium; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137. Choroidal blood flow Laser-Doppler flowmetry; Sympathetic vasodilation; b-Adrenoceptor activation; b-Adrenoceptor antagonist; L-NAME Ž N G -nitro-L-arginine methyl ester.; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227. Chromaffin cell Conotoxin; Neuronal nicotinic receptor; Acetylcholine receptor; Nicotinic receptor antagonist; Catecholamine release ŽBroxton, N. Ž390. 229. Phospholipase C; Histamine; Ca2q; Inositol phospholipid; Adrenal medulla ŽRoberts-Thomson, E.L. Ž398. 199. Ba2q; Cell death; Cytotoxicity; Cytoprotection; Ca2q channel antagonist ŽCano-Abad, M.F. Ž402. 19. Chronic drug administration Ca2q channel antagonist; Amlodipine; Memory enhancement; Maze learning; Active avoidance, mice ŽQuartermain, D. Ž399. 57. Chronic hypoxia 5-HT Ž5-hydroxytryptamine, serotonin. uptake; Pulmonary hypertension; Lung, rat ŽJeffery, T.K. Ž396. 137. Lung; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. Chronic mild stress Antidepressant drug; Desipramine; Grooming; Locomotor activity; Mesolimbic dopamine system; Open field; Restraint stress ŽD’Aquila, P.S. Ž399. 43. Chronic pain Nerve ligation; Protein kinase C; TrkB receptor; Spinal cord; ŽMouse. ŽNarita, M. Ž401. 187. 5-HT Ž5-hydroxytryptamine, serotonin.; Spinal cord; Paw pressure test; ŽRat. ŽBardin, L. Ž409. 37. Chronic treatment 5-HT Ž5-hydroxytryptamine, serotonin.; Microdialysis; ŽRat. ŽCremers, T.I.F.H. Ž397. 351.

Donepezil hydrochloride ŽE2020.; Tacrine; Physostigmine; ENA-713; TAK-147; NIK-247; Cholinesterase ŽKosasa, T. Ž389. 173.

Chronopharmacology L-DOPA methylester; Parkinson’s disease; Daily rhythm; Radiotelemetry; Infusion constant rate ŽSimon, N. Ž401. 79.

Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor ŽHellstrom-Lindahl, E. Ž393. 255. ¨

Chymase Mast cell; Angiogenesis; Compound 48r80; Granuloma ŽMuramatsu, M. Ž402. 181.

32

Master keyword index to Õolumes 386–410 (2000)

CI 988 Fluoxetine; Conditioned place preference; Morphine; RB 120; CCK 2 receptor antagonist ŽSubhan, F. Ž390. 137.

Class I Antiarrhythmic; Myocardial ischaemia; Arrhythmia; Proarrhythmia ŽBarrett, T.D. Ž398. 365.

Enkephalin catabolism, mixed inhibitors; Enkephalin, endogenous; Drug discrimination; Morphine; CCK 1 receptor antagonist; RB 120 ŽHutcheson, D.M. Ž401. 197.

Cl I channel Niflumic acid; Trachea; ICl ŽCa. ŽTeixeira, M.C.L. Ž394. 117.

Cibenzoline Disopyramide; Pilsicainide; QTc; Adrenaline; ŽDog. ŽMiyamoto, S. Ž400. 263. Disopyramide; Ionic current; I Kr ; I Ks ; Rat sino-atrial nodal cell ŽSatoh, H. Ž407. 123. Ciliary ganglion Nicotinic receptor; Acetylcholine receptor; a-Bungarotoxin; Sciatic nerve; Neuronal ŽRoth, A.L. Ž393. 105. Cilostazol Thromboxane A 2 ; Arterial thrombosis; Z-335 ŽTanaka, T. Ž401. 413. Streptozotocin-diabetic, rat; Antiplatelet vasodilating agent; Phosphodiesterase inhibitor ŽYamamoto, Y. Ž409. 1. Ciprofloxacin Fluoroquinolones; Sparfloxacin; Moxifloxacin; Grepafloxacin; Purkinje fibre; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449. Cirazoline a 1-Adrenoceptor subtype; Methoxamine; P7480; Mesenteric artery, rat; BMY 7378 ŽHussain, M.B. Ž395. 69. Circumferential stretch Axial stretch; Impedance planimetry; Coronary artery, large; Tone; Ca2q-channel, voltage-gated; ŽPig. ŽTanko, ´ L.B. Ž387. 303.

Vasoconstriction; Stilbene derivative; Smooth muscle, vascular ŽLamb, F.S. Ž401. 403. Adrenoceptor; b 3 -Adrenoceptor; Kq channel; Ionic secretion; Colon, rat ŽSchultheiss, G. Ž403. 251. Cl I current Neurotensin; SR 48692; Neurotensin receptor; Dorsal root ganglion ŽKawarada, S. Ž404. 69. Clenbuterol Agonist; Contractile response ŽHudman, D. Ž392. 79. Urinary incontinence; b 2-Adrenoceptor; ATP-sensitive Kq channel; Detrusor muscle ŽHudman, D. Ž397. 169. Clomethiazole Chlormethiazole; Spreading depression; Hippocampus; Hypoxia; Neuroprotection ŽStone, T.W. Ž399. 29. Clonal pancreatic b-cell Glibenclamide; Tolbutamide; Desensitization; Insulin release; K AT P channel ŽBall, A.J. Ž408. 327. Clonidine Myometrium Žporcine.; a 2 -Adrenoceptor; Ca2q, intracellular; cAMP; Ca2q sensitivity ŽKitazawa, T. Ž390. 185. Gastroprotection; a 2B -Adrenoceptor; Opioid receptor ŽGyires, K. Ž396. 131.

Cirrhosis Stellate cell; Endothelin; Liver; Fibrosis, rat ŽGandhi, C.R. Ž406. 311.

BAY K 8644; GABA Ž g-aminobutyric acid.; Ca2q channel, L-type; Limbic system; Septum, Epilepsy ŽBaran, H. Ž401. 31.

Cisapride EM574; Motilin; Gastric emptying; ŽDog. ŽSako, F. Ž395. 165.

Clonidine-displacing substance NG108-15 cell; Reverse phase HPLC; Imidazoline binding site ŽParker, C.A. Ž387. 27.

Cisplatin Anti-emesis; ŽCat. ŽRudd, J.A. Ž391. 145. Sensory neuropathy; Superoxide production; Peroxinitrite ŽSzilvassy, J. ´ Ž403. 259. Citalopram Microdialysis; 5-Hydroxytryptamine, serotonin Ž5-HT.; Hippocampus, ventral; 5-Hydroxytryptamine, serotonin Ž5-HT. reuptake inhibitor, selective ŽCremers, T.I.F.H. Ž397. 63. Citric acid Cough; Substance P; C-fibre; Tachykinin ŽMoreaux, B. Ž408. 305. c-jun c-fos; Cholecystokinin; MAP Žmitogen-activated protein., kinase; Hypotonic stress ŽMurai, A. Ž394. 27. c-Jun N-terminal kinase LL-Z1640-2; Radicicol; Mitogen-activated protein kinases; HgCl 2 ŽMatsuoka, M. Ž409. 155.

Clozapine 5-HT1A receptor; GTPgw35 Sx; Brain, human; Antipsychotic drug; Quetiapine ŽElliott, J. Ž386. 313. Muscarinic receptor; Olanzapine; Binding; Antipsychotic ŽBymaster, F.P. Ž390. 245. Dizocilpine ŽŽq.-MK-801.; NMDA receptor antagonist; Neurotoxicity; Retrosplenial cortex; Olanzapine; Immediate early gene ŽFujimura, M. Ž398. 1. Haloperidol; Ritanserin; Ascorbic acid; Ethanol; Microdialysis; ŽRat. ŽLiu, W. Ž398. 333. Fos-protein; Tolerance; DOI; 8-OH-DPAT ŽSebens, J.B. Ž408. 11. Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective ŽVeenstra-VanderWeele, J. Ž410. 165.

Master keyword index to Õolumes 386–410 (2000)

33

Clozapine-induced potentiation NMDA receptor; MK-801; Haloperidol; Long-term potentiation; Perforant path–dentate gyrus pathway ŽKubota, T. Ž395. 37.

g-Aminobutyric acid ŽGABA.; Dopamine; Microdialysis; g-Vinyl GABA Žvigabatrin.; g-Aminobutyric acid ŽGABA. reuptake inhibitor ŽGerasimov, M.R. Ž395. 129.

Clozapine, intravenous Acute tolerance; Clozapine, oral; Pharmacodynamics; Pharmacokinetics; Pharmacokinetic–pharmacodynamic modeling; Potency, relative ŽSun, L. Ž398. 225.

Potentiation; Noradrenaline; Blood pressure; Contractility; Chlorisondamine ŽSabra, R. Ž397. 139.

Clozapine, oral Acute tolerance; Clozapine, intravenous; Pharmacodynamics; Pharmacokinetics; Pharmacokinetic–pharmacodynamic modeling; Potency, relative ŽSun, L. Ž398. 225.

Ibogaine; Sensitization; Dopamine; Stereotypy; Drug addiction ŽSzumlinski, K.K. Ž398. 259. Nandrolone decanoate; Deca durabolin; Radiotelemetry; Cardiac hypertrophy; ECG Želectrocardiogram.; Noradrenaline ŽPhillis, B.D. Ž398. 263. Amphetamine; Dorsal horn; Hyperalgesia ŽOhsawa, M. Ž399. 165.

Cl I secretion Colon, rat; PAF Žplatelet-activating factor.; Thromboxane A 2 ŽSuzuki, T. Ž400. 297. c-myc Droloxifene; Luteal cell; Apoptosis; bax; bcl-2; mRNA ŽLeng, Y. Ž409. 123. Co-agonist Nicotinic acetylcholine receptor; Acetylcholine; Choline; Agonist; Partial; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209. Coagulation Thrombin; Coronary artery disease; ŽHuman. ŽPothula, A. Ž402. 1. Thrombin; Platelet aggregation; Shear; Bifunctional inhibitor ŽTaka, T. Ž406. 181. Coagulation factor Xa Antithrombotic; Thrombin; Heparin; ŽIn vivo. ŽHeran, C. Ž389. 201. Coagulation inhibitor Thrombosis; Factor Xa; Thrombin ŽSinha, U. Ž395. 51. a-Cobratoxin Nicotinic acetylcholine receptor; Neurotoxin ŽServent, D. Ž393. 197. Cocaine Convulsion; Toxicity; AMPA receptor; Kainate receptor; NMDA receptor ŽPouw, B. Ž386. 181. Corticosterone; Neuroendocrine; Hypothalamo pituitary–adrenal axis; Self-administration; Stress ŽGalici, R. Ž387. 59.

Muscarinic receptor agonist; Self-administration; Drug-naive; ŽMouse. ŽRasmussen, T. Ž402. 241. Dopamine transporter; Cocaine analog; Phosphorylation; Chimera; Sitedirected mutagenesis ŽChen, N. Ž405. 329. Cerebellum; Norepinephrine; Purkinje cell; Microiontophoresis; Glutamate; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ Baclofen; Methamphetamine; Drug-discrimination; ŽRat. ŽMunzar, P. Ž408. 169. Cocaine analog Dopamine transporter; Cocaine; Phosphorylation; Chimera; Site-directed mutagenesis ŽChen, N. Ž405. 329. Cocaine, chronic Norepinephrine transporter; Placenta, rat ŽShearman, L.P. Ž386. 1. Coculture Lead; Hepatocyte, rat; Lipopolysaccharide; Kupffer cell; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317. Coeliac ganglion Nicotine; Noradrenaline release; Stomach, rat; Nicotinic receptor ŽYokotani, K. Ž402. 223. Cognition Nicotine; Mecamylamine; Attention ŽStolerman, I.P. Ž393. 147. Nerve growth factor ŽNGF.; Dopamine receptor; Acetylcholine; Extrapyramidal symptom ŽOzaki, T. Ž402. 39.

Psychostimulants sensitization; Amphetamine; Nucleus accumbens shell; Nucleus accumbens core ŽCadoni, C. Ž388. 69.

Neuropeptide; Intranasal administration; Melanocortin ŽFehm, H.L. Ž405. 43.

Dopamine; Dopamine D1 receptor agonist; Drug discrimination; SKF82958; SCH-39166; ŽRat. ŽHaile, C.N. Ž388. 125.

Schizophrenia; Stress; Coping; Hypothalamic–pituitary–adrenal system; Immune system ŽGispen-de Wied, C.C. Ž405. 375.

Dopamine release; Protein kinase C; Amphetamine; Phorbol ester; Transport, reverse ŽCowell, R.M. Ž389. 59.

TC-2559; Nicotinic receptor; Central nervous system ŽBencherif, M. Ž409. 45.

Substance P; Neurotensin; Dopamine; Ibogaine; Methamphetamine; Drug abuse ŽAlburges, M.E. Ž390. 119.

Cognitive function Anandamide; Food intake; Diet restriction; Hippocampus; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147.

Motor activity; Conditioning; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; Memantine; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303. 5-HT3 receptor; Ondansetron; Sensitization; ŽRat. ŽKing, G.R. Ž394. 97.

Vasopressin;

Insulin;

CO-induced amnesia Neuroactive steroid; Pregnenolone; Dehydroepiandrosterone; Learning; Memory; ŽMouse. ŽMaurice, T. Ž390. 145.

34

Master keyword index to Õolumes 386–410 (2000)

Colchicine Preconditioning; Angiotensin; Ischaemia; Prazosin ŽSharma, A. Ž406. 85. Collagen Heart failure; Hypertrophy; Moxonidine; Sympathetic activation; ŽRat. ŽVan Kerckhoven, R. Ž397. 113. Collagen-induced arthritis Leukotriene B 4 ; Air pouch; Leukocyte infiltration; Interleukin-1; LY293111Na ŽKuwabara, K. Ž402. 275. Collision-coupling model m-Opioid receptor; d-Opioid receptor; G-protein; w35 SxGTPgS binding; Compartmentalization ŽRemmers, A.E. Ž396. 67. Colon PACAP Žpituitary adenylate cyclase-activating peptide.; VIP Žvasoactive intestinal peptide.; Apamin; Suramin; PACAP-Ž6–38.; VIP-Ž10–28.; ŽRat. ŽPluja, ` L. Ž389. 217.

Compound 48 r 80 Chymase; Mast cell; Angiogenesis; Granuloma ŽMuramatsu, M. Ž402. 181. Connective tissue mast cell; Mast cell-deficient ŽWsrWs. rat; Tracheal contraction; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽIkawati, Z. Ž420. 297. Conantokin G Conopeptide; Neurotensin; Dynorphin; Methamphetamine; NMDA receptor ŽBush, L. Ž387. 55. Concanavalin A Alanine aminotransferase; Apoptosis; Interferon-g; Soyasapogenol A; Tumor necrosis factor-a ŽTNF-a . ŽKuzuhara, H. Ž391. 175. Cytochrome P450; Hepatitis ŽOkamoto, T. Ž394. 157. Aminoguanidine; Hepatitis ŽOkamoto, T. Ž396. 125.

Dysmotility; Ischemia–reperfusion; Adenosine A 1 receptor antagonist; RT-PCR Žreverse transcription-polymerase chain reaction.; ŽRat. ŽKadowaki, M. Ž409. 319. Colon adenocarcinoma Adenosine receptor; HT29 cell; Adenosine deaminase; Epithelial differentiation ŽLelievre, V. Ž391. 21. ` Colon cancer Non-steroidal anti-inflammatory drug ŽNSAID.; Apoptosis; Ulcer; Pentose phosphate pathway ŽPorter, S.N. Ž397. 1. Colon damage Dinitrobenzene sulfonic acid; Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Poly ŽADP-ribose. synthetase; Free radical ŽCuzzocrea, S. Ž406. 127. Colon, distal NANC Žnonadrenergic, noncholinergic. relaxation; Strain difference; Nitric oxide ŽNO.; VIP Žvasoactive intestinal peptide. ŽOkishio, Y. Ž388. 97. YM-31636; 5-HT3 receptor agonist; Atrium, right; ŽGuinea pig. ŽIto, H. Ž409. 195. Colon, mouse, isolated Nociceptin; ORL1 receptor; Nitric oxide ŽNO. ŽMenzies, J.R.W. Ž388. 183. Colon, rat PAF Žplatelet-activating factor.; Thromboxane A 2 ; Cly secretion ŽSuzuki, T. Ž400. 297. Adrenoceptor; b 3 -Adrenoceptor; Cly channel; Kq channel; Ionic secretion ŽSchultheiss, G. Ž403. 251. Colorectal cancer Neuropathy; Dorsal root ganglia; Hippocampal neuron; Sural nerve ŽAdelsberger, H. Ž406. 25. Compartmentalization m-Opioid receptor; d-Opioid receptor; G-protein; w35 SxGTPgS binding; Collision-coupling model ŽRemmers, A.E. Ž396. 67. Complete Freund adjuvant Hyperalgesia; NF-kB Žnuclear factor kappa B.; AP-1 Žactivator protein-1.; Octamer factor; NO Žnitric oxide. synthase, neuronal ŽChan, C.-F. Ž402. 61.

Conditioned fear stress Anxiety; Freezing behavior; Monoamine oxidase inhibitor ŽMaki, Y. Ž406. 411. Fluvoxamine; Diazepam; Anxiety; Defensive freezing behavior; ŽMouse. ŽMiyamoto, J. Ž409. 81. Conditioned place preference Restraint stress; Adaptation; D-Amphetamine; Dopamine D1 receptor; Dopamine D 2 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127. Fluoxetine; Morphine; RB 120; CI 988; CCK 2 receptor antagonist ŽSubhan, F. Ž390. 137. Nociceptin; Orphanin FQ; ORL1 receptor; Morphine; Spatial learning; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. Cyclo-oxygenase inhibitor; Nimesulide; Abuse liability ŽFattore, L. Ž406. 75. Amitriptyline; Antidepressant; 5-HT Ž5-hyroxytryptamine, serotonin. reuptake inhibitor, selective ŽSubhan, F. Ž408. 257. Conditioned response Immunity; Stress; Psychoneuroimmunology ŽAder, R. Ž405. 167. Conditioning Cocaine; Motor activity; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; Memantine; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303. Connective tissue mast cell Compound 48r80; Mast cell-deficient ŽWsrWs. rat; Tracheal contraction; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽIkawati, Z. Ž420. 297. Connexin Melittin; Phospholipase A 2 ; Gap junction; Endothelium-derived hyperpolarizing factor ŽEDHF.; Endothelium; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239. Conopeptide Conantokin G; Neurotensin; Dynorphin; Methamphetamine; NMDA receptor ŽBush, L. Ž387. 55.

Master keyword index to Õolumes 386–410 (2000) Conotoxin Neuronal nicotinic receptor; Acetylcholine receptor; Chromaffin cell; Nicotinic receptor antagonist; Catecholamine release ŽBroxton, N. Ž390. 229. v-Conotoxin GVIA Ca2q channel, N-type; v-Conotoxin MVIIA; v-Conotoxin MVIIC; Vas deferens; Intestine; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuineapig. ŽSanger, G.J. Ž388. 89. a-Conotoxin MII Conus; Nicotinic acetylcholine receptor, human; b3 subunit ŽMcIntosh, J.M. Ž393. 205. v-Conotoxin MVIIA Ca2q channel, N-type; v-Conotoxin GVIA; v-Conotoxin MVIIC; Vas deferens; Intestine; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuineapig. ŽSanger, G.J. Ž388. 89. v-Conotoxin MVIIC Ca2q channel, N-type; v-Conotoxin GVIA; v-Conotoxin MVIIA; Vas deferens; Intestine; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuineapig. ŽSanger, G.J. Ž388. 89. Conscious, rat Quinpirole; Blood pressure; Spinal cord transection; Intrathecal domperidone; Dopamine D 2 receptor, spinal ŽLahlou, S. Ž408. 51. Constitutive activity Histamine H 1 receptor; Inverse agonism ŽBakker, R.A. Ž387. R5. Constitutively-active receptor Chimeric receptor; IP receptor; Partial agonist; Prostacyclin ŽWise, H. Ž386. 89. Continuous infusion Dihydroetorphine; Morphine; Physical dependence; Stereotypy; ŽRat. ŽAceto, M.D. Ž387. 31. Contractile function Heart, Rat; Carnitine palmitoyltransferase I inhibition; Etomoxir; Hypertrophy; Infarct size ŽGunther, J. Ž406. 123. ¨ Ventricular cardiomyocyte, rat; Ca2q channel, L-type; Nitric oxide ŽNO.; Myoglobin ŽVulcu, S.D. Ž406. 247. Contractile response Clenbuterol; Agonist ŽHudman, D. Ž392. 79. Contractility Adrenomedullin; Papillary muscle; cAMP ŽIhara, T. Ž390. 167. Cocaine; Potentiation; Noradrenaline; Blood pressure; Chlorisondamine ŽSabra, R. Ž397. 139. 2,3-Butanedione monoxime; Ca2i q transient; Fura 2-acetoxymethyl ŽAM. ester; Long-term culture; Ultrastructure; ŽGuinea pig. ŽHorackova, M. Ž404. 247. Contraction Loop-diuretic; Bumetanide; Frusemide; Cardiomyocyte ŽKelso, E. Ž400. 43. Pulmonary artery, porcine; Leukotriene; CysLT receptor; ICI 204,219; BAY u9773 ŽBack, ¨ M. Ž401. 381. Pulmonary artery, human; Cysteinyl–leukotriene receptor; Prostacyclin; BAY u9773; MK 571 ŽBack, ¨ M. Ž401. 389.

35

Nonvascular smooth muscle; Mitogen-activated protein kinase; Prostaglandin F2 a ; Carbachol ŽYousufzai, S.Y.K. Ž407. 17. Conus a-Conotoxin MII; Nicotinic acetylcholine receptor, human; b3 subunit ŽMcIntosh, J.M. Ž393. 205. Convulsion Cocaine; Toxicity; AMPA receptor; Kainate receptor; NMDA receptor ŽPouw, B. Ž386. 181. GEPR Žgenetically epilepsy-prone rat.; Electroshock; a 1 -Adrenoceptor; b-Adrenoceptor; Receptor regulation ŽSeo, D.O. Ž396. 53. Central nervous system; Systemic toxicity ŽSugimoto, M. Ž401. 329. Coping Corticosterone; ACTH Žadrenocorticotropin.; CRH Žcorticotropin-releasing hormone.; Social; Maternal behavior ŽLevine, S. Ž405. 149. Schizophrenia; Stress; Cognition; Hypothalamic–pituitary–adrenal system; Immune system ŽGispen-de Wied, C.C. Ž405. 375. Coronary Diazepam; Progesterone; g-Aminobutyric acid ŽGABA.; Kq channel ŽJacob, M.K. Ž403. 209. Coronary artery Trandolapril; Angiotensin-converting enzyme inhibitor; Cholesterol-fed, rabbit; Aorta; Mesenteric, 5th branch ŽSanz, M. Ž397. 359. Urotensin II; Vasodilatation ŽKatano, Y. Ž402. 209. Eletriptan; GR125743; Middle meningeal artery; Migraine; Saphenous vein; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Coronary artery diameter Eletriptan; Sumatriptan; Carotid artery blood flow; Femoral artery blood flow; Neurogenic inflammation ŽGupta, P. Ž398. 73. Coronary artery disease Thrombin; Coagulation; ŽHuman. ŽPothula, A. Ž402. 1. Coronary artery endothelium AMP579; Neutrophil degranulation; Neutrophil adherence; Superoxide anion ŽNakamura, M. Ž397. 197. Coronary artery, large Circumferential stretch; Axial stretch; Impedance planimetry; Tone; Ca2q-channel, voltage-gated; ŽPig. ŽTanko, ´ L.B. Ž387. 303. Coronary bed Dual coronary perfusion method; Perfusion cannula ŽCoetzee, W.A. Ž402. 263. Coronary blood flow Coronary vasodilatation; Coronary vasodilator tone; b-Adrenoceptor stimulation ŽFernandez, N. Ž387. 93. ´ Coronary flow Diltiazem; Heart, isolated, rat; Ischemia; Microsphere; Reperfusion ŽKatsumata, N. Ž398. 83.

36

Master keyword index to Õolumes 386–410 (2000)

Coronary vasodilatation Coronary blood flow; Coronary vasodilator tone; b-Adrenoceptor stimulation ŽFernandez, N. Ž387. 93. ´ Coronary vasodilator tone Coronary blood flow; Coronary vasodilatation; b-Adrenoceptor stimulation ŽFernandez, N. Ž387. 93. ´ Coronary vasorelaxant Thiazolidinedione; Hemodynamics; Heart; Prostaglandin ŽUchida, K. Ž400. 113. Corpus cavernosa Nitric oxide ŽNO.; Carbon monoxide ŽCO.; Hydrogen peroxide; Urethra relaxation ŽNaseem, K.M. Ž387. 329. Corpus cavernosum Streptozotocin-induced diabetic mouse; Nitric oxide ŽNO.; Antioxidant; Vitamin E; Sodium selenate; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93. Neocuproine; Bathocuproine; S-Nitrosoglutathione; Non-adrenergic noncholinergic ŽNANC. nerve; Nitrergic relaxation ŽGoc ¨ ¸men, C. Ž406. 293. Cortex 5-HT1A receptor; EEDQ; w35 SxGTPgS binding assay; Hippocampus; Receptor reserve; Spare receptor ŽAlper, R.H. Ž390. 67. AMPA Ž a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid.; AMPA receptor modulator; Hippocampus ŽBlack, M.D. Ž394. 85. Cortex, medial prefrontal Acetylcholine; Choline; Norepinephrine; Serotonin ŽHedou, G. Ž390. 127.

Self-administration; Catecholamine; Epinephrine; Norepinephrine; Yoking; Nicotine ŽDonny, E.C. Ž402. 231. ACTH Žadrenocorticotropin.; CRH Žcorticotropin-releasing hormone.; Coping; Social; Maternal behavior ŽLevine, S. Ž405. 149. Vasopressin; Firing pattern; Ion channel; Neurotransmitter ŽJoels, ¨ M. Ž405. 207. Cortisol Fetal, sheep; Angiotensin; AT1 receptor; AT2 receptor; Cardiovascular ŽHegarty, B.D. Ž406. 439. COS-7 cell Dopamine receptor; Receptor fragment; Adenylate cyclase ŽScarselli, M. Ž397. 291. Cough Substance P; C-fibre; Tachykinin; Citric acid ŽMoreaux, B. Ž408. 305. Cough reflex ATP-sensitive Kq channel; Moguisteine; Anti-tussive drug ŽMorita, K. Ž395. 161. CP 55,940 Cannabinoid CB1 receptor; D9-Tetrahydrocannabinol; Anandamide; SR 141716A; SR 144528; Sympathetic neurotransmission ŽLay, L. Ž391. 151. CP-96,345 Wood smoke; Tachykinin NK 1 receptor; Tachykinin NK 2 receptor ŽLin, Y.S. Ž394. 139. (SDZ EAA 494) Cocaine; Motor activity; Conditioning; Dizocilpine ŽMK-801.; Memantine; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303.

Cortex, prefrontal Locus coeruleus; Noradrenaline; Stress; NMDA receptor; GABA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279.

D-CPPene

Acetylcholine; Hippocampus; HU 210; Microdialysis; SR 141716A; WIN 55, 212-2 ŽAcquas, E. Ž401. 179.

Morphine; Antinociception; NMDA receptor antagonist; Memantine; MRZ 2r579; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77.

Cortical culture Chemokine; N-methyl-D-aspartate ŽNMDA.; b-amyloid; Neuroprotection ŽBruno, V. Ž399. 117.

CP-060S Aorta, rat; Ca2q channel, L-type voltage-dependent; Ca2q, Cytosolic ŽSato, K. Ž400. 225.

Oxidative stress; Free radical; Antioxidant; Propofol; Vitamin E ŽBoland, A. Ž404. 21.

CREB (cAMP responsive element binding protein) d-Opioid receptor; DPDPE ŽwD-Pen2,5 xenkephalin., Morphine; NG108-15 neuroblastoma; Protein kinase ŽBilecki, W. Ž390. 1.

Glutamate; Neurotoxicity; s Receptor; Phencyclidine site ŽNishikawa, H. Ž404. 41. Cortical neurone, cultured AMPA receptor; Chloral hydrate; Trichloroethanol; Ca2q concentration, intracellular; Fura-2 microfluorimetry ŽFischer, W. Ž394. 41. Corticosteroid Stress; Hypothalamus–pituitary–adrenal activity ŽDe Kloet, E.R. Ž405. 187.

Cremasteric arteriole Vasopressin; Microvascular constriction; Mesenteric arteriole; OPC21268; OPC-31260 ŽIshiguro, S. Ž400. 121. CRF (corticotropin-releasing factor) Animal model; Depression; Bed nucleus of the stria terminalis ŽStout, S.C. Ž401. 39. Urocortin; CRF receptor; Antisense; Stress; Behaviour; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Corticosterone Cocaine; Neuroendocrine; Hypothalamo pituitary–adrenal axis; Self-administration; Stress ŽGalici, R. Ž387. 59.

Vasopressin; Autonomic nervous system; Learning; Memory ŽCroiset, G. Ž405. 225.

Anandamide; Food intake; Diet restriction; Cognitive function; Hippocampus; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT. ŽHao, S. Ž392. 147.

CRF receptor Locus coeruleus; Noradrenaline; Cortex, prefrontal; Stress; NMDA receptor; GABA receptor; Microdialysis ŽKawahara, H. Ž387. 279.

Master keyword index to Õolumes 386–410 (2000)

37

CRF Žcorticotropin-releasing factor.; Urocortin; Antisense; Stress; Behaviour; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Tryptanthrin; Nitric oxide; Inducible NO synthase; Prostaglandin; Inflammation ŽIshihara, T. Ž407. 197.

CRH (corticotropin-releasing hormone) Neuropeptide; Vasopressin; Dopamine; Homeobox gene; Transcription factors; Development ŽBurbach, J.P.H. Ž405. 55.

Cyclooxygenase-1 FR122047; Formalin test; Acetic acid-induced writhing ŽOchi, T. Ž391. 49.

Corticosterone; ACTH Žadrenocorticotropin.; Coping; Social; Maternal behavior ŽLevine, S. Ž405. 149.

Rheumatoid arthritis; Synoviocyte; Cyclooxygenase-2; Meloxicam ŽTsubouchi, Y. Ž395. 255.

CRLR (calcitonin receptor-like receptor) Lenticulostriate artery, human; RT-PCR; CGRP Žcalcitonin gene-related peptide.; Adrenomedullin; RAMP Žreceptor activity-modifying protein. ŽSams, A. Ž408. 183.

Cyclooxygenase 2 Endothelin-1; Prostaglandin E 2 ; Lipopolysaccharide; Macrophage ŽShimada, K. Ž388. 187.

Cromakalim Smooth muscle, Tracheal; Kq channel, ATP-sensitive; Tyrosine kinase inhibitor ŽMatsushita, Y. Ž389. 51. Cross-tolerance D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; SR 141716; Amphetamine; Operant behavior; Tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251. Crotalus durissus terrificus venom Analgesia; Opioid receptor; Nitric oxide ŽNO. ŽPicolo, G. Ž391. 55. Cryptolepine Neocryptolepine; Plant alkaloid; Topoisomerase II; Cytotoxicity; Apoptosis ŽDassonneville, L. Ž409. 9. CTGF (connective tissue growth factor) TGF-b Žtransforming growth factor b .; Apoptosis; Caspase; Atherosclerosis ŽHishikawa, K. Ž392. 19. CTOP Dorsal periaqueductal gray; m-Opioid receptor; k-Opioid receptor; Norbinaltorphimine; Aversion; Elevated plus-maze ŽNobre, M.J. Ž404. 145. CV-2619 NGF Žnerve growth factor.; Astrocyte; Apoptosis ŽTakuma, K. Ž406. 333.

Cyclooxygenase-2 Kainate; Excitotoxicity; Nimesulide; Oxidative stress; Hippocampus ŽCandelario-Jalil, E. Ž390. 295. Rheumatoid arthritis; Synoviocyte; Cyclooxygenase-1; Meloxicam ŽTsubouchi, Y. Ž395. 255. JTE-522; Prostaglandin E 2 ; Thromboxane A 2 ; U-46619; Airway hyperresponsiveness; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267. Cyclooxygenase inhibitor Nimesulide; Conditioned place preference; Abuse liability ŽFattore, L. Ž406. 75. Cyclophilin Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Cyclopiazonic acid Ischemia–reperfusion; Oxidative stress; Free radical; Reactive oxygen species ŽGrover, A.K. Ž387. 87. Cyclosporin A Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29.

Cyclic peptide Inflammation; Steroid-like anti-inflammatory action; Streptomyce product ŽKuriyama, K. Ž390. 223.

Osteopenia; Arginine; Pyridinoline; ŽRat. ŽFiore, C.E. Ž408. 323.

Wound healing accelerator; Healing-impaired, mouse; SEK-1005; TGF-b1 Žtransforming growth factor-b1. inducer ŽAbe, Y. Ž408. 213.

Cyclosporine Tacrolimus; Glomerulo-tubular balance; Tubulo-glomerular feed-back; Tubular reabsorption; Single nephron filtration rate ŽRomano, G. Ž399. 215.

Cyclin Suramin; Eriochrome Black T; Endothelial cell; Cell cycle ŽLanger, I. Ž399. 85.

Immunosuppressant; Nitric oxide ŽNO.; a 1 -Adrenoceptor; C6 glioma cell ŽIkesue, H. Ž407. 221.

Cyclooxygenase Ibuprofen; Smooth muscle cell; Proliferation ŽWeber, A.-A. Ž389. 67.

Cyclosporine A Naq; Enalapril; Valsartan; Angiotensin II; Vascular response ŽLassila, M. Ž398. 99.

Angiotensin AT2 receptor; Losartan; PD 123319; Kinin; Nitric oxide ŽNO. synthase; Footshock ŽIsrael, A. Ž394. 103. Helicobacter pylori; NSAID; Prostaglandin; Gastric ulceration ŽTakahashi, S. Ž406. 461. Wogonin; Flavonoid; Prostaglandin; Macrophage ŽWakabayashi, I. Ž406. 477.

Cyclothiazide AMPA receptor; Purkinje cell; GYKI 53784; Aniracetam; 1-BCP; BDP-12 ŽKapus, G. Ž397. 43. Cynaropicrin Anti-inflammatory effect; TNF-a Žtumor necrosis factor-a .; Nitric oxide ŽNO. release; Lymphocyte proliferation; Immunosuppressive effect ŽCho, J.Y. Ž398. 399.

38

Master keyword index to Õolumes 386–410 (2000)

CysLT receptor Pulmonary artery, porcine; Leukotriene; Contraction; ICI 204,219; BAY u9773 ŽBack, ¨ M. Ž401. 381.

DAF-2 (4,5-diaminofluorescein) Apoptosis; NOR3; Nitric oxide ŽNO.; Nitric oxide ŽNO. donor; Ascorbic acid ŽYamamoto, T. Ž397. 25.

Cysteinyl–leukotriene receptor Pulmonary artery, human; Contraction; Prostacyclin; BAY u9773; MK 571 ŽBack, ¨ M. Ž401. 389.

Daily rhythm methylester; Parkinson’s disease; Chronopharmacology; Radiotelemetry; Infusion constant rate ŽSimon, N. Ž401. 79.

Cystitis Bradykinin B 2 receptor; Bradykinin receptor antagonist; MEN 11270; Urinary bladder, human; Urinary bladder, rat ŽMeini, S. Ž388. 177.

DAMGO Opioid receptor subtype; Xylazine; DPDPE; Tyr-W-MIF-1; U50,488; a 2 adrenoceptor ŽWare, T.D. Ž389. 181.

Cytochrome oxidase Neurotoxicity; Amphetamine; Histochemistry; Energy metabolism ŽBurrows, K.B. Ž398. 11.

Damnacanthal Tyrosine kinase; Dermal fibroblast; Ca2q, intracellular ŽAoki, K. Ž387. 119.

Cytochrome P450 Deprenyl metabolism; Parkinson’s disease; N-dealkylation pathway; C57BL mouse liver microsomal preparation ŽValoti, M. Ž391. 199.

Daunorubicin Multidrug resistance; P-glycoprotein; MRP1 Žmultidrug resistance-associated protein.; Calcein-AM; Inhibitor; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207.

Cytochrome P450 Concanavalin A; Hepatitis ŽOkamoto, T. Ž394. 157. Cytokine Lipopolysaccharide; Angiotensin II type 2 receptor; Nitric oxide ŽNO.; Cyclic GMP; Cardiac fibroblast ŽTamura, M. Ž386. 289. Bronchial hyperresponsiveness; Bronchial asthma; Arachidonic acid metabolite ŽNakatani, Y. Ž392. 175. Bradykinin B1 receptor; Bradykinin B 2 receptor; Regulation; w3 HxdesArg 10 -kallidin; w3 HxBradykinin; WI-38 cell ŽPhagoo, S.B. Ž397. 237.

L-DOPA

DBA r 2 mouse Epilepsy; Topiramate; Carbamazepine; Phenytoin; Valproate; Felbamate; Anticonvulsant; Audiogenic seizure ŽDe Sarro, G. Ž388. 163. Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure ŽDe Sarro, G. Ž394. 275. Epilepsy; Riluzole; Audiogenic seizure; AMPA Ž a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid.; GlycinerNMDA receptor ŽDe Sarro, G. Ž408. 25.

Stress; Glucocorticoid; Ageing; Alzheimer’s disease ŽAngelucci, L. Ž405. 139.

Death Hippocampal neuron; Veratridine; Swelling; Naq channel; Ca2q channel ŽOkuyama, K. Ž398. 209.

Endothelin ETB receptor; Interleukin-1b; Interleukin-6; Interferon-g; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117.

Deca durabolin Nandrolone decanoate; Cocaine; Radiotelemetry; Cardiac hypertrophy; ECG Želectrocardiogram.; Noradrenaline ŽPhillis, B.D. Ž398. 263.

Endocannabinoid; Radical oxygen intermediate ŽGallily, R. Ž406. R5.

Defensive freezing behavior Fluvoxamine; Diazepam; Anxiety; Conditioned fear stress; ŽMouse. ŽMiyamoto, J. Ž409. 81.

Cytoprotection Ba2q; Cell death; Cytotoxicity; Chromaffin cell; Ca2q channel antagonist ŽCano-Abad, M.F. Ž402. 19. Cytoskeleton Exocytosis; Insulin; Scinderin ŽBruun, T.Z. Ž403. 221. Cytosolic phospholipase A 2 Arachidonic acid; S-Nitroso-cysteine; cGMP; PC12 cell ŽThang, S.H. Ž395. 183. Cytotoxicity Nitric oxide ŽNO.; Nitric oxide ŽNO. synthases; Vanadium; Growth; Osteoblast differentiation; Bone ŽCortizo, A.M. Ž400. 279. Ba2q; Cell death; Cytoprotection; Chromaffin cell; Ca2q channel antagonist ŽCano-Abad, M.F. Ž402. 19. Cryptolepine; Neocryptolepine; Plant alkaloid; Topoisomerase II; Apoptosis ŽDassonneville, L. Ž409. 9. DADLE ([D-Ala 2 , D-Leu 5 ]enkephalin) Methamphetamine; Dopamine transporter ŽTsao, L.-I. Ž404. 89.

Dehydroepiandrosterone CO-induced amnesia; Neuroactive steroid; Pregnenolone; Learning; Memory; ŽMouse. ŽMaurice, T. Ž390. 145. Delirium tremens Alcohol withdrawal, human; Volume and fluid regulation; ANP Žatrial natriuretic peptide. secretion; Withdrawal hyperexcitability, mouse; NMDA Ž N-methyl-D-aspartate. seizure; Glutamate ŽKovacs, ´ G.L. Ž405. 103. Dementia Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Nicotinic agent; Schizophrenia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Dendrosome Nicotinic receptor; Epibatidine; Somatodendritic; Substantia nigra; Ventral tegmental area ŽReuben, M. Ž393. 39. Dependence THC Žtetrahydrocannabinol.; Withdrawal; Operant behavior; Behavioral dependence; SR141716A; ŽRat. ŽBeardsley, P.M. Ž387. 47.

Master keyword index to Õolumes 386–410 (2000) Addiction; Dopamine; Nicotine; Nucleus accumbens; Prefrontal cortex ŽDi Chiara, G. Ž393. 295. Respiration; Opioid; Tolerance; ŽRhesus monkey. ŽKishioka, S. Ž398. 121. D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; SR 141716; Amphetamine; Operant behavior; Tolerance; Cross-tolerance; ŽRat. ŽLamb, R.J. Ž398. 251. Morphine; Zn2q; Intrathecal; Antinociception; Tolerance ŽLarson, A.A. Ž407. 267. Dependence, acute Opiate; Gender difference; Cardiovascular system; Blood pressure; Heart rate; Rat, spinal ŽCruz, S.L. Ž397. 121. Depolarization Nitric oxide ŽNO.; Mesenteric bed; N v -nitro-L-arginine methyl ester; KCl; Nitric oxide ŽNO. synthase ŽMendizabal, V.E. Ž409. 85. Deprenyl metabolism Cytochrome P450; Parkinson’s disease; N-dealkylation pathway; C57BL mouse liver microsomal preparation ŽValoti, M. Ž391. 199. Depression Anxiety; 5-HT2C receptor; ŽRat. ŽKennett, G. Ž387. 197.

39

[3 H]Des-Arg 10 -kallidin Bradykinin B 1 receptor; Bradykinin B 2 receptor; Regulation; w3 HxBradykinin; WI-38 cell; Cytokine ŽPhagoo, S.B. Ž397. 237. Des-Arg 10 -kallidin FLIPR Žfluorometric imaging plate reader.; Bradykinin; Ca2q; Non-competitive antagonism; CHO cells ŽSimpson, P.B. Ž392. 1. Desensitisation 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Supersensitive; Target ŽMoret, C. Ž404. 1. Desensitization G protein-coupled receptor; Dopamine; Palmitoylation; Phosphorylation; Adenylyl cyclase ŽJin, H. Ž386. 305. a 1-Adrenoceptor; Receptor phosphorylation; Protein kinase C; Phosphatidylinositol 3-kinase; G protein receptor kinases ŽGarcıa-Sainz, J.A. ´ ´ Ž389. 1. m-Opioid receptor; Tolerance; cAMP-dependent protein kinase; Morphine; N-Ž2-aminoethyl.-5-isoquinolinesulfonamide ŽH8. ŽWang, Z. Ž389. 165. 5-Hydroxytryptamine Ž5-HT, serotonin.; Serum; T84 cell ŽBurleigh, D. Ž390. 103.

Neuropeptide-Y; Stress ŽStogner, K.A. Ž387. R9. Animal model; CRF Žcorticotropin-releasing factor.; Bed nucleus of the stria terminalis ŽStout, S.C. Ž401. 39.

Glibenclamide; Tolbutamide; Clonal pancreatic b-cell; Insulin release; K AT P channel ŽBall, A.J. Ž408. 327.

Melatonin; Forced-swim test; Antidepressant; Sex difference ŽBrotto, L.A. Ž402. 87.

Desipramine Antidepressant; NMDA receptor; Glycine; DSP-4; Norepinephrine ŽHarkin, A. Ž389. 187.

5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1.

Antidepressant drug; Grooming; Locomotor activity; Mesolimbic dopamine system; Open field; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43.

Antidepressant drug; Dopamine; Mania; Mesolimbic dopamine system ŽD’Aquila, P.S. Ž405. 365.

´ Ž407. Paroxetine; Microdialysis; 5-HT; Noradrenaline ŽHajos-Korcsok, E. ´ 101.

Schizophrenia; Bipolar disorder; Memory; Synaptic plasticity; Ventricle enlargement; Neurocognitive impairment ŽVawter, M.P. Ž405. 385.

Gingivitis; Microbiota; Salivary protein; Salivary flow rate; Tricyclic antidepressant ŽKoller, M.M. Ž408. 91.

Depression, major b 2 -Adrenoceptor; Gs protein, coupling; Neutrophil; Anxiety; Antidepressant, tricyclic ŽGurguis, G.N.M. Ž386. 135.

Desmethylsibutramine Sibutramine; Didemethylsibutramine; Food intake; Obesity; Locomotor activity; Antidepressant ŽGlick, S.D. Ž397. 93.

Dequalinium Kq channel; Calcium; Calmodulin; Patch clamp; Antipsychotic ŽDreixler, J.C. Ž401. 1.

Detrusor b-Adrenoceptor, subtype; Cardiovascular system; ŽFerret. ŽTakeda, H. Ž403. 147.

Dermal fibroblast Tyrosine kinase; Damnacanthal; Ca2q, intracellular ŽAoki, K. Ž387. 119.

Detrusor muscle Urinary incontinence; b 2-Adrenoceptor; ATP-sensitive Kq channel; Clenbuterol ŽHudman, D. Ž397. 169.

Dermatan Chondroitin sulfate; Fibroblast; Proliferation; Chondroitinase ŽDenholm, E.M. Ž400. 145.

Kq channel, Ca2q-activated; Large conductance; b-Adrenoceptor; Protein kinase A ŽKobayashi, H. Ž404. 231.

Dermorphin N-terminal tetrapeptide Tail-flick test; Naloxonazine; b-Funaltrexamine; m1-Opioid receptor ŽSakurada, S. Ž395. 107.

Detrusor smooth muscle Kq channel opener; Smooth muscle relaxation; Kq channels, ATP-sensitive; Sulfonylurea receptor ŽBuckner, S.A. Ž400. 287.

40

Master keyword index to Õolumes 386–410 (2000)

Development Regeneration; Melanocortin ŽStrand, F.L. Ž405. 3. Neuropeptide; Vasopressin; Corticotropin-releasing hormone; Dopamine; Homeobox gene; Transcription factors ŽBurbach, J.P.H. Ž405. 55. Neurosteroid; P19 cell ŽGrobin, A.C. Ž409. R1. Dexamethasone FSH Žfollicle-stimulating hormone.; Inhibin; Ovarian function; ŽRat, female, immature. ŽTohei, A. Ž386. 69. Lipopolysacharide; Melatonin; Naltrexone; TNF-a Žtumor neocrisis factor-a .; Nitric oxide ŽNO.; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15. Substance P; TNF-a Žtumor necrosis factor-a .; Histamine; MAP Žmitogen-activated protein. kinase; Skin ŽOkabe, T. Ž398. 309. Carrageenin-induced pleurisy, rat; Anti-inflammatory steroid; Prostaglandin H synthase-2 Žcyclooxygenase-2.; Phospholipase A 2 ŽKawamura, M. Ž400. 127. Dexfenfluramine Pulmonary arteries; Phentolamine; Prazosin; Ketanserin; Indomethacin ŽPatnaude, L.A. Ž401. 229. DHPG (( RS )-3,5-dihydroxyphenylglycine) Antidepressant; Glutamate receptor, metabotropic, group I; Hippocampus; Imipramine ŽZahorodna, A. Ž386. 173. Diabetes Smooth muscle, vascular; Hypertrophy, cell; Oxyhaemoglobin, glycosylated; Oxidative stress ŽPeiro, ´ C. Ž386. 317. Endothelin receptor; Urinary bladder ŽSaito, M. Ž387. 253. Urinary bladder; Epithelium; Prostaglandin ŽPinna, C. Ž388. 267. Bradykinin; Thermal hyperalgesia; Protein kinase C; Phorbol-12, 13-dibutyrate; Calphostin C; ŽMouse. ŽKamei, J. Ž390. 113. Cardiac hypertrophy; Hyperglycaemia; Peroxisome proliferator-activated receptor g ŽBell, D. Ž390. 237. Endomorphin-1; Endomorphin-2; Antinociception; d-Opioid receptor; mOpioid receptor ŽKamei, J. Ž391. 91. Angiotensin-converting enzyme inhibitor; Nephropathy; Urinary albumin excretion; Immunohistochemistry ŽKatoh, M. Ž398. 381. Nitric oxide ŽNO.; Aminoguanidine; Morphine; Antinociception ŽGrover, V.S. Ž399. 161. m-Opioid receptor; G-protein; Antinociception; Ponsrmedulla ŽOhsawa, M. Ž401. 55. Aldose reductase; Autonomic neuropathy; Non-adrenergic noncholinergic; Gastric fundus, rat; Streptozotocin ŽJenkinson, K.M. Ž401. 251. Endothelium; Nitric oxide ŽNO.; 5-HT Ž5-Hydroxytryptamine, serotonin.; Carotid artery ŽMiranda, F.J. Ž401. 397. Ouabain; Naq,Kq-ATPase; Phenylephrine; Vascular reactivity; Streptozotocin; Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419.

Diabetes mellitus Opioid; Antinociception; G-protein; m-Opioid receptor; d-Opioid receptor ŽPieper, G.M. Ž401. 375. Endothelium; Nitric oxide ŽNO.; Angiotensin ŽPieper, G.M. Ž403. 129. Diabetes, type 2 Dipeptidyl peptidase IV; Glucagon-like peptide-1 ŽGLP-1.; Insulin secretion; Glucose tolerance; Glucose tolerance, impaired ŽAhren, ´ B. Ž404. 239. Diabetic neuropathy Allodynia; Endothelin; Streptozotocin ŽJarvis, M.F. Ž388. 29. Diabetic rat Somatostatin; Neurogenic inflammation; Inflammatory preconditioning ŽNemeth, J. Ž386. 83. ´ Nerve conduction; Blood flow; Kq channel opener; Naq, Kq ATPase; Oxidative stress; Glutathione; Neuropathy ŽHohman, T.C. Ž397. 335. Diabetic, rat Allodynia, tactile; Allodynia, thermal; Tachykinin receptor antagonist ŽCoudore-Civiale, M.-A. Ž401. 47. ´ Diabetic retinopathy Antioxidant; Glutathione; Lipid peroxidation; Superoxide dismutase ŽObrosova, I.G. Ž398. 139. Diagnosis Alzheimer disease; Amyloid precursor protein ŽAPP.; Platelet ŽDi Luca, M. Ž405. 277. 3,4-Diaminopyridine 4-Aminopyridine; Apamin; Passive avoidance; ŽMouse. ŽInan, S.Y. Ž407. 159. Diarylheptanoid Leukocyte adhesion molecule; Vascular endothelial cell; Anti-inflammation; 5-Lipoxygenase ŽYamazaki, R. Ž404. 375. Diastolic dysfunction Ca2q-sensitizer; Inotropic agent; Hemodynamics; Heart failure; Excitation–contraction coupling ŽJanssen, P.M.L. Ž404. 191. Diastolic function, regional Ca2q sensitizer; Myocardial oxygen consumption; Systolic shortening, regional; Systemic haemodynamics ŽSoei, L.K. Ž386. 55. Diazepam Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Progesterone; g-Aminobutyric acid ŽGABA.; Kq channel; Coronary ŽJacob, M.K. Ž403. 209. Glutamate; Flumazenil; ŽRat. ŽKhan, G.M. Ž407. 139. Fluvoxamine; Anxiety; Conditioned fear stress; Defensive freezing behavior; ŽMouse. ŽMiyamoto, J. Ž409. 81. Dichlorobenzamil Ryanodine receptor; Skinned fiber; Phenamil; Caffeine ŽPonte, C.G. Ž391. 11.

Master keyword index to Õolumes 386–410 (2000) Didemethylsibutramine Sibutramine; Desmethylsibutramine; Food intake; Obesity; Locomotor activity; Antidepressant ŽGlick, S.D. Ž397. 93. 2,4-Dideoxyadenosine TGF-a Žtransforming growth factor-a .; TGF-b1 Žtransforming growth factor-b1.; Somatostatin; H-89; Hepatocyte proliferation ŽKimura, M. Ž386. 271. Dienogest Steroid, synthetic; Angiogenesis inhibition; Angiostatic therapy; Angiogenic disease ŽNakamura, M. Ž386. 33.

41

ATP; Ecto-nucleotidase; Ecto-ATPase; Superior cervical ganglion, rat; UTP ŽConnolly, G.P. Ž397. 271. Disinhibition Nicotinic acetylcholine receptor; Sensitization; Locomotor activity; Plusmaze; ŽRat. ŽEricson, M. Ž397. 103. Disopyramide Cibenzoline; Pilsicainide; QTc; Adrenaline; ŽDog. ŽMiyamoto, S. Ž400. 263. Cibenzoline; Ionic current; I Kr ; I Ks ; Rat sino-atrial nodal cell ŽSatoh, H. Ž407. 123.

Diet restriction Anandamide; Food intake; Cognitive function; Hippocampus; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147.

Dispersion I K.ATP ; Glibenclamide; HMR1883; Sulfonylurea; Cardiac ischemia; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273.

Differentiation Nitric oxide ŽNO.; Stromal cell; Osteoblast-like cell; Mineralization ŽKoyama, A. Ž391. 225.

Dissociated neuron and tandospirone Basolateral amygdala; Synaptic g-aminobutyric acid ŽGABA. transmission; 5-HT1A receptors; Presynaptic modulation ŽKishimoto, K. Ž407. 257.

´ Ž405. 297. Stem cell; Hematopoietic; Central nervous system ŽMezey, E. Protein kinase C; Atherosclerosis; Gene expression; a-tropomyosin; ŽRat. ŽHirano, K. Ž406. 209. Dihydroergotamine Affinity; Intrinsic activity; Efficacy; GppŽNH.p shift; 5-HT1A receptor ligand; S-14506 ŽAssie, ´ M.-B. Ž386. 97. Dihydroetorphine Morphine; Physical dependence; Stereotypy; Continuous infusion; ŽRat. ŽAceto, M.D. Ž387. 31. Diisopropyl-flurophosphate Organophosphate; Aorta; Phentolamine; Norepinephrine; ŽRat. ŽLim, S.L. Ž404. 353. Diltiazem Coronary flow; Heart, isolated, rat; Ischemia; Microsphere; Reperfusion ŽKatsumata, N. Ž398. 83. d-cis-Diltiazem l-cis-Diltiazem; Patch-clamp; Whole-cell; Ca2q overload; Naq current; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217. Dimethylsphingosine Muscarinic receptor; Sphingosine 1-phosphate; InsŽ1,4,5.P3 ; Ca2q mobilisation; SH-SY5Y neuroblastoma cell ŽYoung, K.W. Ž402. 55. Dinitrobenzene sulfonic acid Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Poly ŽADP-ribose. synthetase; Colon damage; Free radical ŽCuzzocrea, S. Ž406. 127. Dioclein Flavonoid; Endothelium; Vasorelaxation; Nitric oxide ŽNO.; Aorta ŽLemos, V.S. Ž386. 41.

Dithiocarbamate Cerebral endothelial cell; NF-kB Žnuclear factor-kB.; Zn2q; ŽBovine. ŽKim, C.H. Ž392. 133. Ditriazines Nitric oxide ŽNO.; Eicosanoid; Macrophage; Neutrophil; Air pouch, mouse; Carrageenan paw oedema ŽRioja, I. Ž397. 207. Diuresis Kallikrein secretion; Kq; Natriuresis; Bradykinin B 2 receptor antagonist; FR173657 ŽSuzuki, T. Ž399. 223. Allodynia; Antinociception; Dynorphin; k-Opioid receptors; Sedation ŽKo, M.C.H. Ž402. 69. Dizocilpine Aminoglycoside; Ototoxicity; NMDA receptor ŽHarvey, S.C. Ž387. 1. NMDA receptors; Glutamate; Nucleus accumbens; Tail-flick ŽMillan, M.J. Ž388. 37. Hyperalgesia; Ventral posterolateral nucleus; Excitatory amino acid; Morphine; Riluzole ŽAbarca, C. Ž403. 67. Dizocilpine (MK-801) Cocaine; Motor activity; Conditioning; D-CPPene ŽSDZ EAA 494.; Memantine; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303. Antinociception; Opioid; NMDA receptor; Metabotropic glutamate receptor; Ž S .-4CPG ŽŽ S .-4-carboxyphenylglycine. ŽSuzuki, T. Ž396. 23. Dizocilpine ((H)-MK-801) NMDA receptor antagonist; Neurotoxicity; Retrosplenial cortex; Clozapine; Olanzapine; Immediate early gene ŽFujimura, M. Ž398. 1. Dizocilpine (MK801) Levodopa; 6-Hydroxydopamine; Microdialysis ŽJonkers, N. Ž407. 281.

Dipeptidyl peptidase IV Glucagon-like peptide-1 ŽGLP-1.; Insulin secretion; Glucose tolerance; Diabetes, type 2; Glucose tolerance, impaired ŽAhren, ´ B. Ž404. 239.

Dmt–Tic Inverse agonism; Antagonism ŽLabarre, M. Ž406. R1.

Dipyridamole Aspirin; Nitric oxide ŽNO.; Platelet; Polymorphonuclear leukocyte ŽDe La Cruz, J.P. Ž397. 35.

DNA microarray Schizophrenia; Pharmacogenetics; Single nucleotide polymorphism; Pharmacogenomics; Genome-wide scanning ŽKawanishi, Y. Ž410. 227.

42

Master keyword index to Õolumes 386–410 (2000)

DNA sequence variants Pharmacogenetic; Pharmacogenomic; Molecular epidemiology; Genotype; Phenotype; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107. DNA synthesis Proliferation; Prostaglandin; Primary culture; Hepatocyte; ŽAdult rat. ŽKimura, M. Ž404. 259. DNQX Domoic acid; MK-801; Dopamine; Microdialysis; Striatum, rat ŽQuintela, B.A. Ž401. 173. DOCA-salt hypertensive rat MAP Žmitogen-activated protein. kinase; Angiotensin; Endothelin; Aorta; Spontaneously hypertensive rat ŽSHR. ŽKubo, T. Ž400. 231.

G protein-coupled receptor; Palmitoylation; Phosphorylation; Desensitization; Adenylyl cyclase ŽJin, H. Ž386. 305. Apomorphine; N-propyl analog; Microdialysis; Bioavailability; Striatum ŽRodenhuis, N. Ž387. 39. Stress; Nicotine; Striatum; Hippocampus; ŽRat. ŽPawlak, R. Ž387. 171. Dopamine D 2 receptor, extrastriatal; w123 IxEpidepride; SPECT ŽSingle photon emission computed tomography.; a-Methyl-para-tyrosine; Schizophrenia; Binding, in vivo ŽFujita, M. Ž387. 179. SR 27897B; L-365,260; Cholecystokinin; CCK A receptor; CCK B receptor ŽTieppo, C.A. Ž387. 189. Electrophysiology; Morphine ŽMelis, M. Ž387. R1.

DOI Clozapine; Fos-protein; Tolerance; 8-OH-DPAT ŽSebens, J.B. Ž408. 11.

Noradrenaline; Hypothalamus–pituitary–adrenocortical axis; Tolerance; Morphine; Paraventricular nucleus ŽFuertes, G. Ž388. 49.

Domoic acid DNQX; MK-801; Dopamine; Microdialysis; Striatum, rat ŽQuintela, B.A. Ž401. 173.

Dopamine D1 receptor agonist; Drug discrimination; SKF-82958; SCH39166; Cocaine; ŽRat. ŽHaile, C.N. Ž388. 125.

Donepezil hydrochloride E2020; Tacrine; Cholinesterase inhibitor; Brain; Peripheral tissue; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. Donepezil hydrochloride (E2020) Tacrine; Physostigmine; ENA-713; TAK-147; NIK-247; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173. L-Dopa

Dopamine; Acetylcholine; GABA Ž g-aminobutyric acid.; Substantia nigra; Striatum; Antimuscarinic drug ŽIzurieta-Sanchez, P. Ž399. 151. ´ L-3,4-dihydroxyphenylalanine (L-DOPA)

c-fos; zif268; 6-Hydroxydopamine; N-methyl-D-aspartate ŽNMDA.; Striatum ŽAdams, A.C. Ž404. 303. DOPAC (3,4-dihydroxyphenylacetic acid) Dopamine; Tyrosine hydroxylase; Sulfonylurea; Glipizide; HVA Žhomovalinic acid. ŽLamensdorf, I. Ž388. 147. Ensaculin; Dopamine; Glutamate; Microdialysis; Rat ŽTeismann, P. Ž398. 247. L-Dopa-induced

dyskinesia Dopamine D4 receptor; JL-18; Parkinson’s disease; MPTP Ž1-methyl-4phenyl-1,2,3,6-tetrahydropyridine. ŽTahar, A.H. Ž399. 183.

Tyrosine hydroxylase; Sulfonylurea; Glipizide; DOPAC Ž3,4-dihydroxyphenylacetic acid.; HVA Žhomovalinic acid. ŽLamensdorf, I. Ž388. 147. Substance P; Neurotensin; Ibogaine; Cocaine; Methamphetamine; Drug abuse ŽAlburges, M.E. Ž390. 119. Dopamine D 3 receptor; Žq.-PD128,907; Motor activity; Postnatal development ŽHeijtz, R.D. Ž392. 35. Addiction; Dependence; Nicotine; Nucleus accumbens; Prefrontal cortex ŽDi Chiara, G. Ž393. 295. Somatostatin; Subiculum; Somatostatin sst2 receptor; Microdialysis ŽMitchell, S.N. Ž395. 43. g-Aminobutyric acid ŽGABA.; Microdialysis; Cocaine; g-Vinyl GABA Žvigabatrin.; g-Aminobutyric acid ŽGABA. reuptake inhibitor ŽGerasimov, M.R. Ž395. 129. 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HIAA Ž5-hydroxyindole-3acetic acid.; 5-Hydroxytryptophol; Noradrenaline; Ataxia, cerebellar ŽReader, T.A. Ž398. 41. Ensaculin; DOPAC Ž3,4-dihydroxyphenylacetic acid.; Glutamate; Microdialysis; Rat ŽTeismann, P. Ž398. 247. Ibogaine; Cocaine; Sensitization; Stereotypy; Drug addiction ŽSzumlinski, K.K. Ž398. 259.

L-DOPA (L-3,4-dihydroxyphenylalanine)

Naltrexone; Ethanol; 5-HTP Ž5-hydroxy-L-tryptophan.; Firing rate ŽInoue, H. Ž406. 375.

Acetylcholine; GABA Ž g-aminobutyric acid.; Substantia nigra; Striatum; Antimuscarinic drug; L-Dopa ŽIzurieta-Sanchez, P. Ž399. 151. ´

L-DOPA

Domoic acid; DNQX; MK-801; Microdialysis; Striatum, rat ŽQuintela, B.A. Ž401. 173.

methylester Parkinson’s disease; Daily rhythm; Chronopharmacology; Radiotelemetry; Infusion constant rate ŽSimon, N. Ž401. 79. Dopamine Methamphetamine; 3-Nitropropionic acid; Neurotoxicity; 5-HT, 5-Hydroxytryptamine; Aromatic L-amino acid decarboxylase; Motor behaviour ŽEradiri, O.L. Ž386. 217.

Neuropeptide; Vasopressin; Corticotropin-releasing hormone; Homeobox gene; Transcription factors; Development ŽBurbach, J.P.H. Ž405. 55. Microdialysis, In vivo; Prefrontal cortex; Shuttle-box; Working memory; ŽGerbil. ŽStark, H. Ž405. 263.

Master keyword index to Õolumes 386–410 (2000) Antidepressant drug; Depression; Mania; Mesolimbic dopamine system ŽD’Aquila, P.S. Ž405. 365. D3 receptor; BP 897; Microphysiometry; Radioligand binding ŽWood, M.D. Ž407. 47. Subiculum; Nucleus accumbens; Fimbria-fornix; Microdialysis; ŽRat. ŽMitchell, S.N. Ž407. 131. Nicotine; Ethanol; Microdialysis; Nucleus accumben; Selected line ŽKiianmaa, K. Ž407. 293. cAMP-dependent protein kinase; Adrenoceptor; Loop of Henle; ŽMouse. ŽHiguchi, E. Ž408. 107. Benzodiazepine; Licking behaviour; Bout structure; Palatability ŽHiggs, S. Ž409. 73. CART Žcocaine- and amphetamine-regulated transcript.; TRH Žthyrotropin releasing hormone.; Norepinephrine; Synaptosome; Hypothalamus ŽBrunetti, L. Ž409. 103.

43

Ribozyme; Stereotypy ŽSalmi, P. Ž388. R1. Catalepsy; Dopamine D 3 receptor; Haloperidol; Knock-out mice; SCH 23390 ŽBoulay, D. Ž391. 63. Partial agonist; Dopamine synthesis; Locomotor activity; ŽRat. ŽAhlenius, S. Ž394. 247. Dopaminergic agent; Carrageenan; Dopamine D1 receptor; Anti-hyperalgesia; Hypoalgesia ŽGao, X. Ž406. 53. Dopamine D 2 -like receptor w35 SxGTPgS binding, agonist-stimulated; Quinpirole; Monoamine oxidase inhibitor; Striatum; ŽRat. ŽGilliland, S.L. Ž392. 125. Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143.

Amino acid; Guanidinoethyl sulfonate; Microdialysis; ŽRat. ŽOlive, M.F. Ž409. 291.

Dopamine D 3 receptor Catalepsy; Dopamine D 2 receptor; Haloperidol; Knock-out mice; SCH 23390 ŽBoulay, D. Ž391. 63.

5-HT2A receptor; Transmission disequilibrium; Association; Genome screening; Estrogen b receptor; Leptin ŽHinney, A. Ž410. 147.

Dopamine; Žq.-PD128,907; Motor activity; Postnatal development ŽHeijtz, R.D. Ž392. 35.

Dopamine receptor Scopolamine; Muscarinic acetylcholine receptor; Prepulse inhibition; Startle; Apomorphine; Phencyclidine; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105. w3 HxLysergic acid diethylamide ŽLSD.; Mushroom body; ŽLocust.; ŽInsect. ŽDegen, J. Ž396. 59.

Limbic system ŽCussac, D. Ž394. 47. Dopamine D1 receptor; Knockout mice; Locomotor activity; Exploratory behaviour; Elevated plus maze; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171.

Receptor fragment; COS-7 cell; Adenylate cyclase ŽScarselli, M. Ž397. 291.

Dopamine D4 receptor L-Dopa-induced dyskinesia; JL-18; Parkinson’s disease; MPTP Ž1methyl-4-phenyl-1,2,3,6-tetrahydropyridine. ŽTahar, A.H. Ž399. 183.

Nerve growth factor ŽNGF.; Acetylcholine; Cognition; Extrapyramidal symptom ŽOzaki, T. Ž402. 39.

G protein-coupled receptor; Structure; Pharmacology; Signaling; Physiology; Genetics ŽOak, J.N. Ž405. 303.

Adenosine receptor; Locomotion; Caffeine; In situ hybridization; Autoradiography ŽHalldner, L. Ž406. 345.

Dopamine D 1 receptor agonist Dopamine; Drug discrimination; SKF-82958; SCH-39166; Cocaine; ŽRat. ŽHaile, C.N. Ž388. 125.

Pharmacogenetics; Polymorphism; Mutation; Antipsychotic; Schizophrenia ŽWong, A.H.C. Ž410. 183. Dopamine D 1 receptor Restraint stress; Adaptation; D-Amphetamine; Conditioned place preference; Dopamine D 2 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127. 6-Hydroxydopamine; Turning behavior; Behavioral tolerance ŽCasas, M. Ž396. 93. Dopamine D 3 receptor; Knockout mice; Locomotor activity; Exploratory behaviour; Elevated plus maze; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171. Dopaminergic agent; Carrageenan; Dopamine D 2 receptor; Anti-hyperalgesia; Hypoalgesia ŽGao, X. Ž406. 53. Dopamine D 2 receptor Restraint stress; Adaptation; D-Amphetamine; Conditioned place preference; Dopamine D1 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127.

Dopamine D 2 receptor agonist Steroid; Protein phosphatase; Dopamine D 2 receptor antagonist; Uptake ŽThompson, T.L. Ž401. 357. Dopamine D 2 receptor antagonist Steroid; Protein phosphatase; Dopamine D 2 receptor agonist; Uptake ŽThompson, T.L. Ž401. 357. Dopamine D 2 receptor, extrastriatal Dopamine; w123 IxEpidepride; SPECT ŽSingle photon emission computed tomography.; a-Methyl-para-tyrosine; Schizophrenia; Binding, in vivo ŽFujita, M. Ž387. 179. Dopamine D 2 receptor, spinal Quinpirole; Blood pressure; Spinal cord transection; Intrathecal domperidone; Conscious, rat ŽLahlou, S. Ž408. 51. Dopamine receptor agonist Žy.-OSU6162; 6-Hydroxydopamine; Parkinson’s disease; Dyskinesia ŽEkesbo, A. Ž389. 193.

44

Master keyword index to Õolumes 386–410 (2000)

Microdialysis; Bioavailability; Striatum; Bioisosteric replacement; Thiophene analog ŽRodenhuis, N. Ž394. 255.

Down-regulation d-Opioid receptor; Carboxyl terminal tail ŽOkura, T. Ž387. R11.

Dopamine release Protein kinase C; Amphetamine; Phorbol ester; Cocaine; Transport, reverse ŽCowell, R.M. Ž389. 59.

DPDPE Opioid receptor subtype; Xylazine; DAMGO; Tyr-W-MIF-1; U50,488; a 2 adrenoceptor ŽWare, T.D. Ž389. 181.

RPR 118723; Glycine antagonist; Glutamate; N-methyl-D-aspartate ŽNMDA. receptor–channel complex; TCP binding ŽBoireau, A. Ž401. 131.

DPDPE (c[D-Pen 2 ,D-Pen 5 ]enkephalin) G protein g 2 subunit; Antinociception ŽHosohata, K. Ž392. R9.

Ethanol; Stress of social defeat; Voltammetry in vivo; Nucleus accumbens; ŽMouse. ŽYavich, L. Ž401. 365. Dopaminergic agent Carrageenan; Dopamine D1 receptor; Dopamine D 2 receptor; Anti-hyperalgesia; Hypoalgesia ŽGao, X. Ž406. 53. Dopaminergic neuron s Receptor; Organotypic slice culture; Mesencephalon; N-methyl-Daspartate ŽNMDA. ŽShimazu, S. Ž388. 139. Dopamine synthesis Dopamine D 2 receptor; Partial agonist; Locomotor activity; ŽRat. ŽAhlenius, S. Ž394. 247. Dopamine transporter DADLE ŽwD-Ala2 , D-Leu5 xenkephalin.; Methamphetamine ŽTsao, L.-I. Ž404. 89. Cocaine; Cocaine analog; Phosphorylation; Chimera; Site-directed mutagenesis ŽChen, N. Ž405. 329. Dopamine trasporter Psychostimulant; Amphetamine ŽFleckenstein, A.E. Ž406. 1. Dopamine uptake Glutamate; Parkinson’s disease; NMDA receptor ŽPage, G. Ž403. 75. Dorsal horn Cocaine; Amphetamine; Hyperalgesia ŽOhsawa, M. Ž399. 165. Dorsal periaqueductal gray m-Opioid receptor; k-Opioid receptor; CTOP; Nor-binaltorphimine; Aversion; Elevated plus-maze ŽNobre, M.J. Ž404. 145. Dorsal raphe nucleus 5-HT1A receptor agonist; Flesinoxan; Glucocorticoid receptor; Mineralocorticoid receptor; Hippocampus ŽSibug, R.M. Ž404. 111.

DPDPE ([D-Pen 2,5 ]enkephalin), Morphine CREB ŽcAMP responsive element binding protein.; d-Opioid receptor; NG108-15 neuroblastoma; Protein kinase ŽBilecki, W. Ž390. 1. 3D pharmacophore GABA A rbenzodiazepine receptor; Sedation ŽHarris, D.L. Ž401. 271. DPPE ( N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine) Blood–brain barrier; Brain edema; Cerebral ischemia–reperfusion; Histamine; Intracellular histamine binding site ŽDeli, M.A. Ž387. 63. D2 receptor UV light; Planaria ŽRaffa, R.B. Ž406. R11. D3 receptor Dopamine; BP 897; Microphysiometry; Radioligand binding ŽWood, M.D. Ž407. 47. Droloxifene Luteal cell; Apoptosis; c-myc; bax; bcl-2; mRNA ŽLeng, Y. Ž409. 123. Drug abuse Substance P; Neurotensin; Dopamine; Ibogaine; Cocaine; Methamphetamine ŽAlburges, M.E. Ž390. 119. Drug addiction Ibogaine; Cocaine; Sensitization; Dopamine; Stereotypy ŽSzumlinski, K.K. Ž398. 259. Drug discrimination Dopamine; Dopamine D1 receptor agonist; SKF-82958; SCH-39166; Cocaine; ŽRat. ŽHaile, C.N. Ž388. 125. Glutamate receptor, Metabotropic; Schizophrenia ŽSchreiber, R. Ž388. R3. Enkephalin catabolism, mixed inhibitors; Enkephalin, endogenous; Morphine; CI 988; CCK 1 receptor antagonist; RB 120 ŽHutcheson, D.M. Ž401. 197. Zolpidem; Benzodiazepine ŽRowlett, J.K. Ž406. R9.

Venlafaxine; WAY 100635; 5-HTŽ5-hydroxytryptamine, serotonin.; 5HT1A autoreceptor; 5-HT syndrome; ŽCat. ŽBjorvatn, B. Ž404. 121.

Drug-discrimination Baclofen; Cocaine; Methamphetamine; ŽRat. ŽMunzar, P. Ž408. 169.

Dorsal root ganglia Neuropathy; Colorectal cancer; Hippocampal neuron; Sural nerve ŽAdelsberger, H. Ž406. 25.

Drug disposition P-Glycoprotein; Placenta; BeWo cells; Blood–placental barrier ŽUshigome, F. Ž408. 1.

Dorsal root ganglion Amitriptyline; Antidepressant; Tetrodotoxin-sensitive; Tetrodotoxin-resistant; Naq channel ŽSong, J.-H. Ž401. 297.

Drug interaction Hypoglycemic agent; Nateglinide; Noncompetitive inhibition; Peptide transporter ŽTerada, T. Ž392. 11.

Neurotensin; SR 48692; Neurotensin receptor; Cly current ŽKawarada, S. Ž404. 69.

´ ˛der, Topiramate; Antiepileptic drug; Electroshock, maximal; Seizure ŽSwia M. Ž399. 35.

Master keyword index to Õolumes 386–410 (2000)

45

Drug-naive Muscarinic receptor agonist; Cocaine; Self-administration; ŽMouse. ŽRasmussen, T. Ž402. 241.

EAAT Ž RS .-2-Amino-3-Ž3-hydroxy-1,2,5-thiadiazol-4-yl.propionic acid; TDPA; EAAT2 inhibitor, selective ŽBrauner-Osborne, H. Ž406. 41. ¨

Drug of abuse Glutamate receptor, metabotropic; Excitatory amino acid; Caudoputamen; Nucleus accumbens; Basal ganglia ŽMao, L. Ž404. 289.

EAAT2 inhibitor, selective EAAT; Ž RS .-2-Amino-3-Ž3-hydroxy-1,2,5-thiadiazol-4-yl.propionic acid; TDPA ŽBrauner-Osborne, H. Ž406. 41. ¨

DSP-4 Antidepressant; NMDA receptor; Glycine; Norepinephrine; Desipramine ŽHarkin, A. Ž389. 187.

Ear swelling test, mouse Phosphodiesterase 4 inhibitor; RPR 73401; Allergic dermatitis; Interleukin-4 ŽEhinger, A.M. Ž392. 93.

D9 Tetrahydrocannabinol Knockout mouse; Cannabinoid receptor; Macrophage ŽBuckley, N.E. Ž396. 141.

ECG (electrocardiogram) Nandrolone decanoate; Deca durabolin; Cocaine; Radiotelemetry; Cardiac hypertrophy; Noradrenaline ŽPhillis, B.D. Ž398. 263.

D 9-Tetrahydrocannabinol Ž R .-Methanandamide; Anandamide; SR 141716; Amphetamine; Operant behavior; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251.

ECL cell a-Fluoromethylhistidine; Gastrin; Histamine; Histidine decarboxylase; Microdialysis in vivo; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1.

[3 H]DTG ([3 H]1,3-di (2-tolyl) guanidine) s Receptor; Haloperidol; s1 Receptor mRNA; w3 HxŽq.-Pentazocine; Species difference ŽInoue, A. Ž401. 307. Dual coronary perfusion method Coronary bed; Perfusion cannula ŽCoetzee, W.A. Ž402. 263. Duodenum, guinea pig b-Adrenoceptor, atypical; b 3 -Adrenoceptor; Carteolol; Partial agonist; Bupranolol ŽHorinouchi, T. Ž403. 133. DuP 532 Angiotensin; Nonpeptide angiotensin receptor agonist; PD123,319; ŽFeline. ŽDe Witt, B.J. Ž404. 213. Dynorphin Conopeptide; Conantokin G; Neurotensin; Methamphetamine; NMDA receptor ŽBush, L. Ž387. 55. Allodynia; Antinociception; Diuresis; k-Opioid receptors; Sedation ŽKo, M.C.H. Ž402. 69. Dyskinesia Žy.-OSU6162; 6-Hydroxydopamine; Parkinson’s disease; Dopamine receptor agonist ŽEkesbo, A. Ž389. 193. Dysmotility Ischemia–reperfusion; Colon; Adenosine A 1 receptor antagonist; RT-PCR Žreverse transcription-polymerase chain reaction.; ŽRat. ŽKadowaki, M. Ž409. 319. Dystonia Movement disorder; Paroxysmal choreoathetosis; Barbiturate; GABA Ž g-aminobutyric acid. ŽRichter, A. Ž397. 343. s Receptor; Neuroleptic; Haloperidol; Extrapyramidal ŽMatsumoto, R.R. Ž401. 155. Adenosine receptor agonist; Basal ganglia disorder; Movement disorders ŽRichter, A. Ž404. 299. E2020 Donepezil hydrochloride; Tacrine; Cholinesterase inhibitor; Brain; Peripheral tissue; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. E3040 Urate uptake; Brush border membrane vesicle; ŽRat. ŽYamada, H. Ž406. 45.

Ecstasy MDMA ŽŽ".-3,4-Methylenedioxymethamphetamine.; Anxiety; Odor, cat; Social interaction; Ultrasonic vocalization ŽMorley, K.C. Ž408. 41. Ecto-ATPase ATP; Ecto-nucleotidase; Dipyridamole; Superior cervical ganglion, rat; UTP ŽConnolly, G.P. Ž397. 271. Ectonucleotidase Vas deferens; ATP; Purinergic ŽTennant, J.P. Ž387. 107. Ecto-nucleotidase ATP; Dipyridamole; Ecto-ATPase; Superior cervical ganglion, rat; UTP ŽConnolly, G.P. Ž397. 271. EDHF (endothelin-derived hyperpolarising factor) Endothelium; P2 receptor; Purine; Pyrimidine; Vasodilatation ŽMalmsjo, ¨ M. Ž390. 173. EDHF (Endothelium-derived hyperpolarizing factor) 3-morpholinosydnonimine ŽSIN-1.; Kq channel, Ca2q-activated; Kq channel, ATP-sensitive; Membrane potential ŽQuignard, J.-F. Ž399. 9. Ouabain; 18a-Glycyrrhetinic acid; Gap junctions; Kq; Endothelium ŽHarris, D. Ž402. 119. Melittin; Phospholipase A 2 ; Gap junction; Connexin; Endothelium; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239. EDRF (endothelium-derived relaxing factor) S-Nitrosothiol; Nitric oxide ŽNO.; Ca2q-channel, voltage-sensitive; Vasodilation ŽTravis, M.D. Ž408. 289. EEDQ 5-HT1A receptor; w35 SxGTPgS binding assay; Hippocampus; Cortex; Receptor reserve; Spare receptor ŽAlper, R.H. Ž390. 67. Efficacy Affinity; Intrinsic activity; GppŽNH.p shift; 5-HT1A receptor ligand; S-14506; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97. EGF (epidermal growth factor) Pancreatitis; Pancreatic regeneration; Interleukin 1b ŽDembinski, A. Ž398. ´ 159. Egr-1 (zif-268) MDMA Ž3,4-methylenedioxymethamphetamine.; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Immediate-early gene ŽShirayama, Y. Ž402. 215.

46

Master keyword index to Õolumes 386–410 (2000)

Ehrlich ascites tumour Antitumour; Myelopoiesis; MAPA Žmagnesium ammonium phospholinoleate-palmitoleate anhydride.; CFU-GM Žcolony-forming unitgranulocyte-macrophage. ŽJusto, G.Z. Ž388. 219. Eicosanoid Ditriazines; Nitric oxide ŽNO.; Macrophage; Neutrophil; Air pouch, mouse; Carrageenan paw oedema ŽRioja, I. Ž397. 207. Electrical field stimulation Cannabinoid receptor agonist; WIN 55212-2; Cannabinoid receptor antagonist; SR14716A; Ileum; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207. Electrical signal ATP; Hippocampal slice; Optical recording; Adenosine receptor ŽSato, K. Ž399. 123. Electrical stimulation TAK-637; Tachykinin NK 1 receptor antagonist, non-peptide; Micturition reflex; Spinal cord ŽKamo, I. Ž401. 235. Electrocardiography Ketamine; Ondansetron; 5-HT Ž5-hydroxytryptamine, serotonin.; Heart rate; Fractal ŽDePetrillo, P.B. Ž391. 113. Electroconvulsion 3-Nitropropionic acid; Mitochondrial toxin; Seizure; GABA Ž g-aminobutyric acid.; 4-Aminopyridine ŽHaberek, G. Ž403. 229. Electrophoretic mobility shift assay Opioid peptide; AP-1 Žactivator protein-1.; Transcriptional regulation; Uterus, rat; Hypothalamus, rat ŽOszter, A. Ž395. 103. Electrophysiology Hippocampus; Epileptiform activity; Naq current; Aconitum alkaloid ŽAmeri, A. Ž386. 187. Antidepressant; 5-HT1A receptor; a 2 -Adrenoceptor; Tyramine; Norepinephrine transporter; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. 211. ´ Dopamine; Morphine ŽMelis, M. Ž387. R1. Risperidone; Microdialysis; Schizophrenia; Antipsychotic drug; Noradrenergic system ŽNasif, F.J. Ž394. 67. Cerebral ischaemia model; Ca2q channel antagonist; Naq channel antagonist ŽCampbell, C.A. Ž401. 419. Electroshock GEPR Žgenetically epilepsy-prone rat.; Convulsion; a 1 -Adrenoceptor; b-Adrenoceptor; Receptor regulation ŽSeo, D.O. Ž396. 53. Electroshock, maximal ´ ˛der, M. Topiramate; Antiepileptic drug; Drug interaction; Seizure ŽSwia Ž399. 35. Eletriptan Sumatriptan; Carotid artery blood flow; Femoral artery blood flow; Neurogenic inflammation; Coronary artery diameter ŽGupta, P. Ž398. 73. Coronary artery; GR125743; Middle meningeal artery; Migraine; Saphenous vein; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Elevated plus maze Dopamine D1 receptor; Dopamine D 3 receptor; Knockout mice; Locomotor activity; Exploratory behaviour; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171.

Elevated plus-maze Dorsal periaqueductal gray; m-Opioid receptor; k-Opioid receptor; CTOP; Nor-binaltorphimine; Aversion ŽNobre, M.J. Ž404. 145. Nicotine; Anxiety; a-Adrenoceptor; ŽMouse. ŽZarrindast, M.-R. Ž407. 145. Eliprodil Cocaine; Motor activity; Conditioning; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; Memantine; ACEA-1021; ŽRat. ŽBespalov, A.Y. Ž390. 303. EM574 Motilin; Cisapride; Gastric emptying; ŽDog. ŽSako, F. Ž395. 165. Emedastine difumarate Itch-associated response; Substance P; Histamine; Leukotriene B 4 ; 5-HT Ž5-hydroxytryptamine, Serotonin. ŽAndoh, T. Ž406. 149. ENA-713 Donepezil hydrochloride ŽE2020.; Tacrine; Physostigmine; TAK-147; NIK-247; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173. Enalapril Blood pressure; Endothelin-1; Bradykinin; Losartan; ŽRat. ŽTanus-Santos, J.E. Ž397. 367. Cyclosporine A; Naq; Valsartan; Angiotensin II; Vascular response ŽLassila, M. Ž398. 99. Encephalomyocarditis virus Glucose intolerance; Branched chain amino acid; Insulitis ŽUtsugi, T. Ž398. 409. Endocannabinoid Radical oxygen intermediate; Cytokine ŽGallily, R. Ž406. R5. Endocrine response Behaviour; Autonomic response; Anxiety; Affective disorder; Post-traumatic stress disorder ŽPTSD.; ŽRat. ŽStam, R. Ž405. 217. Endogenous opoid Addiction; Reward; Brain stimulation reward; Self-administration; Sexual behaviour; Social behaviour ŽVan Ree, J.M. Ž405. 89. Endomorphin-1 Endomorphin-2; Diabetes; Antinociception; d-Opioid receptor; m-Opioid receptor ŽKamei, J. Ž391. 91. Endomorphin-2; m-Opioid receptor; Spontaneous alternation performance; ŽMouse. ŽUkai, M. Ž395. 211. Endomorphin-2 Endomorphin-1; Diabetes; Antinociception; d-Opioid receptor; m-Opioid receptor ŽKamei, J. Ž391. 91. Endomorphin-1; m-Opioid receptor; Spontaneous alternation performance; ŽMouse. ŽUkai, M. Ž395. 211. b-Endorphin Pain; Antinociception; Sex difference; Gonadectomy, adult ŽKrzanowska, E.K. Ž392. 157. Endothelial cell Thrombin receptor; Protein phosphatase ŽMizuno, O. Ž389. 13.

Master keyword index to Õolumes 386–410 (2000)

47

Smooth muscle cell, Vascular; Integrin; Vitronectin; Glycoprotein IIbrIIIa-inhibitor; ŽHuman. ŽKintscher, U. Ž390. 75.

Endothelin ETA rETB receptor antagonist bifunctional; IRL 3630A; Respiratory mechanics ŽMakatani, M. Ž406. 139.

Endothelin; TNF Žtumor necrosis factor. receptor; Epithelial cell; Inflammation; Atherosclerosis ŽLees, D.M. Ž390. 89.

Stellate cell; Cirrhosis; Liver; Fibrosis, rat ŽGandhi, C.R. Ž406. 311.

Fractalkine; Chemokine; Chemotaxis; Adhesion; Umbilical vein, human ŽChapman, G.A. Ž392. 189. Angiogenesis; Ca2q influx; Proliferation ŽKawasaki, J. Ž398. 19. Suramin; Eriochrome Black T; Cyclin; Cell cycle ŽLanger, I. Ž399. 85. Endothelial cell, rat 5-HT Ž5-Hydroxytryptamine, serotonin.; Protein kinase C; w3 HxPhorbol 12,13-dibutyrate binding; Trypsin-treated protein kinase C activity; cAMP; cGMP ŽLee, H.-Z. Ž403. 195.

Nitric oxide ŽNO.; Noradrenaline; Smooth muscle, vascular ŽLui, A.H. Ž410. 25. Endothelin-1 Endothelin ETA -receptor; Endothelin ETB -receptor; A-192621; PD 155080; Endotoxaemia; Septic shock ŽWanecek, M. Ž386. 235. Cyclooxygenase 2; Prostaglandin E 2 ; Lipopolysaccharide; Macrophage ŽShimada, K. Ž388. 187. d-Opioid receptor; Short-circuit current; Intestine, large ŽGauthier, C. Ž390. 335. Cardiac muscle; wCa2q xi transient; Protein kinase C ŽIzumi, M. Ž396. 109.

Endothelial cell, cultured Angiotensin-converting enzyme; Angiotensin-converting enzyme inhibitor; Umbilical veins, human; Nitric oxide ŽNO.; Platelet aggregation ŽPersson, K. Ž406. 15. Endothelial factor Hemostasis; Nitric oxide ŽNO.; Platelet; Thrombosis ŽMomi, S. Ž397. 177. Endothelial injury Carotid artery, rat; Angiotensin I-converting enzyme; Angiotensin I-converting enzyme inhibitor; Vasoconstriction ŽLemay, J. Ž394. 301. Endothelial mediator Hormonal control; Endothelial receptor, luminal; ATP; Purinoceptor; Cardiac function control ŽZenteno-Savin, T. Ž410. 15. Endothelial reactivity Hypersensitivity; Ovalbumin; Nitric oxide ŽNO.; Pulmonary artery ŽAkar, F. Ž395. 225. Endothelial receptor, luminal Hormonal control; ATP; Purinoceptor; Endothelial mediator; Cardiac function control ŽZenteno-Savin, T. Ž410. 15.

Blood pressure; Bradykinin; Enalapril; Losartan; ŽRat. ŽTanus-Santos, J.E. Ž397. 367. Hypocapnic constriction; Basilar artery; Nitric oxide ŽNO. ŽZuccarello, M. Ž401. 213. Chronic hypoxia; Lung; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. FR139317; BQ-788; Phosphoramidon; Transmural electrical stimulation ŽNagayama, T. Ž406. 69. Endothelin receptor antagonism; Septic shock; Endotoxin ŽWanecek, M. Ž407. 1. Basilar artery; 5-HT Ž5-hydroxytryptamine, serotonin.; Hypocapnia; Isocapnia; Alkaline ŽZuccarello, M. Ž407. 191. Endothelin-converting enzyme Endothelin; Atherosclerosis; Cholesterol; Lipid peroxide; ŽRabbit. ŽMitani, H. Ž387. 313. Endothelin ETA r ETB receptor antagonist bifunctional Endothelin; IRL 3630A; Respiratory mechanics ŽMakatani, M. Ž406. 139.

Endothelin Endothelin-converting enzyme; Atherosclerosis; Cholesterol; Lipid peroxide; ŽRabbit. ŽMitani, H. Ž387. 313.

Endothelin ETA -receptor Endothelin-1; Endothelin ETB -receptor; A-192621; PD 155080; Endotoxaemia; Septic shock ŽWanecek, M. Ž386. 235.

Allodynia; Streptozotocin; Diabetic neuropathy ŽJarvis, M.F. Ž388. 29.

Endothelin ETB receptor; Fibroblast; HeLa cell; ŽHuman. ŽDrimal, J. Ž396. 19.

Arginine; Glutamine; Endotoxin; Nitro-arginine ŽMitchell, J.A. Ž389. 209. Airway; Prostaglandin; Leukotriene; Neuromediator; ŽMouse. ŽRichter, M. Ž389. 225. TNF Žtumor necrosis factor. receptor; Endothelial cell; Epithelial cell; Inflammation; Atherosclerosis ŽLees, D.M. Ž390. 89.

Endothelin ETB receptor; Splanchnic nerve stimulation; FR139317; BQ788 ŽHosokawa, A. Ž397. 55. Endothelin; Prostate; Neuromuscular transmission; ŽRat. ŽSalamoussa, A. Ž403. 139. Endothelin ETB -receptor Endothelin-1; Endothelin ETA -receptor; A-192621; PD 155080; Endotoxaemia; Septic shock ŽWanecek, M. Ž386. 235.

MAP Žmitogen-activated protein. kinase; Angiotensin; Aorta; Spontaneously hypertensive rat ŽSHR.; DOCA-salt hypertensive rat ŽKubo, T. Ž400. 231.

Endothelin ETA receptor; Fibroblast; HeLa cell; ŽHuman. ŽDrimal, J. Ž396. 19.

Prostate; Neuromuscular transmission; Endothelin ETA receptor; ŽRat. ŽSalamoussa, A. Ž403. 139.

Endothelin ETA receptor; Splanchnic nerve stimulation; FR139317; BQ788 ŽHosokawa, A. Ž397. 55.

Master keyword index to Õolumes 386–410 (2000)

48

Chronic hypoxia; Lung; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; ŽRat. ŽLal, H. Ž402. 101. Cytokine; Interleukin-1b; Interleukin-6; Interferon-g; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117.

Purinergic neuromodulation; Bradykinin; Prostanoid ŽThapaliya, S. Ž408. 313. Histamine; Pre-eclampsia; Nitric oxide ŽNO.; ANP Žatrial natriuretic peptide.; ŽHuman. ŽSuzuki, Y. Ž410. 7.

Endothelin receptor Diabetes; Urinary bladder ŽSaito, M. Ž387. 253.

Endothelium-dependent relaxation Aorta; Streptozotocin-diabetes; Endothelium-independent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163.

Endothelin receptor antagonist Blood pressure; Nicotine; Thromboxane; ŽRat. ŽTanus-Santos, J.E. Ž396. 33.

Very low-density lipoprotein; Low-density lipoprotein; High-density lipoprotein; Oxysterol ŽPersegol, L. Ž406. 429. ´

Endothelin receptor antagonism Endothelin-1; Septic shock; Endotoxin ŽWanecek, M. Ž407. 1. Endothelin receptor subtype S-0139; Antagonist activity; Blood vessel, rabbit; Blood vessel, canine ŽIwasaki, T. Ž400. 255. Endothelium Flavonoid; Dioclein; Vasorelaxation; Nitric oxide ŽNO.; Aorta ŽLemos, V.S. Ž386. 41. EDHF Žendothelin-derived hyperpolarising factor.; P2 receptor; Purine; Pyrimidine; Vasodilatation ŽMalmsjo, ¨ M. Ž390. 173.

Endothelium-independent relaxation Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163. Endotoxaemia Endothelin-1; Endothelin ETA -receptor; Endothelin ETB -receptor; A192621; PD 155080; Septic shock ŽWanecek, M. Ž386. 235. Endotoxic shock Aminoguanidine; Nitric oxide ŽNO.; ŽRat. ŽErol, A. Ž408. 175. Endotoxin Arginine; Glutamine; Endothelin; Nitro-arginine ŽMitchell, J.A. Ž389. 209.

Harman; Vasorelaxant; Nitric oxide ŽNO. ŽShi, C.-C. Ž390. 319. Thapsigargin; Nitric oxide ŽNO.; Kq channel; Relaxation; Aorta; ŽRat. ŽHuang, Y. Ž392. 51. Stroke-prone spontaneously hypertensive rats ŽSHRSP.; Pulmonary artery; a-Adrenoceptors; Nitric oxide ŽNO. ŽMatsuda, K. Ž392. 61. b-Adrenoceptor; Age; Isoprenaline; ŽVan der Zypp, A. Ž397. 129.

Relaxation;

Kq

channel

Mesenteric artery, rat; Levcromakalim; Hyperpolarisation; 18a-Glycyrrhetinic acid; Carbachol ŽWhite, R. Ž397. 279. b-Adrenoceptor; b-Adrenoceptor, atypical; Nitric oxide ŽNO.; Guanylyl cyclase; Smooth muscle, vascular ŽBrawley, L. Ž398. 285. Diabetes; Nitric oxide ŽNO.; 5-HT Ž5-Hydroxytryptamine, serotonin.; Carotid artery ŽMiranda, F.J. Ž401. 397. Oxidant stress; Nitric oxide ŽNO.; Insulin resistance; Obese Zucker rat ŽLaight, D.W. Ž402. 95. Endothelium-derived hyperpolarizing factor ŽEDHF.; Ouabain; 18aGlycyrrhetinic acid; Gap junctions; Kq ŽHarris, D. Ž402. 119. Nitric oxide ŽNO.; Diabetes mellitus; Angiotensin ŽPieper, G.M. Ž403. 129. Melittin; Phospholipase A 2 ; Gap junction; Connexin; Endothelium-derived hyperpolarizing factor ŽEDHF.; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239. Thiazide; Methyclothiazide; Ca2q; Spontaneously hypertensive, rat ŽSHR.; Hypertension ŽColas, B. Ž408. 63.

Endothelin-1; Endothelin receptor antagonism; Septic shock ŽWanecek, M. Ž407. 1. End-systolic elastance Ca2q-responsiveness; Ca2q-sensitizer; Myocardial contractility; Stunning ŽDe Zeeuw, S. Ž403. 99. Energetic metabolism Cannabinoid; Behavioural tolerance; Brain; Cannabinoid CB1 receptorspecific antagonist ŽCosta, B. Ž395. 1. Energy balance Genomic; Essential obesity ŽRavussin, E. Ž410. 131. Energy metabolism Neurotoxicity; Cytochrome oxidase; Amphetamine; Histochemistry ŽBurrows, K.B. Ž398. 11. Enhancer Nicotinic receptor; Transcription; Promoter; Neuron ŽDeneris, E.S. Ž393. 69. Enkephalin Neutral endopeptidase; Enkephalinase; Knockout mouse; Alcohol consumption; Angiotensin-converting enzyme; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327. Enkephalinase Neutral endopeptidase; Enkephalin; Knockout mouse; Alcohol consumption; Angiotensin-converting enzyme; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327. Enkephalin catabolism, mixed inhibitors Enkephalin, endogenous; Drug discrimination; Morphine; CI 988; CCK 1 receptor antagonist; RB 120 ŽHutcheson, D.M. Ž401. 197.

Master keyword index to Õolumes 386–410 (2000) Enkephalin-degrading peptidases Neutral endopeptidase; Enkephalinase; Enkephalin; Knockout mouse; Alcohol consumption; Angiotensin-converting enzyme; Opioid ŽSiems, W.-E. Ž397. 327. Enkephalin, endogenous Enkephalin catabolism, mixed inhibitors; Drug discrimination; Morphine; CI 988; CCK 1 receptor antagonist; RB 120 ŽHutcheson, D.M. Ž401. 197. Ensaculin Dopamine; DOPAC Ž3,4-dihydroxyphenylacetic acid.; Glutamate; Microdialysis; Rat ŽTeismann, P. Ž398. 247. Enteric nervous system Submucous plexus; Small intestine; Synaptic transmission, inhibitory; Norepinephrine; Somatostatin ŽLiu, S. Ž397. 49. Enteric neuron Submucosal neuron; ATP receptor; Ca2q; Receptor; P2X receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´ Enterochromaffin-like cell Histamine; Mast cell; Rabeprazole; Mast cell-deficient, rat ŽNakamura, S. Ž394. 9. Enteropooling Inflammation, peripheral; Intestine; Opioid; Opioid receptor; Permeability ŽValle, L. Ž389. 235. Entorhinal cortex Retigabine; Anticonvulsant; Spike frequency habituation; EPSP Žexcitatory postsynaptic potential.; IPSP Žinhibitory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165. Enzyme regulation Oestrogen receptor modulator; Oestrogen; Nitric oxide ŽNO.; Blood pressure; Vasopressin ŽPavo, ´ ´ I. Ž410. 101. Eosinophil Apoptosis; Fluticasone propionate; Budesonide; Beclomethasone ŽZhang, X. Ž406. 325. EP 50885 Penile erection; Hexarelin; EP 60761; Oxytocin; Nitric oxide ŽNO.; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137. EP 60761 Penile erection; Hexarelin; EP 50885; Oxytocin; Nitric oxide ŽNO.; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137. Epibatidine Nicotinic acetylcholine receptor subtype; a-Bungarotoxin ŽVailati, S. Ž393. 23.

49

Epilepsy Topiramate; Carbamazepine; Phenytoin; Valproate; Felbamate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. GYKI 52466; 2,3-Benzodiazepine; Anticonvulsant; Hippocampus; Brain slice; Epileptiform bursting ŽMarinelli, S. Ž391. 75. Movement disorder; Nootropic drug; Anticonvulsant drug ŽLoscher, W. ¨ Ž391. 251. Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Nicotinic agent; Schizophrenia; Dementia; Ageing; Tobacco addiction ŽClementi, F. Ž393. 3. Acetylcholine receptor; Mutation ŽSteinlein, O.K. Ž393. 243. Nitric oxide ŽNO.; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Riluzole; Audiogenic seizure; AMPA Ž a-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid.; GlycinerNMDA receptor; DBAr2 mouse ŽDe Sarro, G. Ž408. 25. Epileptic activity Antiepileptic drug; Vigabatrin; Temporal lobe epilepsy; Pharmacoresistant; Brain slice ŽMusshoff, U. Ž401. 167. Epileptiform activity Hippocampus; Electrophysiology; Naq current; ŽAmeri, A. Ž386. 187.

Aconitum alkaloid

Epileptiform bursting GYKI 52466; 2,3-Benzodiazepine; Anticonvulsant; Epilepsy; Hippocampus; Brain slice ŽMarinelli, S. Ž391. 75. Epinastine Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Epinephrine Self-administration; Catecholamine; Norepinephrine; Corticosterone; Yoking; Nicotine ŽDonny, E.C. Ž402. 231. Epithelial cell Endothelin; TNF Žtumor necrosis factor. receptor; Endothelial cell; Inflammation; Atherosclerosis ŽLees, D.M. Ž390. 89. Epithelial differentiation Adenosine receptor; Colon adenocarcinoma; HT29 cell; Adenosine deaminase ŽLelievre, V. Ž391. 21. ` Epithelial Na H channel cAMP; Urinary bladder ŽBurton, T.J. Ž404. 273.

Nicotinic receptor; Somatodendritic; Substantia nigra; Ventral tegmental area; Dendrosome ŽReuben, M. Ž393. 39.

Epithelium Urinary bladder; Prostaglandin; Diabetes ŽPinna, C. Ž388. 267.

Nicotinic acetylcholine receptor; Molecular model; ABT-594; A-85380; Analgesia; Antinociception ŽMeyer, M.D. Ž393. 171.

EPSP (excitatory postsynaptic potential) Retigabine; Anticonvulsant; Entorhinal cortex; Spike frequency habituation; IPSP Žinhibitory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165.

[123 I]Epidepride Dopamine; Dopamine D 2 receptor, extrastriatal; SPECT ŽSingle photon emission computed tomography.; a-Methyl-para-tyrosine; Schizophrenia; Binding, in vivo ŽFujita, M. Ž387. 179.

Eriochrome Black T Suramin; Endothelial cell; Cyclin; Cell cycle ŽLanger, I. Ž399. 85.

50

Master keyword index to Õolumes 386–410 (2000)

ERK (extracellular signal-regulated kinase) CGRP Žcalcitonin gene-related peptide.; P38; Forskolin; HEK 293 cell ŽParameswaran, N. Ž389. 125. Estrogen; Non-genomic effect; Hippocampus, rat ŽKuroki, Y. Ž400. 205. ERK (extracellular signal-related kinase) Okadaic acid; Adrenomedullin; JNK Žjun amino-terminal kinase.; P38 MAPK ŽP38 mitogen-activated protein kinase. ŽParameswaran, N. Ž388. 133. Erythropoietin Subarachnoid hemorrhage; Brain ŽBuemi, M. Ž392. 31. Cerebral ischemia; Brain injury; Neuronal death delayed; Nitric oxide ŽNO. ŽCalapai, G. Ž401. 349. Brain ischemia; Subarachnoid hemorrhage ŽAlafaci, C. Ž406. 219. Escin Ib Escin IIb; Mg 2q absorption; Nitric oxide ŽNO. ŽLi, Y. Ž387. 337. Escin IIb Escin Ib; Mg 2q absorption; Nitric oxide ŽNO. ŽLi, Y. Ž387. 337. E-Selectin Nitric oxide ŽNO.; Nitric oxide-releasing compound; Adhesion; ICAM-1; Lipopolysaccharide ŽKosonen, O. Ž394. 149. Esophageal sphincter relaxation, transient, lower GABA Ž g-aminobutyric acid.; Baclofen; Tolerance ŽLehmann, A. Ž403. 163. Essential obesity Genomic; Energy balance ŽRavussin, E. Ž410. 131. Estrogen ´ Ž392. R5. Nitric oxide ŽNO.; Gastric mucus ŽMorschl, E. Non-genomic effect; ERK Žextracellular signal-regulated kinase.; Hippocampus, rat ŽKuroki, Y. Ž400. 205. Androgen; Th1rTh2; Immune function; Prenatal; Autoimmunity ŽMartin, J.T. Ž405. 251. Estrogen b receptor 5-HT2A receptor; Transmission disequilibrium; Association; Genome screening; Dopamine; Leptin ŽHinney, A. Ž410. 147. Estrogenic activity Apigenin; Luteolin; Anti-implantation activity ŽHiremath, S.P. Ž391. 193. Ethanol Acamprosate; Spermine; NMDA receptor; Primary cultured neuron; Patch-clamp, whole-cell ŽPopp, R.L. Ž394. 221. Acetaldehyde; Hepatocyte; MAPK Žmitogen-activated protein kinase.; Angiotensin II ŽWeng, Y.-I. Ž398. 323. Clozapine; Haloperidol; Ritanserin; Ascorbic acid; Microdialysis; ŽRat. ŽLiu, W. Ž398. 333. Dopamine release; Stress of social defeat; Voltammetry in vivo; Nucleus accumbens; ŽMouse. ŽYavich, L. Ž401. 365.

Naltrexone; L-DOPA ŽL-3,4-dihydroxyphenylalanine.; 5-HTP Ž5-hydroxyL-tryptophan.; Firing rate ŽInoue, H. Ž406. 375. Dopamine; Nicotine; Microdialysis; Nucleus accumben; Selected line ŽKiianmaa, K. Ž407. 293. P2X 3 receptor; Trichloroethanol ŽKoles, L. Ž409. R3. ¨ Ethanol dependence SP1 Žstimulatory protein-1. gene transcription factor; NF-kB Žnuclear factor-kB. gene transcription factor; Brain; Ethanol tolerance ŽMittal, N. Ž386. 113. Ethanol tolerance; Withdrawal; NMDA Ž N-methyl-D-aspartate.; ANP Žatrial natriuretic peptide.; Antiserum against atrial natriuretic peptide ŽKovacs, ´ G.L. Ž401. 343. Ethanol intake 5-HT1B receptor; Knockout mouse; Water intake; Food intake ŽBouwknecht, J.A. Ž403. 95. Ethanol tolerance SP1 Žstimulatory protein-1. gene transcription factor; NF-kB Žnuclear factor-kB. gene transcription factor; Brain; Ethanol dependence ŽMittal, N. Ž386. 113. Ethanol dependence; Withdrawal; NMDA Ž N-methyl-D-aspartate.; ANP Žatrial natriuretic peptide.; Antiserum against atrial natriuretic peptide ŽKovacs, ´ G.L. Ž401. 343. Ethanol withdrawal Ifenprodil; NMDA receptor subunit; Liquid diet method ŽNarita, M. Ž401. 191. Adipose tissue; Hormone-sensitive lipase, cAMP; Phosphodiesterase ŽShih, M.-F. Ž409. 223. Ethosuximide Generalized absence epilepsy; Ca2q channel; WAGrRij rat; Spike-wave discharge; Nimodipine; BAY K8644; Genetic model ŽVan Luijtelaar, G. Ž406. 381. Ethylestrenol Anabolic steroid; Pregnenolone sulfate; Passive avoidance behavior; Memory; Non-linear dynamics; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177. Eticlopride SCH23390; Species-specificity; Monoamine ŽSandoval, V. Ž409. 265. Etomoxir Carnitine palmitoyltransferase; SDZ CPI 975; Hypertrophy ŽYotsumoto, T. Ž398. 297. Heart, Rat; Contractile function; Carnitine palmitoyltransferase I inhibition; Hypertrophy; Infarct size ŽGunther, J. Ž406. 123. ¨ a-Eudesmol v-Agatoxin IVA-sensitive Ca2q channel; Glutamate release; Synaptosome; Microdialysis; Focal ischemia ŽAsakura, K. Ž394. 57. Excitation Hippocampus; Choline; Interneuron; Nicotinic receptor; Methyllycaconitine; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59.

Master keyword index to Õolumes 386–410 (2000) Excitation–contraction coupling Ca2q-sensitizer; Inotropic agent; Hemodynamics; Heart failure; Diastolic dysfunction ŽJanssen, P.M.L. Ž404. 191. Excitatory amino acid Paraventricular nucleus; Cardiovascular regulation; Central; Microinjection; ŽRat. ŽGoren, M.Z. Ž388. 77. ¨ Hyperalgesia; Ventral posterolateral nucleus; Morphine; Riluzole; Dizocilpine ŽAbarca, C. Ž403. 67. Glutamate receptor, metabotropic; Caudoputamen; Nucleus accumbens; Basal ganglia; Drug of abuse ŽMao, L. Ž404. 289. Excitotoxicity 7-Chlorokynurenate; Glycine B receptor; Neuroprotection ŽWu, H.-Q. Ž390. 267. Kainate; Cyclooxygenase-2; Nimesulide; Oxidative stress; Hippocampus ŽCandelario-Jalil, E. Ž390. 295. Exocytosis Glucagon; K AT P channel; Nateglinide; Repaglinide ŽBokvist, K. Ž386. 105. Alzheimer’s disease; Cholinergic; Neuromuscular junction; Oocyte; Synaptic vesicle; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7. Cytoskeleton; Insulin; Scinderin ŽBruun, T.Z. Ž403. 221. Experimental diabetes ¨ Cholinergic neurotransmission; Nitric oxide ŽNO. ŽOzdem, S.S. Ž387. 321. Exploratory behaviour Dopamine D1 receptor; Dopamine D 3 receptor; Knockout mice; Locomotor activity; Elevated plus maze; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171. Extracellular signal-regulated protein kinase Ribavirin; Ras; Raf-1; Cell cycle; Heat shock; GTP ŽVallee, ´ S. Ž404. 49. Extrapyramidal s Receptor; Neuroleptic; Haloperidol; Dystonia ŽMatsumoto, R.R. Ž401. 155. Extrapyramidal side-effect Neuroleptic; Antipsychotic; Catalepsy; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. Extrapyramidal symptom Nerve growth factor ŽNGF.; Dopamine receptor; Acetylcholine; Cognition ŽOzaki, T. Ž402. 39.

51

Fas Glycyrrhizin; Hepatitis ŽOkamoto, T. Ž387. 229. Fatty acid ethanolamides Cannabinoid; Anandamide; High-performance liquid chromatography; Mass spectrometry; Anandamide transport ŽGiuffrida, A. Ž408. 161. Feeding a-MSH Ž a-melanocyte stimulating hormone.; Neuropeptide Y; ŽChick. ŽKawakami, S.-i. Ž398. 361. Melanocortin; Central nervous system; Behavior; Body weight homeostasis; Anorexia; Obesity ŽVergoni, A.V. Ž405. 25. Feeding behaviour P2 purinoceptors; ATP ŽKittner, H. Ž406. R13. Felbamate Epilepsy; Topiramate; Carbamazepine; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. Femoral artery Hyperpolarization; Nitric oxide ŽNO.; Prostanoid; N v -nitro-L-arginine; ODQ Ž1 H-w1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Carotid artery ŽCrauwels, H.M. Ž404. 341. Femoral artery blood flow Eletriptan; Sumatriptan; Carotid artery blood flow; Neurogenic inflammation; Coronary artery diameter ŽGupta, P. Ž398. 73. D-Fenfluramine

Hypothermia; 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275. Fenugreek seed 4-Hydroxyisoleucine; Insulin release; Structural analogue; Pancreas; ŽRat. ŽBroca, C. Ž390. 339. Fetal gene expression Taurine; Angiotensin II; Cell size; Growth factor gene expression; Protein kinase C ŽAzuma, M. Ž403. 181. Fetal, sheep Angiotensin; AT1 receptor; AT2 receptor; Cardiovascular; Cortisol ŽHegarty, B.D. Ž406. 439. Fever Lipopolysaccharide; m-Opioid receptor antagonist; Preoptic anterior hypothalamus ŽBenamar, K. Ž401. 161. Fibroblast Endothelin ETA receptor; Endothelin ETB receptor; HeLa cell; ŽHuman. ŽDrimal, J. Ž396. 19.

Eye Adrenomedullin; Inflammation; CGRP Žcalcitonin gene-related peptide.; Nitric oxide ŽNO. ŽClementi, G. Ž400. 321.

Dermatan; Chondroitin sulfate; Proliferation; Chondroitinase ŽDenholm, E.M. Ž400. 145.

Factor Xa Thrombosis; Thrombin; Coagulation inhibitor ŽSinha, U. Ž395. 51.

Fibrosis, rat Stellate cell; Cirrhosis; Endothelin; Liver ŽGandhi, C.R. Ž406. 311.

Factor Xa r antithrombin complex Hemophilia A; Blood coagulation control; Antithrombin consumption; Thrombin–antithrombin complex; Protein SV-IV ŽDi Micco, B. Ž391. 1.

Fimbria-fornix Dopamine; Subiculum; Nucleus accumbens; Microdialysis; ŽRat. ŽMitchell, S.N. Ž407. 131.

52

Master keyword index to Õolumes 386–410 (2000)

Firing pattern Corticosterone; Vasopressin; Ion channel; Neurotransmitter ŽJoels, ¨ M. Ž405. 207. Firing rate Naltrexone; Ethanol; L-DOPA ŽL-3,4-dihydroxyphenylalanine.; 5-HTP Ž5-hydroxy-L-tryptophan. ŽInoue, H. Ž406. 375. FITC-dextran Arteriole; Permeability; Nitric oxide ŽNO.; Platelet-activating factor ŽPAF.; Nitric oxide synthase ŽNOS. inhibitor; Microcirculation ŽKlabunde, R.E. Ž404. 387. FK506 (Tacrolimus) Neutrophil chemotaxis; Interleukin-8; Mononuclear cell peripheral blood ŽSasakawa, Y. Ž403. 281. Flavonoid Dioclein; Endothelium; Vasorelaxation; Nitric oxide ŽNO.; Aorta ŽLemos, V.S. Ž386. 41. Wogonin; Cyclooxygenase; Prostaglandin; Macrophage ŽWakabayashi, I. Ž406. 477. Flesinoxan 5-HT1A receptor agonist; Glucocorticoid receptor; Mineralocorticoid receptor; Hippocampus; Dorsal raphe nucleus ŽSibug, R.M. Ž404. 111. Flexor reflex C-fibre; Rostral ventromedial medulla; Wind-up; Spino-bulbo-spinal; Inhibitory feedback mechanism; Morphine ŽGozariu, M. Ž394. 75. FLIPR (flourescent imaging plate reader) 5-HT Ž5-Hydroxytryptamine serotonin.; 5-HT receptor; Fluorescence; Meta-chlorophenylpiperazine; 8-OH-DPAT Ž8-hydroxy-N, N-dipropylaminotetralin. ŽWood, M. Ž396. 1. FLIPR (Fluorescent imaging plate reader) Bombesin; Chinese hamster ovary ŽBrough, S.J. Ž409. 259. FLIPR (fluorometric imaging plate reader) Des-Arg 10 -kallidin; Bradykinin; Ca2q; Non-competitive antagonism; CHO cells ŽSimpson, P.B. Ž392. 1. Flow Nitric oxide ŽNO.; Oxidative stress; Ischemia-reperfusion; Vascular ŽWalia, M. Ž400. 249. Fluid secretion Calcium ion; cAMP; Calcein; Multidrug resistance protein ŽSugita, M. Ž388. 227. Flumazenil Glutamate; Diazepam; ŽRat. ŽKhan, G.M. Ž407. 139. Fluorescence 5-HT Ž5-Hydroxytryptamine serotonin.; 5-HT receptor; FLIPR Žflourescent imaging plate reader.; Meta-chlorophenylpiperazine; 8-OH-DPAT Ž8-hydroxy-N, N-dipropylaminotetralin. ŽWood, M. Ž396. 1. a-Fluoromethylhistidine Bafilomycin A 1 ; Histidine decarboxylase; Reserpine; Vacuolar-type ATPase; Vesicular monoamine transporter ŽLindstrom, ¨ E. Ž387. 19.

Gastrin; Histamine; Histidine decarboxylase; Microdialysis in vivo; ECL cell; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1. Fluoroquinolone Histamine release; Mast cell; G protein ŽMori, K. Ž394. 51. Fluoroquinolones HERG; QT-prolongation; Patch-clamp technique ŽBischoff, U. Ž406. 341. Sparfloxacin; Moxifloxacin; Grepafloxacin; Ciprofloxacin; Purkinje fibre; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449. Fluoxetine Conditioned place preference; Morphine; RB 120; CI 988; CCK 2 receptor antagonist ŽSubhan, F. Ž390. 137. Forced swim test; 5-HT4 receptor; SB 204070A; Antidepressant ŽCryan, J.F. Ž409. 295. Flupirtine Retigabine; Glutamate toxicity; PC12 cells; Reactive oxygen intermediates; Glutathione ŽSeyfried, J. Ž400. 155. Fluticasone propionate Apoptosis; Eosinophil; Budesonide; Beclomethasone ŽZhang, X. Ž406. 325. Fluvoxamine Diazepam; Anxiety; Conditioned fear stress; Defensive freezing behavior; ŽMouse. ŽMiyamoto, J. Ž409. 81. Focal adhesion kinase Neuromedin B receptor antagonist, nonpeptide; Ca2q, cytosolic; c-fos mRNA; Proliferation ŽMoody, T.W. Ž409. 133. Focal cerebral ischemia a 2 -Adrenoceptor antagonist; Recovery; Sensorimotor functions; ŽRat. ŽJolkkonen, J. Ž400. 211. Focal ischemia Chloromethyl ketone; Stroke; Apoptosis; Serine protease inhibitor; Nitric oxide ŽNO. ŽLeBlanc, M.H. Ž390. 249. v-Agatoxin IVA-sensitive Ca2q channel; a-Eudesmol; Glutamate release; Synaptosome; Microdialysis ŽAsakura, K. Ž394. 57. Food intake Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Locomotor activity ŽPrinssen, E.P.M. Ž388. 57. Imidazoline I 2 receptor ligand; Idazoxan; RX821002; Metrazoline; Benazoline; Tracizoline; Water intake ŽPolidori, C. Ž392. 41. Anandamide; Diet restriction; Cognitive function; Hippocampus; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147. Histamine; Hypothalamus; Leptin; Tele-methylhistamine; ŽIntracereboventricular infusion. ŽLecklin, A. Ž395. 113. Sibutramine; Desmethylsibutramine; Didemethylsibutramine; Obesity; Locomotor activity; Antidepressant ŽGlick, S.D. Ž397. 93.

Master keyword index to Õolumes 386–410 (2000) Nitric oxide ŽNO.; 8-OH-DPAT Ž8-hydroxy-2-di-n-Žpropylamino.tetralin.; 5-HT Ž5-hydroxytryptamine, serotonin.; N G -nitro-L-arginine methyl ester ŽL-NAME.; Hypothalamus ŽYamada, J. Ž402. 247.

53

Endothelin-1; BQ-788; Phosphoramidon; Transmural electrical stimulation ŽNagayama, T. Ž406. 69.

5-HT1B receptor; Knockout mouse; Ethanol intake; Water intake ŽBouwknecht, J.A. Ž403. 95.

FR173657 Kallikrein secretion; Kq; Diuresis; Natriuresis; Bradykinin B 2 receptor antagonist ŽSuzuki, T. Ž399. 223.

ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Peptide– receptor interaction; Avoidance; Grooming; Pain ŽAdan, R.A.H. Ž405. 13.

Lipopolysaccharide, bacterial; Bradykinin receptor; Microphysiometer; Aortic endothelial cell, bovine ŽBentley, K.R. Ž402. 11.

Ipsapirone; 5-HT1A receptor agonist; WAY-100635 ŽArkle, M. Ž408. 273. Footshock Angiotensin AT2 receptor; Losartan; PD 123319; Kinin; Nitric oxide ŽNO. synthase; Cyclo-oxygenase ŽIsrael, A. Ž394. 103. Forced-swim test Melatonin; Antidepressant; Sex difference; Depression ŽBrotto, L.A. Ž402. 87. Forced swim test 5-HT4 receptor; SB 204070A; Fluoxetine; Antidepressant ŽCryan, J.F. Ž409. 295. Forebrain basal Neuroinflammation; Acetylcholine; Caspase; Non-steroidal anti-inflammatory drug; ŽRat. ŽWenk, G.L. Ž402. 77. Formalin Adenosine; Adenosine kinase; Adenosine deaminase; Microdialysis; Pain; Inflammation ŽLiu, X.J. Ž408. 143. Formalin test FR122047; Cyclooxygenase-1; Acetic acid-induced writhing ŽOchi, T. Ž391. 49.

Antagonism; Bradykinin B 2 receptor; FR190997; MEN 11270; Nonpeptide ŽMeini, S. Ž409. 185. FR140423 Antinociception; Noradrenergic system; a 2 -Adrenoceptor; Spinal cord; ŽMouse. ŽOchi, T. Ž400. 199. Antinociception; Serotonergic system; 5-HT2A receptor; 5-HT3 receptor; Spinal cord; ŽMice. ŽOchi, T. Ž409. 167. FR190997 Antagonism; Bradykinin B 2 receptor; FR173657; MEN 11270; Nonpeptide ŽMeini, S. Ž409. 185. Fractal Ketamine; Ondansetron; 5-HT Ž5-hydroxytryptamine, serotonin.; Heart rate; Electrocardiography ŽDePetrillo, P.B. Ž391. 113. Fractalkine Chemokine; Chemotaxis; Adhesion; Umbilical vein, human; Endothelial cell ŽChapman, G.A. Ž392. 189. Free radical Ischemia–reperfusion; Cyclopiazonic acid; Oxidative stress; Reactive oxygen species ŽGrover, A.K. Ž387. 87.

Nigella satiÕa oil; Thymoquinone; Antinociception; Opioid system ŽAbdel-Fattah, A.-F.M. Ž400. 89.

Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Learning; Memory; Alzheimer’s disease ŽWang, L.M. Ž398. 65.

Sarpogrelate; 5-HT2A receptor antagonist; Antinociception; ŽRat. ŽObata, H. Ž404. 95.

Oxidative stress; Antioxidant; Cortical culture; Propofol; Vitamin E ŽBoland, A. Ž404. 21.

Forskolin Thromboxane A 2 ; TP receptor; cAMP; Mammary artery, internal; Saphenous vein ŽCracowski, J.-L. Ž387. 295. CGRP Žcalcitonin gene-related peptide.; ERK Žextracellular signal-regulated kinase.; P38; HEK 293 cell ŽParameswaran, N. Ž389. 125. Anococcygeus, mouse; Nitrergic; Nitric oxide ŽNO.; Papaverine; Sildenafil; Sodium nitroprusside ŽFrith, D. Ž400. 305.

Dinitrobenzene sulfonic acid; Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Poly ŽADP-ribose. synthetase; Colon damage ŽCuzzocrea, S. Ž406. 127. Freezing behavior Anxiety; Conditioned fear stress; Monoamine oxidase inhibitor ŽMaki, Y. Ž406. 411.

Mesenteric artery, rat; cAMP; Levcromakalim; Protein kinase A; K AT P channels ŽOmar, R. Ž401. 85.

Frontal cortex 5-HT Ž5-hydroxytryptamine, serotonin.; Paroxetine; Tianeptine; Raphe nuclei; Microdialysis, in vivo ŽMalagie, ´ I. Ž403. 55.

Fos-protein Clozapine; Tolerance; DOI; 8-OH-DPAT ŽSebens, J.B. Ž408. 11.

5-HT2A receptor; 5-HT2C receptor; ŽRabbit.; ŽHuman. ŽAloyo, V.J. Ž406. 163.

FR122047 Cyclooxygenase-1; Formalin test; Acetic acid-induced writhing ŽOchi, T. Ž391. 49.

FRTL-5 thyroid cell Adenosine A 1 receptor; ATP; Protein kinase C; Signal transduction ŽVainio, M. Ž390. 43.

FR139317 Endothelin ETA receptor; Endothelin ETB receptor; Splanchnic nerve stimulation; BQ-788 ŽHosokawa, A. Ž397. 55.

Fructose 2,6-bisphosphate Troglitazone; Hepatocyte; Insulin; Thiazolidinedione ŽRaman, P. Ž409. 19.

54

Master keyword index to Õolumes 386–410 (2000)

Frusemide Loop-diuretic; Bumetanide; Cardiomyocyte; Contraction ŽKelso, E. Ž400. 43. FSH (follicle-stimulating hormone) Dexamethasone; Inhibin; Ovarian function; ŽRat, female, immature. ŽTohei, A. Ž386. 69.

Esophageal sphincter relaxation, transient, lower; Baclofen; Tolerance ŽLehmann, A. Ž403. 163. 3-Nitropropionic acid; Mitochondrial toxin; Seizure; 4-Aminopyridine; Electroconvulsion ŽHaberek, G. Ž403. 229. GABA C receptor; r1 subunit; Loreclezole ŽThomet, U. Ž408. R1.

b-Funaltrexamine Dermorphin N-terminal tetrapeptide; Tail-flick test; Naloxonazine; m1Opioid receptor ŽSakurada, S. Ž395. 107.

GABA ( g-aminobutyric acid) release s Receptor; Glutamate release; Synaptosome; Cerebellum ŽGarrone, B. Ž400. 35.

Functional affinity Muscarinic receptor subtype; Ileum, avian; Binding affinity ŽDarroch, S. Ž402. 161.

Gabapentin Substantia nigra reticulata; g-Aminobutyric acid; Microdialysis ŽTimmerman, W. Ž398. 53.

Fura-2 Ca2q entry, capacitative; Ca2q store, internal; Cation channel, non-selective; Tyrosine kinase ŽOhta, T. Ž387. 211.

GABA receptor Locus coeruleus; Noradrenaline; Cortex, prefrontal; Stress; NMDA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279.

Ca2q; Tyrosine kinase; Adrenoceptor; Inositol phosphate ŽBerts, A. Ž389. 35.

GABA A receptor Anesthetic; Propofol; Locus coeruleus ŽChen, C.-L. Ž386. 201.

Betulinic acid; Ca2q; Ca2q store; MDCK cell; Thapsigargin ŽChou, K.-J. Ž408. 99.

GABA Ž g-aminobutyrate.; Caged compound; Synaptic inhibition; Hippocampus; Granule cell ŽMolnar, ´ P. Ž391. 255.

Fura 2-acetoxymethyl (AM) ester 2,3-Butanedione monoxime; Ca2i q transient; Long-term culture; Contractility; Ultrastructure; ŽGuinea pig. ŽHorackova, M. Ž404. 247.

Ivermectin; Subunit composition; Patch clamp ŽAdelsberger, H. Ž394. 163.

Fura-2 microfluorimetry AMPA receptor; Cortical neurone, cultured; Chloral hydrate; Trichloroethanol; Ca2q concentration, intracellular ŽFischer, W. Ž394. 41. GABA A 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT3 receptor; glycine receptor; Nicotinic acetylcholine receptor; Bicuculline ŽSun, H. Ž391. 243. GABA A r benzodiazepine receptor Hippocampus; Olfactory bulb; Ligand affinity; Receptor heterogeneity; a subunit ŽLameh, J. Ž400. 167. Sedation; 3D pharmacophore ŽHarris, D.L. Ž401. 271. GABA ( g-aminobutyrate) Caged compound; Synaptic inhibition; Hippocampus; Granule cell; GABA A receptor ŽMolnar, ´ P. Ž391. 255. GABA ( g-aminobutyric acid) Hippocampus; Choline; Interneuron; Nicotinic receptor; Excitation; Methyllycaconitine ŽAlkondon, M. Ž393. 59. Movement disorder; Dystonia; Paroxysmal choreoathetosis; Barbiturate ŽRichter, A. Ž397. 343. Dopamine; Acetylcholine; Substantia nigra; Striatum; Antimuscarinic P. Ž399. 151. drug; L-Dopa ŽIzurieta-Sanchez, ´ Clonidine; BAY K 8644; Ca2q channel, L-type; Limbic system; Septum, Epilepsy ŽBaran, H. Ž401. 31. Anaesthetic; Benzodiazepine; Optic nerve; Propofol ŽEmpson, R.M. Ž401. 339.

Urocanic acid; UV-induced immunosuppression ŽUusi-Oukari, M. Ž400. 11. GABA A receptor subtype Brain regional heterogeneity; w35 SxTBPS binding; Agonist coupling; Taurine; b-Alanine; Muscimol; 4-PIOL; 5-Ž4-piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233. GABA B receptor G-protein; w35 SxGTPgS autoradiography; 5-HT1 A receptor; Anxiolytic; Antidepressant ŽSim-Selley, L.J. Ž389. 147. GABA C receptor GABA Ž g-aminobutyric acid.; r1 subunit; Loreclezole ŽThomet, U. Ž408. R1. Gacyclidine NMDA receptor; Phencyclidine receptor; Gacyclidine enantiomer; Neuroprotection ŽHirbec, H. Ž388. 235. Gacyclidine enantiomer NMDA receptor; Phencyclidine receptor; Gacyclidine; Neuroprotection ŽHirbec, H. Ž388. 235. Gadd45 Apoptosis; Smooth muscle cell, vascular; p53; Troglitazone; Pioglitazone ŽOkura, T. Ž407. 227. Galanin-(1–15) Galanin; Galanin receptor; Galanin receptor antagonist; Cardiovascular; Neuropeptide; Brain ŽNarvaez, ´ J.A. Ž399. 197. Galanin Galanin-Ž1–15.; Galanin receptor; Galanin receptor antagonist; Cardiovascular; Neuropeptide; Brain ŽNarvaez, ´ J.A. Ž399. 197.

Master keyword index to Õolumes 386–410 (2000) Galanin receptor Galanin; Galanin-Ž1–15.; Galanin receptor antagonist; Cardiovascular; Neuropeptide; Brain ŽNarvaez, ´ J.A. Ž399. 197. Galanin receptor antagonist Galanin; Galanin-Ž1–15.; Galanin receptor; Cardiovascular; Neuropeptide; Brain ŽNarvaez, ´ J.A. Ž399. 197. Galanthamine Nicotinic acetylcholine receptor; Allosteric modulation; Alzheimer’s disease; Cholinergic deficit ŽMaelicke, A. Ž393. 165. Gallbladder Muscarinic receptor; Receptor heterogeneity; Radioligand binding; Kinetics; Ca2q, Intracellular; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Gap junction Melittin; Phospholipase A 2 ; Connexin; Endothelium-derived hyperpolarizing factor ŽEDHF.; Endothelium; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239. Gap junctions Endothelium-derived hyperpolarizing factor ŽEDHF.; Ouabain; 18aGlycyrrhetinic acid; Kq; Endothelium ŽHarris, D. Ž402. 119. Gastric blood flow Ischemia–reperfusion; Gastric secretion; Omeprazole; Ranitidine; Ulcer healing; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147. Gastric emptying EM574; Motilin; Cisapride; ŽDog. ŽSako, F. Ž395. 165. Gastric fundus, Pig Nitric oxide ŽNO.; VIP Žvasoactive intestinal polypeptide. ŽDick, J.M.C. Ž397. 389.

55

a-Fluoromethylhistidine; Histamine; Histidine decarboxylase; Microdialysis in vivo; ECL cell; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1. Gastrin-binding protein Gastrin; CCK receptor antagonist ŽRorison, K.A. Ž388. 9. Gastrin-releasing peptide Bombesin, synthetic glycine-extended form; Biological effect; Gastrin-releasing peptiderbombesin receptor antagonist; ŽIn vitro. ŽOiry, C. Ž403. 17. r bombesin receptor antagonist Gastrin-releasing peptider Gastrin-releasing peptide; Bombesin, synthetic glycine-extended form; Biological effect; ŽIn vitro. ŽOiry, C. Ž403. 17. Gastrointestinal motility Gastrointestinal transit; Interdigestive migrating contraction; Post-operative ileus; SK-896; Prostaglandin F2 a ; ŽDog. ŽTsukamoto, K. Ž401. 97. Gastrointestinal transit Momordin Ic; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2 receptor; Prostaglandin ŽLi, Y. Ž392. 71. Gastrointestinal motility; Interdigestive migrating contraction; Post-operative ileus; SK-896; Prostaglandin F2 a ; ŽDog. ŽTsukamoto, K. Ž401. 97. Gastroprotection Amtolmetin guacyl; Antisecretion; Capsaicin; CGRP Žcalcitonin gene-related peptide. ŽTubaro, E. Ž387. 233. Clonidine; a 2B -Adrenoceptor; Opioid receptor ŽGyires, K. Ž396. 131. Gender wMet 5 xenkephalin; T-lymphocyte; B-lymphocyte; Proliferation; Opioid receptor ŽGabrilovac, J. Ž392. 101.

Gastric fundus, rat Aldose reductase; Autonomic neuropathy; Diabetes; Non-adrenergic non-cholinergic; Streptozotocin ŽJenkinson, K.M. Ž401. 251.

Gender difference Opiate; Dependence, acute; Cardiovascular system; Blood pressure; Heart rate; Rat, spinal ŽCruz, S.L. Ž397. 121.

Gastric mucin biosynthesis HGF Žhepatocyte growth factor.; HGF receptor; ŽRat. ŽIchikawa, T. Ž392. 87.

Gene Nicotinic receptor; Neuron, human; Transcriptional regulation; Promoter ŽFlora, A. Ž393. 85.

Gastric mucus ´ Ž392. R5. Nitric oxide ŽNO.; Estrogen ŽMorschl, E.

Gene duplication Nicotinic receptor; Schizophrenia; Nicotine; Smoking; Neutrophil ŽLeonard, S. Ž393. 237.

Gastric secretion Ischemia–reperfusion; Omeprazole; Ranitidine; Ulcer healing; Gastric blood flow; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147.

Gene expression Differentiation; Protein kinase C; Atherosclerosis; a-tropomyosin; ŽRat. ŽHirano, K. Ž406. 209.

Gastric ulceration Helicobacter pylori; NSAID; Prostaglandin; Cyclooxygenase ŽTakahashi, S. Ž406. 461.

Gene polymorphism Opioid system, endogenous; Single nucleotide polymorphism; Addiction; Pharmacogenetics; Physiogenetics ŽLaForge, K.S. Ž410. 249.

Gastric ulcer healing Heparin; Intragastric administration; Nitric oxide ŽNO. synthase, Constitutive; Proliferation; Regeneration; Angiogenesis ŽLi, Y. Ž399. 205.

Susceptibility; Cardiovascular disease; Angiotensin-converting enzyme; Angiotensinogen; Angiotensin II type 1 receptor ŽWang, J.-G. Ž410. 289.

Gastrin CCK receptor antagonist; Gastrin-binding protein ŽRorison, K.A. Ž388. 9.

Generalized absence epilepsy Ca2q channel; WAGrRij rat; Spike-wave discharge; Nimodipine; BAY K8644; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381.

Ischemia–reperfusion; Gastric secretion; Omeprazole; Ranitidine; Ulcer healing; Gastric blood flow; Interleukin-1b; Somatostatin ŽBrzozowski, T. Ž398. 147.

Genes Personality; Neurotransmission; Polymorphism; Temperament; Abnormal behavior ŽEbstein, R.P. Ž410. 205.

56

Master keyword index to Õolumes 386–410 (2000)

Gene targeting Histamine H 1 receptor; Pain perception; Histamine; Somatic pain; Visceral pain ŽMobarakeh, J.I. Ž391. 81.

Glia Neonatal; ACTH Žadrenocorticotropin.; Neuroprotection; Magnocellular basal nucleus; Cholinergic neuron ŽHorvath, K.M. Ž405. 33.

Genetic Psychoneuroendocrinology; Psychoneuroimmunoendocrinology; Molecular biology ŽBrambilla, F. Ž405. 341.

Glibenclamide Thiazolidinedione; Troglitazone; Rosiglitazone; BRL 49653; K AT P current; Kq channel ŽMishra, S.K. Ž386. 121.

Opiate; Heroin; Addiction; Pharmacogenomics; Candidate gene ŽLichtermann, D. Ž410. 269.

I K.ATP ; HMR1883; Sulfonylurea; Cardiac ischemia; Dispersion; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273.

Genetic model Generalized absence epilepsy; Ca2q channel; WAGrRij rat; Spike-wave discharge; Nimodipine; BAY K8644; Ethosuximide ŽVan Luijtelaar, G. Ž406. 381.

Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1onex.; Temperature ŽTiritilli, A. Ž406. 79.

Genetic polymorphism Smoking; Neurotransmitter; Association; Linkage ŽArinami, T. Ž410. 215.

Preconditioning; CGRP Žcalcitonin gene-related peptide.; TNF-a Žtumor necrosis factor-a .; Heart, rat ŽPeng, J. Ž407. 303.

Genetics Dopamine D4 receptor; G protein-coupled receptor; Structure; Pharmacology; Signaling; Physiology ŽOak, J.N. Ž405. 303. Alcohol; Opioid receptor; Alcoholism; Quantitative trait locus ŽTown, T. Ž410. 243. Genome screening 5-HT2A receptor; Transmission disequilibrium; Association; Dopamine; Estrogen b receptor; Leptin ŽHinney, A. Ž410. 147. Genome-wide scanning Schizophrenia; Pharmacogenetics; Single nucleotide polymorphism; Pharmacogenomics; DNA microarray ŽKawanishi, Y. Ž410. 227. Genomic Essential obesity; Energy balance ŽRavussin, E. Ž410. 131. Genotype Pharmacogenetic; Pharmacogenomic; Molecular epidemiology; Phenotype; DNA sequence variants; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107.

Tolbutamide; Desensitization; Clonal pancreatic b-cell; Insulin release; K AT P channel ŽBall, A.J. Ž408. 327. Glioma PolyŽADP–ribose. polymerase; Nitrosoureas; 3-Aminobenzamide ŽWinter, S. Ž398. 177. Telomerase; Chemosensitivity; Penclomedine; p53 ŽVietor, M. Ž407. 27. Glipizide Dopamine; Tyrosine hydroxylase; Sulfonylurea; DOPAC Ž3,4-dihydroxyphenylacetic acid.; HVA Žhomovalinic acid. ŽLamensdorf, I. Ž388. 147. Glomerulo-tubular balance Cyclosporine; Tacrolimus; Tubulo-glomerular feed-back; Tubular reabsorption; Single nephron filtration rate ŽRomano, G. Ž399. 215. Glucagon Exocytosis; K AT P channel; Nateglinide; Repaglinide ŽBokvist, K. Ž386. 105. Sodium tungstate; Insulin; Pancreas, rat ŽRodrıguez-Gallardo, J. Ž402. ´ 199.

Gentamicin Renal failure; Nitric oxide ŽNO.; L-arginine; L-NAME Ž N v -nitro-Larginine methyl ester.; ŽRat. ŽCan, C. Ž390. 327.

mCPP Ž m-chlorophenylpiperazine.; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2C r2B receptor; Adrenaline ŽYamada, J. Ž406. 153.

GEPR (genetically epilepsy-prone rat) Electroshock; Convulsion; a 1-Adrenoceptor; b-Adrenoceptor; Receptor regulation ŽSeo, D.O. Ž396. 53.

Glucagon-like peptide-1 Insulin secretion; Glucose elimination; 1,5-Anhydro-D-fructose; ŽMouse. ŽAhren, ´ B. Ž397. 219.

GH (genetically hypertensive) rat Tachykinin NK 1 receptor; Substance P; Inflammation; Hypertension genetic; Nitric oxide ŽNO. ŽCampbell, V.A. Ž401. 109.

Dipeptidyl peptidase IV; Insulin secretion; Glucose tolerance; Diabetes, type 2; Glucose tolerance, impaired ŽAhren, ´ B. Ž404. 239.

Gingival fibroblast, human Bradykinin; Interleukin-1b; Prostaglandin E 2 ; Ca2q mobilization ŽNakao, S. Ž395. 247. Gingivitis Desipramine; Microbiota; Salivary protein; Salivary flow rate; Tricyclic antidepressant ŽKoller, M.M. Ž408. 91. Glaucine Phosphodiesterase 4 inhibitor; Sensitized, guinea pig; Airway hyperreactivity; Airway eosinophil infiltration; Airway microvascular leakage ŽPons, R. Ž397. 187.

Glucocorticoid Stress; Cytokine; Ageing; Alzheimer’s disease ŽAngelucci, L. Ž405. 139. Glucocorticoid receptor 5-HT1A receptor agonist; Flesinoxan; Mineralocorticoid receptor; Hippocampus; Dorsal raphe nucleus ŽSibug, R.M. Ž404. 111. Mineralocorticoid receptor; Hypothalamic–pituitary–adrenocortical axis; Stress; Antidepressants; Major depression ŽReul, J.M.H.M. Ž405. 235. Glucose, blood Glucose production, hepatic; Glucose-6-phosphatase; Glycogenesis; Chlorogenic acid derivative ŽHerling, A.W. Ž386. 75.

Master keyword index to Õolumes 386–410 (2000) Glucose clamp Streptozotocin; T-1095; Phlorizin; Naq-glucose cotransporter; Glucose tolerance test; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Glucose elimination Insulin secretion; 1,5-Anhydro-D-fructose; Glucagon-like peptide-1; ŽMouse. ŽAhren, ´ B. Ž397. 219. Glucose intolerance Encephalomyocarditis virus; Branched chain amino acid; Insulitis ŽUtsugi, T. Ž398. 409. Glucose metabolism b 3 -Adrenoceptor agonists; Thermogenesis; Pyruvate-oxidation; Soleus muscle, isolated ŽBoard, M. Ž406. 33. Glucose-6-phosphatase Glucose production, hepatic; Glucose, blood; Glycogenesis; Chlorogenic acid derivative ŽHerling, A.W. Ž386. 75. Glucose production, hepatic Glucose-6-phosphatase; Glucose, blood; Glycogenesis; Chlorogenic acid derivative ŽHerling, A.W. Ž386. 75. Glucose tolerance Dipeptidyl peptidase IV; Glucagon-like peptide-1 ŽGLP-1.; Insulin secretion; Diabetes, type 2; Glucose tolerance, impaired ŽAhren, ´ B. Ž404. 239. Glucose tolerance, impaired Dipeptidyl peptidase IV; Glucagon-like peptide-1 ŽGLP-1.; Insulin secretion; Glucose tolerance; Diabetes, type 2 ŽAhren, ´ B. Ž404. 239. Glucose tolerance test Streptozotocin; T-1095; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Glucose transporter Streptozotocin; T-1095; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Glucose transporter isotype 4 C2C12 cell; Insulin resistance; YM-126414 ŽShimokawa, T. Ž410. 1. Glutamate NMDA receptors; Dizocilpine; Nucleus accumbens; Tail-flick ŽMillan, M.J. Ž388. 37. Acetylcholine; Cholinergic; Interaction; Motivation; Behaviour ŽAura, J. Ž390. 313. Anxiety; Blood pressure; Heart rate; Kindling; Long-term potentiation; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265. Metabotropic receptor; Mouse ŽSpooren, W.P.J.M. Ž397. R1. Ensaculin; Dopamine; DOPAC Ž3,4-dihydroxyphenylacetic acid.; Microdialysis; Rat ŽTeismann, P. Ž398. 247. RPR 118723; Glycine antagonist; N-methyl-D-aspartate ŽNMDA. receptor–channel complex; TCP binding; Dopamine release ŽBoireau, A. Ž401. 131.

57

Dopamine uptake; Parkinson’s disease; NMDA receptor ŽPage, G. Ž403. 75. Acetycholine; Cannabinoid; Learning; Short-term memory ŽHan, C.J. Ž403. 87. Neurotoxicity; s Receptor; Phencyclidine site; Cortical culture ŽNishikawa, H. Ž404. 41. Alcohol withdrawal, human; Delirium tremens; Volume and fluid regulation; ANP Žatrial natriuretic peptide. secretion; Withdrawal hyperexcitability, mouse; NMDA Ž N-methyl-D-aspartate. seizure ŽKovacs, ´ G.L. Ž405. 103. Receptor; Metabotropic; Antagonist; 2-Methyl-6-Žphenylethynyl.-pyridine ŽMPEP. ŽSpooren, W.P.J.M. Ž406. 403. Nucleus tractus solitarii; Nitric oxide; Microdialysis ŽLin, H.-C. Ž407. 83. Cocaine; Cerebellum; Norepinephrine; Purkinje cell; Microiontophoresis; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ Diazepam; Flumazenil; ŽRat. ŽKhan, G.M. Ž407. 139. Glutamate excitotoxicity Cerebrocortical neuronal culture; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Glutamate receptor Scopolamine; Muscarinic acetylcholine receptor; Prepulse inhibition; Startle; Apomorphine; Phencyclidine; Dopamine receptor; ŽRat. ŽJones, C.K. Ž391. 105. Glutamate receptor antagonist Nicotinic receptor, presynaptic; Nicotine; Anatoxin-a; Immunogold electron microscopy; Synaptosome ŽWonnacott, S. Ž393. 51. Glutamate receptor, metabotropic, group I Antidepressant; DHPG ŽŽ RS .-3,5-dihydroxyphenylglycine.; Hippocampus; Imipramine ŽZahorodna, A. Ž386. 173. Glutamate receptor, metabotropic NS-105; Adenylyl cyclase; Antisense oligodeoxynucleotide, knockdown; Primary neuronal culture ŽHirouchi, M. Ž387. 9. Amphetamine; LY379268; Motor activity; Stereotypy ŽCartmell, J. Ž400. 221. Excitatory amino acid; Caudoputamen; Nucleus accumbens; Basal ganglia; Drug of abuse ŽMao, L. Ž404. 289. Glutamate receptor, Metabotropic Drug discrimination; Schizophrenia ŽSchreiber, R. Ž388. R3. Glutamate release v-Agatoxin IVA-sensitive Ca2q channel; a-Eudesmol; Synaptosome; Microdialysis; Focal ischemia ŽAsakura, K. Ž394. 57. s Receptor; GABA Ž g-aminobutyric acid. release; Synaptosome; Cerebellum ŽGarrone, B. Ž400. 35.

58

Master keyword index to Õolumes 386–410 (2000)

Glutamate toxicity Flupirtine; Retigabine; PC12 cells; Reactive oxygen intermediates; Glutathione ŽSeyfried, J. Ž400. 155.

Glycogenesis Glucose production, hepatic; Glucose-6-phosphatase; Glucose, blood; Chlorogenic acid derivative ŽHerling, A.W. Ž386. 75.

Glutamate transporter Neuroprotection; Glutamate uptake; Naq current ŽShimada, F. Ž386. 263.

Glycoprotein IIb r IIIa-inhibitor Smooth muscle cell, Vascular; Endothelial cell; Integrin; Vitronectin; ŽHuman. ŽKintscher, U. Ž390. 75.

Glutamate uptake Neuroprotection; Glutamate transporter; Naq current ŽShimada, F. Ž386. 263. Glutamic acid mGlu 1 receptor, Arg 78 ; Agonist binding; Quisqualic acid; Mutagenesis ŽJensen, A.A. Ž397. 247. Glutamine Arginine; Endothelin; Endotoxin; Nitro-arginine ŽMitchell, J.A. Ž389. 209. Glutathione Antioxidant; Sleep deprivation; Melatonin; Hypothalamus ŽD’Almeida, V. Ž390. 299. Nerve conduction; Blood flow; Kq channel opener; Naq, Kq ATPase; Oxidative stress; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335. Antioxidant; Diabetic retinopathy; Lipid peroxidation; Superoxide dismutase ŽObrosova, I.G. Ž398. 139.

Glycoprotein IIb r IIIa receptor TA-993; Platelet; ADP; Actin polymerization; Ca2q, intracellular ŽKatoh, M. Ž399. 91. 18 a-Glycyrrhetinic acid Mesenteric artery, rat; Endothelium; Levcromakalim; Hyperpolarisation; Carbachol ŽWhite, R. Ž397. 279. Endothelium-derived hyperpolarizing factor ŽEDHF.; Ouabain; Gap junctions; Kq; Endothelium ŽHarris, D. Ž402. 119. Glycyrrhizin Fas; Hepatitis ŽOkamoto, T. Ž387. 229. Goblet cell hypersecretion Neutrophil elastase inhibitor; Ozone-exposure; Mucus score ŽNogami, H. Ž390. 197. Gonadectomy, adult Pain; Antinociception; Sex difference; b-Endorphin ŽKrzanowska, E.K. Ž392. 157.

Methamphetamine; Oxidative stress ŽHarold, C. Ž400. 99. Flupirtine; Retigabine; Glutamate toxicity; PC12 cells; Reactive oxygen intermediates ŽSeyfried, J. Ž400. 155.

Gpp(NH)p shift Affinity; Intrinsic activity; Efficacy; 5-HT1A receptor ligand; S-14506; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97.

Liver, rat; Ischemia–reperfusion; Protective effect; ATP; Bile flow; Antioxidant ŽSettaf, A. Ž406. 281.

G protein d-Opioid receptor; m-Opioid receptor; m-Opioid receptor-knockout mice; Antinociception; Opioid drug ŽHosohata, Y. Ž388. 241.

Glycine Antidepressant; NMDA receptor; DSP-4; Norepinephrine; Desipramine ŽHarkin, A. Ž389. 187.

Fluoroquinolone; Histamine release; Mast cell ŽMori, K. Ž394. 51.

Glycine antagonist RPR 118723; Glutamate; N-methyl-D-aspartate ŽNMDA. receptor–channel complex; TCP binding; Dopamine release ŽBoireau, A. Ž401. 131. Glyciner r NMDA receptor Epilepsy; Riluzole; Audiogenic seizure; AMPA Ž a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid.; DBAr2 mouse ŽDe Sarro, G. Ž408. 25. Glycine B receptor 7-Chlorokynurenate; Excitotoxicity; Neuroprotection ŽWu, H.-Q. Ž390. 267. Glycine receptor 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT3 receptor; GABA A ; Nicotinic acetylcholine receptor; Bicuculline ŽSun, H. Ž391. 243. 5-HT3 receptor antagonist; Potentiation; Interaction; Pharmacophore model; Selectivity ŽChesnoy-Marchais, D. Ž402. 205. Glycine site NMDA receptor; Receptor binding; GV150526A ŽMugnaini, M. Ž391. 233.

Pancreastatin receptor; Signaling; Phospholipase C; MAPK; HTC cell; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´ Signal transduction; a 2 -Adrenoceptor; G protein coupled receptor; Second messenger; 5-HT receptor; 5-HT1A receptor ŽHappe, H.K. Ž399. 17. Nociceptin; Inflammatory response; Histamine; Mast cell; ORL 1 receptor; ŽRat. ŽKimura, T. Ž407. 327. G-protein w35 SxGTPgS autoradiography; 5-HT1 A receptor; GABA B receptor; Anxiolytic; Antidepressant ŽSim-Selley, L.J. Ž389. 147. w35 SxGTPgS binding; Brain, human; a 2 -Adrenoceptor; 5-HT1A receptor; m-Opioid receptor ŽGonzalez-Maeso, J. Ž390. 25. ´ m-Opioid receptor; d-Opioid receptor; w35 SxGTPgS binding; Collisioncoupling model; Compartmentalization ŽRemmers, A.E. Ž396. 67. Salmeterol; Benzalkonium chloride; Mast cell; b 2 -Adrenoceptor; Asthma ŽSeebeck, J. Ž397. 19. m-Opioid receptor; Antinociception; Ponsrmedulla; Diabetes ŽOhsawa, M. Ž401. 55.

Master keyword index to Õolumes 386–410 (2000) Opioid; Diabetes mellitus; Antinociception; m-Opioid receptor; d-Opioid receptor ŽPieper, G.M. Ž401. 375. G protein-coupled receptor Dopamine; Palmitoylation; Phosphorylation; Desensitization; Adenylyl cyclase ŽJin, H. Ž386. 305. a 2 -Adrenoceptor; Agonist, Inverse; RX821002; MK-912; GTP; Rauwolscine ŽMurrin, L.C. Ž398. 185. Dopamine D4 receptor; Structure; Pharmacology; Signaling; Physiology; Genetics ŽOak, J.N. Ž405. 303. G-protein coupled receptor RNA-mediated interference; npr-1 ŽGomes, A.V. Ž397. R3. Chemokine; Receptor coupling; HIV Žhuman immunodeficiency virus. ŽDi Salvo, J. Ž409. 143. G protein coupled receptor Signal transduction; G protein; a 2 -Adrenoceptor; Second messenger; 5-HT receptor; 5-HT1A receptor ŽHappe, H.K. Ž399. 17.

59

ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Peptide– receptor interaction; Avoidance; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. Grooming, Novelty-induced Low dose; Prolactin; Sexual behavior, Male; Sexual behavior, Female ŽDrago, F. Ž405. 131. Growth Nitric oxide ŽNO.; Nitric oxide ŽNO. synthases; Vanadium; Osteoblast differentiation; Bone; Cytotoxicity ŽCortizo, A.M. Ž400. 279. Growth factor gene expression Taurine; Angiotensin II; Cell size; Fetal gene expression; Protein kinase C ŽAzuma, M. Ž403. 181. GTP a 2 -Adrenoceptor; Agonist, Inverse; G protein-coupled receptor; RX821002; MK-912; Rauwolscine ŽMurrin, L.C. Ž398. 185. Ribavirin; Ras; Raf-1; Cell cycle; Heat shock; Extracellular signal-regulated protein kinase ŽVallee, ´ S. Ž404. 49.

G protein-coupled receptor kinase CGRP receptor, porcine, cloned; Homologous desensitization; CGRP Žcalcitonin gene-related peptide.; Ro 32-0432; Antisense oligonucleotide ŽAiyar, N. Ž403. 1.

GTPase s Receptor; Žq.Pentazocine; Haloperidol; Cerebellum; w35 SxGTPgS autoradiography ŽHong, W. Ž408. 117.

Gs protein, coupling b 2 -Adrenoceptor; Neutrophil; Depression, major; Anxiety; Antidepressant, tricyclic ŽGurguis, G.N.M. Ž386. 135.

GTPg[35 S] 5-HT1A receptor; Brain, human; Antipsychotic drug; Clozapine; Quetiapine ŽElliott, J. Ž386. 313.

G protein g 2 subunit DPDPE ŽcwD-Pen2 ,D-Pen 5 xenkephalin.; Antinociception ŽHosohata, K. Ž392. R9.

GTPgS Nociceptin; Orphanin FQ; ORL1; Opioid; Opioid receptor ŽHawkinson, J.E. Ž389. 107.

G protein receptor kinases a 1-Adrenoceptor; Receptor phosphorylation; Protein kinase C; Phosphatidylinositol 3-kinase; Desensitization ŽGarcıa-Sainz, J.A. Ž389. 1. ´ ´

GTS-21 4OH-GTS-21; a7 Receptor-selective agonist ŽPapke, R.L. Ž393. 179.

GR127935 5-HT1B rD receptor; Locomotor activity; SKF99101H; WAY100635; ŽGuinea pig. ŽO’Neill, M.F. Ž399. 49. GR125743 Coronary artery; Eletriptan; Middle meningeal artery; Migraine; Saphenous vein; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Granule cell GABA Ž g-aminobutyrate.; Caged compound; Synaptic inhibition; Hippocampus; GABA A receptor ŽMolnar, ´ P. Ž391. 255. Granuloma Chymase; Mast cell; Angiogenesis; Compound 48r80 ŽMuramatsu, M. Ž402. 181. Grepafloxacin Fluoroquinolones; Sparfloxacin; Moxifloxacin; Ciprofloxacin; Purkinje fibre; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449. Grooming Antidepressant drug; Desipramine; Locomotor activity; Mesolimbic dopamine system; Open field; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43.

Guanidinoethyl sulfonate Amino acid; Dopamine; Microdialysis; ŽRat. ŽOlive, M.F. Ž409. 291. Guanylate cyclase Zaldaride maleate; Calmodulin; Adenylate cyclase; Ion secretion ŽAikawa, N. Ž394. 233. Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79. Nitric oxide ŽNO.; Ambroxol ŽSeverina, I.S. Ž407. 61. Guanylyl cyclase b-Adrenoceptor; b-Adrenoceptor, atypical; Endothelium; Nitric oxide ŽNO.; Smooth muscle, vascular ŽBrawley, L. Ž398. 285. Guanylyl cyclase, soluble Superoxide anion; Aorta; Renin–angiotensin system; Hypertension ŽJacke, K. Ž403. 27. GV150526A NMDA receptor; Glycine site; Receptor binding ŽMugnaini, M. Ž391. 233.

60

Master keyword index to Õolumes 386–410 (2000)

GYKI 52466 2,3-Benzodiazepine; Anticonvulsant; Epilepsy; Hippocampus; Brain slice; Epileptiform bursting ŽMarinelli, S. Ž391. 75. GYKI 53784 AMPA receptor; Purkinje cell; Aniracetam; Cyclothiazide; 1-BCP; BDP12 ŽKapus, G. Ž397. 43. H-89 TGF-a Žtransforming growth factor-a .; TGF-b1 Žtransforming growth factor-b1.; 2,4-Dideoxyadenosine; Somatostatin; Hepatocyte proliferation ŽKimura, M. Ž386. 271. Protein kinase A; Rp-cAMPS; Mitogenesis ŽOsinski, M.T. Ž395. 173. Haemoxygenase Ozone; Carbon monoxide ŽCO.; Neutrophil; Bronchial hyperresponsiveness ŽHisada, T. Ž399. 229. Haloperidol

Heart failure g-Butyrobetaine hydroxylase inhibitor; Survival rate; Ventricular remodeling; Cardiac functional adaptability; High-energy phosphate ŽHayashi, Y. Ž395. 217. Collagen; Hypertrophy; Moxonidine; Sympathetic activation; ŽRat. ŽVan Kerckhoven, R. Ž397. 113. Ca2q-sensitizer; Inotropic agent; Hemodynamics; Excitation–contraction coupling; Diastolic dysfunction ŽJanssen, P.M.L. Ž404. 191. Heart, isolated Adrenomedullin; Myocyte; Papillary muscle; Ca2q transient; ŽRat. ŽStangl, V. Ž408. 83. Heart, isolated, rat Diltiazem; Coronary flow; Ischemia; Microsphere; Reperfusion ŽKatsumata, N. Ž398. 83.

D-Fenfluramine; Hypothermia; 5-HT1A

receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275.

Heart lesion N v-nitro-L-arginine methyl ester; Ventricular hypertrophy; Stereology ŽDe Oliveira, C.F. Ž391. 121.

Catalepsy; Dopamine D 2 receptor; Dopamine D 3 receptor; Knock-out mice; SCH 23390 ŽBoulay, D. Ž391. 63.

Heart, Rat Contractile function; Carnitine palmitoyltransferase I inhibition; Etomoxir; Hypertrophy; Infarct size ŽGunther, J. Ž406. 123. ¨

Clozapine-induced potentiation; NMDA receptor; MK-801; Long-term potentiation; Perforant path–dentate gyrus pathway ŽKubota, T. Ž395. 37. Clozapine; Ritanserin; Ascorbic acid; Ethanol; Microdialysis; ŽRat. ŽLiu, W. Ž398. 333.

Heart, rat Preconditioning; CGRP Žcalcitonin gene-related peptide.; TNF-a Žtumor necrosis factor-a .; Glibenclamide ŽPeng, J. Ž407. 303.

s Receptor; Neuroleptic; Dystonia; Extrapyramidal ŽMatsumoto, R.R. Ž401. 155.

Heart rate Ketamine; Ondansetron; 5-HT Ž5-hydroxytryptamine, serotonin.; Electrocardiography; Fractal ŽDePetrillo, P.B. Ž391. 113.

s Receptor; s1 Receptor mRNA; w3 HxDTG Žw3 Hx1,3-di Ž2-tolyl. guanidine.; w3 HxŽq.-Pentazocine; Species difference ŽInoue, A. Ž401. 307.

Anxiety; Blood pressure; Glutamate; Kindling; Long-term potentiation; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

Tyrosine hydroxylase; Substantia nigra; Immunohistochemistry; Antioxidant; ŽRat. ŽBesret, L. Ž408. 35.

Opiate; Dependence, acute; Gender difference; Cardiovascular system; Blood pressure; Rat, spinal ŽCruz, S.L. Ž397. 121.

s Receptor; Žq.Pentazocine; Cerebellum; GTPase; w35 SxGTPgS autoradiography ŽHong, W. Ž408. 117. Harman Vasorelaxant; Endothelium; Nitric oxide ŽNO. ŽShi, C.-C. Ž390. 319. HCL-31D, platelet aggregation cAMP; Thromboxane B 2 ; Phosphoinositide breakdown ŽChou, T.-C. Ž387. 125. Healing-impaired, mouse Wound healing accelerator; Cyclic peptide; SEK-1005; TGF-b1 Žtransforming growth factor-b1. inducer ŽAbe, Y. Ž408. 213. Heart Thiazolidinedione; Hemodynamics; Coronary vasorelaxant; Prostaglandin ŽUchida, K. Ž400. 113.

Heat shock Ribavirin; Ras; Raf-1; Cell cycle; Extracellular signal-regulated protein kinase; GTP ŽVallee, ´ S. Ž404. 49. Heat shock protein Brain; Cerebral ischemia; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Nitro-L-arginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. HEK 293 cell CGRP Žcalcitonin gene-related peptide.; ERK Žextracellular signal-regulated kinase.; P38; Forskolin ŽParameswaran, N. Ž389. 125. 5-HT3 receptor; 5-HT3 receptor agonist; 5-HT3 receptor antagonist; Ligand-gated ion channel; ŽFerret. ŽMochizuki, S. Ž399. 97.

Mitoxantrone; Anti-muscarinic action; ŽGuinea pig. ŽChugun, A. Ž407. 183.

HEK293 cell Melatonin receptor; cAMP response element; Luciferase; Reporter gene assay ŽConway, S. Ž390. 15.

Long QT syndrome; Kq channel; Pharmacogenetics ŽEscande, D. Ž410. 281.

Ca2q channel; Recombinant; Pharmacology ŽMcNaughton, N.C.L. Ž407. 53.

Master keyword index to Õolumes 386–410 (2000) HeLa cell Endothelin ETA receptor; Endothelin ETB receptor; Fibroblast; ŽHuman. ŽDrimal, J. Ž396. 19. Helicobacter pylori NSAID; Prostaglandin; Cyclooxygenase; Gastric ulceration ŽTakahashi, S. Ž406. 461. Hematopoietic ´ Ž405. 297. Stem cell; Differentiation; Central nervous system ŽMezey, E. Hemodynamics Thiazolidinedione; Heart; Coronary vasorelaxant; Prostaglandin ŽUchida, K. Ž400. 113. Ca2q-sensitizer; Inotropic agent; Heart failure; Excitation–contraction coupling; Diastolic dysfunction ŽJanssen, P.M.L. Ž404. 191. Hemoglobin Angiogenesis; S-nitrosocaptopril; Captopril; Nitric oxide ŽNO.; Capillary endothelium; Chorioallantoic membrane; Chick embryo ŽJia, L. Ž391. 137.

61

Hepatocyte, rat Lead; Lipopolysaccharide; Kupffer cell; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317. Herbal drug Sesquiterpene; Ca2q channel blocker; Smooth muscle ŽIrie, K. Ž403. 235. Herbimycin A Insulin; Primary culture of hepatocyte; Tyrosine phosphorylation; cAMP phosphodiesterase; Microtubule; Wortmannin ŽIshibashi, K. Ž409. 109. HERG QT-prolongation; Fluoroquinolones; Patch-clamp technique ŽBischoff, U. Ž406. 341. HERG (human ether-a-go-go-related gene) Kq channel; Pimozide; Arrhythmia; Antipsychotic agent ŽKang, J. Ž392. 137. Heroin Opiate; Addiction; Genetic; Pharmacogenomics; Candidate gene ŽLichtermann, D. Ž410. 269.

Hemophilia A Blood coagulation control; Antithrombin consumption; Thrombin–antithrombin complex; Factor Xarantithrombin complex; Protein SV-IV ŽDi Micco, B. Ž391. 1.

Hexarelin Penile erection; EP 60761; EP 50885; Oxytocin; Nitric oxide ŽNO.; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137.

Hemostasis Endothelial factor; Nitric oxide ŽNO.; Platelet; Thrombosis ŽMomi, S. Ž397. 177.

HgCl 2 LL-Z1640-2; Radicicol; Mitogen-activated protein kinases; c-Jun Nterminal kinase ŽMatsuoka, M. Ž409. 155.

Heparin Antithrombotic; Coagulation factor Xa; Thrombin; ŽIn vivo. ŽHeran, C. Ž389. 201.

HGF (hepatocyte growth factor) Gastric mucin biosynthesis; HGF receptor; ŽRat. ŽIchikawa, T. Ž392. 87.

Intragastric administration; Gastric ulcer healing; Nitric oxide ŽNO. synthase, Constitutive; Proliferation; Regeneration; Angiogenesis ŽLi, Y. Ž399. 205. r reperfusion Hepatic ischemiar ATP–MgCl 2 ; Mitochondrial energy metabolism; Mitochondrial enzyme; Lipid peroxidation ŽJeong, C. Ž403. 243. Hepatitis Fas; Glycyrrhizin ŽOkamoto, T. Ž387. 229. Concanavalin A; Cytochrome P450 ŽOkamoto, T. Ž394. 157. Concanavalin A; Aminoguanidine ŽOkamoto, T. Ž396. 125.

HGF receptor HGF Žhepatocyte growth factor.; Gastric mucin biosynthesis; ŽRat. ŽIchikawa, T. Ž392. 87. 5-HIAA (5-hydroxyindole-3-acetic acid) 5-HT Ž5-hydroxytryptamine, serotonin.; 5-Hydroxytryptophol; Dopamine; Noradrenaline; Ataxia, cerebellar ŽReader, T.A. Ž398. 41. High-density lipoprotein Endothelium-dependent relaxation; Very low-density lipoprotein; Lowdensity lipoprotein; Oxysterol ŽPersegol, L. Ž406. 429. ´ High-energy phosphate g-Butyrobetaine hydroxylase inhibitor; Heart failure; Survival rate; Ventricular remodeling; Cardiac functional adaptability ŽHayashi, Y. Ž395. 217.

Anti-Fas antibody; Aminoguanidine ŽOkamoto, T. Ž403. 277. Hepatocyte Ethanol; Acetaldehyde; MAPK Žmitogen-activated protein kinase.; Angiotensin II ŽWeng, Y.-I. Ž398. 323. DNA synthesis; Proliferation; Prostaglandin; Primary culture; ŽAdult rat. ŽKimura, M. Ž404. 259. Troglitazone; Fructose 2,6-bisphosphate; Insulin; Thiazolidinedione ŽRaman, P. Ž409. 19. Hepatocyte proliferation TGF-a Žtransforming growth factor-a .; TGF-b1 Žtransforming growth factor-b1.; 2,4-Dideoxyadenosine; Somatostatin; H-89 ŽKimura, M. Ž386. 271.

High-performance liquid chromatography Cannabinoid; Anandamide; Fatty acid ethanolamides; Mass spectrometry; Anandamide transport ŽGiuffrida, A. Ž408. 161. Hindered phenol BHA Ž3-t-butyl-4-hydroxyanisole.; Ca2q homeostasis ŽFusi, F. Ž394. 109. Hippocampal brain membrane, porcine NMDA receptor; s site; w3 HxIfenprodil; w3 HxMK-801 ŽHofner, G. Ž394. ¨ 211. Hippocampal neuron Veratridine; Swelling; Death; Naq channel; Ca2q channel ŽOkuyama, K. Ž398. 209.

Master keyword index to Õolumes 386–410 (2000)

62

Neuropathy; Colorectal cancer; Dorsal root ganglia; Sural nerve ŽAdelsberger, H. Ž406. 25.

Vasopressin; Norepinephrine; Neuromodulation; Associative memory mechanism ŽBrinton, R.D. Ž405. 73.

Hippocampal slice ATP; Electrical signal; Optical recording; Adenosine receptor ŽSato, K. Ž399. 123.

Adenosine; Chloroadenosine; Interneuron; Afterhyperpolarization ŽLi, H. Ž407. 237.

Hippocampus Antidepressant; DHPG ŽŽ RS .-3,5-dihydroxyphenylglycine.; Glutamate receptor, metabotropic, group I; Imipramine ŽZahorodna, A. Ž386. 173. q

Electrophysiology; Epileptiform activity; Na ŽAmeri, A. Ž386. 187.

current; Aconitum alkaloid

Stress; Nicotine; Dopamine; Striatum; ŽRat. ŽPawlak, R. Ž387. 171. 5-HT1A receptor; EEDQ; w35 SxGTPgS binding assay; Cortex; Receptor reserve; Spare receptor ŽAlper, R.H. Ž390. 67. Kainate; Excitotoxicity; Cyclooxygenase-2; Nimesulide; Oxidative stress ŽCandelario-Jalil, E. Ž390. 295. GYKI 52466; 2,3-Benzodiazepine; Anticonvulsant; Epilepsy; Brain slice; Epileptiform bursting ŽMarinelli, S. Ž391. 75. GABA Ž g-aminobutyrate.; Caged compound; Synaptic inhibition; Granule cell; GABA A receptor ŽMolnar, ´ P. Ž391. 255. Anandamide; Food intake; Diet restriction; Cognitive function; Hypothalamus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147. Choline; Interneuron; Nicotinic receptor; Excitation; Methyllycaconitine; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59. AMPA Ž a-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid.; AMPA receptor modulator; Cortex ŽBlack, M.D. Ž394. 85.

Purine; Adenosine; ATP; Nucleotide; Suramin; Long-term potentiation ŽO’Kane, E.M. Ž409. 159. Hippocampus, dorsal Nicotine; 5-HT1A receptor; Anxiety; Phobia; Septum, lateral ŽFile, S.E. Ž393. 231. Hippocampus, rat Estrogen; Non-genomic effect; ERK Žextracellular signal-regulated kinase. ŽKuroki, Y. Ž400. 205. Hippocampus, ventral Microdialysis; 5-Hydroxytryptamine, serotonin Ž5-HT.; Citalopram; 5Hydroxytryptamine, serotonin Ž5-HT. reuptake inhibitor, selective ŽCremers, T.I.F.H. Ž397. 63. Histamine Blood–brain barrier; Brain edema; Cerebral ischemia–reperfusion; Intracellular histamine binding site; DPPE Ž N,N-diethyl-2-w4-Žphenylmethyl. phenoxyxethanamine. ŽDeli, M.A. Ž387. 63. Histamine H 1 receptor; Pain perception; Somatic pain; Visceral pain; Gene targeting ŽMobarakeh, J.I. Ž391. 81. Enterochromaffin-like cell; Mast cell; Rabeprazole; Mast cell-deficient, rat ŽNakamura, S. Ž394. 9. Food intake; Hypothalamus; Leptin; Tele-methylhistamine; ŽIntracereboventricular infusion. ŽLecklin, A. Ž395. 113.

g-Hydroxybutyrate; Cerebral ischemia; Immunochemistry; Sensory–motor test; Spatial learning ŽVergoni, A.V. Ž397. 75.

Phospholipase C; Chromaffin cell; Ca2q; Inositol phospholipid; Adrenal medulla ŽRoberts-Thomson, E.L. Ž398. 199.

5-HT Ž5-hydroxytryptamine, serotonin.; Kindling; Seizure ŽWatanabe, K.-i. Ž398. 239.

Substance P; TNF-a Žtumor necrosis factor-a .; Dexamethasone; MAP Žmitogen-activated protein. kinase; Skin ŽOkabe, T. Ž398. 309.

NMDA Ž N-methyl-D-aspartate.; Quinolinic acid; Kynurenine; Long-term potentiation; NMDA receptor subunit ŽYoussef, F. Ž398. 349.

a-Fluoromethylhistidine; Gastrin; Histidine decarboxylase; Microdialysis in vivo; ECL cell; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1.

Clomethiazole; Chlormethiazole; Spreading depression; Hypoxia; Neuroprotection ŽStone, T.W. Ž399. 29.

Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73.

GABA A rbenzodiazepine receptor; Olfactory bulb; Ligand affinity; Receptor heterogeneity; a subunit ŽLameh, J. Ž400. 167. AMPA receptor; S18986-1; Noradrenaline release; Allosteric modulator ŽLockhart, B. Ž401. 145. Acetylcholine; HU 210; Microdialysis; Cortex, prefrontal; SR 141716A; WIN 55, 212-2 ŽAcquas, E. Ž401. 179. 5-HT1A receptor agonist; Flesinoxan; Glucocorticoid receptor; Mineralocorticoid receptor; Dorsal raphe nucleus ŽSibug, R.M. Ž404. 111. BIIE0246; Neuropeptide Y; Neuropeptide Y Y2 receptor ŽWeiser, T. Ž404. 133. Vasopressin; Memory process ŽAlescio-Lautier, B. Ž405. 63.

Apomorphine; Licking behavior; ŽRat. ŽFarzin, D. Ž404. 169. Emedastine difumarate; Itch-associated response; Substance P; Leukotriene B 4 ; 5-HT Ž5-hydroxytryptamine, Serotonin. ŽAndoh, T. Ž406. 149. Histamine release; Microdialysis; Veratrine; Ouabain ŽWashington, B. Ž407. 117. Nociceptin; Inflammatory response; Mast cell; G protein; ORL 1 receptor; ŽRat. ŽKimura, T. Ž407. 327. Allergic conjunctivitis; Vascular permeability; Histamine H 1 receptors; 5-HT Ž5-hydroxytryptamine, serotonin. ŽNakahara, H. Ž409. 313.

Master keyword index to Õolumes 386–410 (2000) Pre-eclampsia; Nitric oxide ŽNO.; Endothelium; ANP Žatrial natriuretic peptide.; ŽHuman. ŽSuzuki, Y. Ž410. 7. Compound 48r80; Connective tissue mast cell; Mast cell-deficient ŽWsrWs. rat; Tracheal contraction; 5-HT Ž5-hydroxytryptamine, serotonin. ŽIkawati, Z. Ž420. 297. Histamine H 1 receptor Constitutive activity; Inverse agonism ŽBakker, R.A. Ž387. R5. Pain perception; Histamine; Somatic pain; Visceral pain; Gene targeting ŽMobarakeh, J.I. Ž391. 81. Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Histamine H 3 receptor Acetylcholine release; Stomach; Pertussis toxin ŽYokotani, K. Ž392. 23. Histamine H 1 receptors Allergic conjunctivitis; Vascular permeability; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽNakahara, H. Ž409. 313. Histamine release Fluoroquinolone; Mast cell; G protein ŽMori, K. Ž394. 51. Histamine; Microdialysis; Veratrine; Ouabain ŽWashington, B. Ž407. 117. Histidine decarboxylase Bafilomycin A 1 ; a-Fluoromethylhistidine; Reserpine; Vacuolar-type ATPase; Vesicular monoamine transporter ŽLindstrom, ¨ E. Ž387. 19. a-Fluoromethylhistidine; Gastrin; Histamine; Microdialysis in vivo; ECL cell; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1. Histochemistry Neurotoxicity; Cytochrome oxidase; Amphetamine; Energy metabolism ŽBurrows, K.B. Ž398. 11. HIV (human immunodeficiency virus) Chemokine; G-protein coupled receptor; Receptor coupling ŽDi Salvo, J. Ž409. 143. HMR1883 I K.ATP ; Glibenclamide; Sulfonylurea; Cardiac ischemia; Dispersion; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273. hnRNP K Acetylcholine receptor; Sox protein; Sp1; Transcriptional regulation ŽMelnikova, I.N. Ž393. 75. Hoe 140 Vas deferens, rat; Bradykinin; Bradykinin receptor; Antagonism, insurmountable ŽAsghar, A.U.R. Ž398. 131. Homeobox gene Neuropeptide; Vasopressin; Corticotropin-releasing hormone; Dopamine; Transcription factors; Development ŽBurbach, J.P.H. Ž405. 55. Homologous desensitization CGRP receptor, porcine, cloned; G protein-coupled receptor kinase; CGRP Žcalcitonin gene-related peptide.; Ro 32-0432; Antisense oligonucleotide ŽAiyar, N. Ž403. 1.

63

Hormonal control Endothelial receptor, luminal; ATP; Purinoceptor; Endothelial mediator; Cardiac function control ŽZenteno-Savin, T. Ž410. 15. Hormone-sensitive lipase, cAMP Ethanol withdrawal; Adipose tissue; Phosphodiesterase ŽShih, M.-F. Ž409. 223. Hotplate Opioid analgesia; U69,593; Sex differences; Lick latency; ŽRat. ŽVan Haaren, F. Ž408. 153. Hot plate test NTŽ8–13.; NT69L ŽTyler-McMahon, B.M. Ž390. 107. Hot-plate test Baclofen; Imipramine; Ligation; ŽMouse. ŽZarrindast, M.-R. Ž407. 65. HTC cell Pancreastatin receptor; Signaling; G protein; Phospholipase C; MAPK; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´ HT29 cell Adenosine receptor; Colon adenocarcinoma; Adenosine deaminase; Epithelial differentiation ŽLelievre, V. Ž391. 21. ` 5-HT (5-hydroxytryptamine, serotonin) Methamphetamine; 3-Nitropropionic acid; Neurotoxicity; Dopamine; Aromatic L-amino acid decarboxylase; Motor behaviour ŽEradiri, O.L. Ž386. 217. Antipsychotic; Neuroleptic; 5-HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57. Nicotinic acetylcholine receptor; Photoaffinity labeling; Antagonist, noncompetitive; Antagonist, competitive ŽBlanton, M.P. Ž389. 155. Ketamine; Ondansetron; Heart rate; Electrocardiography; Fractal ŽDePetrillo, P.B. Ž391. 113. 5-HT3 receptor; glycine receptor; GABA A ; Nicotinic acetylcholine receptor; Bicuculline ŽSun, H. Ž391. 243. Momordin Ic; Gastrointestinal transit; 5-HT2 receptor; Prostaglandin ŽLi, Y. Ž392. 71. Chronic treatment; Microdialysis; ŽRat. ŽCremers, T.I.F.H. Ž397. 351. 5-HIAA Ž5-hydroxyindole-3-acetic acid . ; 5-Hydroxytryptophol; Dopamine; Noradrenaline; Ataxia, cerebellar ŽReader, T.A. Ž398. 41. Kindling; Hippocampus; Seizure ŽWatanabe, K.-i. Ž398. 239. a-Methyl-5-hydroxytryptamine; Vasoconstrictor effect; Mesenteric blood flow; 5-HT2B r2C receptor ŽFernandez, M.M. Ž401. 221. ´ Nitric oxide ŽNO.; 8-OH-DPAT Ž8-hydroxy-2-di-n-Žpropylamino.tetralin.; Food intake; N G -nitro-L-arginine methyl ester ŽL-NAME.; Hypothalamus ŽYamada, J. Ž402. 247. Paroxetine; Tianeptine; Frontal cortex; Raphe nuclei; Microdialysis, in vivo ŽMalagie, ´ I. Ž403. 55.

64

Master keyword index to Õolumes 386–410 (2000)

Umbilical artery, human; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79. Emedastine difumarate; Itch-associated response; Substance P; Histamine; Leukotriene B 4 ŽAndoh, T. Ž406. 149. mCPP Ž m-chlorophenylpiperazine.; Glucagon; 5-HT2Cr2B Adrenaline ŽYamada, J. Ž406. 153.

receptor;

Leptin; 5-HTP Ž5-Hydroxytryptophan.; Benserazide; ŽMouse. ŽYamada, J. Ž406. 159. Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; Methacholine; Bronchoconstriction; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469.

5-HT (5-hydroxytryptamine, serotonin) transporter MDMA Ž3,4-methylenedioxymethamphetamine.; Egr-1 Žzif-268.; Immediate-early gene ŽShirayama, Y. Ž402. 215. 5-HT2A receptor; Nefazodone ŽPullar, I.A. Ž407. 39. Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT receptor; Monoamine oxidase; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstraVanderWeele, J. Ž410. 165. 5-HT (5-hydroxytryptamine, serotonin) transport 5-HT receptor; Brush border membrane; Jejunum, rabbit ŽAlcalde, A.I. Ž403. 9.

Paroxetine; Desipramine; Microdialysis; Noradrenaline ŽHajos-Korcsok, ´ ´ Ž407. 101. E.

5-HT (5-hydroxytryptamine, serotonin) release 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1.

Endothelin-1; Basilar artery; Hypocapnia; Isocapnia; Alkaline ŽZuccarello, M. Ž407. 191.

Microdialysis, in vivo; 5-HT1A receptor; WAY 100635 ŽAssie, ´ M.-B. Ž409. 173.

Pulmonary supernumerary artery; 5-HT1D -like receptor ŽShaw, A.M. Ž408. 69.

5-HT (5-hydroxytryptamine, serotonin) syndrome Venlafaxine; WAY 100635; 5-HTŽ5-hydroxytryptamine, serotonin.; 5HT1A autoreceptor; Dorsal raphe nucleus; ŽCat. ŽBjorvatn, B. Ž404. 121.

Chronic pain; Spinal cord; Paw pressure test; ŽRat. ŽBardin, L. Ž409. 37. Allergic conjunctivitis; Vascular permeability; Histamine H 1 receptors; Histamine ŽNakahara, H. Ž409. 313. Pharmacogenetics; Tryptophan hydroxylase; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; 5-HT Ž5hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. Compound 48r80; Connective tissue mast cell; Mast cell-deficient ŽWsrWs. rat; Tracheal contraction; Histamine ŽIkawati, Z. Ž420. 297. 5-HT (5-hydroxytryptamine, serotonin) depletion Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; Dopamine D 2 -like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. 5-HT (5-Hydroxytryptamine serotonin) Desensitization; Serum; T84 cell ŽBurleigh, D. Ž390. 103. 5-HT receptor; FLIPR Žflourescent imaging plate reader.; Fluorescence; Meta-chlorophenylpiperazine; 8-OH-DPAT Ž8-hydroxy-N, N-dipropylaminotetralin. ŽWood, M. Ž396. 1. Microdialysis; Citalopram; Hippocampus, ventral; 5-Hydroxytryptamine, serotonin Ž5-HT. reuptake inhibitor, selective ŽCremers, T.I.F.H. Ž397. 63. Endothelium; Diabetes; Nitric oxide ŽNO.; Carotid artery ŽMiranda, F.J. Ž401. 397.

5-HT (5-hydroxytryptamine, serotonin) synthesis 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1. 5-HT (5-hydroxytryptamine, serotonin) reuptake inhibitor, selective Microdialysis; 5-Hydroxytryptamine, serotonin Ž5-HT.; Citalopram; Hippocampus, ventral ŽCremers, T.I.F.H. Ž397. 63. Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. Conditioned place preference; Amitriptyline; Antidepressant ŽSubhan, F. Ž408. 257. 5-HT1D -like receptor Pulmonary supernumerary artery; 5-HT Ž5-hydroxytryptamine, serotonin. ŽShaw, A.M. Ž408. 69. 5-HTP (5-hydroxy-L-tryptophan) Naltrexone; Ethanol; L-DOPA ŽL-3,4-dihydroxyphenylalanine.; Firing rate ŽInoue, H. Ž406. 375. 5-HTP (5-Hydroxytryptophan) Leptin; 5-HT Ž5-hydroxytryptamine, serotonin.; Benserazide; ŽMouse. ŽYamada, J. Ž406. 159.

Endothelial cell, rat; Protein kinase C; w3 HxPhorbol 12,13-dibutyrate binding; Trypsin-treated protein kinase C activity; cAMP; cGMP ŽLee, H.-Z. Ž403. 195.

5-HT receptor Cerebral ischemia; 8-OH-DPAT Ž8-hydroxy-2-Ždi-n-propylamino.tetralin.; Stereology; ŽRat. ŽTorup, L. Ž395. 137.

5-HT (5-hydroxytryptamine, serotonin) uptake Chronic hypoxia; Pulmonary hypertension; Lung, rat ŽJeffery, T.K. Ž396. 137.

5-HT Ž5-Hydroxytryptamine serotonin.; FLIPR Žflourescent imaging plate reader.; Fluorescence; Meta-chlorophenylpiperazine; 8-OH-DPAT Ž8-hydroxy-N, N-dipropylaminotetralin. ŽWood, M. Ž396. 1.

Master keyword index to Õolumes 386–410 (2000) Signal transduction; G protein; a 2 -Adrenoceptor; G protein coupled receptor; Second messenger; 5-HT1A receptor ŽHappe, H.K. Ž399. 17. 5-HT Ž5-hydroxytryptamine, serotonin. transport; Brush border membrane; Jejunum, rabbit ŽAlcalde, A.I. Ž403. 9. Saphenous vein; In vivo; Adrenoceptor; ŽRabbit. ŽVayssettes-Courchay, C. Ž408. 277. cAMP accumulation; Vasoconstriction ŽBou, J. Ž410. 33. Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. 5-HT1A receptor Electrophysiology; Antidepressant; a 2 -Adrenoceptor; Tyramine; Norepinephrine transporter; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. 211. ´ GTPgw35 Sx; Brain, human; Antipsychotic drug; Clozapine; Quetiapine ŽElliott, J. Ž386. 313. G-protein; w35 SxGTPgS autoradiography; GABA B receptor; Anxiolytic; Antidepressant ŽSim-Selley, L.J. Ž389. 147. w35 SxGTPgS binding; Brain, human; a 2 -Adrenoceptor; m-Opioid receptor; G-protein ŽGonzalez-Maeso, J. Ž390. 25. ´ EEDQ; w35 SxGTPgS binding assay; Hippocampus; Cortex; Receptor reserve; Spare receptor ŽAlper, R.H. Ž390. 67. D-Fenfluramine;

Hypothermia; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275.

65

5-HT1A autoreceptor Venlafaxine; WAY 100635; 5-HTŽ5-hydroxytryptamine, serotonin.; Dorsal raphe nucleus; 5-HT syndrome; ŽCat. ŽBjorvatn, B. Ž404. 121. 5-HT1B receptor Knockout mouse; Ethanol intake; Water intake; Food intake ŽBouwknecht, J.A. Ž403. 95. SL 65.0472; Vasoconstriction; 5-HT2A receptor ŽGalzin, A.-M. Ž404. 361. 5-HT1B r D receptor Locomotor activity; SKF99101H; GR127935; WAY100635; ŽGuinea pig. ŽO’Neill, M.F. Ž399. 49. Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1. 5-HT2 receptor Momordin Ic; Gastrointestinal transit; 5-HT Ž5-hydroxytryptamine, serotonin.; Prostaglandin ŽLi, Y. Ž392. 71. 5-HT2A receptor p-Chloroamphetamine; Hyperthermia; 5-HT2B r2C receptor; ŽMouse. ŽSugimoto, Y. Ž403. 225. SL 65.0472; Vasoconstriction; 5-HT1B receptor ŽGalzin, A.-M. Ž404. 361. 5-HT2C receptor; Frontal cortex; ŽRabbit.; ŽHuman. ŽAloyo, V.J. Ž406. 163. 5-HT transporter; Nefazodone ŽPullar, I.A. Ž407. 39.

Nicotine; Anxiety; Phobia; Septum, lateral; Hippocampus, dorsal ŽFile, S.E. Ž393. 231.

FR140423; Antinociception; Serotonergic system; 5-HT3 receptor; Spinal cord; ŽMice. ŽOchi, T. Ž409. 167.

Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143.

Transmission disequilibrium; Association; Genome screening; Dopamine; Estrogen b receptor; Leptin ŽHinney, A. Ž410. 147.

Signal transduction; G protein; a 2-Adrenoceptor; G protein coupled receptor; Second messenger; 5-HT receptor ŽHappe, H.K. Ž399. 17.

5-HT2B r 2C receptor 5-HT Ž5-hydroxytryptamine, serotonin.; a-Methyl-5-hydroxytryptamine; Vasoconstrictor effect; Mesenteric blood flow ŽFernandez, M.M. Ž401. ´ 221.

Anxiety; Stress; Tachycardia; Hyperthermia; Radiotelemetry ŽBouwknecht, J.A. Ž400. 59.

p-Chloroamphetamine; Hyperthermia; 5-HT2A ŽSugimoto, Y. Ž403. 225.

w35 SxGTPgS binding; Inverse agonist; WAY 100635 ŽCosi, C. Ž401. 9.

5-HT2C receptor Anxiety; Depression; ŽRat. ŽKennett, G. Ž387. 197.

8-OH-DPAT; Naq channel; Ca2q channel; Neuroprotection; Ischemia ŽMelena, J. Ž406. 319. Positron Emission Tomography ŽPET.; P-glycoprotein ŽPasschier, J. Ž407. 273.

receptor; ŽMouse.

Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57.

Nicotine; Tail tremor; ŽRat. ŽSuemaru, K. Ž408. 19.

Parkinson’s disease; 6-Hydroxydopamine-lesioned rat; SKF 82958 ŽFox, S.H. Ž398. 59.

Microdialysis, in vivo; 5-HT Ž5-hydroxytryptamine, serotonin. release; WAY 100635 ŽAssie, ´ M.-B. Ž409. 173.

5-HT2A receptor; Frontal cortex; ŽRabbit.; ŽHuman. ŽAloyo, V.J. Ž406. 163.

Basolateral amygdala; Synaptic g-aminobutyric acid ŽGABA. transmission; Presynaptic modulation; Dissociated neuron and tandospirone ŽKishimoto, K. Ž407. 257.

5-HT2C r 2B receptor mCPP Ž m-chlorophenylpiperazine.; Glucagon; 5-HT Ž5-hydroxytryptamine, serotonin.; Adrenaline ŽYamada, J. Ž406. 153.

66

Master keyword index to Õolumes 386–410 (2000)

5-HT3 receptor 5-HTŽ5-hydroxytryptamine, serotonin.; glycine receptor; GABA A ; Nicotinic acetylcholine receptor; Bicuculline ŽSun, H. Ž391. 243. Cocaine; Ondansetron; Sensitization; ŽRat. ŽKing, G.R. Ž394. 97. Zn2q; Cation, Divalent; Voltage-clamp, Whole-cell; Radioligand binding; Neuromodulation ŽHubbard, P.C. Ž394. 189. 5-HT3 receptor agonist; 5-HT3 receptor antagonist; Ligand-gated ion channel; HEK 293 cell; ŽFerret. ŽMochizuki, S. Ž399. 97. FR140423; Antinociception; Serotonergic system; 5-HT2A receptor; Spinal cord; ŽMice. ŽOchi, T. Ž409. 167. 5-HT4 receptor Forced swim test; SB 204070A; Fluoxetine; Antidepressant ŽCryan, J.F. Ž409. 295. 5-HT7 receptor Ileum, mouse; w3 HxMesulergine ŽHemedah, M. Ž387. 265. 5-HT1A receptor agonist Flesinoxan; Glucocorticoid receptor; Mineralocorticoid receptor; Hippocampus; Dorsal raphe nucleus ŽSibug, R.M. Ž404. 111.

Acetylcholine; Hippocampus; Microdialysis; Cortex, prefrontal; SR 141716A; WIN 55, 212-2 ŽAcquas, E. Ž401. 179. (I)-Huperzine A Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Learning; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65. HVA (homovalinic acid) Dopamine; Tyrosine hydroxylase; Sulfonylurea; Glipizide; DOPAC Ž3,4dihydroxyphenylacetic acid. ŽLamensdorf, I. Ž388. 147. Hybridization, in situ Nicotinic receptor; Parkinson’s disease; MPTP Ž1-methyl-4-phenyl1,2,3,6-tetrahydropteridine.; Neuroprotection; ŽMonkey. ŽQuik, M. Ž393. 223. Hydrogen peroxide Nitric oxide ŽNO.; Carbon monoxide ŽCO.; Corpus cavernosa; Urethra relaxation ŽNaseem, K.M. Ž387. 329. Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Endothelium-independent relaxation; Nitric oxide ŽNO.; Superoxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163.

Ipsapirone; Food intake; WAY-100635 ŽArkle, M. Ž408. 273.

Monoamine oxidase; Adipocyte, white; Cell metabolism ŽRaimondi, L. Ž395. 177.

5-HT1B r 1D receptor agonist Migraine; Almotriptan; Preclinical study ŽGras, J. Ž410. 43.

Nitric oxide ŽNO.; Apoptosis; Neuroblastoma; PC12; NO donor; Annexin V ŽTerwel, D. Ž400. 19.

Cardiovascular safety; Migraine; Almotriptan ŽGras, J. Ž410. 53.

4 -Hydroxy aceclofenac Osteoarthritis; Rheumatoid arthritis; Aceclofenac; Pro-matrix metalloproteinase 1; Pro-matrix metalloproteinase 3; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429.

5-HT3 receptor agonist 5-HT3 receptor; 5-HT3 receptor antagonist; Ligand-gated ion channel; HEK 293 cell; ŽFerret. ŽMochizuki, S. Ž399. 97. YM-31636; Colon, distal; Atrium, right; ŽGuinea pig. ŽIto, H. Ž409. 195. 5-HT2A receptor antagonist Norepinephrine; Microdialysis; YM992; Venlafaxine; Antidepressant ŽHatanaka, K.-i. Ž395. 31.

X

3-Hydroxyanthranilic acid Kynurenine; Inhibitor; Plasma; Brain; ŽRat. ŽFornstedt-Wallin, B. Ž386. 15. g-Hydroxybutyrate Cerebral ischemia; Hippocampus; Immunochemistry; Sensory–motor test; Spatial learning ŽVergoni, A.V. Ž397. 75.

Sarpogrelate; Antinociception; Formalin test; ŽRat. ŽObata, H. Ž404. 95. 5-HT3 receptor antagonist 5-HT3 receptor; 5-HT3 receptor agonist; Ligand-gated ion channel; HEK 293 cell; ŽFerret. ŽMochizuki, S. Ž399. 97. Glycine receptor; Potentiation; Interaction; Pharmacophore model; Selectivity ŽChesnoy-Marchais, D. Ž402. 205. 5-HT1B receptor, human Zolmitriptan; Kq channel, Ca2q-dependent; C6 glioma cell ŽLe Grand, B. Ž397. 297. 5-HT1A receptor ligand Affinity; Intrinsic activity; Efficacy; GppŽNH.p shift; S-14506; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97. HU 210 Cannabinoid; Ingestive behaviour; Body weight, rat ŽGiuliani, D. Ž391. 275.

6-Hydroxydopamine Ligand binding autoradiography; Neostriatum; Substantia nigra ŽVasiliadis, H.-M. Ž386. 155. Žy.-OSU6162; Parkinson’s disease; Dopamine receptor agonist; Dyskinesia ŽEkesbo, A. Ž389. 193. Dopamine D1 receptor; Turning behavior; Behavioral tolerance ŽCasas, M. Ž396. 93. c-fos; zif268; N-methyl-D-aspartate ŽNMDA.; L-3,4-dihydroxyphenylalanine ŽL-DOPA.; Striatum ŽAdams, A.C. Ž404. 303. Dizocilpine ŽMK801.; Levodopa; Microdialysis ŽJonkers, N. Ž407. 281. KF17837 ŽŽ E .-1,3-dipropyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; KW-6002 ŽŽ E .-1,3-diethyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; Parkinson’s disease; Adenosine A 2A receptor antagonist ŽKoga, K. Ž408. 249.

Master keyword index to Õolumes 386–410 (2000) 6-Hydroxydopamine-lesioned rat Parkinson’s disease; 5-HT2C receptor; SKF 82958 ŽFox, S.H. Ž398. 59. 4-Hydroxyisoleucine Insulin release; Structural analogue; Fenugreek seed; Pancreas; ŽRat. ŽBroca, C. Ž390. 339. 5-Hydroxytryptophol 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HIAA Ž5-hydroxyindole-3acetic acid.; Dopamine; Noradrenaline; Ataxia, cerebellar ŽReader, T.A. Ž398. 41. Hyperalgesia Protein kinase, cGMP-dependent; N-methyl-D-aspartate ŽNMDA.; Nitric oxide ŽNO.; Nociception; Spinal cord; Pain ŽTao, Y.-X. Ž392. 141. Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. Cocaine; Amphetamine; Dorsal horn ŽOhsawa, M. Ž399. 165. Arthritis; Phosphodiesterase 4; Oedema; TNF-a Žtumor necrosis factor-a .; Rolipram ŽFrancischi, J.N. Ž399. 243. Complete Freund adjuvant; NF-kB Žnuclear factor kappa B.; AP-1 Žactivator protein-1.; Octamer factor; NO Žnitric oxide. synthase, neuronal ŽChan, C.-F. Ž402. 61. Ventral posterolateral nucleus; Excitatory amino acid; Morphine; Riluzole; Dizocilpine ŽAbarca, C. Ž403. 67. Nerve ligation; Inflammation; Protein kinase C; Spinal cord; ŽMouse. ŽOhsawa, M. Ž403. 81. r peripheral Hyperalgesia, centralr Lipopolysacharide; Melatonin; Dexamethasone; Naltrexone; TNF-a Žtumor neocrisis factor-a .; Nitric oxide ŽNO. ŽRaghavendra, V. Ž395. 15. Hyperalgesia, inflammatory Thalidomide; TNF-a Žtumor necrosis factor-a .; Pain ŽRibeiro, R.A. Ž391. 97.

67

Hyperpolarization Nitric oxide ŽNO.; Prostanoid; N v -nitro-L-arginine; ODQ Ž1 Hw1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Carotid artery; Femoral artery ŽCrauwels, H.M. Ž404. 341. Hypersensitivity Ovalbumin; Endothelial reactivity; Nitric oxide ŽNO.; Pulmonary artery ŽAkar, F. Ž395. 225. Hypersensitivity, delayed-type Porigonum tinctorium Lour.; Indirubin; Interferon-g ŽKunikata, T. Ž410. 93. Hypertension K AT P channel; Arrhythmias; Myocardial ischemia; Reperfusion ŽLee, Y.-M. Ž397. 151. Guanylyl cyclase, soluble; Superoxide anion; Aorta; Renin–angiotensin system ŽJacke, K. Ž403. 27. Thiazide; Methyclothiazide; Endothelium; Ca2q; Spontaneously hypertensive, rat ŽSHR. ŽColas, B. Ž408. 63. Hypertension genetic Tachykinin NK 1 receptor; Substance P; Inflammation; GH Žgenetically hypertensive. rat; Nitric oxide ŽNO. ŽCampbell, V.A. Ž401. 109. Hyperthermia Anxiety; Stress; 5-HT1A receptor; Tachycardia; Radiotelemetry ŽBouwknecht, J.A. Ž400. 59. p-Chloroamphetamine; 5-HT2A receptor; 5-HT2Br2C receptor; ŽMouse. ŽSugimoto, Y. Ž403. 225. Hypertrophy Vasopressin; Vasopressin V1A receptor; Vasopressin V2 receptor; Myocyte; Cell culture ŽNakamura, Y. Ž391. 39. Collagen; Heart failure; Moxonidine; Sympathetic activation; ŽRat. ŽVan Kerckhoven, R. Ž397. 113. Carnitine palmitoyltransferase; Etomoxir; SDZ CPI 975 ŽYotsumoto, T. Ž398. 297.

Hyperglycaemia Cardiac hypertrophy; Diabetes; Peroxisome proliferator-activated receptor g ŽBell, D. Ž390. 237.

Heart, Rat; Contractile function; Carnitine palmitoyltransferase I inhibition; Etomoxir; Infarct size ŽGunther, J. Ž406. 123. ¨

Hyperhidrosis P2Y receptor; Sweat gland; Anionic secretion; Ca2q, intracellular; Ussing chamber ŽBovell, D.L. Ž403. 45.

Hypertrophy, cell Diabetes; Smooth muscle, vascular; Oxyhaemoglobin, glycosylated; Oxidative stress ŽPeiro, ´ C. Ž386. 317.

Hyperosmolarity Prostaglandin; Nitric oxide ŽNO.; Vasoactive intestinal peptide ŽVIP.; Tracheal perfusion; ŽGuinea-pig. ŽHjoberg, J. Ž398. 303.

Hypoalgesia Dopaminergic agent; Carrageenan; Dopamine D1 receptor; Dopamine D 2 receptor; Anti-hyperalgesia ŽGao, X. Ž406. 53.

Hyperoxia Lecithinized superoxide dismutase; Neutrophil elastase; ONO-5046; Lung injury ŽYamamoto, H. Ž409. 179.

Hypocapnia Endothelin-1; Basilar artery; 5-HT Ž5-hydroxytryptamine, serotonin.; Isocapnia; Alkaline ŽZuccarello, M. Ž407. 191.

Hyperpolarisation Mesenteric artery, rat; Endothelium; Levcromakalim; 18a-Glycyrrhetinic acid; Carbachol ŽWhite, R. Ž397. 279.

Hypocapnic constriction Endothelin-1; Basilar artery; Nitric oxide ŽNO. ŽZuccarello, M. Ž401. 213.

68

Master keyword index to Õolumes 386–410 (2000)

Hypoglycemic agent Drug interaction; Nateglinide; Noncompetitive inhibition; Peptide transporter ŽTerada, T. Ž392. 11.

Hypothalamus, rat Opioid peptide; AP-1 Žactivator protein-1.; Electrophoretic mobility shift assay; Transcriptional regulation; Uterus, rat ŽOszter, A. Ž395. 103.

Hypoglycemic effect Ž R .-ACX; Sulfonylurea compound; Insulin releasing effect ŽSeri, K. Ž389. 253.

D-Fenfluramine;

Hypolocomotion Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57.

Hypothermia 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275. Hypotonic stress c-fos; c-jun; Cholecystokinin; MAP Žmitogen-activated protein., kinase ŽMurai, A. Ž394. 27.

Hypophagia Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57.

Hypoxia Clomethiazole; Chlormethiazole; Spreading depression; Hippocampus; Neuroprotection ŽStone, T.W. Ž399. 29.

Hypothalamic–pituitary–adrenal system Schizophrenia; Stress; Cognition; Coping; Immune system ŽGispende Wied, C.C. Ž405. 375.

Hypoxic pulmonary vasoconstriction Nitric oxide ŽNO.; Pulmonary arterial tone; L-NAME; N-g-nitro-L-argine methyl ester; Prostaglandin F2 a ŽJones, R.D. Ž402. 111.

Hypothalamic–pituitary–adrenocortical axis Mineralocorticoid receptor; Glucocorticoid receptor; Stress; Antidepressants; Major depression ŽReul, J.M.H.M. Ž405. 235.

I K.ATP Glibenclamide; HMR1883; Sulfonylurea; Cardiac ischemia; Dispersion; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273.

Hypothalamo pituitary–adrenal axis Cocaine; Corticosterone; Neuroendocrine; Self-administration; Stress ŽGalici, R. Ž387. 59.

I Kr Cibenzoline; Disopyramide; Ionic current; I Ks ; Rat sino-atrial nodal cell ŽSatoh, H. Ž407. 123.

Hypothalamo-pituitary-adrenal axis Aggressive behavior; Monoamine; Pertussis toxin; ŽMouse. ŽKim, D.-H. Ž409. 67.

I Ks Cibenzoline; Disopyramide; Ionic current; I Kr ; Rat sino-atrial nodal cell ŽSatoh, H. Ž407. 123.

Hypothalamus Glutathione; Antioxidant; Sleep deprivation; Melatonin ŽD’Almeida, V. Ž390. 299.

Iberiotoxin Maxi-Kq channel; Radioligand binding; Urinary bladder ŽMolinari, E.J. Ž388. 155.

Anandamide; Food intake; Diet restriction; Cognitive function; Hippocampus; Catecholamine, 5-hydroxytryptamine, serotonin Ž5-HT.; Corticosterone ŽHao, S. Ž392. 147.

Nitric oxide ŽNO.; b 2-Adrenoceptor agonist; Smooth muscle; cGMP; cAMP ŽVaali, K. Ž399. 75.

Food intake; Histamine; Leptin; Tele-methylhistamine; ŽIntracereboventricular infusion. ŽLecklin, A. Ž395. 113.

Ibogaine Substance P; Neurotensin; Dopamine; Cocaine; Methamphetamine; Drug abuse ŽAlburges, M.E. Ž390. 119.

Neuropeptide Y-Ž13-36.; ŽRat. ŽKing, P.J. Ž396. R1. Nitric oxide ŽNO.; 8-OH-DPAT Ž8-hydroxy-2-di-n-Žpropylamino.tetralin.; Food intake; 5-HT Ž5-hydroxytryptamine, serotonin.; N G -nitro-L-arginine methyl ester ŽL-NAME. ŽYamada, J. Ž402. 247. Anxiety; Stress; Noradrenaline; Amygdala; Locus coeruleus; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397. CART Žcocaine- and amphetamine-regulated transcript.; TRH Žthyrotropin releasing hormone.; Dopamine; Norepinephrine; Synaptosome ŽBrunetti, L. Ž409. 103.

Cocaine; Sensitization; Dopamine; Stereotypy; Drug addiction ŽSzumlinski, K.K. Ž398. 259. Ibuprofen Cyclooxygenase; Smooth muscle cell; Proliferation ŽWeber, A.-A. Ž389. 67. ICAM-1 Nitric oxide ŽNO.; Nitric oxide-releasing compound; Adhesion; E-Selectin; Lipopolysaccharide ŽKosonen, O. Ž394. 149.

Hypothalamus–pituitary–adrenal activity Stress; Corticosteroid ŽDe Kloet, E.R. Ž405. 187.

ICI 204,219 Pulmonary artery, porcine; Leukotriene; Contraction; CysLT receptor; BAY u9773 ŽBack, ¨ M. Ž401. 381.

Hypothalamus–pituitary–adrenocortical axis Noradrenaline; Dopamine; Tolerance; Morphine; Paraventricular nucleus ŽFuertes, G. Ž388. 49.

Idazoxan Imidazoline I 2 receptor ligand; RX821002; Metrazoline; Benazoline; Tracizoline; Food intake; Water intake ŽPolidori, C. Ž392. 41.

Master keyword index to Õolumes 386–410 (2000) ICl (Ca) Niflumic acid; Trachea; Cly channel ŽTeixeira, M.C.L. Ž394. 117. [3 H]Ifenprodil NMDA receptor; s site; w3 HxMK-801; Hippocampal brain membrane, porcine ŽHofner, G. Ž394. 211. ¨ Ifenprodil Ethanol withdrawal; NMDA receptor subunit; Liquid diet method ŽNarita, M. Ž401. 191.

69

Immunochemistry g-Hydroxybutyrate; Cerebral ischemia; Hippocampus; Sensory–motor test; Spatial learning ŽVergoni, A.V. Ž397. 75. Immunoglobulin E Scratching behavior; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Asthma; TEI-9874 ŽNonaka, T. Ž402. 287.

Ileum Cannabinoid receptor agonist; WIN 55212-2; Cannabinoid receptor antagonist; SR14716A; Electrical field stimulation; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207.

Immunogold electron microscopy Nicotinic receptor, presynaptic; Glutamate receptor antagonist; Nicotine; Anatoxin-a; Synaptosome ŽWonnacott, S. Ž393. 51.

Ileum, avian Muscarinic receptor subtype; Binding affinity; Functional affinity ŽDarroch, S. Ž402. 161.

Immunohistochemistry Nicotine; Neurofilament; NF-68; NF-160; NF-200; Ventral tegmental area ŽBunnemann, B. Ž393. 249.

Ileum, mouse 5-HT7 receptor; w3 HxMesulergine ŽHemedah, M. Ž387. 265.

Angiotensin-converting enzyme inhibitor; Diabetes; Nephropathy; Urinary albumin excretion ŽKatoh, M. Ž398. 381.

Ileum, rabbit Nociceptin; wNphe1 xnociceptin-Ž1–13.NH 2 ; OP4 receptor ŽPheng, L.-H. Ž397. 383.

Tyrosine hydroxylase; Haloperidol; Substantia nigra; Antioxidant; ŽRat. ŽBesret, L. Ž408. 35.

Imidazoline binding site Clonidine-displacing substance; NG108-15 cell; Reverse phase HPLC ŽParker, C.A. Ž387. 27.

Immunosuppressant Cyclosporine; Nitric oxide ŽNO.; a 1-Adrenoceptor; C6 glioma cell ŽIkesue, H. Ž407. 221.

Imidazoline I 2 receptor ligand Idazoxan; RX821002; Metrazoline; Benazoline; Tracizoline; Food intake; Water intake ŽPolidori, C. Ž392. 41.

Immunosuppressive effect Cynaropicrin; Anti-inflammatory effect; TNF-a Žtumor necrosis factor-a .; Nitric oxide ŽNO. release; Lymphocyte proliferation ŽCho, J.Y. Ž398. 399.

Imipramine Antidepressant; DHPG ŽŽ RS .-3,5-dihydroxyphenylglycine.; Glutamate receptor, metabotropic, group I; Hippocampus ŽZahorodna, A. Ž386. 173. Antidepressant drug; Lithium chloride; Locomotor activity; Mania ŽD’Aquila, P.S. Ž395. 157. Baclofen; Ligation; Hot-plate test; ŽMouse. ŽZarrindast, M.-R. Ž407. 65. Immediate early gene Dizocilpine ŽŽq.-MK-801.; NMDA receptor antagonist; Neurotoxicity; Retrosplenial cortex; Clozapine; Olanzapine ŽFujimura, M. Ž398. 1. Immediate-early gene MDMA Ž3,4-methylenedioxymethamphetamine.; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Egr-1 Žzif-268. ŽShirayama, Y. Ž402. 215. Immune function Androgen; Th1rTh2; Prenatal; Estrogen; Autoimmunity ŽMartin, J.T. Ž405. 251.

Impedance planimetry Circumferential stretch; Axial stretch; Coronary artery, large; Tone; Ca2q-channel, voltage-gated; ŽPig. ŽTanko, ´ L.B. Ž387. 303. Indirubin Porigonum tinctorium Lour.; Interferon-g; Delayed-type, hypersensitivity ŽKunikata, T. Ž410. 93. Indolocarbazole Cell membrane; Cellular uptake; Carbohydrate; Rebeccamycin ŽGoossens, J.-F. Ž389. 141. Indomethacin Choroidal blood flow; Laser-Doppler flowmetry; Sympathetic vasodilation; b-Adrenoceptor activation; b-Adrenoceptor antagonist; L-NAME Ž N G -nitro-L-arginine methyl ester.; ŽRat. ŽKawarai, M. Ž386. 227. Pulmonary arteries; Dexfenfluramine; Phentolamine; Prazosin; Ketanserin ŽPatnaude, L.A. Ž401. 229.

Immune system Schizophrenia; Stress; Cognition; Coping; Hypothalamic–pituitary– adrenal system ŽGispen-de Wied, C.C. Ž405. 375.

Acetylcholine; Airway epithelium; Smooth muscle, airway; Nitric oxide ŽNO.; Airway segment ŽMcParland, B.E. Ž402. 151.

Immunity Conditioned response; Stress; Psychoneuroimmunology ŽAder, R. Ž405. 167.

Inducible Transplantation; Nitric oxide ŽNO. synthase; Macrophage; Peroxynitrite ŽVos, I.H.C. Ž391. 31.

70

Master keyword index to Õolumes 386–410 (2000)

Phenylethanoid; Macrophage; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase; 1-propanamine-3-hydroxy-2-nitroso-1-propylhydrazino ŽPAPA NONOate. ŽXiong, Q. Ž400. 137. Inducible NO synthase Inflammation; Nitric oxide ŽNO.; NF-kB Žnuclear factor-kB.; b-Carboline alkaloid ŽLee, B.G. Ž406. 301. Tryptanthrin; Nitric oxide; Prostaglandin; Cyclooxygenase; Inflammation ŽIshihara, T. Ž407. 197. Infarct Apoptosis; Cardiac ischemia; Caspase inhibitor; Reperfusion injury ŽHuang, J.-Q. Ž402. 139. Infarct size Heart, Rat; Contractile function; Carnitine palmitoyltransferase I inhibition; Etomoxir; Hypertrophy ŽGunther, J. Ž406. 123. ¨ Inflammation m-Opioid receptor; Knockout mice ŽQiu, C. Ž387. 163. Phospholipase A 2 ; Nuclear-factor-kB; Mitogen-activated protein kinase; Interleukin-1 ŽBurgermeister, E. Ž388. 195. Endothelin; TNF Žtumor necrosis factor. receptor; Endothelial cell; Epithelial cell; Atherosclerosis ŽLees, D.M. Ž390. 89. Carrageenan; Nitric oxide ŽNO.; Peroxynitrite; Superoxide dismutase; Tempol ŽCuzzocrea, S. Ž390. 209. Steroid-like anti-inflammatory action; Cyclic peptide; Streptomyce product ŽKuriyama, K. Ž390. 223. Leukocyte; Ropivacaine ŽZhang, X.W. Ž392. R1. Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Nociception ŽBeaulieu, P. Ž396. 85. Adrenomedullin; Eye; CGRP Žcalcitonin gene-related peptide.; Nitric oxide ŽNO. ŽClementi, G. Ž400. 321. Tachykinin NK 1 receptor; Substance P; Hypertension genetic; GH Žgenetically hypertensive. rat; Nitric oxide ŽNO. ŽCampbell, V.A. Ž401. 109. Peroxisome proliferator-activated receptor ŽPPAR.; Retinoid X receptor ŽRXR.; Monocyte; Migration; Matrix metalloproteinase ŽKintscher, U. Ž401. 259. Hyperalgesia; Nerve ligation; Protein kinase C; Spinal cord; ŽMouse. ŽOhsawa, M. Ž403. 81. Ischemia–reperfusion; Neutrophil; Oedema; Mesenteric artery ŽSouza, D.G. Ž403. 121. Dinitrobenzene sulfonic acid; Nitric oxide ŽNO.; Peroxynitrite; Poly ŽADP-ribose. synthetase; Colon damage; Free radical ŽCuzzocrea, S. Ž406. 127. Nitric oxide ŽNO.; Inducible NO synthase; NF-kB Žnuclear factor-kB.; b-Carboline alkaloid ŽLee, B.G. Ž406. 301.

Tryptanthrin; Nitric oxide; Inducible NO synthase; Prostaglandin; Cyclooxygenase ŽIshihara, T. Ž407. 197. Adenosine; Adenosine kinase; Adenosine deaminase; Formalin; Microdialysis; Pain ŽLiu, X.J. Ž408. 143. Bradykinin; Neurogenic; Phorbol ester; Protein kinase C; Triterpenoid ŽHuguet, A.-I. Ž410. 69. Pravastatin; Monocyte; Lipid metabolism; Pro-inflammatory molecule ŽGrip, O. Ž410. 83. Inflammation, intestinal Nitric oxide ŽNO.; Non-steroid anti-inflammatory drug ŽEvans, S.M. Ž388. 281. Inflammation, peripheral Enteropooling; Intestine; Opioid; Opioid receptor; Permeability ŽValle, L. Ž389. 235. Inflammatory preconditioning Diabetic rat; Somatostatin; Neurogenic inflammation ŽNemeth, J. Ž386. ´ 83. Inflammatory response Nociceptin; Histamine; Mast cell; G protein; ORL 1 receptor; ŽRat. ŽKimura, T. Ž407. 327. Information processing Nicotine; Pre-pulse inhibition; Schizophrenia; ŽRat. ŽMirza, N.R. Ž407. 73. Infusion constant rate L-DOPA methylester; Parkinson’s disease; Daily rhythm; Chronopharmacology; Radiotelemetry ŽSimon, N. Ž401. 79. Ingestive behaviour Cannabinoid; HU 210; Body weight, rat ŽGiuliani, D. Ž391. 275. Inhibin Dexamethasone; FSH Žfollicle-stimulating hormone.; Ovarian function; ŽRat, female, immature. ŽTohei, A. Ž386. 69. Inhibitor Kynurenine; 3-Hydroxyanthranilic acid; Plasma; Brain; ŽRat. ŽFornstedtWallin, B. Ž386. 15. Multidrug resistance; P-glycoprotein; MRP1 Žmultidrug resistance-associated protein.; Daunorubicin; Calcein-AM; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207. Inhibitory feedback mechanism C-fibre; Flexor reflex; Rostral ventromedial medulla; Wind-up; Spinobulbo-spinal; Morphine ŽGozariu, M. Ž394. 75. Inositol phosphate Ca2q; Tyrosine kinase; Adrenoceptor; Fura-2 ŽBerts, A. Ž389. 35. Inositol phospholipid Phospholipase C; Histamine; Chromaffin cell; Ca2q; Adrenal medulla ŽRoberts-Thomson, E.L. Ž398. 199. Inotropic agent Ca2q-sensitizer; Hemodynamics; Heart failure; Excitation–contraction coupling; Diastolic dysfunction ŽJanssen, P.M.L. Ž404. 191.

Master keyword index to Õolumes 386–410 (2000) In situ hybridization Acetylcholine receptor; Ligand-gated ion channel; RNA blot; Peripheral nervous system; Neural development ŽErkman, L. Ž393. 97. Adenosine receptor; Locomotion; Dopamine receptor; Caffeine; Autoradiography ŽHalldner, L. Ž406. 345.

71

Insulin secretion Streptozotocin; T-1095; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin sensitivity ŽOku, A. Ž391. 183. Glucose elimination; 1,5-Anhydro-D-fructose; Glucagon-like peptide-1; ŽMouse. ŽAhren, ´ B. Ž397. 219.

Ins(1,4,5)P3 Muscarinic receptor; Sphingosine 1-phosphate; Dimethylsphingosine; Ca2q mobilisation; SH-SY5Y neuroblastoma cell ŽYoung, K.W. Ž402. 55.

Dipeptidyl peptidase IV; Glucagon-like peptide-1 ŽGLP-1.; Glucose tolerance; Diabetes, type 2; Glucose tolerance, impaired ŽAhren, ´ B. Ž404. 239.

InsP3 receptor Ca2q signalling; Paxilline; Mycotoxin ŽLongland, C.L. Ž408. 219.

Insulin sensitivity Streptozotocin; T-1095; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin secretion ŽOku, A. Ž391. 183.

Insulin Sodium tungstate; Glucagon; Pancreas, rat ŽRodrıguez-Gallardo, J. Ž402. ´ 199.

Insulitis Encephalomyocarditis virus; Glucose intolerance; Branched chain amino acid ŽUtsugi, T. Ž398. 409.

Cytoskeleton; Exocytosis; Scinderin ŽBruun, T.Z. Ž403. 221. Neuropeptide; Intranasal administration; Vasopressin; Melanocortin; Cognition ŽFehm, H.L. Ž405. 43.

Integrin Smooth muscle cell, Vascular; Endothelial cell; Vitronectin; Glycoprotein IIbrIIIa-inhibitor; ŽHuman. ŽKintscher, U. Ž390. 75.

Troglitazone; Fructose 2,6-bisphosphate; Hepatocyte; Thiazolidinedione ŽRaman, P. Ž409. 19.

Interaction Acetylcholine; Cholinergic; Glutamate; Motivation; Behaviour ŽAura, J. Ž390. 313.

Primary culture of hepatocyte; Tyrosine phosphorylation; cAMP phosphodiesterase; Microtubule; Wortmannin; Herbimycin A ŽIshibashi, K. Ž409. 109.

Glycine receptor; 5-HT3 receptor antagonist; Potentiation; Pharmacophore model; Selectivity ŽChesnoy-Marchais, D. Ž402. 205.

Insulin action Aging; Vanadyl sulfate; Insulin release; Islet, isolated ŽDe Tata, V. Ž398. 169. Insulin release 4-Hydroxyisoleucine; Structural analogue; Fenugreek seed; Pancreas; ŽRat. ŽBroca, C. Ž390. 339. Aging; Vanadyl sulfate; Insulin action; Islet, isolated ŽDe Tata, V. Ž398. 169. Glibenclamide; Tolbutamide; Desensitization; Clonal pancreatic b-cell; K AT P channel ŽBall, A.J. Ž408. 327. Insulin releasing effect Ž R .-ACX; Sulfonylurea compound; Hypoglycemic effect ŽSeri, K. Ž389. 253. Insulin resistance Superoxide; Nitric oxide ŽNO.; Isometric tension study ŽShinozaki, K. Ž394. 295. Pancreastatin receptor; Signaling; G protein; Phospholipase C; MAPK; HTC cell ŽSanchez-Margalet, V. Ž397. 229. ´ Oxidant stress; Endothelium; Nitric oxide ŽNO.; Obese Zucker rat ŽLaight, D.W. Ž402. 95. C2C12 cell; Glucose transporter isotype 4; YM-126414 ŽShimokawa, T. Ž410. 1.

Interdigestive migrating contraction Gastrointestinal transit; Gastrointestinal motility; Post-operative ileus; SK-896; Prostaglandin F2 a ; ŽDog. ŽTsukamoto, K. Ž401. 97. Interferon g D 9-Tetrahydrocannabinol; SR 141716; SR 144528; Natural killer cell cytolytic activity ŽMassi, P. Ž387. 343. Interferon-g Alanine aminotransferase; Concanavalin A; Apoptosis; Soyasapogenol A; Tumor necrosis factor-a ŽTNF-a . ŽKuzuhara, H. Ž391. 175. Cytokine; Endothelin ETB receptor; Interleukin-1b; Interleukin-6; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117. Alzheimer’s disease; Microglia; NSAIDs; Aspirin ŽOgawa, O. Ž408. 137. Porigonum tinctorium Lour.; Indirubin; Delayed-type, hypersensitivity ŽKunikata, T. Ž410. 93. Interleukin-1 Phospholipase A 2 ; Nuclear-factor-kB; Mitogen-activated protein kinase; Inflammation ŽBurgermeister, E. Ž388. 195. Leukotriene B 4 ; Air pouch; Leukocyte infiltration; Collagen-induced arthritis; LY293111Na ŽKuwabara, K. Ž402. 275. Interleukin-4 Phosphodiesterase 4 inhibitor; RPR 73401; Allergic dermatitis; Ear swelling test, mouse ŽEhinger, A.M. Ž392. 93.

Master keyword index to Õolumes 386–410 (2000)

72

Interleukin-6 Cytokine; Endothelin ETB receptor; Interleukin-1b; Interferon-g; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117. Interleukin-8 Nociception; Interleukin 1b; TNF-a; Macrophage; Mast cell; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111. FK506 ŽTacrolimus.; Neutrophil chemotaxis; Mononuclear cell peripheral blood ŽSasakawa, Y. Ž403. 281. Interleukin-10 TNF-a, tumor necrosis factor-a; Lipopolysaccharide ŽFukuda, T. Ž391. 317. Y-39041; Arthritis; TNF-a ŽTumor necrosis factor-a .; Lipopolysaccharide ŽHisadome, M. Ž409. 331. Interleukin-1b Nociception; Interleukin 8; TNF-a; Macrophage; Mast cell; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111. Bradykinin; Prostaglandin E 2 ; Ca human ŽNakao, S. Ž395. 247.

2q

mobilization; Gingival fibroblast,

Ischemia–reperfusion; Gastric secretion; Omeprazole; Ranitidine; Ulcer healing; Gastric blood flow; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147.

Intestine, large d-Opioid receptor; Short-circuit current; Endothelin-1 ŽGauthier, C. Ž390. 335. Intracellular, free Sphingomyelinase; Smooth muscle, Aortic, rat; Ca2q concentration ŽZheng, T. Ž391. 127. Intracellular histamine binding site Blood–brain barrier; Brain edema; Cerebral ischemia–reperfusion; Histamine; DPPE Ž N,N-diethyl-2-w4-Žphenylmethyl.phenoxyxethanamine. ŽDeli, M.A. Ž387. 63. Intracellular signaling Antidepressant; Mechanism of action; Monoamine; Neuropeptide; Transcription factor ŽVetulani, J. Ž405. 351. Intragastric administration Heparin; Gastric ulcer healing; Nitric oxide ŽNO. synthase, Constitutive; Proliferation; Regeneration; Angiogenesis ŽLi, Y. Ž399. 205. Intrahecal Antinociception; Cannabinoid; Intraventricular; Structure–activity relationship; Tetrahydrocannabinol ŽWiley, J.L. Ž397. 319. Intranasal administration Neuropeptide; Vasopressin; Insulin; Melanocortin; Cognition ŽFehm, H.L. Ž405. 43.

Pancreatitis; EGF Žepidermal growth factor.; Pancreatic regeneration ŽDembinski, A. Ž398. 159. ´

Intrathecal Nicotine; Antinociception; CaM kinase II; Ca2q channels; ŽMice. ŽDamaj, M.I. Ž404. 103.

Cytokine; Endothelin ETB receptor; Interleukin-6; Interferon-g; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117.

Morphine; Zn2q; Antinociception; Tolerance; Dependence ŽLarson, A.A. Ž407. 267.

Interneuron Hippocampus; Choline; Nicotinic receptor; Excitation; Methyllycaconitine; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59.

Intrathecal domperidone Quinpirole; Blood pressure; Spinal cord transection; Dopamine D 2 receptor, spinal; Conscious, rat ŽLahlou, S. Ž408. 51.

Adenosine; Chloroadenosine; Hippocampus; Afterhyperpolarization ŽLi, H. Ž407. 237.

Intraventricular Antinociception; Cannabinoid; Intrahecal; Structure–activity relationship; Tetrahydrocannabinol ŽWiley, J.L. Ž397. 319.

Intestinal motility Salivary protein; Lipopolysaccharide ŽTan, D. Ž409. 203. Intestine Ca2q channel, N-type; v-Conotoxin GVIA; v-Conotoxin MVIIA; vConotoxin MVIIC; Vas deferens; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuinea-pig. ŽSanger, G.J. Ž388. 89.

Intrinsic activity Affinity; Efficacy; GppŽNH.p shift; 5-HT1A receptor ligand; S-14506; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97. Inverse agonism Histamine H 1 receptor; Constitutive activity ŽBakker, R.A. Ž387. R5.

Enteropooling; Inflammation, peripheral; Opioid; Opioid receptor; Permeability ŽValle, L. Ž389. 235.

Dmt–Tic; Antagonism ŽLabarre, M. Ž406. R1.

Multidrug resistance protein; MRP2 Žmultidrug resistance protein 2. ŽVan Aubel, R.A.M.H. Ž400. 195.

Inverse agonist w35 SxGTPgS binding; 5-HT1A receptor; WAY 100635 ŽCosi, C. Ž401. 9.

Intestine, human Nepadutant; Tachykinin receptor; Tachykinin receptor antagonist; Urinary bladder, human ŽPatacchini, R. Ž398. 389.

In vivo Saphenous vein; Adrenoceptor; 5-HT receptor; ŽRabbit. ŽVayssettesCourchay, C. Ž408. 277.

Master keyword index to Õolumes 386–410 (2000) Iodonium NADPH oxidase; Xanthine oxidase; Nitric oxidase ŽNO. synthase; NADH–ubiquinone reductase ŽMoulton, P. Ž401. 115. Ion channel Corticosterone; Vasopressin; Firing pattern; Neurotransmitter ŽJoels, ¨ M. Ž405. 207.

73

Neutrophil; Oedema; Mesenteric artery; Inflammation ŽSouza, D.G. Ž403. 121. Liver, rat; Protective effect; ATP; Bile flow; Glutathione; Antioxidant ŽSettaf, A. Ž406. 281. Dysmotility; Colon; Adenosine A 1 receptor antagonist; RT-PCR Žreverse transcription-polymerase chain reaction.; ŽRat. ŽKadowaki, M. Ž409. 319.

Ionic current Cibenzoline; Disopyramide; I Kr ; I Ks ; Rat sino-atrial nodal cell ŽSatoh, H. Ž407. 123.

Ischemia-reperfusion Flow; Nitric oxide ŽNO.; Oxidative stress; Vascular ŽWalia, M. Ž400. 249.

Ionic secretion Adrenoceptor; b 3 -Adrenoceptor; Cly channel; Kq channel; Colon, rat ŽSchultheiss, G. Ž403. 251.

Ischemia–reperfusion injury Picroliv; Liver; Antioxidant ŽSingh, A.K. Ž395. 229.

Ion secretion Zaldaride maleate; Calmodulin; Adenylate cyclase; Guanylate cyclase ŽAikawa, N. Ž394. 233. IP receptor Constitutively-active receptor; Chimeric receptor; Partial agonist; Prostacyclin ŽWise, H. Ž386. 89. Ipsapirone 5-HT1A receptor agonist; Food intake; WAY-100635 ŽArkle, M. Ž408. 273. IPSP (inhibitory postsynaptic potential) Retigabine; Anticonvulsant; Entorhinal cortex; Spike frequency habituation; EPSP Žexcitatory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165. IRL 3630A Endothelin; Endothelin ETA rETB receptor antagonist bifunctional; Respiratory mechanics ŽMakatani, M. Ž406. 139. Ischaemia Amrinone; Reperfusion injury; ŽRat. ŽRechtman, M.P. Ž402. 255. Preconditioning; Angiotensin; Prazosin; Colchicine ŽSharma, A. Ž406. 85. Ischemia Angiotensin-converting enzyme inhibitor; Bradykinin; Reperfusion; Ventricular function, dog ŽHosoya, K. Ž390. 157. Diltiazem; Coronary flow; Heart, isolated, rat; Microsphere; Reperfusion ŽKatsumata, N. Ž398. 83. TY-12533; NaqrHq exchanger; Reperfusion; Arrhythmia; Myocardial infarction ŽAihara, K. Ž404. 221. 8-OH-DPAT; 5-HT1A receptor; Naq channel; Ca2q channel; Neuroprotection ŽMelena, J. Ž406. 319. NAAG Ž N-acetylaspartylglutamate.; mGlu receptor; MCPG ŽŽ R,S .-amethyl-4-carboxyphenylglycine.; NAALADase Ž N-acetylated a-linked acidic dipeptidase. ŽLu, X.-C.M. Ž408. 233. Ischemia-induced arrhythmia Zatebradine; Reperfusion arrhythmia; Propranolol; ŽDog. ŽNaito, H. Ž388. 171. Ischemia–reperfusion Cyclopiazonic acid; Oxidative stress; Free radical; Reactive oxygen species ŽGrover, A.K. Ž387. 87. Gastric secretion; Omeprazole; Ranitidine; Ulcer healing; Gastric blood flow; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147.

Ischemic tolerance Brain; Cerebral ischemia; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-Larginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Islet, isolated Aging; Vanadyl sulfate; Insulin action; Insulin release ŽDe Tata, V. Ž398. 169. Isocapnia Endothelin-1; Basilar artery; 5-HT Ž5-hydroxytryptamine, serotonin.; Hypocapnia; Alkaline ŽZuccarello, M. Ž407. 191. Isolated lung, guinea pig ORL1 receptors; Nociceptinrorphanin FQ; ORL1 receptor antagonist ŽCorboz, M.R. Ž402. 171. Isometric tension study Insulin resistance; Superoxide; Nitric oxide ŽNO. ŽShinozaki, K. Ž394. 295. Isoprenaline Spectral analysis; Valsartan; Catecholamine; Arterial pressure ŽBlanc, J. Ž394. 311. b-Adrenoceptor; Age; Endothelium; Relaxation; K q ŽVan der Zypp, A. Ž397. 129.

channel

Isoprostane Oxidative stress; Mammary artery; Vasoconstriction ŽCracowski, J.-L. Ž397. 161. Itch-associated response Emedastine difumarate; Substance P; Histamine; Leukotriene B 4 ; 5-HT Ž5-hydroxytryptamine, Serotonin. ŽAndoh, T. Ž406. 149. Ivermectin GABA A receptors; Subunit composition; Patch clamp ŽAdelsberger, H. Ž394. 163. Jejunum, rabbit 5-HT Ž5-hydroxytryptamine, serotonin. transport; 5-HT receptor; Brush border membrane ŽAlcalde, A.I. Ž403. 9. JL-18 Dopamine D4 receptor; L-Dopa-induced dyskinesia; Parkinson’s disease; MPTP Ž1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. ŽTahar, A.H. Ž399. 183. JNK (jun amino-terminal kinase) Okadaic acid; Adrenomedullin; ERK Žextracellular signal-related kinase.; P38 MAPK ŽP38 mitogen-activated protein kinase. ŽParameswaran, N. Ž388. 133. JTE-522 Cyclooxygenase-2; Prostaglandin E 2 ; Thromboxane A 2 ; U-46619; Airway hyperresponsiveness; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267.

74

Master keyword index to Õolumes 386–410 (2000)

JTH-601 a 1-Adrenoceptor; a 1L -Adrenoceptor; Prostate; ŽDog. ŽSuzuki, Y. Ž394. 123. Jurkat cell NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Patch clamp; Ca2q current; Ca2q current, Capacitative; Ca2q release-activated current; pH Modulation ŽLi, J.H. Ž394. 171. KH Kallikrein secretion; Diuresis; Natriuresis; Bradykinin B 2 receptor antagonist; FR173657 ŽSuzuki, T. Ž399. 223. Endothelium-derived hyperpolarizing factor ŽEDHF.; Ouabain; 18aGlycyrrhetinic acid; Gap junctions; Endothelium ŽHarris, D. Ž402. 119.

Diazepam; Progesterone; g-Aminobutyric acid ŽGABA.; Coronary ŽJacob, M.K. Ž403. 209. Adrenoceptor; b 3-Adrenoceptor; Cly channel; Ionic secretion; Colon, rat ŽSchultheiss, G. Ž403. 251. Long QT syndrome; Pharmacogenetics; Heart ŽEscande, D. Ž410. 281. K H channel, ATP-sensitive Smooth muscle, Tracheal; Cromakalim; Tyrosine kinase inhibitor ŽMatsushita, Y. Ž389. 51. 3-morpholinosydnonimine ŽSIN-1.; Endothelium-derived hyperpolarizing factor ŽEDHF.; Kq channel, Ca2q-activated; Membrane potential ŽQuignard, J.-F. Ž399. 9.

Kainate Excitotoxicity; Cyclooxygenase-2; Nimesulide; Oxidative stress; Hippocampus ŽCandelario-Jalil, E. Ž390. 295.

K H channel, Ca 2H-activated 3-morpholinosydnonimine ŽSIN-1.; Endothelium-derived hyperpolarizing factor ŽEDHF.; Kq channel, ATP-sensitive; Membrane potential ŽQuignard, J.-F. Ž399. 9.

Kainate receptor Cocaine; Convulsion; Toxicity; AMPA receptor; NMDA receptor ŽPouw, B. Ž386. 181.

Large conductance; Detrusor muscle; b-Adrenoceptor; Protein kinase A ŽKobayashi, H. Ž404. 231.

Kallikrein secretion Kq; Diuresis; Natriuresis; Bradykinin B 2 receptor antagonist; FR173657 ŽSuzuki, T. Ž399. 223. K AT P channel Exocytosis; Glucagon; Nateglinide; Repaglinide ŽBokvist, K. Ž386. 105. Anaesthetic volatile; Action potential; Arrhythmia; Myocyte; Patch clamp ŽTerrenoire, C. Ž390. 95. Hypertension; Arrhythmias; Myocardial ischemia; Reperfusion ŽLee, Y.M. Ž397. 151. Glibenclamide; Tolbutamide; Desensitization; Clonal pancreatic b-cell; Insulin release ŽBall, A.J. Ž408. 327. K H channel Thiazolidinedione; Troglitazone; Rosiglitazone; BRL 49653; K AT P current; Glibenclamide ŽMishra, S.K. Ž386. 121. Thapsigargin; Nitric oxide ŽNO.; Endothelium; Relaxation; Aorta; ŽRat. ŽHuang, Y. Ž392. 51. Pimozide; HERG Žhuman ether-a-go-go-related gene.; Arrhythmia; Antipsychotic agent ŽKang, J. Ž392. 137. Anesthetic; volatile; Ca2q-activated; Xenopus oocyte ŽNamba, T. Ž395. 95. b-Adrenoceptor; Age; Endothelium; ŽVan der Zypp, A. Ž397. 129.

Isoprenaline;

Relaxation

Berberine; Nitric oxide ŽNO.; Ca2q channel; Vasorelaxation; Proliferation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187.

K H channel, Ca 2H-dependent Smooth muscle, vascular; Adenosine ŽLi, G. Ž394. 35. Zolmitriptan; 5-HT1B receptor, human; C6 glioma cell ŽLe Grand, B. Ž397. 297. K H channel, Inward rectifier Antiarrhythmic drug; Maxi-Kq channel; Smooth muscle; ŽBovine. ŽNakahara, T. Ž402. 143. K Hchannel opener Retigabine; Anticonvulsant; Entorhinal cortex; Spike frequency habituation; EPSP Žexcitatory postsynaptic potential.; IPSP Žinhibitory postsynaptic potential. ŽHetka, R. Ž386. 165. K H channel opener Nerve conduction; Blood flow; Naq, Kq ATPase; Oxidative stress; Glutathione; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335. Detrusor smooth muscle; Smooth muscle relaxation; Kq channels, ATPsensitive; Sulfonylurea receptor ŽBuckner, S.A. Ž400. 287. K AT P channels Mesenteric artery, rat; cAMP; Levcromakalim; Forskolin; Protein kinase A ŽOmar, R. Ž401. 85. K H channels, ATP-sensitive Kq channel opener; Detrusor smooth muscle; Smooth muscle relaxation; Sulfonylurea receptor ŽBuckner, S.A. Ž400. 287. KCl Nitric oxide ŽNO.; Mesenteric bed; N v -nitro-L-arginine methyl ester; Depolarization; Nitric oxide ŽNO. synthase ŽMendizabal, V.E. Ž409. 85. K AT P current Thiazolidinedione; Troglitazone; Rosiglitazone; BRL 49653; Glibenclamide; Kq channel ŽMishra, S.K. Ž386. 121.

cGMP; Sodium nitroprusside; Antinociception ŽSoares, A.C. Ž400. 67. Calcium; Calmodulin; Patch clamp; Antipsychotic; Dequalinium ŽDreixler, J.C. Ž401. 1.

K H current, delayed-rectifier Nifedipine; Ventricular myocyte, guinea-pig; Kq current, inward-rectifier ŽZhabyeyev, P. Ž401. 137.

Master keyword index to Õolumes 386–410 (2000)

75

K H current, Delayed rectifier Sinoatrial node; Atrioventricular node; Antiarrhythmic agent, Class III ŽSato, N. Ž404. 281.

Dopamine D1 receptor; Dopamine D 3 receptor; Locomotor activity; Exploratory behaviour; Elevated plus maze; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171.

K H current, inward-rectifier Nifedipine; Ventricular myocyte, guinea-pig; Kq current, delayed-rectifier ŽZhabyeyev, P. Ž401. 137.

Knockout mouse Cannabinoid receptor; D9 Tetrahydrocannabinol; Macrophage ŽBuckley, N.E. Ž396. 141.

Ketamine Synaptic plasticity; Long-term potentiation; Primed-burst stimulation; Visual cortex ŽSalami, M. Ž390. 287. Ondansetron; 5-HT Ž5-hydroxytryptamine, serotonin.; Heart rate; Electrocardiography; Fractal ŽDePetrillo, P.B. Ž391. 113.

Neutral endopeptidase; Enkephalinase; Enkephalin; Alcohol consumption; Angiotensin-converting enzyme; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327. 5-HT1B receptor; Ethanol intake; Water intake; Food intake ŽBouwknecht, J.A. Ž403. 95.

Ketanserin D-Fenfluramine; Hypothermia; 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275.

Adenosine A 2A receptor; SCH 58261; ZM 241385; CGS 21680; Motor activity ŽEl Yacoubi, M. Ž401. 63.

Pulmonary arteries; Dexfenfluramine; Phentolamine; Prazosin; Indomethacin ŽPatnaude, L.A. Ž401. 229.

Kupffer cell Lead; Hepatocyte, rat; Lipopolysaccharide; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317.

KF17837 (( E )-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1 H-purine-2,6-dione) KW-6002 ŽŽ E .-1,3-diethyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; Parkinson’s disease; Adenosine A 2A receptor antagonist; 6-Hydroxydopamine ŽKoga, K. Ž408. 249. Kidney OAT1 Žorganic anion transporter 1.; p-Aminohippurate; Methotrexate; Probenecid; NSAID Žnonsteroidal anti-inflammatory drug.; ŽRat. ŽUwai, Y. Ž409. 31.

KW-6002 (( E )-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1 H-purine-2,6-dione) KF17837 ŽŽ E .-1,3-dipropyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; Parkinson’s disease; Adenosine A 2A receptor antagonist; 6-Hydroxydopamine ŽKoga, K. Ž408. 249. Kynurenine 3-Hydroxyanthranilic acid; Inhibitor; Plasma; Brain; ŽRat. ŽFornstedtWallin, B. Ž386. 15.

Kindling Anxiety; Blood pressure; Glutamate; Heart rate; Long-term potentiation; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

NMDA Ž N-methyl-D-aspartate.; Quinolinic acid; Long-term potentiation; Hippocampus; NMDA receptor subunit ŽYoussef, F. Ž398. 349.

5-HT Ž5-hydroxytryptamine, serotonin .; Hippocampus; Seizure ŽWatanabe, K.-i. Ž398. 239.

L-365,260 SR 27897B; Cholecystokinin; Dopamine; CCK A receptor; CCK B receptor ŽTieppo, C.A. Ž387. 189.

Kinetics Muscarinic receptor; Gallbladder; Receptor heterogeneity; Radioligand binding; Ca2q, Intracellular; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Kinin Angiotensin AT2 receptor; Losartan; PD 123319; Nitric oxide ŽNO. synthase; Cyclo-oxygenase; Footshock ŽIsrael, A. Ž394. 103. Staphylococcal enterotoxin B; Mast cell; Neurogenic inflammation; Tachykinin NK 1 receptor; Vanilloid receptor ŽLinardi, A. Ž399. 235. Knee joint, rabbit Substance P; Vasodilatation; Plasma extravasation ŽLam, F.F.Y. Ž400. 327. Knockout mice Inflammation; m-Opioid receptor ŽQiu, C. Ž387. 163.

l-cis-Diltiazem d-cis-Diltiazem; Patch-clamp; Whole-cell; Ca2q overload; Naq current; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217. Lamotrigine Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Large conductance Kq channel, Ca2q-activated; Detrusor muscle; b-Adrenoceptor; Protein kinase A ŽKobayashi, H. Ž404. 231. Laser-Doppler flowmetry Choroidal blood flow; Sympathetic vasodilation; b-Adrenoceptor activation; b-Adrenoceptor antagonist; L-NAME Ž N G -nitro-L-arginine methyl ester.; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227.

Knock-out mice Catalepsy; Dopamine D 2 receptor; Dopamine D 3 receptor; Haloperidol; SCH 23390 ŽBoulay, D. Ž391. 63.

Morphine tolerance; Morphine dependence; Naloxone; Opiate withdrawal; Cerebral blood flow ŽZamani, R. Ž408. 299.

Knockout mice Nicotinic receptor; Nicotinic receptor subunit; Bladder; Autonomic dysfunction ŽDe Biasi, M. Ž393. 137.

LDH (lactate dehydrogenase) Astrocyte; Ca2q; Mitochondrion; MTT; Naq,Kq-ATPase; Ouabain ŽTakahashi, S. Ž408. 127.

76

Master keyword index to Õolumes 386–410 (2000)

Lead Hepatocyte, rat; Lipopolysaccharide; Kupffer cell; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317. Learning CO-induced amnesia; Neuroactive steroid; Pregnenolone; Dehydroepiandrosterone; Memory; ŽMouse. ŽMaurice, T. Ž390. 145. Nicotine; Attention; Memory ŽLevin, E.D. Ž393. 141. Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65. Acetycholine; Cannabinoid; Glutamate; Short-term memory ŽHan, C.J. Ž403. 87. Corticotropin-releasing factor ŽCRF.; Vasopressin; Autonomic nervous system; Memory ŽCroiset, G. Ž405. 225. Lecithinized superoxide dismutase Hyperoxia; Neutrophil elastase; ONO-5046; Lung injury ŽYamamoto, H. Ž409. 179. Left atrium, rat Calcitonin gene-related peptide ŽCGRP.; BIBN4096BS; CGRP Ž8-38.; CGRP receptor subtypes; Vas deferens, rat ŽWu, D. Ž400. 313. Lenticulostriate artery, human RT-PCR; CGRP Žcalcitonin gene-related peptide.; Adrenomedullin; CRLR Žcalcitonin receptor-like receptor.; RAMP Žreceptor activity-modifying protein. ŽSams, A. Ž408. 183. Leptin Food intake; Histamine; Hypothalamus; Tele-methylhistamine; ŽIntracereboventricular infusion. ŽLecklin, A. Ž395. 113. 5-HTP Ž5-Hydroxytryptophan.; 5-HT Ž5-hydroxytryptamine, serotonin.; Benserazide; ŽMouse. ŽYamada, J. Ž406. 159. 5-HT2A receptor; Transmission disequilibrium; Association; Genome screening; Dopamine; Estrogen b receptor ŽHinney, A. Ž410. 147. Lethality Seizure; Sensitization ŽGasior, M. Ž387. R15. Leukocyte Inflammation; Ropivacaine ŽZhang, X.W. Ž392. R1. Leukocyte adhesion molecule Diarylheptanoid; Vascular endothelial cell; Anti-inflammation; 5-Lipoxygenase ŽYamazaki, R. Ž404. 375. Leukocyte infiltration Leukotriene B 4 ; Air pouch; Collagen-induced arthritis; Interleukin-1; LY293111Na ŽKuwabara, K. Ž402. 275. Leukotriene Opioid; Nociception; LTD4 receptor antagonist; Naloxone ŽGok, ¨ S¸ . Ž386. 195. Airway; Prostaglandin; Neuromediator; Endothelin; ŽMouse. ŽRichter, M. Ž389. 225. Pulmonary artery, porcine; Contraction; CysLT receptor; ICI 204,219; BAY u9773 ŽBack, ¨ M. Ž401. 381. Thromboxane; YM158; Asthma ŽArakida, Y. Ž403. 169.

Leukotriene B 4 Air pouch; Leukocyte infiltration; Collagen-induced arthritis; Interleukin1; LY293111Na ŽKuwabara, K. Ž402. 275. Emedastine difumarate; Itch-associated response; Substance P; Histamine; 5-HT Ž5-hydroxytryptamine, Serotonin. ŽAndoh, T. Ž406. 149. Leukotrienes Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193. Levcromakalim Mesenteric artery, rat; Endothelium; Hyperpolarisation; 18a-Glycyrrhetinic acid; Carbachol ŽWhite, R. Ž397. 279. Mesenteric artery, rat; cAMP; Forskolin; Protein kinase A; K AT P channels ŽOmar, R. Ž401. 85. Levodopa Dizocilpine ŽMK801.; 6-Hydroxydopamine; Microdialysis ŽJonkers, N. Ž407. 281. Levosimendan Positive inotropic effect; Ventricular muscle, dog; Ca2q transient; Myofibrillar Ca2q sensitivity; cAMP ŽTakahashi, R. Ž400. 103. Licking behavior Histamine; Apomorphine; ŽRat. ŽFarzin, D. Ž404. 169. Licking behaviour Benzodiazepine; Dopamine; Bout structure; Palatability ŽHiggs, S. Ž409. 73. Lick latency Opioid analgesia; U69,593; Hotplate; Sex differences; ŽRat. ŽVan Haaren, F. Ž408. 153. Ligand affinity GABA A rbenzodiazepine receptor; Hippocampus; Olfactory bulb; Receptor heterogeneity; a subunit ŽLameh, J. Ž400. 167. Ligand binding Receptor expression; cAMP; mRNA detection ŽDautzenberg, F.M. Ž390. 51. Ligand binding autoradiography 6-Hydroxydopamine; Neostriatum; Substantia nigra ŽVasiliadis, H.-M. Ž386. 155. Ligand binding domain Acetylcholine receptor; Neuron; Property; Pharmacological; Physiological ŽCurtis, L. Ž393. 155. Ligand docking Cannabinoid receptor; SR 144528; WIN 55212-2; Mutagenesis; Molecular model ŽGouldson, P. Ž401. 17. Ligand-gated channel Enteric neuron; Submucosal neuron; ATP receptor; Ca2q; Receptor; P2X receptor; P2Y receptor ŽBarajas-Lopez, C. Ž409. 243. ´ Ligand-gated ion channel Acetylcholine receptor; RNA blot; In situ hybridization; Peripheral nervous system; Neural development ŽErkman, L. Ž393. 97. 5-HT3 receptor; 5-HT3 receptor agonist; 5-HT3 receptor antagonist; HEK 293 cell; ŽFerret. ŽMochizuki, S. Ž399. 97.

Master keyword index to Õolumes 386–410 (2000) Ligand selectivity Opioid receptor; Mutagenesis; w35 SxGTPgS ŽBonner, G. Ž403. 37. Ligation Baclofen; Imipramine; Hot-plate test; ŽMouse. ŽZarrindast, M.-R. Ž407. 65. Limbic system Dopamine D 3 receptor ŽCussac, D. Ž394. 47.

77

Lipopolysaccharide, bacterial Bradykinin receptor; Microphysiometer; Aortic endothelial cell, bovine; FR173657 ŽBentley, K.R. Ž402. 11. Lipopolysacharide Melatonin; Dexamethasone; Naltrexone; TNF-a Žtumor neocrisis factora .; Nitric oxide ŽNO.; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15.

Clonidine; BAY K 8644; GABA Ž g-aminobutyric acid.; Ca2q channel, L-type; Septum, Epilepsy ŽBaran, H. Ž401. 31.

5-Lipoxygenase Diarylheptanoid; Leukocyte adhesion molecule; Vascular endothelial cell; Anti-inflammation ŽYamazaki, R. Ž404. 375.

Linkage Smoking; Genetic polymorphism; Neurotransmitter; Association ŽArinami, T. Ž410. 215.

Liquid diet method Ethanol withdrawal; Ifenprodil; NMDA receptor subunit ŽNarita, M. Ž401. 191.

Lipid metabolism Pravastatin; Monocyte; Inflammation; Pro-inflammatory molecule ŽGrip, O. Ž410. 83. Lipid peroxidation Antioxidant; Diabetic retinopathy; Glutathione; Superoxide dismutase ŽObrosova, I.G. Ž398. 139. ATP–MgCl 2 ; Mitochondrial energy metabolism; Mitochondrial enzyme; Hepatic ischemiarreperfusion ŽJeong, C. Ž403. 243. Lipid peroxide Endothelin-converting enzyme; Endothelin; Atherosclerosis; Cholesterol; ŽRabbit. ŽMitani, H. Ž387. 313. Lipolysis Tachycardia; Rhesus ŽForrest, M.J. Ž407. 175. Lipopolysaccharide Angiotensin II type 2 receptor; Cytokine; Nitric oxide ŽNO.; Cyclic GMP; Cardiac fibroblast ŽTamura, M. Ž386. 289. Endothelin-1; Cyclooxygenase 2; Prostaglandin E 2 ; Macrophage ŽShimada, K. Ž388. 187. Brain; Cerebral ischemia; Ischemic tolerance; Preconditioning; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-Larginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Interleukin-10; TNF-a, tumor necrosis factor-a ŽFukuda, T. Ž391. 317. Selectin; Sialyl Lewis X; Acute lung injury ŽHayashi, H. Ž392. 109. Nitric oxide ŽNO.; Nitric oxide-releasing compound; Adhesion; E-Selectin; ICAM-1 ŽKosonen, O. Ž394. 149. Fever; m-Opioid receptor antagonist; Preoptic anterior hypothalamus ŽBenamar, K. Ž401. 161. Lead; Hepatocyte, rat; Kupffer cell; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317. Vascular hyporeactivity; Ventricular myocyte; Ca2q transient; b-adrenergic stimulation; Nitric oxide ŽNO. ŽShan, Q. Ž406. 257.

Lithium chloride b-Amyloid; Bcl-2; Alzheimer’s disease ŽWei, H. Ž392. 117. Antidepressant drug; Imipramine; Locomotor activity; Mania ŽD’Aquila, P.S. Ž395. 157. Lithogenic index Acetophenone analogue; Choleretic; Cholesterol; Phloacetophenone; Ž Curcuma comosa. ŽPiyachaturawat, P. Ž387. 221. Liver Ischemia–reperfusion injury; Picroliv; Antioxidant ŽSingh, A.K. Ž395. 229. Stellate cell; Cirrhosis; Endothelin; Fibrosis, rat ŽGandhi, C.R. Ž406. 311. Liver, rat Ischemia–reperfusion; Protective effect; ATP; Bile flow; Glutathione; Antioxidant ŽSettaf, A. Ž406. 281. LL-Z1640-2 Radicicol; Mitogen-activated protein kinases; c-Jun N-terminal kinase; HgCl 2 ŽMatsuoka, M. Ž409. 155. L-NAME ( N G -nitro-L-arginine methyl ester) Choroidal blood flow; Laser-Doppler flowmetry; Sympathetic vasodilation; b-Adrenoceptor activation; b-Adrenoceptor antagonist; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227. Locomotion Adenosine receptor; Dopamine receptor; Caffeine; In situ hybridization; Autoradiography ŽHalldner, L. Ž406. 345. Locomotor activity Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Food intake ŽPrinssen, E.P.M. Ž388. 57. Dopamine D 2 receptor; Partial agonist; Dopamine synthesis; ŽRat. ŽAhlenius, S. Ž394. 247. Antinociception; Straub tail; Morphine; SC17599; ŽMouse. ŽHoushyar, H. Ž395. 121. Antidepressant drug; Imipramine; Lithium chloride; Mania ŽD’Aquila, P.S. Ž395. 157.

Salivary protein; Intestinal motility ŽTan, D. Ž409. 203.

Sibutramine; Desmethylsibutramine; Didemethylsibutramine; Food intake; Obesity; Antidepressant ŽGlick, S.D. Ž397. 93.

Y-39041; Arthritis; TNF-a ŽTumor necrosis factor-a .; Interleukin-10 ŽHisadome, M. Ž409. 331.

Nicotinic acetylcholine receptor; Sensitization; Disinhibition; Plus-maze; ŽRat. ŽEricson, M. Ž397. 103.

78

Master keyword index to Õolumes 386–410 (2000)

Antidepressant drug; Desipramine; Grooming; Mesolimbic dopamine system; Open field; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43. 5-HT1B rD receptor; SKF99101H; GR127935; WAY100635; ŽGuinea pig. ŽO’Neill, M.F. Ž399. 49. Dopamine D1 receptor; Dopamine D 3 receptor; Knockout mice; Exploratory behaviour; Elevated plus maze; Rotarod; Spatial learning ŽKarasinska, J.M. Ž399. 171. Locomotor sensitization Nociceptin; Orphanin FQ; ORL1 receptor; Morphine; Conditioned place preference; Spatial learning ŽCiccocioppo, R. Ž404. 153. Locus coeruleus GABA A receptor; Anesthetic; Propofol ŽChen, C.-L. Ž386. 201. Noradrenaline; Cortex, prefrontal; Stress; NMDA receptor; GABA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279. Morphine withdrawal; Prostaglandin; Prostanoid EP3 receptor; m-Opioid receptor; c-fos ŽNakagawa, T. Ž390. 257. Anxiety; Stress; Noradrenaline; Hypothalamus; Amygdala; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397. Long QT syndrome Kq channel; Pharmacogenetics; Heart ŽEscande, D. Ž410. 281. Long-term culture 2,3-Butanedione monoxime; Ca2i q transient; Fura 2-acetoxymethyl ŽAM. ester; Contractility; Ultrastructure; ŽGuinea pig. ŽHorackova, M. Ž404. 247.

Angiotensin AT2 receptor; PD 123319; Kinin; Nitric oxide ŽNO. synthase; Cyclo-oxygenase; Footshock ŽIsrael, A. Ž394. 103. Blood pressure; Endothelin-1; Bradykinin; Enalapril; ŽRat. ŽTanus-Santos, J.E. Ž397. 367. Low-density lipoprotein Endothelium-dependent relaxation; Very low-density lipoprotein; Highdensity lipoprotein; Oxysterol ŽPersegol, L. Ž406. 429. ´ Low dose Prolactin; Grooming, Novelty-induced; Sexual behavior, Male; Sexual behavior, Female ŽDrago, F. Ž405. 131. LTD4 receptor antagonist Leukotriene; Opioid; Nociception; Naloxone ŽGok, ¨ S¸ . Ž386. 195. Luciferase Melatonin receptor; cAMP response element; Reporter gene assay; HEK293 cell ŽConway, S. Ž390. 15. Lung Nicotine; Nicotinic receptor, Non-neuronal; Blood vessel; Skin ŽContiFine, B.M. Ž393. 279. Chronic hypoxia; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. Lung injury Hyperoxia; Lecithinized superoxide dismutase; Neutrophil elastase; ONO-5046 ŽYamamoto, H. Ž409. 179. Lung, rat Chronic hypoxia; 5-HT Ž5-hydroxytryptamine, serotonin. uptake; Pulmonary hypertension ŽJeffery, T.K. Ž396. 137.

Long-term potentiation Synaptic plasticity; Primed-burst stimulation; Visual cortex; Ketamine ŽSalami, M. Ž390. 287.

Luteal cell Droloxifene; Apoptosis; c-myc; bax; bcl-2; mRNA ŽLeng, Y. Ž409. 123.

Anxiety; Blood pressure; Glutamate; Heart rate; Kindling; Panic; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

Luteolin Apigenin; Anti-implantation activity; Estrogenic activity ŽHiremath, S.P. Ž391. 193.

Clozapine-induced potentiation; NMDA receptor; MK-801; Haloperidol; Perforant path–dentate gyrus pathway ŽKubota, T. Ž395. 37. NMDA Ž N-methyl-D-aspartate.; Quinolinic acid; Kynurenine; Hippocampus; NMDA receptor subunit ŽYoussef, F. Ž398. 349. Purine; Adenosine; ATP; Nucleotide; Hippocampus; Suramin ŽO’Kane, E.M. Ž409. 159.

LY341122 Cerebral ischemia, focal; Neuroprotection; Stroke; Oxygen radical; ŽRat. ŽHuh, P.W. Ž389. 79. LY379268 Glutamate receptor, metabotropic; Amphetamine; Motor activity; Stereotypy ŽCartmell, J. Ž400. 221.

Loop-diuretic Bumetanide; Frusemide; Cardiomyocyte; Contraction ŽKelso, E. Ž400. 43.

Lymphocyte proliferation Cynaropicrin; Anti-inflammatory effect; TNF-a Žtumor necrosis factor-a .; Nitric oxide ŽNO. release; Immunosuppressive effect ŽCho, J.Y. Ž398. 399.

Loop of Henle cAMP-dependent protein kinase; Adrenoceptor; Dopamine; ŽMouse. ŽHiguchi, E. Ž408. 107.

LY293111Na Leukotriene B 4 ; Air pouch; Leukocyte infiltration; Collagen-induced arthritis; Interleukin-1 ŽKuwabara, K. Ž402. 275.

Loreclezole GABA Ž g-aminobutyric acid.; GABA C receptor; r1 subunit ŽThomet, U. Ž408. R1.

[3 H]Lysergic acid diethylamide (LSD) Dopamine receptor; Mushroom body; ŽLocust.; ŽInsect. ŽDegen, J. Ž396. 59.

Losartan Angiotensin II; MAP Žmitogen activated protein. kinase; Mechanical stress; Aorta ŽKubo, T. Ž391. 281.

Lysophosphatidylcholine l-cis-Diltiazem; d-cis-Diltiazem; Patch-clamp; Whole-cell; Ca2q overload; Naq current ŽHashimoto, Y. Ž391. 217.

Master keyword index to Õolumes 386–410 (2000) Macrophage Nociception; Interleukin 1b; Interleukin 8; TNF-a; Mast cell; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111. Endothelin-1; Cyclooxygenase 2; Prostaglandin E 2 ; Lipopolysaccharide ŽShimada, K. Ž388. 187. Transplantation; Nitric oxide ŽNO. synthase; Inducible; Peroxynitrite ŽVos, I.H.C. Ž391. 31. Knockout mouse; Cannabinoid receptor; D9 Tetrahydrocannabinol ŽBuckley, N.E. Ž396. 141. Ditriazines; Nitric oxide ŽNO.; Eicosanoid; Neutrophil; Air pouch, mouse; Carrageenan paw oedema ŽRioja, I. Ž397. 207. Phenylethanoid; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase; Inducible; 1-propanamine-3-hydroxy-2-nitroso-1-propylhydrazino ŽPAPA NONOate. ŽXiong, Q. Ž400. 137. Cannabinoid CB 2 receptor; WIN55212; Palmitoylethanolamide; Nitric oxide ŽNO.; RAW264.7; cAMP ŽRoss, R.A. Ž401. 121. Wogonin; Flavonoid; Cyclooxygenase; Prostaglandin ŽWakabayashi, I. Ž406. 477. Magnocellular basal nucleus Neonatal; ACTH Žadrenocorticotropin.; Neuroprotection; Cholinergic neuron; Glia ŽHorvath, K.M. Ž405. 33. Major depression Mineralocorticoid receptor; Glucocorticoid receptor; Hypothalamic–pituitary–adrenocortical axis; Stress; Antidepressants ŽReul, J.M.H.M. Ž405. 235. Malignant hyperthermia Shortening velocity; Skeletal muscle ŽEtchrivi, T.S. Ž388. 107. Mammary artery Isoprostane; Oxidative stress; Vasoconstriction ŽCracowski, J.-L. Ž397. 161. Mammary artery, internal Thromboxane A 2 ; TP receptor; Forskolin; cAMP; Saphenous vein ŽCracowski, J.-L. Ž387. 295. Mania Antidepressant drug; Imipramine; Lithium chloride; Locomotor activity ŽD’Aquila, P.S. Ž395. 157. Antidepressant drug; Dopamine; Depression; Mesolimbic dopamine system ŽD’Aquila, P.S. Ž405. 365.

79

c-fos; c-jun; Cholecystokinin; Hypotonic stress ŽMurai, A. Ž394. 27. Substance P; TNF-a Žtumor necrosis factor-a .; Histamine; Dexamethasone; Skin ŽOkabe, T. Ž398. 309. Ca2q reperfusion; T-588; NGF Žnerve growth factor.; PD98059; Astrocyte ŽTakuma, K. Ž399. 1. Angiotensin; Endothelin; Aorta; Spontaneously hypertensive rat ŽSHR.; DOCA-salt hypertensive rat ŽKubo, T. Ž400. 231. MAP (mitogen-activated protein) kinase cascade Regulation; Protein kinase, cAMP-dependent; Signal transduction ŽMizuno, K. Ž404. 63. Marijuana, medical Cannabinoid; D9-THC Ž D9-tetrahydrocannabinol.; SR 141716A; Antinociception; Aerosol; Nebulizer ŽLichtman, A.H. Ž399. 141. Mass spectrometry Cannabinoid; Anandamide; Fatty acid ethanolamides; High-performance liquid chromatography; Anandamide transport ŽGiuffrida, A. Ž408. 161. Mast cell Nociception; Interleukin 1b; Interleukin 8; TNF-a; Macrophage; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111. Histamine; Enterochromaffin-like cell; Rabeprazole; Mast cell-deficient, rat ŽNakamura, S. Ž394. 9. Fluoroquinolone; Histamine release; G protein ŽMori, K. Ž394. 51. Oedema; Adenosine A 1 receptor; Adenosine A 2B receptor ŽSawynok, J. Ž395. 47. Salmeterol; Benzalkonium chloride; G-protein; b 2-Adrenoceptor; Asthma ŽSeebeck, J. Ž397. 19. Staphylococcal enterotoxin B; Kinin; Neurogenic inflammation; Tachykinin NK 1 receptor; Vanilloid receptor ŽLinardi, A. Ž399. 235. Chymase; Angiogenesis; Compound 48r80; Granuloma ŽMuramatsu, M. Ž402. 181. Nociceptin; Inflammatory response; Histamine; G protein; ORL 1 receptor; ŽRat. ŽKimura, T. Ž407. 327. Mast cell-deficient rat Histamine; Enterochromaffin-like cell; Mast cell; Rabeprazole ŽNakamura, S. Ž394. 9.

MAPA (magnesium ammonium phospholinoleate-palmitoleate anhydride) Ehrlich ascites tumour; Antitumour; Myelopoiesis; CFU-GM Žcolony-forming unit-granulocyte-macrophage. ŽJusto, G.Z. Ž388. 219.

Mast cell-deficient (Ws r Ws) rat Compound 48r80; Connective tissue mast cell; Tracheal contraction; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽIkawati, Z. Ž420. 297.

MAPK Pancreastatin receptor; Signaling; G protein; Phospholipase C; HTC cell; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´

Maternal behavior Corticosterone; ACTH Žadrenocorticotropin.; CRH Žcorticotropin-releasing hormone.; Coping; Social ŽLevine, S. Ž405. 149.

MAPK (mitogen-activated protein kinase) Ethanol; Acetaldehyde; Hepatocyte; Angiotensin II ŽWeng, Y.-I. Ž398. 323.

Matrix metalloproteinase Peroxisome proliferator-activated receptor ŽPPAR.; Retinoid X receptor ŽRXR.; Inflammation; Monocyte; Migration ŽKintscher, U. Ž401. 259.

MAP (mitogen-activated protein) kinase Angiotensin II; Mechanical stress; Aorta; Losartan ŽKubo, T. Ž391. 281.

Phosphodiesterase inhibitor; Tissue remodelling; Bronchoalveolar lavage; ŽMouse. ŽBelleguic, C. Ž404. 369.

80

Master keyword index to Õolumes 386–410 (2000)

Maxi-K H channel Radioligand binding; Iberiotoxin; Urinary bladder ŽMolinari, E.J. Ž388. 155.

Melatonin Glutathione; Antioxidant; Sleep deprivation; Hypothalamus ŽD’Almeida, V. Ž390. 299.

Antiarrhythmic drug; Inward rectifier Kq channel; Smooth muscle; ŽBovine. ŽNakahara, T. Ž402. 143.

Lipopolysacharide; Dexamethasone; Naltrexone; TNF-a Žtumor neocrisis factor-a .; Nitric oxide ŽNO.; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15.

Maze learning Ca2q channel antagonist; Amlodipine; Memory enhancement; Active avoidance, mice; Chronic drug administration ŽQuartermain, D. Ž399. 57. MCPG (( R, S )-a-methyl-4-carboxyphenylglycine) NAAG Ž N-acetylaspartylglutamate.; mGlu receptor; Ischemia; NAALADase Ž N-acetylated a-linked acidic dipeptidase. ŽLu, X.-C.M. Ž408. 233. mCPP-(3-chlorophenyl)piperazine Antipsychotic; Neuroleptic; 5-HT Ž5-hydroxytryptamine., serotonin; 5HT2C receptor; Behavior; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57. mCPP ( m-chlorophenylpiperazine) Glucagon; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2C r2B receptor; Adrenaline ŽYamada, J. Ž406. 153. MDCK cell Betulinic acid; Ca2q; Ca2q store; Fura-2; Thapsigargin ŽChou, K.-J. Ž408. 99. MDMA (3,4-methylenedioxymethamphetamine) 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Egr-1 Žzif-268.; Immediate-early gene ŽShirayama, Y. Ž402. 215. MDMA ((")-3,4-Methylenedioxymethamphetamine) Ecstasy; Anxiety; Odor, cat; Social interaction; Ultrasonic vocalization ŽMorley, K.C. Ž408. 41. Mecamylamine Nicotine; Cognition; Attention ŽStolerman, I.P. Ž393. 147.

X X Pineal gland; N -acetyl-5-hydroxytryptamine Ž N -acetyl-5-HT.; Suramin; P2-receptor ŽMortani Barbosa Jr., E.J. Ž401. 59.

Forced-swim test; Antidepressant; Sex difference; Depression ŽBrotto, L.A. Ž402. 87. Central nervous system; Analgesia; Naloxone ŽYu, C.-X. Ž403. 49. Melatonin MT1 receptor Morphine tolerance; Morphine dependence; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Melatonin MT2 receptor Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Melatonin MT3 receptor Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Melatonin receptor cAMP response element; Luciferase; Reporter gene assay; HEK293 cell ŽConway, S. Ž390. 15.

Mechanical stress Angiotensin II; MAP Žmitogen activated protein. kinase; Aorta; Losartan ŽKubo, T. Ž391. 281.

Melittin Brain phospholipase A 2 ; Catecholamines, plasma; Sympatho-adrenomedullary outflow, central; Mepacrine ŽYokotani, K. Ž398. 341.

Mechanism of action Antidepressant; Monoamine; Neuropeptide; Intracellular signaling; Transcription factor ŽVetulani, J. Ž405. 351.

Phospholipase A 2 ; Gap junction; Connexin; Endothelium-derived hyperpolarizing factor ŽEDHF.; Endothelium; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239.

Mechanosensitive channel Calmodulin antagonist; Stretch receptor; Voltage clamp ŽLin, J.-H. Ž397. 11.

Meloxicam Nitric oxide ŽNO.; cGMP; N G -L-nitro-arginine methyl ester ŽL-NAME.; ODQ Ž1 H-Ž1,2,4.-oxadiazoloŽ4,2-a.quinoxalin-1-one. ŽAguirre-Banuelos, ˜ P. Ž395. 9.

Medullary collecting duct, inner Vasopressin; Vasopressin receptor; Vasopressin V1B receptor; Vasopressin V2 receptor, CHO ŽChinese hamster ovary. cell ŽSaito, M. Ž401. 289. Melanocortin Regeneration; Development ŽStrand, F.L. Ž405. 3. Feeding; Central nervous system; Behavior; Body weight homeostasis; Anorexia; Obesity ŽVergoni, A.V. Ž405. 25.

Rheumatoid arthritis; Synoviocyte; Cyclooxygenase-1; Cyclooxygenase-2 ŽTsubouchi, Y. Ž395. 255. Memantine Cocaine; Motor activity; Conditioning; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303.

Neuropeptide; Intranasal administration; Vasopressin; Insulin; Cognition ŽFehm, H.L. Ž405. 43.

Morphine; Antinociception; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; MRZ 2r579; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77.

Melanocortin receptor ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Brain melanocortin system; Peptide–receptor interaction; Avoidance; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13.

Membrane potential 3-morpholinosydnonimine ŽSIN-1.; Endothelium-derived hyperpolarizing factor ŽEDHF.; Kq channel, Ca2q-activated; Kq channel, ATP-sensitive ŽQuignard, J.-F. Ž399. 9.

Master keyword index to Õolumes 386–410 (2000) Memory a 2 -Adrenoceptor; Atipamezole; Ageing; Cholinergic system; Noradrenergic system ŽHaapalinna, A. Ž387. 141. CO-induced amnesia; Neuroactive steroid; Pregnenolone; Dehydroepiandrosterone; Learning; ŽMouse. ŽMaurice, T. Ž390. 145.

81

Berberine; Nitric oxide ŽNO.; Kq channel; Ca2q channel; Vasorelaxation; Proliferation; ŽRat. ŽKo, W.-H. Ž399. 187. Ischemia–reperfusion; Neutrophil; Oedema; Inflammation ŽSouza, D.G. Ž403. 121.

Nicotine; Attention; Learning ŽLevin, E.D. Ž393. 141.

Mesenteric artery, rat a 1-Adrenoceptor subtype; Methoxamine; Cirazoline; P7480; BMY 7378 ŽHussain, M.B. Ž395. 69.

Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Morris water maze; Learning; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65.

Endothelium; Levcromakalim; Hyperpolarisation; 18a-Glycyrrhetinic acid; Carbachol ŽWhite, R. Ž397. 279.

AMPA receptor; Object recognition; S 18986-1; ŽRat. ŽLebrun, C. Ž401. 205.

cAMP; Levcromakalim; Forskolin; Protein kinase A; K AT P channels ŽOmar, R. Ž401. 85.

Phosphatidylserine; Reserpine; Passive avoidance ŽAlves, C.S.D. Ž404. 161.

Mesenteric bed Nitric oxide ŽNO.; N v -nitro-L-arginine methyl ester; Depolarization; KCl; Nitric oxide ŽNO. synthase ŽMendizabal, V.E. Ž409. 85.

Anabolic steroid; Pregnenolone sulfate; Ethylestrenol; Passive avoidance behavior; Non-linear dynamics; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177. Corticotropin-releasing factor ŽCRF.; Vasopressin; Autonomic nervous system; Learning ŽCroiset, G. Ž405. 225. Schizophrenia; Bipolar disorder; Depression; Synaptic plasticity; Ventricle enlargement; Neurocognitive impairment ŽVawter, M.P. Ž405. 385. Memory enhancement Ca2q channel antagonist; Amlodipine; Maze learning; Active avoidance, mice; Chronic drug administration ŽQuartermain, D. Ž399. 57. Memory process Vasopressin; Hippocampus ŽAlescio-Lautier, B. Ž405. 63. MEN 11270 Bradykinin B 2 receptor; Bradykinin receptor antagonist; Cystitis; Urinary bladder, human; Urinary bladder, rat ŽMeini, S. Ž388. 177. Antagonism; Bradykinin B 2 receptor; FR173657; FR190997; Non-peptide ŽMeini, S. Ž409. 185. Mepacrine Brain phospholipase A 2 ; Catecholamines, plasma; Sympatho-adrenomedullary outflow, central; Melittin ŽYokotani, K. Ž398. 341. Cardiomyocyte; Ca2q channel; Phospholipase A 2 ; Arachidonic acid ŽXiao, Y.-F. Ž399. 107. Mesangial cell, rat Biscoclaurine alkaloid; ŽPDGF. Platelet-derived growth factor; ŽTGF-b . Transforming growth factor-b ŽHayama, M. Ž390. 37. Mesencephalon s Receptor; Organotypic slice culture; N-methyl-D-aspartate ŽNMDA.; Dopaminergic neuron ŽShimazu, S. Ž388. 139. Mesenteric arterial bed Acidosis; ATP; P2X receptor; pH; Purine; Vasoconstriction ŽRalevic, V. Ž406. 99. Mesenteric arteriole Vasopressin; Microvascular constriction; Cremasteric arteriole; OPC21268; OPC-31260 ŽIshiguro, S. Ž400. 121. Mesenteric artery Somatostatin; Aorta; Ca2q ŽRuiz, E. Ž388. 255.

Mesenteric blood flow 5-HT Ž5-hydroxytryptamine, serotonin.; a-Methyl-5-hydroxytryptamine; Vasoconstrictor effect; 5-HT2B r2C receptor ŽFernandez, M.M. Ž401. 221. ´ Mesenteric, 5th branch Trandolapril; Angiotensin-converting enzyme inhibitor; Cholesterol-fed, rabbit; Aorta; Coronary artery ŽSanz, M. Ž397. 359. Mesentery, hamster Adenosine; ATP; Prejunctional neuromodulation; Purine receptor; Sympathetic neurotransmission ŽRalevic, V. Ž387. 287. Mesolimbic dopamine system Antidepressant drug; Desipramine; Grooming; Locomotor activity; Open field; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43. Antidepressant drug; Dopamine; Depression; Mania ŽD’Aquila, P.S. Ž405. 365. Mesothelial cell Angiotensin II; Angiotensin II type 1 receptor; Ca2q, cytosolic; Pleura ŽKuwahara, M. Ž388. 21. [3 H]Mesulergine 5-HT7 receptor; Ileum, mouse ŽHemedah, M. Ž387. 265. Metabotropic Glutamate; Receptor; Antagonist; 2-Methyl-6-Žphenylethynyl.-pyridine ŽMPEP. ŽSpooren, W.P.J.M. Ž406. 403. Metabotropic glutamate receptor Antinociception; Opioid; Dizocilpine ŽMK-801.; NMDA receptor; Ž S .4CPG ŽŽ S .-4-carboxyphenylglycine. ŽSuzuki, T. Ž396. 23. Metabotropic receptor Glutamate; Mouse ŽSpooren, W.P.J.M. Ž397. R1. Meta-chlorophenylpiperazine 5-HT Ž5-Hydroxytryptamine serotonin.; 5-HT receptor; FLIPR Žflourescent imaging plate reader.; Fluorescence; 8-OH-DPAT Ž8-hydroxy-N, Ndipropylaminotetralin. ŽWood, M. Ž396. 1. Meta-hydroxyephedrine Noradrenaline reuptake site; PET Žpositron emission tomography.; Tricyclic antidepressant; ŽHuman. ŽMalizia, A.L. Ž391. 263. [Met 5 ]enkephalin Gender; T-lymphocyte; B-lymphocyte; Proliferation; Opioid receptor ŽGabrilovac, J. Ž392. 101.

82

Master keyword index to Õolumes 386–410 (2000)

Methacholine Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; 5-HT; Bronchoconstriction; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469. Methamphetamine 3-Nitropropionic acid; Neurotoxicity; Dopamine; 5-HT, 5-Hydroxytryptamine; Aromatic L-amino acid decarboxylase; Motor behaviour ŽEradiri, O.L. Ž386. 217. Conopeptide; Conantokin G; Neurotensin; Dynorphin; NMDA receptor ŽBush, L. Ž387. 55. Sensitization; Adenosine; Adenosine A 1 receptor; Adenosine A 2A receptor ŽShimazoe, T. Ž388. 249. Substance P; Neurotensin; Dopamine; Ibogaine; Cocaine; Drug abuse ŽAlburges, M.E. Ž390. 119.

Metoprolol Ramipril; Myocardial infarction; Action potential; Papillary muscle ŽWagner, K.-D. Ž388. 263. Metrazoline Imidazoline I 2 receptor ligand; Idazoxan; RX821002; Benazoline; Tracizoline; Food intake; Water intake ŽPolidori, C. Ž392. 41. MF 10058 Muscarinic M 2 receptor antagonist; Cardioselective muscarinic receptor antagonist; Antibradycardic agent; Sick sinus syndrome; Bradycardia ŽLamperti, G. Ž406. 93. mGlu receptor NAAG Ž N-acetylaspartylglutamate.; MCPG ŽŽ R,S .-a-methyl-4-carboxyphenylglycine.; Ischemia; NAALADase Ž N-acetylated a-linked acidic dipeptidase. ŽLu, X.-C.M. Ž408. 233.

Glutathione; Oxidative stress ŽHarold, C. Ž400. 99.

mGlu4 receptor mGlu8 receptor; Pharmacophore model; ŽRat. ŽDe Colle, C. Ž394. 17.

DADLE ŽwD-Ala2 , D-Leu5 xenkephalin.; Dopamine transporter ŽTsao, L.-I. Ž404. 89.

mGlu8 receptor mGlu4 receptor; Pharmacophore model; ŽRat. ŽDe Colle, C. Ž394. 17.

Baclofen; Cocaine; Drug-discrimination; ŽRat. ŽMunzar, P. Ž408. 169. ( R )-Methanandamide D9-Tetrahydrocannabinol; Anandamide; SR 141716; Amphetamine; Operant behavior; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251. Methoclocinnamox Respiration; Buprenorphine; Opioid receptor agonist; Opioid receptor antagonist; ŽRhesus monkey. ŽKishioka, S. Ž391. 289. Methotrexate OAT1 Žorganic anion transporter 1.; p-Aminohippurate; Probenecid; NSAID Žnonsteroidal anti-inflammatory drug.; Kidney; ŽRat. ŽUwai, Y. Ž409. 31. Methoxamine a 1-Adrenoceptor subtype; Cirazoline; P7480; Mesenteric artery, rat; BMY 7378 ŽHussain, M.B. Ž395. 69. Methyclothiazide Thiazide; Endothelium; Ca2q; Spontaneously hypertensive, rat ŽSHR.; Hypertension ŽColas, B. Ž408. 63. Methylene methylimino linkage Antisense; Platelet-derived growth factor A-chain; Spontaneously hypertensive rat ŽSHR.; Smooth muscle cell, vascular ŽKishioka, H. Ž392. 129. a-Methyl-5-hydroxytryptamine 5-HT Ž5-hydroxytryptamine, serotonin.; Vasoconstrictor effect; Mesenteric blood flow; 5-HT2B r2C receptor ŽFernandez, M.M. Ž401. 221. ´ Methyllycaconitine Hippocampus; Choline; Interneuron; Nicotinic receptor; Excitation; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59. a-Methyl-para-tyrosine Dopamine; Dopamine D 2 receptor, extrastriatal; w123 IxEpidepride; SPECT ŽSingle photon emission computed tomography.; Schizophrenia; Binding, in vivo ŽFujita, M. Ž387. 179. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) Glutamate; Receptor; Metabotropic; Antagonist ŽSpooren, W.P.J.M. Ž406. 403.

mGlu 1 receptor, Arg 78 Agonist binding; Glutamic acid; Quisqualic acid; Mutagenesis ŽJensen, A.A. Ž397. 247. Mg 2H absorption Escin Ib; Escin IIb; Nitric oxide ŽNO. ŽLi, Y. Ž387. 337. Mibefradil Sinus node cell; Ca2q current ŽProtas, L. Ž401. 27. Mice Naloxone; Morphine; Sensitization; Place conditioning; NMDA receptor antagonist ŽBlokhina, E.A. Ž406. 227. Microbiota Desipramine; Gingivitis; Salivary protein; Salivary flow rate; Tricyclic antidepressant ŽKoller, M.M. Ž408. 91. Microcirculation FITC-dextran; Arteriole; Permeability; Nitric oxide ŽNO.; Platelet-activating factor ŽPAF.; Nitric oxide synthase ŽNOS. inhibitor ŽKlabunde, R.E. Ž404. 387. Microdialysis Apomorphine; Dopamine; N-propyl analog; Bioavailability; Striatum ŽRodenhuis, N. Ž387. 39. Locus coeruleus; Noradrenaline; Cortex, prefrontal; Stress; NMDA receptor; GABA receptor; CRF receptor ŽKawahara, H. Ž387. 279. v-Agatoxin IVA-sensitive Ca2q channel; a-Eudesmol; Glutamate release; Synaptosome; Focal ischemia ŽAsakura, K. Ž394. 57. Risperidone; Schizophrenia; Antipsychotic drug; Electrophysiology; Noradrenergic system ŽNasif, F.J. Ž394. 67. Dopamine receptor agonist; Bioavailability; Striatum; Bioisosteric replacement; Thiophene analog ŽRodenhuis, N. Ž394. 255. Serotonin Ž5-hydroxytryptamine, 5-HT.; Selective serotonin Ž5-hydroxytryptamine, 5-HT. reuptake inhibitor; Venlafaxine; YM992; Antidepressant ŽHatanaka, K.-i. Ž395. 23. Norepinephrine; 5-HT2A receptor antagonist; YM992; Venlafaxine; Antidepressant ŽHatanaka, K.-i. Ž395. 31.

Master keyword index to Õolumes 386–410 (2000) Somatostatin; Subiculum; Somatostatin sst2 receptor; Dopamine ŽMitchell, S.N. Ž395. 43. g-Aminobutyric acid ŽGABA.; Dopamine; Cocaine; g-Vinyl GABA Žvigabatrin.; g-Aminobutyric acid ŽGABA. reuptake inhibitor ŽGerasimov, M.R. Ž395. 129. 5-Hydroxytryptamine, serotonin Ž5-HT.; Citalopram; Hippocampus, ventral; 5-Hydroxytryptamine, serotonin Ž5-HT. reuptake inhibitor, selective ŽCremers, T.I.F.H. Ž397. 63. Chronic treatment; 5-HT Ž5-hydroxytryptamine, serotonin.; ŽRat. ŽCremers, T.I.F.H. Ž397. 351. Gabapentin; Substantia nigra reticulata; g-Aminobutyric acid ŽTimmerman, W. Ž398. 53. Ensaculin; Dopamine; DOPAC Ž3,4-dihydroxyphenylacetic acid.; Glutamate; Rat ŽTeismann, P. Ž398. 247. Clozapine; Haloperidol; Ritanserin; Ascorbic acid; Ethanol; ŽRat. ŽLiu, W. Ž398. 333. Domoic acid; DNQX; MK-801; Dopamine; Striatum, rat ŽQuintela, B.A. Ž401. 173. Acetylcholine; Hippocampus; HU 210; Cortex, prefrontal; SR 141716A; WIN 55, 212-2 ŽAcquas, E. Ž401. 179. Nucleus tractus solitarii; Nitric oxide; Glutamate ŽLin, H.-C. Ž407. 83.

´ Ž407. Paroxetine; Desipramine; 5-HT; Noradrenaline ŽHajos-Korcsok, E. ´ 101. Histamine; Histamine release; Veratrine; Ouabain ŽWashington, B. Ž407. 117. Dopamine; Subiculum; Nucleus accumbens; Fimbria-fornix; ŽRat. ŽMitchell, S.N. Ž407. 131. Dizocilpine ŽMK801.; Levodopa; 6-Hydroxydopamine ŽJonkers, N. Ž407. 281. Dopamine; Nicotine; Ethanol; Nucleus accumben; Selected line ŽKiianmaa, K. Ž407. 293. Adenosine; Adenosine kinase; Adenosine deaminase; Formalin; Pain; Inflammation ŽLiu, X.J. Ž408. 143. Amino acid; Dopamine; Guanidinoethyl sulfonate; ŽRat. ŽOlive, M.F. Ž409. 291. Microdialysis, in vivo a-Fluoromethylhistidine; Gastrin; Histamine; Histidine decarboxylase; ECL cell; Secretory vesicle; Stomach ŽNorlen, ´ P. Ž400. 1. 5-HT Ž5-hydroxytryptamine, serotonin.; Paroxetine; Tianeptine; Frontal cortex; Raphe nuclei ŽMalagie, ´ I. Ž403. 55. Dopamine; Prefrontal cortex; Shuttle-box; Working memory; ŽGerbil. ŽStark, H. Ž405. 263.

83

Microinjection Paraventricular nucleus; Excitatory amino acid; Cardiovascular regulation; Central; ŽRat. ŽGoren, M.Z. Ž388. 77. ¨ Microiontophoresis Cocaine; Cerebellum; Norepinephrine; Purkinje cell; Glutamate; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ Microphysiometer Lipopolysaccharide, bacterial; Bradykinin receptor; Aortic endothelial cell, bovine; FR173657 ŽBentley, K.R. Ž402. 11. Microphysiometry Dopamine; D3 receptor; BP 897; Radioligand binding ŽWood, M.D. Ž407. 47. Microsphere Diltiazem; Coronary flow; Heart, isolated, rat; Ischemia; Reperfusion ŽKatsumata, N. Ž398. 83. Microtubule Insulin; Primary culture of hepatocyte; Tyrosine phosphorylation; cAMP phosphodiesterase; Wortmannin; Herbimycin A ŽIshibashi, K. Ž409. 109. Microvascular constriction Vasopressin; Mesenteric arteriole; Cremasteric arteriole; OPC-21268; OPC-31260 ŽIshiguro, S. Ž400. 121. Micturition reflex Tachykinin NK 1 receptor; Tachykinin NK 2 receptor; Orphanin FQ; Tachykinin ŽLecci, A. Ž389. 99. TAK-637; Tachykinin NK 1 receptor antagonist, non-peptide; Urinary tract, lower ŽDoi, T. Ž395. 241. TAK-637; Tachykinin NK 1 receptor antagonist, non-peptide; Spinal cord; Electrical stimulation ŽKamo, I. Ž401. 235. Middle cerebral artery occlusion Cerebral ischemia; Cerebral blood flow, local ŽTakamatsu, H. Ž398. 375. Middle meningeal artery Coronary artery; Eletriptan; GR125743; Migraine; Saphenous vein; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Migraine Vasodilation; Sensory nerve fibre; CGRP Žcalcitonin-gene-related peptide. ŽOlivar, T. Ž395. 61. Coronary artery; Eletriptan; GR125743; Middle meningeal artery; Saphenous vein; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. 5-HT1B r1D receptor agonist; Almotriptan; Preclinical study ŽGras, J. Ž410. 43. Cardiovascular safety; 5-HT1B r1D receptor agonist; Almotriptan ŽGras, J. Ž410. 53.

5-HT1A receptor; 5-HT Ž5-hydroxytryptamine, serotonin. release; WAY 100635 ŽAssie, ´ M.-B. Ž409. 173.

Migration Peroxisome proliferator-activated receptor ŽPPAR.; Retinoid X receptor ŽRXR.; Inflammation; Monocyte; Matrix metalloproteinase ŽKintscher, U. Ž401. 259.

Microglia Alzheimer’s disease; NSAIDs; Aspirin; Interferon-g ŽOgawa, O. Ž408. 137.

Mineralization Nitric oxide ŽNO.; Stromal cell; Osteoblast-like cell; Differentiation ŽKoyama, A. Ž391. 225.

84

Master keyword index to Õolumes 386–410 (2000)

Mineralocorticoid receptor 5-HT1A receptor agonist; Flesinoxan; Glucocorticoid receptor; Hippocampus; Dorsal raphe nucleus ŽSibug, R.M. Ž404. 111.

MK-912 a 2 -Adrenoceptor; Agonist, Inverse; G protein-coupled receptor; RX821002; GTP; Rauwolscine ŽMurrin, L.C. Ž398. 185.

Glucocorticoid receptor; Hypothalamic–pituitary–adrenocortical axis; Stress; Antidepressants; Major depression ŽReul, J.M.H.M. Ž405. 235.

MK 571 Pulmonary artery, human; Contraction; Cysteinyl–leukotriene receptor; Prostacyclin; BAY u9773 ŽBack, ¨ M. Ž401. 389.

Mitochondrial energy metabolism ATP–MgCl 2 ; Mitochondrial enzyme; Lipid peroxidation; Hepatic ischemiarreperfusion ŽJeong, C. Ž403. 243. Mitochondrial enzyme ATP–MgCl 2 ; Mitochondrial energy metabolism; Lipid peroxidation; Hepatic ischemiarreperfusion ŽJeong, C. Ž403. 243. Mitochondrial toxin 3-Nitropropionic acid; Seizure; GABA Ž g-aminobutyric acid.; 4-Aminopyridine; Electroconvulsion ŽHaberek, G. Ž403. 229. Mitochondrion w3 HxAdenosine; Adenosine uptake; Testis, rat; Benzodiazepine receptor ligand, mitochondrial ŽJimenez, A. Ž398. 31. ´ Cerebrocortical neuronal culture; Glutamate excitotoxicity; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Astrocyte; Ca2q; LDH Žlactate dehydrogenase.; MTT; Naq,Kq-ATPase; Ouabain ŽTakahashi, S. Ž408. 127.

Modelling CCK 1 receptor; Binding site; SR 27897; SR 146131 ŽGouldson, P. Ž400. 185. Moguisteine Cough reflex; ATP-sensitive Kq channel; Anti-tussive drug ŽMorita, K. Ž395. 161. Molecular biology Psychoneuroendocrinology; Psychoneuroimmunoendocrinology; Genetic ŽBrambilla, F. Ž405. 341. Molecular cloning a 1a -Adrenoceptor; a 1b-Adrenoceptor; a 1d-Adrenoceptor; Rabbit; Pharmacology; Tissue distribution ŽPiao, H. Ž396. 9. Molecular epidemiology Pharmacogenetic; Pharmacogenomic; Genotype; Phenotype; DNA sequence variants; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107.

Mitogen-activated protein kinase Phospholipase A 2 ; Nuclear-factor-k B; Interleukin-1; Inflammation ŽBurgermeister, E. Ž388. 195.

Molecular model Nicotinic acetylcholine receptor; Epibatidine; ABT-594; A-85380; Analgesia; Antinociception ŽMeyer, M.D. Ž393. 171.

Nonvascular smooth muscle; Contraction; Prostaglandin F2 a ; Carbachol ŽYousufzai, S.Y.K. Ž407. 17.

Cannabinoid receptor; SR 144528; WIN 55212-2; Mutagenesis; Ligand docking ŽGouldson, P. Ž401. 17.

Mitogen-activated protein kinases LL-Z1640-2; Radicicol; c-Jun N-terminal kinase; HgCl 2 ŽMatsuoka, M. Ž409. 155.

Molecule antagonist Species selectivity; CCR1 ŽLiang, M. Ž389. 41.

Mitogen-activated protein (MAP) kinase Picroside I; Picroside II; Neurite outgrowth activity; Nerve growth factor ŽNGF.; PC12D cell ŽLi, P. Ž406. 203.

Momordin Ic Gastrointestinal transit; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2 receptor; Prostaglandin ŽLi, Y. Ž392. 71.

Mitogenesis Protein kinase A; Rp-cAMPS; H-89 ŽOsinski, M.T. Ž395. 173.

Monoamine Antidepressant; Mechanism of action; Neuropeptide; Intracellular signaling; Transcription factor ŽVetulani, J. Ž405. 351.

Mitogenic signal transduction a 7 Nicotinic receptor; Nicotine; Nicotine-derived nitrosamine; Small cell lung carcinoma; Pulmonary neuroendocrine cell ŽSchuller, H.M. Ž393. 265.

Hypothalamo-pituitary-adrenal axis; Aggressive behavior; Pertussis toxin; ŽMouse. ŽKim, D.-H. Ž409. 67. SCH23390; Eticlopride; Species-specificity ŽSandoval, V. Ž409. 265.

Mitoxantrone Heart; Anti-muscarinic action; ŽGuinea pig. ŽChugun, A. Ž407. 183. 3

[ H]MK-801 NMDA receptor; s site; w3 HxIfenprodil; Hippocampal brain membrane, porcine ŽHofner, G. Ž394. 211. ¨ MK-801 Clozapine-induced potentiation; NMDA receptor; Haloperidol; Long-term potentiation; Perforant path–dentate gyrus pathway ŽKubota, T. Ž395. 37. NMDA receptor; Receptor occupancy, in vivo; NR2B subunit; Radioligand binding ŽMurray, F. Ž397. 263. Domoic acid; DNQX; Dopamine; Microdialysis; Striatum, rat ŽQuintela, B.A. Ž401. 173.

Monoamine oxidase Hydrogen peroxide; Adipocyte, white; Cell metabolism ŽRaimondi, L. Ž395. 177. Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. Monoamine oxidase inhibitor w35 SxGTPgS binding, agonist-stimulated; Dopamine D 2 -like receptor; Quinpirole; Striatum; ŽRat. ŽGilliland, S.L. Ž392. 125. Anxiety; Conditioned fear stress; Freezing behavior ŽMaki, Y. Ž406. 411.

Master keyword index to Õolumes 386–410 (2000) Monocyte Peroxisome proliferator-activated receptor ŽPPAR.; Retinoid X receptor ŽRXR.; Inflammation; Migration; Matrix metalloproteinase ŽKintscher, U. Ž401. 259. Pravastatin; Inflammation; Lipid metabolism; Pro-inflammatory molecule ŽGrip, O. Ž410. 83. Mononuclear cell peripheral blood FK506 ŽTacrolimus.; Neutrophil chemotaxis; Interleukin-8 ŽSasakawa, Y. Ž403. 281. Monosodium glutamate X Smooth muscle; Adenosine-5 -triphosphate; Acetylcholine; Bradykinin; Angiotensin II ŽSukhanov, S.N. Ž386. 247. Morphine Dihydroetorphine; Physical dependence; Stereotypy; Continuous infusion; ŽRat. ŽAceto, M.D. Ž387. 31.

85

Neuropeptide FF; Adenosine; Spinal cord; Antinociception ŽGouarderes, ` C. Ž406. 391. Zn2q; Intrathecal; Antinociception; Tolerance; Dependence ŽLarson, A.A. Ž407. 267. Morphine dependence Morphine tolerance; Naloxone; Opiate withdrawal; Cerebral blood flow; Laser–Doppler flowmetry, ŽRat. ŽZamani, R. Ž408. 299. Morphine tolerance; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Morphine tolerance Morphine dependence; Naloxone; Opiate withdrawal; Cerebral blood flow; Laser–Doppler flowmetry, ŽRat. ŽZamani, R. Ž408. 299.

Noradrenaline; Dopamine; Hypothalamus–pituitary–adrenocortical axis; Tolerance; Paraventricular nucleus ŽFuertes, G. Ž388. 49.

Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279.

m-Opioid receptor; Tolerance; Desensitization; cAMP-dependent protein kinase; N-Ž2-aminoethyl.-5-isoquinolinesulfonamide ŽH8. ŽWang, Z. Ž389. 165.

Morphine withdrawal Prostaglandin; Prostanoid EP3 receptor; m-Opioid receptor; c-fos; Locus coeruleus ŽNakagawa, T. Ž390. 257.

Fluoxetine; Conditioned place preference; RB 120; CI 988; CCK 2 receptor antagonist ŽSubhan, F. Ž390. 137.

Ventricle, right; Catecholaminergic activity; Yohimbine; Prazosin ŽMilanes, ´ M.V. Ž397. 311.

C-fibre; Flexor reflex; Rostral ventromedial medulla; Wind-up; Spinobulbo-spinal; Inhibitory feedback mechanism ŽGozariu, M. Ž394. 75.

Morris water maze Žy.-Huperzine A; Acetylcholinesterase; Cholinesterase inhibitor; Cerebral ischemia; Learning; Memory; Free radical; Alzheimer’s disease ŽWang, L.M. Ž398. 65.

Dopamine; Electrophysiology ŽMelis, M. Ž387. R1.

TRK-820; U-50,488H; Antinociceptive tolerance; ŽMouse. ŽTsuji, M. Ž394. 91. Antinociception; Locomotor activity; Straub tail; SC17599; ŽMouse. ŽHoushyar, H. Ž395. 121. Analgesia; NMDA receptor; AMPA receptor; Spinal cord; ŽRat. ŽNishiyama, T. Ž395. 203. Antinociception; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r579; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77. Diabetes; Nitric oxide ŽNO.; Aminoguanidine; Antinociception ŽGrover, V.S. Ž399. 161. G

Sildenafil; cGMP; N -L-nitro-arginine methyl ester ŽL-NAME.; ODQ Ž1 H-w1,2,4x-oxadiazolow4,3-axquinoxalin-1-one.; Naloxone ŽMixcoatlZecuatl, T. Ž400. 81.

Motilin EM574; Cisapride; Gastric emptying; ŽDog. ŽSako, F. Ž395. 165. Motivation Acetylcholine; Cholinergic; Glutamate; Interaction; Behaviour ŽAura, J. Ž390. 313. Motor activity Cocaine; Conditioning; Dizocilpine ŽMK-801.; D-CPPene ŽSDZ EAA 494.; Memantine; ACEA-1021; Eliprodil; ŽRat. ŽBespalov, A.Y. Ž390. 303. Dopamine; Dopamine D 3 receptor; Žq.-PD128,907; Postnatal development ŽHeijtz, R.D. Ž392. 35. Glutamate receptor, metabotropic; Amphetamine; LY379268; Stereotypy ŽCartmell, J. Ž400. 221.

Enkephalin catabolism, mixed inhibitors; Enkephalin, endogenous; Drug discrimination; CI 988; CCK 1 receptor antagonist; RB 120 ŽHutcheson, D.M. Ž401. 197.

Adenosine A 2A receptor; SCH 58261; ZM 241385; CGS 21680; Knockout, mouse ŽEl Yacoubi, M. Ž401. 63.

Hyperalgesia; Ventral posterolateral nucleus; Excitatory amino acid; Riluzole; Dizocilpine ŽAbarca, C. Ž403. 67.

Motor behavior Nitric oxide ŽNO.; NMDA Ž N-methyl-D-aspartate.; Anxiety; Ultrasonic vocalization; ŽRat. ŽPodhorna, J. Ž408. 265.

Nociceptin; Orphanin FQ; ORL1 receptor; Conditioned place preference; Spatial learning; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. Naloxone; Sensitization; Place conditioning; NMDA receptor antagonist; Mice ŽBlokhina, E.A. Ž406. 227.

Motor behaviour Methamphetamine; 3-Nitropropionic acid; Neurotoxicity; Dopamine; 5HT, 5-Hydroxytryptamine; Aromatic L-amino acid decarboxylase ŽEradiri, O.L. Ž386. 217.

86

Master keyword index to Õolumes 386–410 (2000)

Motor neuron Amyotrophic lateral sclerosis ŽALS.; Apoptosis; Cell culture; Tissue culture; Neurodegenerative disease ŽBar, ¨ P.R. Ž405. 285. Mouse Glutamate; Metabotropic receptor ŽSpooren, W.P.J.M. Ž397. R1. Movement D9 -Tetrahydrocannabinol; Activity; Cannabinoid; Biphasic effect ŽSanudo-Pena, ˜ ˜ M.C. Ž391. 269. Movement disorder Nootropic drug; Epilepsy; Anticonvulsant drug ŽLoscher, W. Ž391. 251. ¨ Dystonia; Paroxysmal choreoathetosis; Barbiturate; GABA Ž g-aminobutyric acid. ŽRichter, A. Ž397. 343.

a-MSH ( a-melanocyte stimulating hormone) Feeding; Neuropeptide Y; ŽChick. ŽKawakami, S.-i. Ž398. 361. MSH (melanocyte-stimulating hormone) ACTH Žadrenocorticotropic hormone.; Melanocortin receptor; Brain melanocortin system; Peptide–receptor interaction; Avoidance; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. MTT Astrocyte; Ca2q; LDH Žlactate dehydrogenase.; Mitochondrion; Naq,Kq-ATPase; Ouabain ŽTakahashi, S. Ž408. 127. Mucus score Neutrophil elastase inhibitor; Ozone-exposure; Goblet cell hypersecretion ŽNogami, H. Ž390. 197.

Movement disorders Adenosine receptor agonist; Basal ganglia disorder; Dystonia ŽRichter, A. Ž404. 299.

Multidrug resistance P-glycoprotein; MRP1 Žmultidrug resistance-associated protein.; Daunorubicin; Calcein-AM; Inhibitor; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207.

Moxifloxacin Fluoroquinolones; Sparfloxacin; Grepafloxacin; Ciprofloxacin; Purkinje fibre; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449.

Multidrug resistance protein Calcium ion; cAMP; Fluid secretion; Calcein ŽSugita, M. Ž388. 227.

Moxonidine Collagen; Heart failure; Hypertrophy; Sympathetic activation; ŽRat. ŽVan Kerckhoven, R. Ž397. 113. MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropteridine) Nicotinic receptor; Parkinson’s disease; Hybridization, in situ; Neuroprotection; ŽMonkey. ŽQuik, M. Ž393. 223. MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Dopamine D4 receptor; L-Dopa-induced dyskinesia; JL-18; Parkinson’s disease ŽTahar, A.H. Ž399. 183. mRNA Droloxifene; Luteal cell; Apoptosis; c-myc; bax; bcl-2 ŽLeng, Y. Ž409. 123. mRNA detection Receptor expression; Ligand binding; cAMP ŽDautzenberg, F.M. Ž390. 51. MRP1 (multidrug resistance-associated protein) Multidrug resistance; P-glycoprotein; Daunorubicin; Calcein-AM; Inhibitor; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207. MRP2 (multidrug resistance protein 2) Multidrug resistance protein; Intestine ŽVan Aubel, R.A.M.H. Ž400. 195. MRZ 2 r 576 Morphine; Antinociception; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r579; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77. MRZ 2 r 579 Morphine; Antinociception; NMDA receptor antagonist; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77. MS-377 s Binding site; Radiolabeled ligand binding; Brain membrane, rat ŽKarasawa, J.-i. Ž400. 51. Prepulse inhibition; Apomorphine; Phencyclidine; s1 Receptor ligand ŽYamada, S. Ž402. 251.

MRP2 Žmultidrug resistance protein 2.; Intestine ŽVan Aubel, R.A.M.H. Ž400. 195. Muscarinic acetylcholine receptor b-Adrenoceptor; Radioligand binding ŽManukhin, B.N. Ž386. 279. Scopolamine; Prepulse inhibition; Startle; Apomorphine; Phencyclidine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105. Muscarinic M 2 receptor antagonist MF 10058; Cardioselective muscarinic receptor antagonist; Antibradycardic agent; Sick sinus syndrome; Bradycardia ŽLamperti, G. Ž406. 93. Muscarinic receptor Gallbladder; Receptor heterogeneity; Radioligand binding; Kinetics; Ca2q, Intracellular; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Olanzapine; Clozapine; Binding; Antipsychotic ŽBymaster, F.P. Ž390. 245. Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Tangle; Nicotine; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨ Sphingosine 1-phosphate; Dimethylsphingosine; InsŽ1,4,5.P3 ; Ca2q mobilisation; SH-SY5Y neuroblastoma cell ŽYoung, K.W. Ž402. 55. Rabies virus; NG108-15 cell; Ca2q current; a-Adrenoceptor; Patch clamp, Whole-cell ŽIwata, M. Ž404. 79. Muscarinic receptor agonist Cocaine; Self-administration; Drug-naive; ŽMouse. ŽRasmussen, T. Ž402. 241. Muscarinic receptor subtype Ileum, avian; Binding affinity; Functional affinity ŽDarroch, S. Ž402. 161. Muscimol GABA A receptor subtype; Brain regional heterogeneity; w35 SxTBPS binding; Agonist coupling; Taurine; b-Alanine; 4-PIOL; 5-Ž4-piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233.

Master keyword index to Õolumes 386–410 (2000)

87

Mushroom body Dopamine receptor; w3 HxLysergic acid diethylamide ŽLSD.; ŽLocust.; ŽInsect. ŽDegen, J. Ž396. 59.

Myocardial ischaemia Antiarrhythmic; Class I; Arrhythmia; Proarrhythmia ŽBarrett, T.D. Ž398. 365.

Mustard oil Vagal afferent; Somatostatin; Capsaicin; Antidromic stimulation; Anti-inflammatory effect ŽThan, ´ M. Ž399. 251.

Myocardial ischemia K AT P channel; Hypertension; Arrhythmias; Reperfusion ŽLee, Y.-M. Ž397. 151.

Mutagenesis Allosteric modulator; Catecholamine ŽSchetz, J.A. Ž388. R5.

NaqrHq exchange; Reperfusion injury ŽYamada, K. Ž404. 201. b-Adrenoceptor antagonist; Antioxidant ŽGao, F. Ž406. 109.

Cholecystokinin CCK 1 receptor; Charged residue; SR 27897; SR 146131 ŽGouldson, P. Ž389. 115. mGlu 1 receptor, Arg 78 ; Agonist binding; Glutamic acid; Quisqualic acid ŽJensen, A.A. Ž397. 247. Cannabinoid receptor; SR 144528; WIN 55212-2; Ligand docking; Molecular model ŽGouldson, P. Ž401. 17. Opioid receptor; Ligand selectivity; w35 SxGTPgS ŽBonner, G. Ž403. 37. Mutation Acetylcholine receptor; Epilepsy ŽSteinlein, O.K. Ž393. 243. Dopamine receptor; Pharmacogenetics; Polymorphism; Antipsychotic; Schizophrenia ŽWong, A.H.C. Ž410. 183. Mycotoxin InsP3 receptor; Ca2q signalling; Paxilline ŽLongland, C.L. Ž408. 219. Myelopoiesis Ehrlich ascites tumour; Antitumour; MAPA Žmagnesium ammonium phospholinoleate-palmitoleate anhydride.; CFU-GM Žcolony-forming unit-granulocyte-macrophage. ŽJusto, G.Z. Ž388. 219. Myenteric neuron X X Capsaicin; PPADS ŽPyridoxal-phosphate-6-azophenyl-2 ,4 -disulphonic acid.; VIP ŽVasoactive intestinal polypeptide.; PACAP ŽPituitary adenylate cyclase activating peptide.; NO ŽNitric oxide.; Small intestine ŽBartho, ´ L. Ž392. 183. Myocardial contractility Ca2q-responsiveness; Ca2q-sensitizer; End-systolic elastance; Stunning ŽDe Zeeuw, S. Ž403. 99. Myocardial contraction Amylin; Adrenomedullin; Calcitonin gene-related peptide ŽCGRP.; Calcitonin receptor-like receptor; Receptor associated modifying protein ŽRAMP. ŽSaetrum Opgaard, O. Ž397. 373. Myocardial infarct Nitric oxide synthase inhibition; Angiotensin II cardiac; Angiotensin AT1 receptor antagonist ŽVerhagen, A.M.G. Ž400. 239. Myocardial infarction Adenosine receptor agonist; Protection, delayed; ŽMinipig. ŽMeng, H. Ž387. 101. Metoprolol; Ramipril; Action potential; Papillary muscle ŽWagner, K.-D. Ž388. 263. TY-12533; NaqrHq exchanger; Ischemia; Reperfusion; Arrhythmia ŽAihara, K. Ž404. 221. Myocardial infarct size Sodium–hydrogen exchanger; Arrhythmias ŽGumina, R.J. Ž396. 119.

Myocardial oxygen consumption Ca2q sensitizer; Diastolic function, regional; Systolic shortening, regional; Systemic haemodynamics ŽSoei, L.K. Ž386. 55. Myocyte Anaesthetic volatile; Action potential; Arrhythmia; K AT P channel; Patch clamp ŽTerrenoire, C. Ž390. 95. Vasopressin; Vasopressin V1A receptor; Vasopressin V2 receptor; Hypertrophy; Cell culture ŽNakamura, Y. Ž391. 39. Adrenomedullin; Papillary muscle; Heart, isolated; Ca2q transient; ŽRat. ŽStangl, V. Ž408. 83. Myofibrillar Ca 2H sensitivity Positive inotropic effect; Ventricular muscle, dog; Ca2q transient; cAMP; Levosimendan ŽTakahashi, R. Ž400. 103. Myoglobin Ventricular cardiomyocyte, rat; Contractile function; Ca2q channel, Ltype; Nitric oxide ŽNO. ŽVulcu, S.D. Ž406. 247. Myometrium (porcine) a 2 -Adrenoceptor; Clonidine; Ca2q, intracellular; cAMP; Ca2q sensitivity ŽKitazawa, T. Ž390. 185. Na H Cyclosporine A; Enalapril; Valsartan; Angiotensin II; Vascular response ŽLassila, M. Ž398. 99. Ouabain; Ca2q; Aldosterone; NaŽq. –KŽq. –exchanging ATPase ŽYingst, D.R. Ž406. 49. Na Hr Ca 2H exchange Antisense oligodeoxynucleotide; Ca2q pump; Ca2q concentration, Intracellular; Thapsigargin ŽNakao, M. Ž387. 273. Na H channel Hippocampal neuron; Veratridine; Swelling; Death; Ca2q channel ŽOkuyama, K. Ž398. 209. Amitriptyline; Antidepressant; Tetrodotoxin-sensitive; Tetrodotoxin-resistant; Dorsal root ganglion ŽSong, J.-H. Ž401. 297. 8-OH-DPAT; 5-HT1A receptor; Ca2q channel; Neuroprotection; Ischemia ŽMelena, J. Ž406. 319. Na H channel antagonist Cerebral ischaemia model; Ca2q channel antagonist; Electrophysiology ŽCampbell, C.A. Ž401. 419. Na H current Hippocampus; Electrophysiology; Epileptiform activity; Aconitum alkaloid ŽAmeri, A. Ž386. 187.

Master keyword index to Õolumes 386–410 (2000)

88

Neuroprotection; Glutamate transporter; Glutamate uptake ŽShimada, F. Ž386. 263. l-cis-Diltiazem; d-cis-Diltiazem; Patch-clamp; Whole-cell; Ca2q overload; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217. Na H-glucose cotransporter Streptozotocin; T-1095; Phlorizin; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Na Hr H H exchange Myocardial ischemia; Reperfusion injury ŽYamada, K. Ž404. 201. Na Hr H H exchanger Arrhythmias; Myocardial infarct size ŽGumina, R.J. Ž396. 119. TY-12533; Ischemia; Reperfusion; Arrhythmia; Myocardial infarction ŽAihara, K. Ž404. 221. H

H

Na ,K -ATPase Nitric oxide ŽNO.; cGMP-dependent protein kinase; Aging; Trachea, rat ŽScavone, C. Ž388. 1. Oligomycin; Ca2q-ATPase; Naq occlusion; Chimeric ATPase ŽHomareda, H. Ž400. 177. Na H, K H ATPase Nerve conduction; Blood flow; Kq channel opener; Oxidative stress; Glutathione; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335. Diabetes; Ouabain; Phenylephrine; Vascular reactivity; Streptozotocin; Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419. Astrocyte; Ca2q; LDH Žlactate dehydrogenase.; Mitochondrion; MTT; Ouabain ŽTakahashi, S. Ž408. 127.

Naloxonazine Dermorphin N-terminal tetrapeptide; Tail-flick test; b-Funaltrexamine; m1 -Opioid receptor ŽSakurada, S. Ž395. 107. [3 H]Naloxone Amphibian; Antinociception; Opioid receptor ŽNewman, L.C. Ž397. 255. Naloxone Leukotriene; Opioid; Nociception; LTD4 receptor antagonist ŽGok, ¨ S¸ . Ž386. 195. Anxiety; Plus-maze; Opiate; Benzodiazepine ŽBelzung, C. Ž394. 289. Morphine; Sildenafil; cGMP; N G -L-nitro-arginine methyl ester ŽLNAME.; ODQ Ž1 H-w1,2,4x-oxadiazolow4,3-axquinoxalin-1-one. ŽMixcoatl-Zecuatl, T. Ž400. 81. Melatonin; Central nervous system; Analgesia ŽYu, C.-X. Ž403. 49. Morphine; Sensitization; Place conditioning; NMDA receptor antagonist; Mice ŽBlokhina, E.A. Ž406. 227. Morphine tolerance; Morphine dependence; Opiate withdrawal; Cerebral blood flow; Laser–Doppler flowmetry, ŽRat. ŽZamani, R. Ž408. 299. Naloxone benzoylhydrazone Nocistatin; k-Opioid receptor; Spontaneous alternation; Passive avoidance ŽHiramatsu, M. Ž395. 149. Naltrexone Lipopolysacharide; Melatonin; Dexamethasone; TNF-a Žtumor neocrisis factor-a .; Nitric oxide ŽNO.; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15. Ethanol; L-DOPA ŽL-3,4-dihydroxyphenylalanine.; 5-HTP Ž5-hydroxy-Ltryptophan.; Firing rate ŽInoue, H. Ž406. 375. L-NAME

Na H occlusion Oligomycin; Naq,K q-ATPase; Ca 2q-ATPase; Chimeric ATPase ŽHomareda, H. Ž400. 177.

Nitric oxide ŽNO.; Hypoxic pulmonary vasoconstriction; Pulmonary arterial tone; N-g-nitro-L-argine methyl ester; Prostaglandin F2 a ŽJones, R.D. Ž402. 111.

NAAG ( N-acetylaspartylglutamate) mGlu receptor; MCPG ŽŽ R,S .-a-methyl-4-carboxyphenylglycine.; Ischemia; NAALADase Ž N-acetylated a-linked acidic dipeptidase. ŽLu, X.-C.M. Ž408. 233.

N-(2-aminoethyl)-5-isoquinolinesulfonamide (H8) m-Opioid receptor; Tolerance; Desensitization; cAMP-dependent protein kinase; Morphine ŽWang, Z. Ž389. 165.

NAALADase inhibition ( N-acetylated-a-linked-acidic dipeptidase) Stroke; Neuroprotection; ŽRat. ŽTortella, F.C. Ž402. 31. NAALADase ( N-acetylated a-linked acidic dipeptidase) NAAG Ž N-acetylaspartylglutamate.; mGlu receptor; MCPG ŽŽ R,S .-amethyl-4-carboxyphenylglycine.; Ischemia ŽLu, X.-C.M. Ž408. 233. X

X

N -acetyl-5-hydroxytryptamine ( N -acetyl-5-HT) Pineal gland; Melatonin; Suramin; P2-receptor ŽMortani Barbosa Jr., E.J. Ž401. 59.

N G -L-nitro-arginine methyl ester (L-NAME) Meloxicam; Nitric oxide ŽNO.; cGMP; ODQ Ž1 H-Ž1,2,4.-oxadiazoloŽ4,2a.quinoxalin-1-one. ŽAguirre-Banuelos, P. Ž395. 9. ˜ Morphine; Sildenafil; cGMP; ODQ Ž1 H-w1,2,4x-oxadiazolow4,3axquinoxalin-1-one.; Naloxone ŽMixcoatl-Zecuatl, T. Ž400. 81. N G -nitro-L-arginine methyl ester (L-NAME) Nitric oxide ŽNO.; 8-OH-DPAT Ž8-hydroxy-2-di-n-Žpropylamino.tetralin.; Food intake; 5-HT Ž5-hydroxytryptamine, serotonin.; Hypothalamus ŽYamada, J. Ž402. 247. ( N v -nitro-L-arginine methyl ester) Renal failure; Gentamicin; Nitric oxide ŽNO.; L-arginine; ŽRat. ŽCan, C. Ž390. 327. L-NAME

NADH–ubiquinone reductase Iodonium; NADPH oxidase; Xanthine oxidase; Nitric oxidase ŽNO. synthase ŽMoulton, P. Ž401. 115. NADPH oxidase Iodonium; Xanthine oxidase; Nitric oxidase ŽNO. synthase; NADH– ubiquinone reductase ŽMoulton, P. Ž401. 115. Na(H) –K(H) –exchanging ATPase Ouabain; Naq; Ca2q; Aldosterone ŽYingst, D.R. Ž406. 49.

NANC (nonadrenergic, noncholinergic) relaxation Strain difference; Colon, distal; Nitric oxide ŽNO.; VIP Žvasoactive intestinal peptide. ŽOkishio, Y. Ž388. 97. NANC (non-adrenergic–non-cholinergic) nerve, excitatory Asthma; Neuropeptide; Animal model; ŽHuman. ŽKraneveld, A.D. Ž405. 113.

Master keyword index to Õolumes 386–410 (2000)

89

Nandrolone decanoate Deca durabolin; Cocaine; Radiotelemetry; Cardiac hypertrophy; ECG Želectrocardiogram.; Noradrenaline ŽPhillis, B.D. Ž398. 263.

Nephropathy Angiotensin-converting enzyme inhibitor; Diabetes; Urinary albumin excretion; Immunohistochemistry ŽKatoh, M. Ž398. 381.

Nasal mucosa vasculature Noradrenaline; NS-49; a 1 -Adrenoceptor subtype; Vasoconstrictor response ŽTanimitsu, N. Ž387. 73.

Nerve conduction Blood flow; Kq channel opener; Naq, Kq ATPase; Oxidative stress; Glutathione; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335.

Nateglinide Exocytosis; Glucagon; K AT P channel; Repaglinide ŽBokvist, K. Ž386. 105.

Nerve ligation Chronic pain; Protein kinase C; TrkB receptor; Spinal cord; ŽMouse. ŽNarita, M. Ž401. 187.

Drug interaction; Hypoglycemic agent; Noncompetitive inhibition; Peptide transporter ŽTerada, T. Ž392. 11.

Hyperalgesia; Inflammation; Protein kinase C; Spinal cord; ŽMouse. ŽOhsawa, M. Ž403. 81.

OAT1 Žorganic anion transporter 1.; Renal tubular secretion; Xenopus oocytes; Sulfonylurea; p-Aminohippurate ŽUwai, Y. Ž398. 193.

Neural development Acetylcholine receptor; Ligand-gated ion channel; RNA blot; In situ hybridization; Peripheral nervous system ŽErkman, L. Ž393. 97.

Natriuresis Kallikrein secretion; Kq; Diuresis; Bradykinin B 2 receptor antagonist; FR173657 ŽSuzuki, T. Ž399. 223. Natural killer cell cytolytic activity D 9-Tetrahydrocannabinol; SR 141716; SR 144528; Interferon g ŽMassi, P. Ž387. 343. N-dealkylation pathway Deprenyl metabolism; Cytochrome P450; Parkinson’s disease; C57BL mouse liver microsomal preparation ŽValoti, M. Ž391. 199. Nebulizer Cannabinoid; D9-THC Ž D9-tetrahydrocannabinol.; SR 141716A; Antinociception; Marijuana, medical; Aerosol ŽLichtman, A.H. Ž399. 141. Nefazodone 5-HT transporter; 5-HT2A receptor ŽPullar, I.A. Ž407. 39. Nemonapride Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. Neocryptolepine Cryptolepine; Plant alkaloid; Topoisomerase II; Cytotoxicity; Apoptosis ŽDassonneville, L. Ž409. 9. Neocuproine Bathocuproine; Corpus cavernosum; S-Nitrosoglutathione; Non-adrenergic non-cholinergic ŽNANC. nerve; Nitrergic relaxation ŽGoc ¨ ¸men, C. Ž406. 293. Neonatal ACTH Žadrenocorticotropin.; Neuroprotection; Magnocellular basal nucleus; Cholinergic neuron; Glia ŽHorvath, K.M. Ž405. 33.

Neurite outgrowth activity Picroside I; Picroside II; Nerve growth factor ŽNGF.; Mitogen-activated protein ŽMAP. kinase; PC12D cell ŽLi, P. Ž406. 203. Neuroactive steroid CO-induced amnesia; Pregnenolone; Dehydroepiandrosterone; Learning; Memory; ŽMouse. ŽMaurice, T. Ž390. 145. Neuroblastoma Nitric oxide ŽNO.; Hydrogen peroxide; Apoptosis; PC12; NO donor; Annexin V ŽTerwel, D. Ž400. 19. Neurocognitive impairment Schizophrenia; Bipolar disorder; Depression; Memory; Synaptic plasticity; Ventricle enlargement ŽVawter, M.P. Ž405. 385. Neurodegenerative disease Amyotrophic lateral sclerosis ŽALS.; Motor neuron; Apoptosis; Cell culture; Tissue culture ŽBar, ¨ P.R. Ž405. 285. Neuroendocrine Cocaine; Corticosterone; Hypothalamo pituitary–adrenal axis; Self-administration; Stress ŽGalici, R. Ž387. 59. Neurofilament Nicotine; NF-68; NF-160; NF-200; Ventral tegmental area; Immunohistochemistry ŽBunnemann, B. Ž393. 249. Neurogenic Bradykinin; Inflammation; Phorbol ester; Protein kinase C; Triterpenoid ŽHuguet, A.-I. Ž410. 69. Neurogenic inflammation Diabetic rat; Somatostatin; Inflammatory preconditioning ŽNemeth, J. ´ Ž386. 83. Eletriptan; Sumatriptan; Carotid artery blood flow; Femoral artery blood flow; Coronary artery diameter ŽGupta, P. Ž398. 73.

Neonate Cardiac myocyte; Ca2q current, L-type; Adenosine; ATP; Purinoceptor ŽSuto, F. Ž409. 213.

Staphylococcal enterotoxin B; Kinin; Mast cell; Tachykinin NK 1 receptor; Vanilloid receptor ŽLinardi, A. Ž399. 235.

Neostriatum 6-Hydroxydopamine; Ligand binding autoradiography; Substantia nigra ŽVasiliadis, H.-M. Ž386. 155.

Neurogenic plasma extravasation Phoneutria nigriÕenter venom; Sensory nerve; Tachykinin NK 1 receptor agonist; Vanilloid receptor; Purinoceptor ŽCosta, S.K.P. Ž391. 305.

Nepadutant Tachykinin receptor; Tachykinin receptor antagonist; Intestine, human; Urinary bladder, human ŽPatacchini, R. Ž398. 389.

Neuroinflammation Forebrain basal; Acetylcholine; Caspase; Non-steroidal anti-inflammatory drug; ŽRat. ŽWenk, G.L. Ž402. 77.

90

Master keyword index to Õolumes 386–410 (2000)

Neurokinin-A Vagus nerve; C-fiber; Cholinergic nerve; Acetylcholine ŽMatsumoto, K. Ž403. 157.

Neuron, human Nicotinic receptor; Gene; Transcriptional regulation; Promoter ŽFlora, A. Ž393. 85.

Neuroleptic Antipsychotic; 5-HT Ž5-hydroxytryptamine., serotonin; 5-HT2C receptor; mCPP-Ž3-chlorophenyl.piperazine; Behavior; Hypolocomotion; Hypophagia; Locomotor activity; Food intake ŽPrinssen, E.P.M. Ž388. 57.

Neuropathic pain Amitriptyline; Caffeine; Thermal hyperalgesia ŽEsser, M.J. Ž399. 131.

Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2 -like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. s Receptor; Haloperidol; Dystonia; Extrapyramidal ŽMatsumoto, R.R. Ž401. 155. Neuromediator Airway; Prostaglandin; Leukotriene; Endothelin; ŽMouse. ŽRichter, M. Ž389. 225. Neuromedin B receptor antagonist, nonpeptide Ca2q, cytosolic; c-fos mRNA; Focal adhesion kinase; Proliferation ŽMoody, T.W. Ž409. 133. Neuromodulation 5-HT3 receptor; Zn2q; Cation, Divalent; Voltage-clamp, Whole-cell; Radioligand binding ŽHubbard, P.C. Ž394. 189. Vasopressin; Norepinephrine; Associative memory mechanism; Hippocampus ŽBrinton, R.D. Ž405. 73. Neuromuscular junction Alzheimer’s disease; Cholinergic; Exocytosis; Oocyte; Synaptic vesicle; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7. Ca2q channel blocker; Thapsigargin; Stimulus pattern; Acetylcholine release ŽCorreia-de-Sa, ´ P. Ž406. 355. Neuromuscular transmission Endothelin; Prostate; Endothelin ETA receptor; ŽRat. ŽSalamoussa, A. Ž403. 139. Neuron Nicotinic receptor; Transcription; Enhancer; Promoter ŽDeneris, E.S. Ž393. 69. Acetylcholine receptor; Property; Ligand binding domain; Pharmacological; Physiological ŽCurtis, L. Ž393. 155. Cannabinoid; Capsaicin; Afferent; Pain; Receptor; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39.

Neuropathy Nerve conduction; Blood flow; Kq channel opener; Naq, Kq ATPase; Oxidative stress; Glutathione; Diabetic rat ŽHohman, T.C. Ž397. 335. Colorectal cancer; Dorsal root ganglia; Hippocampal neuron; Sural nerve ŽAdelsberger, H. Ž406. 25. Neuropeptide Galanin; Galanin-Ž1–15.; Galanin receptor; Galanin receptor antagonist; Cardiovascular; Brain ŽNarvaez, ´ J.A. Ž399. 197. Intranasal administration; Vasopressin; Insulin; Melanocortin; Cognition ŽFehm, H.L. Ž405. 43. Vasopressin; Corticotropin-releasing hormone; Dopamine; Homeobox gene; Transcription factors; Development ŽBurbach, J.P.H. Ž405. 55. Asthma; NANC Žnon-adrenergic–non-cholinergic. nerve, excitatory; Animal model; ŽHuman. ŽKraneveld, A.D. Ž405. 113. Stressful stimuli; c-fos; Paraventricular nucleus; Supraoptic nucleus; Amygdaloid nucleus, central ŽPalkovits, M. Ž405. 161. Antidepressant; Mechanism of action; Monoamine; Intracellular signaling; Transcription factor ŽVetulani, J. Ž405. 351. Neuropeptide FF Morphine; Adenosine; Spinal cord; Antinociception ŽGouarderes, ` C. Ž406. 391. Analgesia; Antinociception; Pain; Spinal cord; Supraspinal ŽAltier, N. Ž407. 245. Neuropeptide-Y Stress; Depression ŽStogner, K.A. Ž387. R9. Neuropeptide Y Neuropeptide Y receptor; Neuropeptide Y y6 receptor; Orexigenesis; 1229U91 ŽMullins, D.E. Ž395. 87. a-MSH Ž a-melanocyte stimulating hormone.; Feeding; ŽChick. ŽKawakami, S.-i. Ž398. 361. BIIE0246; Neuropeptide Y Y2 receptor; Hippocampus ŽWeiser, T. Ž404. 133.

Neuronal Nicotinic receptor; Acetylcholine receptor; a-Bungarotoxin; Ciliary ganglion; Sciatic nerve ŽRoth, A.L. Ž393. 105.

Neuropeptide Y-(13-36) Hypothalamus; ŽRat. ŽKing, P.J. Ž396. R1.

Neuronal death delayed Erythropoietin; Cerebral ischemia; Brain injury; Nitric oxide ŽNO. ŽCalapai, G. Ž401. 349.

Neuropeptide Y receptor Neuropeptide Y y6 receptor; Neuropeptide Y; Orexigenesis; 1229U91 ŽMullins, D.E. Ž395. 87.

Neuronal nicotinic receptor Conotoxin; Acetylcholine receptor; Chromaffin cell; Nicotinic receptor antagonist; Catecholamine release ŽBroxton, N. Ž390. 229.

Neuropeptide Y y6 receptor Neuropeptide Y receptor; Neuropeptide Y; Orexigenesis; 1229U91 ŽMullins, D.E. Ž395. 87.

Nicotinic receptor distribution; Nicotine; Nicotinic agent; Schizophrenia; Dementia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3.

Neuropeptide Y Y2 receptor BIIE0246; Neuropeptide Y; Hippocampus ŽWeiser, T. Ž404. 133.

Master keyword index to Õolumes 386–410 (2000) Neuroprotection Glutamate transporter; Glutamate uptake; Naq current ŽShimada, F. Ž386. 263. NMDA receptor; Phencyclidine receptor; Gacyclidine; Gacyclidine enantiomer ŽHirbec, H. Ž388. 235. LY341122; Cerebral ischemia, focal; Stroke; Oxygen radical; ŽRat. ŽHuh, P.W. Ž389. 79. 7-Chlorokynurenate; Excitotoxicity; Glycine B receptor ŽWu, H.-Q. Ž390. 267. Nicotinic receptor; Parkinson’s disease; MPTP Ž1-methyl-4-phenyl1,2,3,6-tetrahydropteridine.; Hybridization, in situ; ŽMonkey. ŽQuik, M. Ž393. 223. Clomethiazole; Chlormethiazole; Spreading depression; Hippocampus; Hypoxia ŽStone, T.W. Ž399. 29. Chemokine; N-methyl-D-aspartate ŽNMDA.; b-amyloid; Cortical culture ŽBruno, V. Ž399. 117. NAALADase inhibition Ž N-acetylated-a-linked-acidic dipeptidase.; Stroke; ŽRat. ŽTortella, F.C. Ž402. 31. Neonatal; ACTH Žadrenocorticotropin.; Magnocellular basal nucleus; Cholinergic neuron; Glia ŽHorvath, K.M. Ž405. 33.

91

Glutamate; s Receptor; Phencyclidine site; Cortical culture ŽNishikawa, H. Ž404. 41. Antiepileptic drug; Neuroprotection; Apoptosis ŽAmbrosio, A.F. Ž406. ´ 191. Neurotoxin Nicotinic acetylcholine receptor; a-Cobratoxin ŽServent, D. Ž393. 197. Neurotransmission Personality; Genes; Polymorphism; Temperament; Abnormal behavior ŽEbstein, R.P. Ž410. 205. Neurotransmitter Corticosterone; Vasopressin; Firing pattern; Ion channel ŽJoels, ¨ M. Ž405. 207. Smoking; Genetic polymorphism; Association; Linkage ŽArinami, T. Ž410. 215. Neutral endopeptidase Enkephalinase; Enkephalin; Knockout mouse; Alcohol consumption; Angiotensin-converting enzyme; Enkephalin-degrading peptidases; Opioid ŽSiems, W.-E. Ž397. 327. Bradykinin; Bradykinin B 2 receptor; Carboxypeptidase; Angiotensin I converting enzyme; Aminopeptidase P; Renal vasculature, rat ŽBagate, ´ K. Ž407. 317.

Antiepileptic drug; Neurotoxicity; Apoptosis ŽAmbrosio, A.F. Ž406. 191. ´

Neutrophil b 2-Adrenoceptor; Gs protein, coupling; Depression, major; Anxiety; Antidepressant, tricyclic ŽGurguis, G.N.M. Ž386. 135.

8-OH-DPAT; 5-HT1A receptor; Naq channel; Ca2q channel; Ischemia ŽMelena, J. Ž406. 319.

Nicotinic receptor; Schizophrenia; Nicotine; Smoking; Gene duplication ŽLeonard, S. Ž393. 237.

Cerebral ischaemia; Ca2q channel, neuronal ŽHicks, C.A. Ž408. 241.

Ditriazines; Nitric oxide ŽNO.; Eicosanoid; Macrophage; Air pouch, mouse; Carrageenan paw oedema ŽRioja, I. Ž397. 207.

Neurosteroid Development; P19 cell ŽGrobin, A.C. Ž409. R1. Neurotensin Conopeptide; Conantokin G; Dynorphin; Methamphetamine; NMDA receptor ŽBush, L. Ž387. 55. Substance P; Dopamine; Ibogaine; Cocaine; Methamphetamine; Drug abuse ŽAlburges, M.E. Ž390. 119. SR 48692; Neurotensin receptor; Cly current; Dorsal root ganglion ŽKawarada, S. Ž404. 69. Neurotensin receptor Neurotensin; SR 48692; Cly current; Dorsal root ganglion ŽKawarada, S. Ž404. 69. Neurotoxicity Methamphetamine; 3-Nitropropionic acid; Dopamine; 5-HT, 5-Hydroxytryptamine; Aromatic L-amino acid decarboxylase; Motor behaviour ŽEradiri, O.L. Ž386. 217. Dizocilpine ŽŽq.-MK-801.; NMDA receptor antagonist; Retrosplenial cortex; Clozapine; Olanzapine; Immediate early gene ŽFujimura, M. Ž398. 1. Cytochrome oxidase; Amphetamine; Histochemistry; Energy metabolism ŽBurrows, K.B. Ž398. 11.

Ozone; Haemoxygenase; Carbon monoxide ŽCO.; Bronchial hyperresponsiveness ŽHisada, T. Ž399. 229. Ischemia–reperfusion; Oedema; Mesenteric artery; Inflammation ŽSouza, D.G. Ž403. 121. Caspase; Apoptosis inhibitory protein; Transcription factor; NF-kB Žnuclear factor-kB.; TNF-a Žtumor necrosis factor-a . ŽNiwa, M. Ž407. 211. Neutrophil adherence AMP579; Coronary artery endothelium; Neutrophil degranulation; Superoxide anion ŽNakamura, M. Ž397. 197. Neutrophil chemotaxis FK506 ŽTacrolimus.; Interleukin-8; Mononuclear cell peripheral blood ŽSasakawa, Y. Ž403. 281. Neutrophil degranulation AMP579; Coronary artery endothelium; Neutrophil adherence; Superoxide anion ŽNakamura, M. Ž397. 197. Neutrophil elastase Hyperoxia; Lecithinized superoxide dismutase; ONO-5046; Lung injury ŽYamamoto, H. Ž409. 179. Neutrophil elastase inhibitor Ozone-exposure; Mucus score; Goblet cell hypersecretion ŽNogami, H. Ž390. 197.

Master keyword index to Õolumes 386–410 (2000)

92

Neutrophil granulocytes Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193.

N-g-nitro-L-argine methyl ester Nitric oxide ŽNO.; Hypoxic pulmonary vasoconstriction; Pulmonary arterial tone; L-NAME; Prostaglandin F2 a ŽJones, R.D. Ž402. 111.

Neutrophils, rat p38 Mitogen-activated protein kinase; Tyrosine kinase; Protein kinase C; Phospholipase C; Ca2q, cytosolic-free ŽChang, L.-C. Ž390. 61.

N v-nitro-L-arginine Hyperpolarization; Nitric oxide ŽNO .; Prostanoid; ODQ Ž1 Hw1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Carotid artery; Femoral artery ŽCrauwels, H.M. Ž404. 341.

NF-68 Nicotine; Neurofilament; NF-160; NF-200; Ventral tegmental area; Immunohistochemistry ŽBunnemann, B. Ž393. 249.

N v-nitro-L-arginine methyl ester Heart lesion; Ventricular hypertrophy; Stereology ŽDe Oliveira, C.F. Ž391. 121.

NF-160 Nicotine; Neurofilament; NF-68; NF-200; Ventral tegmental area; Immunohistochemistry ŽBunnemann, B. Ž393. 249.

Nitric oxide ŽNO.; Mesenteric bed; Depolarization; KCl; Nitric oxide ŽNO. synthase ŽMendizabal, V.E. Ž409. 85.

NF-200 Nicotine; Neurofilament; NF-68; NF-160; Ventral tegmental area; Immunohistochemistry ŽBunnemann, B. Ž393. 249. X

NF279 (8,8 -(carbonylbis(imino-4,1-phenylenecarbonylimino-4,1phenylenecarbonylimino))bis(1,3,5-naphthalenetrisulfonic acid)) ATP receptor; Oocyte; Antagonist; Voltage clamp; Whole cell ŽKlapperstuck, ¨ M. Ž387. 245. NF-k B (nuclear factor kappa B) Hyperalgesia; Complete Freund adjuvant; AP-1 Žactivator protein-1.; Octamer factor; NO Žnitric oxide. synthase, neuronal ŽChan, C.-F. Ž402. 61. NF-k B (nuclear factor-k B) Cerebral endothelial cell; Dithiocarbamate; Zn2q; ŽBovine. ŽKim, C.H. Ž392. 133. Inflammation; Nitric oxide ŽNO.; Inducible NO synthase; b-Carboline alkaloid ŽLee, B.G. Ž406. 301. Neutrophil; Caspase; Apoptosis inhibitory protein; Transcription factor; TNF-a Žtumor necrosis factor-a . ŽNiwa, M. Ž407. 211. NF-kB (nuclear factor-kB) gene transcription factor SP1 Žstimulatory protein-1. gene transcription factor; Brain; Ethanol tolerance; Ethanol dependence ŽMittal, N. Ž386. 113. NG108-15 cell Clonidine-displacing substance; Reverse phase HPLC; Imidazoline binding site ŽParker, C.A. Ž387. 27. Rabies virus; Ca2q current; a-Adrenoceptor; Muscarinic receptor; Patch clamp, Whole-cell ŽIwata, M. Ž404. 79. NGF (nerve growth factor) Ca2q reperfusion; T-588; PD98059; MAP Žmitogen-activated protein. kinase; Astrocyte ŽTakuma, K. Ž399. 1. Dopamine receptor; Acetylcholine; Cognition; Extrapyramidal symptom ŽOzaki, T. Ž402. 39. Picroside I; Picroside II; Neurite outgrowth activity; Mitogen-activated protein ŽMAP. kinase; PC 12D cell ŽLi, P. Ž406. 203.

Nicorandil Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; ATPsensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79. Nicotine Stress; Dopamine; Striatum; Hippocampus; ŽRat. ŽPawlak, R. Ž387. 171. Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotinic agent; Schizophrenia; Dementia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Nicotinic acetylcholine receptor ŽKuryatov, A. Ž393. 11. Activation; Cholinergic; Tobacco; Addiction; Ventral tegmental area ŽDani, J.A. Ž393. 31. Nicotinic receptor, presynaptic; Glutamate receptor antagonist; Anatoxina; Immunogold electron microscopy; Synaptosome ŽWonnacott, S. Ž393. 51. Attention; Learning; Memory ŽLevin, E.D. Ž393. 141. Mecamylamine; Cognition; Attention ŽStolerman, I.P. Ž393. 147. 5-HT1A receptor; Anxiety; Phobia; Septum, lateral; Hippocampus, dorsal ŽFile, S.E. Ž393. 231. Nicotinic receptor; Schizophrenia; Smoking; Gene duplication; Neutrophil ŽLeonard, S. Ž393. 237. Neurofilament; NF-68; NF-160; NF-200; Ventral tegmental area; Immunohistochemistry ŽBunnemann, B. Ž393. 249. Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Tangle; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨ a 7 Nicotinic receptor; Nicotine-derived nitrosamine; Small cell lung carcinoma; Pulmonary neuroendocrine cell; Mitogenic signal transduction ŽSchuller, H.M. Ž393. 265.

CV-2619; Astrocyte; Apoptosis ŽTakuma, K. Ž406. 333. NG108-15 neuroblastoma CREB ŽcAMP responsive element binding protein.; d-Opioid receptor; DPDPE ŽwD-Pen2,5 xenkephalin., Morphine; Protein kinase ŽBilecki, W. Ž390. 1.

Nicotinic receptor, Non-neuronal; Lung; Blood vessel; Skin ŽConti-Fine, B.M. Ž393. 279. Addiction; Dependence; Dopamine; Nucleus accumbens; Prefrontal cortex ŽDi Chiara, G. Ž393. 295.

Master keyword index to Õolumes 386–410 (2000)

93

Blood pressure; Endothelin receptor antagonist; Thromboxane; ŽRat. ŽTanus-Santos, J.E. Ž396. 33.

Nicotinic receptor subunit; Bladder; Autonomic dysfunction; Knockout mice ŽDe Biasi, M. Ž393. 137.

Coeliac ganglion; Noradrenaline release; Stomach, rat; Nicotinic receptor ŽYokotani, K. Ž402. 223.

Allosteric modulation; Alzheimer’s disease; Galanthamine; Cholinergic deficit ŽMaelicke, A. Ž393. 165.

Self-administration; Catecholamine; Epinephrine; Norepinephrine; Corticosterone; Yoking ŽDonny, E.C. Ž402. 231.

Molecular model; Epibatidine; ABT-594; A-85380; Analgesia; Antinociception ŽMeyer, M.D. Ž393. 171.

Antinociception; CaM kinase II; Ca2q channels; Intrathecal; ŽMice. ŽDamaj, M.I. Ž404. 103.

Neurotoxin; a-Cobratoxin ŽServent, D. Ž393. 197.

Pre-pulse inhibition; Schizophrenia; Information processing; ŽRat. ŽMirza, N.R. Ž407. 73.

Acetylcholine; Choline; Agonist; Partial; Co-agonist; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209.

Anxiety; Elevated plus-maze; a-Adrenoceptor; ŽMouse. ŽZarrindast, M.R. Ž407. 145.

Parkinson’s disease; MPTP Ž1-methyl-4-phenyl-1,2,3,6-tetrahydropteridine.; Hybridization, in situ; Neuroprotection; ŽMonkey. ŽQuik, M. Ž393. 223.

Dopamine; Ethanol; Microdialysis; Nucleus accumben; Selected line ŽKiianmaa, K. Ž407. 293.

Schizophrenia; Nicotine; Smoking; Gene duplication; Neutrophil ŽLeonard, S. Ž393. 237.

Tail tremor; 5-HT1A receptor; ŽRat. ŽSuemaru, K. Ž408. 19.

Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Tangle; Nicotine; Muscarinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨

Nicotine-derived nitrosamine a 7 Nicotinic receptor; Nicotine; Small cell lung carcinoma; Pulmonary neuroendocrine cell; Mitogenic signal transduction ŽSchuller, H.M. Ž393. 265. Nicotine sensitization Nucleus accumben, Shell; Nucleus accumben, Core ŽCadoni, C. Ž387. R23. Nicotinic agent Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Schizophrenia; Dementia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Nicotinic receptor Photoaffinity labeling; Antagonist, noncompetitive; Antagonist, competitive; 5-HT Ž5-hydroxytryptamine, serotonin. ŽBlanton, M.P. Ž389. 155. 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT3 receptor; glycine receptor; GABA A ; Bicuculline ŽSun, H. Ž391. 243. Nicotine ŽKuryatov, A. Ž393. 11. Epibatidine; Somatodendritic; Substantia nigra; Ventral tegmental area; Dendrosome ŽReuben, M. Ž393. 39. Hippocampus; Choline; Interneuron; Excitation; Methyllycaconitine; GABA Ž g-aminobutyric acid. ŽAlkondon, M. Ž393. 59. Transcription; Enhancer; Promoter; Neuron ŽDeneris, E.S. Ž393. 69. Neuron, human; Gene; Transcriptional regulation; Promoter ŽFlora, A. Ž393. 85. Acetylcholine receptor; a-Bungarotoxin; Ciliary ganglion; Sciatic nerve; Neuronal ŽRoth, A.L. Ž393. 105.

Patch-clamp; Anthelmintic resistance; Parasitic nematode ŽRobertson, A.P. Ž394. 1. Sensitization; Disinhibition; Locomotor activity; Plus-maze; ŽRat. ŽEricson, M. Ž397. 103. Coeliac ganglion; Nicotine; Noradrenaline release; Stomach, rat ŽYokotani, K. Ž402. 223. TC-2559; Cognition; Central nervous system ŽBencherif, M. Ž409. 45. a 7 Nicotinic receptor Nicotine; Nicotine-derived nitrosamine; Small cell lung carcinoma; Pulmonary neuroendocrine cell; Mitogenic signal transduction ŽSchuller, H.M. Ž393. 265. Nicotinic receptor antagonist Conotoxin; Neuronal nicotinic receptor; Acetylcholine receptor; Chromaffin cell; Catecholamine release ŽBroxton, N. Ž390. 229. Nicotinic receptor distribution Neuronal nicotinic receptor; Nicotine; Nicotinic agent; Schizophrenia; Dementia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Nicotinic receptor, human a-Conotoxin MII; Conus; b3 subunit ŽMcIntosh, J.M. Ž393. 205. Nicotinic receptor, Non-neuronal Nicotine; Lung; Blood vessel; Skin ŽConti-Fine, B.M. Ž393. 279. Nicotinic receptor, presynaptic Glutamate receptor antagonist; Nicotine; Anatoxin-a; Immunogold electron microscopy; Synaptosome ŽWonnacott, S. Ž393. 51. Nicotinic receptor subtype Epibatidine; a-Bungarotoxin ŽVailati, S. Ž393. 23.

ŽMarubio, L.M. Ž393. 113. Pharmacological comparison; Subunit null mutation; Binding; Activation ŽWhiteaker, P. Ž393. 123.

Nicotinic receptor subunit Nicotinic receptor; Bladder; Autonomic dysfunction; Knockout mice ŽDe Biasi, M. Ž393. 137.

94

Master keyword index to Õolumes 386–410 (2000)

Nifedipine Apoptosis; Ca2q; Cardiomyocyte ŽRabkin, S.W. Ž388. 209.

Carbon monoxide ŽCO.; Hydrogen peroxide; Corpus cavernosa; Urethra relaxation ŽNaseem, K.M. Ž387. 329.

Ventricular myocyte, guinea-pig; Kq current, inward-rectifier; Kq current, delayed-rectifier ŽZhabyeyev, P. Ž401. 137.

Escin Ib; Escin IIb; Mg 2q absorption ŽLi, Y. Ž387. 337.

Niflumic acid Trachea; Cly channel; ICl ŽCa. ŽTeixeira, M.C.L. Ž394. 117. Nigella satiza oil Thymoquinone; Antinociception; Opioid system; Formalin test ŽAbdelFattah, A.-F.M. Ž400. 89. NIK-247 Donepezil hydrochloride ŽE2020.; Tacrine; Physostigmine; ENA-713; TAK-147; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173. ( N-iminoethyl-L-lysine) Nitrate; Atherosclerosis; Nitric oxide ŽNO. synthase; Nitric oxide ŽNO.; ŽRabbit. ŽBehr-Roussel, D. Ž388. 275.

L-NIL

Nimesulide Kainate; Excitotoxicity; Cyclooxygenase-2; Oxidative stress; Hippocampus ŽCandelario-Jalil, E. Ž390. 295. Cyclo-oxygenase inhibitor; Conditioned place preference; Abuse liability ŽFattore, L. Ž406. 75. Nimodipine Generalized absence epilepsy; Ca2q channel; WAGrRij rat; Spike-wave discharge; BAY K8644; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381. Nitrate Atherosclerosis; Nitric oxide ŽNO. synthase; Nitric oxide ŽNO.; L-NIL Ž N-iminoethyl-L-lysine.; ŽRabbit. ŽBehr-Roussel, D. Ž388. 275. Nitrergic Anococcygeus, mouse; Forskolin; Nitric oxide ŽNO.; Papaverine; Sildenafil; Sodium nitroprusside ŽFrith, D. Ž400. 305. Nitrergic nerve Urethra; Nitric oxide ŽNO.; Adrenoceptor; ŽRabbit. ŽSeshita, H. Ž400. 271. Nitrergic relaxation Neocuproine; Bathocuproine; Corpus cavernosum; S-Nitrosoglutathione; Non-adrenergic non-cholinergic ŽNANC. nerve ŽGoc ¨ ¸men, C. Ž406. 293. Nitric oxidase (NO) synthase Iodonium; NADPH oxidase; Xanthine oxidase; NADH–ubiquinone reductase ŽMoulton, P. Ž401. 115.

cGMP-dependent protein kinase; Naq,Kq-ATPase; Aging; Trachea, rat ŽScavone, C. Ž388. 1. NANC Žnonadrenergic, noncholinergic. relaxation; Strain difference; Colon, distal; VIP Žvasoactive intestinal peptide. ŽOkishio, Y. Ž388. 97. Nociceptin; ORL1 receptor; Colon, mouse, isolated ŽMenzies, J.R.W. Ž388. 183. Nitrate; Atherosclerosis; Nitric oxide ŽNO. synthase; oethyl-L-lysine.; ŽRabbit. ŽBehr-Roussel, D. Ž388. 275.

L-NIL

Ž N-imin-

Inflammation, intestinal; Non-steroid anti-inflammatory drug ŽEvans, S.M. Ž388. 281. Brain; Cerebral ischemia; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-L-arginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Carrageenan; Inflammation; Peroxynitrite; Superoxide dismutase; Tempol ŽCuzzocrea, S. Ž390. 209. Chloromethyl ketone; Stroke; Focal ischemia; Apoptosis; Serine protease inhibitor ŽLeBlanc, M.H. Ž390. 249. Harman; Vasorelaxant; Endothelium ŽShi, C.-C. Ž390. 319. Renal failure; Gentamicin; L-arginine; methyl ester.; ŽRat. ŽCan, C. Ž390. 327.

L-NAME

Ž N v -nitro-L-arginine

Crotalus durissus terrificus venom; Analgesia; Opioid receptor ŽPicolo, G. Ž391. 55. Angiogenesis; S-nitrosocaptopril; Captopril; Capillary endothelium; Chorioallantoic membrane; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137. Stromal cell; Osteoblast-like cell; Mineralization; Differentiation ŽKoyama, A. Ž391. 225. Thapsigargin; Endothelium; Kq channel; Relaxation; Aorta; ŽRat. ŽHuang, Y. Ž392. 51. Stroke-prone spontaneously hypertensive rats ŽSHRSP.; Pulmonary artery; a-Adrenoceptors; Endothelium ŽMatsuda, K. Ž392. 61. Protein kinase, cGMP-dependent; N-methyl-D-aspartate ŽNMDA.; Nociception; Spinal cord; Hyperalgesia; Pain ŽTao, Y.-X. Ž392. 141.

Nitric oxide (NO) Flavonoid; Dioclein; Endothelium; Vasorelaxation; Aorta ŽLemos, V.S. Ž386. 41.

Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Endothelium-independent relaxation; Superoxide; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163.

Polygodial; Relaxation; Aorta, rabbit; Pulmonary artery, rabbit; Pulmonary artery, guinea-pig ŽAndre, ´ E. Ž386. 47.

´ Ž392. R5. Gastric mucus; Estrogen ŽMorschl, E.

Lipopolysaccharide; Angiotensin II type 2 receptor; Cytokine; Cyclic GMP; Cardiac fibroblast ŽTamura, M. Ž386. 289.

¨ Experimental diabetes; Cholinergic neurotransmission ŽOzdem, S.S. Ž387. 321.

Nitric oxide-releasing compound; Adhesion; E-Selectin; ICAM-1; Lipopolysaccharide ŽKosonen, O. Ž394. 149. Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275.

Master keyword index to Õolumes 386–410 (2000)

95

Insulin resistance; Superoxide; Isometric tension study ŽShinozaki, K. Ž394. 295.

Adrenomedullin; Inflammation; Eye; CGRP Žcalcitonin gene-related peptide. ŽClementi, G. Ž400. 321.

Meloxicam; cGMP; N G -L-nitro-arginine methyl ester ŽL-NAME.; ODQ Ž1 H-Ž1,2,4.-oxadiazoloŽ4,2-a.quinoxalin-1-one. ŽAguirre-Banuelos, P. ˜ Ž395. 9.

Tachykinin NK 1 receptor; Substance P; Inflammation; Hypertension genetic; GH Žgenetically hypertensive. rat ŽCampbell, V.A. Ž401. 109.

Lipopolysacharide; Melatonin; Dexamethasone; Naltrexone; TNF-a Žtumor neocrisis factor-a .; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15. PACAP Žpituitary adenylate cyclase activating peptide.; VIP Žvasoactive intestinal peptide.; Nonadrenergic noncholinergic ŽNANC. relaxation, inhibitory; Smooth muscle, tracheal; ŽCat. ŽYoshida, M. Ž395. 77. Hypersensitivity; Ovalbumin; Endothelial reactivity; Pulmonary artery ŽAkar, F. Ž395. 225. Apoptosis; NOR3; Nitric oxide ŽNO. donor; DAF-2 Ž4,5-diaminofluorescein.; Ascorbic acid ŽYamamoto, T. Ž397. 25. Aspirin; Dipyridamole; Platelet; Polymorphonuclear leukocyte ŽDe La Cruz, J.P. Ž397. 35. Endothelial factor; Hemostasis; Platelet; Thrombosis ŽMomi, S. Ž397. 177. Ditriazines; Eicosanoid; Macrophage; Neutrophil; Air pouch, mouse; Carrageenan paw oedema ŽRioja, I. Ž397. 207. VIP Žvasoactive intestinal polypeptide.; Gastric fundus, Pig ŽDick, J.M.C. Ž397. 389. Streptozotocin-induced diabetic mouse; Corpus cavernosum; Antioxidant; Vitamin E; Sodium selenate; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93. b-Adrenoceptor; b-Adrenoceptor, atypical; Endothelium; Guanylyl cyclase; Smooth muscle, vascular ŽBrawley, L. Ž398. 285. Hyperosmolarity; Prostaglandin; Vasoactive intestinal peptide ŽVIP.; Tracheal perfusion; ŽGuinea-pig. ŽHjoberg, J. Ž398. 303. b 2 -Adrenoceptor agonist; Smooth muscle; cGMP; cAMP; Iberiotoxin ŽVaali, K. Ž399. 75.

Cannabinoid CB 2 receptor; WIN55212; Palmitoylethanolamide; RAW264.7; Macrophage; cAMP ŽRoss, R.A. Ž401. 121. Hypocapnic constriction; Endothelin-1; Basilar artery ŽZuccarello, M. Ž401. 213. Urinary bladder; Urethra; cGMP; Smooth muscle ŽFujiwara, M. Ž401. 241. Lead; Hepatocyte, rat; Lipopolysaccharide; Kupffer cell; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317. Erythropoietin; Cerebral ischemia; Brain injury; Neuronal death delayed ŽCalapai, G. Ž401. 349. Endothelium; Diabetes; 5-HT Ž5-Hydroxytryptamine, serotonin.; Carotid artery ŽMiranda, F.J. Ž401. 397. Oxidant stress; Endothelium; Insulin resistance; Obese Zucker rat ŽLaight, D.W. Ž402. 95. Hypoxic pulmonary vasoconstriction; Pulmonary arterial tone; L-NAME; N-g-nitro-L-argine methyl ester; Prostaglandin F2 a ŽJones, R.D. Ž402. 111. Acetylcholine; Airway epithelium; Smooth muscle, airway; Indomethacin; Airway segment ŽMcParland, B.E. Ž402. 151. Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193. 8-OH-DPAT Ž8-hydroxy-2-di-n-Žpropylamino.tetralin.; Food intake; 5-HT Ž5-hydroxytryptamine, serotonin.; N G -nitro-L-arginine methyl ester ŽLNAME.; Hypothalamus ŽYamada, J. Ž402. 247. S-Nitrosothiol; Organic nitrate; Tolerance; Blood vessel ŽMiller, M.R. Ž403. 111.

Diabetes; Aminoguanidine; Morphine; Antinociception ŽGrover, V.S. Ž399. 161.

Endothelium; Diabetes mellitus; Angiotensin ŽPieper, G.M. Ž403. 129.

Berberine; Kq channel; Ca2q channel; Vasorelaxation; Proliferation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187.

Penile erection; Hexarelin; EP 60761; EP 50885; Oxytocin; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137.

Hydrogen peroxide; Apoptosis; Neuroblastoma; PC12; NO donor; Annexin V ŽTerwel, D. Ž400. 19.

Hyperpolarization; Prostanoid; N v -nitro-L-arginine; ODQ Ž1 Hw1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Carotid artery; Femoral artery ŽCrauwels, H.M. Ž404. 341.

Phenylethanoid; Macrophage; Nitric oxide ŽNO. synthase; Inducible; 1-propanamine-3-hydroxy-2-nitroso-1-propylhydrazino ŽPAPA NONOate. ŽXiong, Q. Ž400. 137. Flow; Oxidative stress; Ischemia-reperfusion; Vascular ŽWalia, M. Ž400. 249.

FITC-dextran; Arteriole; Permeability; Platelet-activating factor ŽPAF.; Nitric oxide synthase ŽNOS. inhibitor; Microcirculation ŽKlabunde, R.E. Ž404. 387.

Urethra; Adrenoceptor; Nitrergic nerve; ŽRabbit. ŽSeshita, H. Ž400. 271.

Angiotensin-converting enzyme; Angiotensin-converting enzyme inhibitor; Endothelial cells, cultured; Umbilical veins, human; Platelet aggregation ŽPersson, K. Ž406. 15.

Nitric oxide ŽNO. synthases; Vanadium; Growth; Osteoblast differentiation; Bone; Cytotoxicity ŽCortizo, A.M. Ž400. 279.

Dinitrobenzene sulfonic acid; Inflammation; Peroxynitrite; Poly ŽADPribose. synthetase; Colon damage; Free radical ŽCuzzocrea, S. Ž406. 127.

Anococcygeus, mouse; Forskolin; Nitrergic; Papaverine; Sildenafil; Sodium nitroprusside ŽFrith, D. Ž400. 305.

Ventricular cardiomyocyte, rat; Contractile function; Ca2q channel, Ltype; Myoglobin ŽVulcu, S.D. Ž406. 247.

Master keyword index to Õolumes 386–410 (2000)

96

Lipopolysaccharide; Vascular hyporeactivity; Ventricular myocyte; Ca2q transient; b-adrenergic stimulation ŽShan, Q. Ž406. 257. Inflammation; Inducible NO synthase; NF-kB Žnuclear factor-kB.; bCarboline alkaloid ŽLee, B.G. Ž406. 301. Diabetes; Ouabain; Naq,Kq-ATPase; Phenylephrine; Vascular reactivity; Streptozotocin; ŽRat. ŽDavel, A.P.C. Ž406. 419.

Brain; Cerebral ischemia; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Heat shock protein; Nitro-Larginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Transplantation; Inducible; Macrophage; Peroxynitrite ŽVos, I.H.C. Ž391. 31. Angiotensin AT2 receptor; Losartan; PD 123319; Kinin; Cyclo-oxygenase; Footshock ŽIsrael, A. Ž394. 103.

Guanylate cyclase; Ambroxol ŽSeverina, I.S. Ž407. 61. Nucleus tractus solitarii; Glutamate; Microdialysis ŽLin, H.-C. Ž407. 83. Tryptanthrin; Inducible NO synthase; Prostaglandin; Cyclooxygenase; Inflammation ŽIshihara, T. Ž407. 197. Immunosuppressant; Cyclosporine; a 1 -Adrenoceptor; C6 glioma cell ŽIkesue, H. Ž407. 221. S-Nitrosothiol; N-Methyl-D-aspartate receptor ŽTravis, M.D. Ž407. 309.

Phenylethanoid; Macrophage; Nitric oxide ŽNO.; Inducible; 1-propanamine-3-hydroxy-2-nitroso-1-propylhydrazino ŽPAPA NONOate. ŽXiong, Q. Ž400. 137. Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Nitric oxide ŽNO.; Mesenteric bed; N v -nitro-L-arginine methyl ester; Depolarization; KCl ŽMendizabal, V.E. Ž409. 85.

Endotoxic shock; Aminoguanidine; ŽRat. ŽErol, A. Ž408. 175. L-S-Nitrosocysteine;

Redox; Vasodilation; ŽRat. ŽHoque, A. Ž408. 195.

NMDA Ž N-methyl-D-aspartate.; Anxiety; Motor behavior; Ultrasonic vocalization; ŽRat. ŽPodhorna, J. Ž408. 265. S-Nitrosothiol; EDRF Žendothelium-derived relaxing factor.; Ca2q-channel, voltage-sensitive; Vasodilation ŽTravis, M.D. Ž408. 289. S-Nitrosothiol; Organic nitrate; Tolerance; Blood vessel ŽMiller, M.R. Ž408. 335. Phencyclidine; N G -nitro-L-arginine methyl ester; Behaviour; c-fos; ŽRat. ŽBujas-Bobanovic, M. Ž409. 57. v

Mesenteric bed; N -nitro-L-arginine methyl ester; Depolarization; KCl; Nitric oxide ŽNO. synthase ŽMendizabal, V.E. Ž409. 85. Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Tail-flick latency; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Histamine; Pre-eclampsia; Endothelium; ANP Žatrial natriuretic peptide.; ŽHuman. ŽSuzuki, Y. Ž410. 7. Endothelin; Noradrenaline; Smooth muscle, vascular ŽLui, A.H. Ž410. 25. Oestrogen receptor modulator; Oestrogen; Blood pressure; Vasopressin; Enzyme regulation ŽPavo, ´ ´ I. Ž410. 101. Nitric oxide (NO) donor Apoptosis; NOR3; Nitric oxide ŽNO.; DAF-2 Ž4,5-diaminofluorescein.; Ascorbic acid ŽYamamoto, T. Ž397. 25. Nitric oxide (NO) release Cynaropicrin; Anti-inflammatory effect; TNF-a Žtumor necrosis factor-a .; Lymphocyte proliferation; Immunosuppressive effect ŽCho, J.Y. Ž398. 399. Nitric oxide (NO) synthase Nitrate; Atherosclerosis; Nitric oxide ŽNO.; lysine.; ŽRabbit. ŽBehr-Roussel, D. Ž388. 275.

L-NIL

Ž N-iminoethyl-L-

Nitric oxide (NO) synthase, Constitutive Heparin; Intragastric administration; Gastric ulcer healing; Proliferation; Regeneration; Angiogenesis ŽLi, Y. Ž399. 205. Nitric oxide (NO) synthase, inducible Lead; Hepatocyte, rat; Lipopolysaccharide; Kupffer cell; Coculture; TNF-alpha Žtumor necrosis factor-a .; Nitric oxide ŽNO. ŽMilosevic, N. Ž401. 317. Nitric oxide (NO) synthases Nitric oxide ŽNO.; Vanadium; Growth; Osteoblast differentiation; Bone; Cytotoxicity ŽCortizo, A.M. Ž400. 279. Nitric oxide (NO)-releasing compound Nitric oxide ŽNO.; Adhesion; E-Selectin; ICAM-1; Lipopolysaccharide ŽKosonen, O. Ž394. 149. Nitric oxide (NO) synthase inhibition Myocardial infarct; Angiotensin II cardiac; Angiotensin AT1 receptor antagonist ŽVerhagen, A.M.G. Ž400. 239. Nitric oxide (NO) synthase inhibitor FITC-dextran; Arteriole; Permeability; Nitric oxide ŽNO.; Platelet-activating factor ŽPAF.; Microcirculation ŽKlabunde, R.E. Ž404. 387. Nitro-arginine Arginine; Glutamine; Endothelin; Endotoxin ŽMitchell, J.A. Ž389. 209. 7-Nitroindazole Nitric oxide ŽNO.; Epilepsy; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Nitro-L-arginine methyl ester Brain; Cerebral ischemia; Ischemic tolerance; Preconditioning; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; ŽRat. ŽPuisieux, F. Ž389. 71. 3-Nitropropionic acid Methamphetamine; Neurotoxicity; Dopamine; 5-HT, 5-Hydroxytryptamine; Aromatic L-amino acid decarboxylase; Motor behaviour ŽEradiri, O.L. Ž386. 217.

Master keyword index to Õolumes 386–410 (2000)

97

Mitochondrial toxin; Seizure; GABA Ž g-aminobutyric acid.; 4-Aminopyridine; Electroconvulsion ŽHaberek, G. Ž403. 229.

Analgesia; AMPA receptor; Morphine; Spinal cord; ŽRat. ŽNishiyama, T. Ž395. 203.

Nitrosoureas Glioma; PolyŽADP–ribose. polymerase; 3-Aminobenzamide ŽWinter, S. Ž398. 177.

Antinociception; Opioid; Dizocilpine ŽMK-801.; Metabotropic glutamate receptor; Ž S .-4CPG ŽŽ S .-4-carboxyphenylglycine. ŽSuzuki, T. Ž396. 23.

N-Methyl-D-aspartate receptor S-Nitrosothiol; Nitric oxide ŽTravis, M.D. Ž407. 309.

Receptor occupancy, in vivo; NR2B subunit; MK-801; Radioligand binding ŽMurray, F. Ž397. 263. Glutamate; Dopamine uptake; Parkinson’s disease ŽPage, G. Ž403. 75.

NMDA ( N-methyl-D-aspartate) s Receptor; Organotypic slice culture; Mesencephalon; Dopaminergic neuron ŽShimazu, S. Ž388. 139. Protein kinase, cGMP-dependent; Nitric oxide ŽNO.; Nociception; Spinal cord; Hyperalgesia; Pain ŽTao, Y.-X. Ž392. 141. Quinolinic acid; Kynurenine; Long-term potentiation; Hippocampus; NMDA receptor subunit ŽYoussef, F. Ž398. 349. Chemokine; b-amyloid; Cortical culture; Neuroprotection ŽBruno, V. Ž399. 117. Ethanol tolerance; Ethanol dependence; Withdrawal; ANP Žatrial natriuretic peptide.; Antiserum against atrial natriuretic peptide ŽKovacs, ´ G.L. Ž401. 343. c-fos; zif268; 6-Hydroxydopamine; L-3,4-dihydroxyphenylalanine ŽLDOPA.; Striatum ŽAdams, A.C. Ž404. 303. Nitric oxide ŽNO.; Anxiety; Motor behavior; Ultrasonic vocalization; ŽRat. ŽPodhorna, J. Ž408. 265. NMDA ( N-methyl-D-aspartate) seizure Alcohol withdrawal, human; Delirium tremens; Volume and fluid regulation; ANP Žatrial natriuretic peptide. secretion; Withdrawal hyperexcitability, mouse; Glutamate ŽKovacs, ´ G.L. Ž405. 103. NMDA receptor Cocaine; Convulsion; Toxicity; AMPA receptor; Kainate receptor ŽPouw, B. Ž386. 181. Aminoglycoside; Ototoxicity; Dizocilpine ŽHarvey, S.C. Ž387. 1. Conopeptide; Conantokin G; Neurotensin; Dynorphin; Methamphetamine ŽBush, L. Ž387. 55. Locus coeruleus; Noradrenaline; Cortex, prefrontal; Stress; GABA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279. Phencyclidine receptor; Gacyclidine; Gacyclidine enantiomer; Neuroprotection ŽHirbec, H. Ž388. 235. Antidepressant; Glycine; DSP-4; Norepinephrine; Desipramine ŽHarkin, A. Ž389. 187.

NMDA receptor antagonist Morphine; Antinociception; D-CPPene ŽSDZ EAA 494.; Memantine; MRZ 2r579; MRZ 2r576; ACEA-1021 ŽBelozertseva, I.V. Ž396. 77. Dizocilpine ŽŽq.-MK-801.; Neurotoxicity; Retrosplenial cortex; Clozapine; Olanzapine; Immediate early gene ŽFujimura, M. Ž398. 1. Naloxone; Morphine; Sensitization; Place conditioning; Mice ŽBlokhina, E.A. Ž406. 227. NMDA receptor–channel complex RPR 118723; Glycine antagonist; Glutamate; TCP binding; Dopamine release ŽBoireau, A. Ž401. 131. NMDA receptors Glutamate; Dizocilpine; Nucleus accumbens; Tail-flick ŽMillan, M.J. Ž388. 37. NMDA receptor subunit NMDA Ž N-methyl-D-aspartate.; Quinolinic acid; Kynurenine; Long-term potentiation; Hippocampus ŽYoussef, F. Ž398. 349. Ethanol withdrawal; Ifenprodil; Liquid diet method ŽNarita, M. Ž401. 191. N G-nitro-L-arginine methyl ester Phencyclidine; Nitric oxide ŽNO.; Behaviour; c-fos; ŽRat. ŽBujasBobanovic, M. Ž409. 57. Nociceptin ORL1 receptor; Colon, mouse, isolated; Nitric oxide ŽNO. ŽMenzies, J.R.W. Ž388. 183. Orphanin FQ; ORL1; Opioid; Opioid receptor; GTPgS ŽHawkinson, J.E. Ž389. 107. wNphe1 xnociceptin-Ž1–13.NH 2 ; OP4 receptor; Ileum, rabbit ŽPheng, L.-H. Ž397. 383. Orphanin FQ; ORL1 receptor; Morphine; Conditioned place preference; Spatial learning; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. Inflammatory response; Histamine; Mast cell; G protein; ORL 1 receptor; ŽRat. ŽKimura, T. Ž407. 327.

Glycine site; Receptor binding; GV150526A ŽMugnaini, M. Ž391. 233.

Nociceptinr r orphanin FQ ORL1 receptor; Opioid ŽOzaki, S. Ž387. R17.

s site; w3 HxIfenprodil; w3 HxMK-801; Hippocampal brain membrane, porcine ŽHofner, G. Ž394. 211. ¨

ORL1 receptor; Opioid ŽOzaki, S. Ž402. 45.

Acamprosate; Ethanol; Spermine; Primary cultured neuron; Patch-clamp, whole-cell ŽPopp, R.L. Ž394. 221. Clozapine-induced potentiation; MK-801; Haloperidol; Long-term potentiation; Perforant path–dentate gyrus pathway ŽKubota, T. Ž395. 37.

Isolated lung, guinea pig; ORL1 receptors; ORL1 receptor antagonist ŽCorboz, M.R. Ž402. 171. Nociception Leukotriene; Opioid; LTD4 receptor antagonist; Naloxone ŽGok, ¨ S¸ . Ž386. 195.

98

Master keyword index to Õolumes 386–410 (2000)

Interleukin 1b; Interleukin 8; TNF-a; Macrophage; Mast cell; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111. Protein kinase, cGMP-dependent; N-methyl-D-aspartate ŽNMDA.; Nitric oxide ŽNO.; Spinal cord; Hyperalgesia; Pain ŽTao, Y.-X. Ž392. 141. Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; Palmitoylethanolamide; 2-Arachidonylglycerol; Inflammation ŽBeaulieu, P. Ž396. 85. Capsaicin; Pain; Ricinoleic acid; Substance P; Tachykinin; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Nocistatin Naloxone benzoylhydrazone; k-Opioid receptor; Spontaneous alternation; Passive avoidance ŽHiramatsu, M. Ž395. 149. NO donor Nitric oxide ŽNO.; Hydrogen peroxide; Apoptosis; Neuroblastoma; PC12; Annexin V ŽTerwel, D. Ž400. 19. Nonadrenergic noncholinergic (NANC) relaxation, inhibitory PACAP Žpituitary adenylate cyclase activating peptide.; VIP Žvasoactive intestinal peptide.; Nitric oxide ŽNO.; Smooth muscle, tracheal; ŽCat. ŽYoshida, M. Ž395. 77. Non-adrenergic non-cholinergic Aldose reductase; Autonomic neuropathy; Diabetes; Gastric fundus, rat; Streptozotocin ŽJenkinson, K.M. Ž401. 251. Non-adrenergic non-cholinergic (NANC) nerve Neocuproine; Bathocuproine; Corpus cavernosum; S-Nitrosoglutathione; Nitrergic relaxation ŽGoc ¨ ¸men, C. Ž406. 293. Non-competitive antagonism Des-Arg 10 -kallidin; FLIPR Žfluorometric imaging plate reader.; Bradykinin; Ca2q; CHO cells ŽSimpson, P.B. Ž392. 1. Noncompetitive inhibition Drug interaction; Hypoglycemic agent; Nateglinide; Peptide transporter ŽTerada, T. Ž392. 11. Non-genomic effect Estrogen; ERK Žextracellular signal-regulated kinase.; Hippocampus, rat ŽKuroki, Y. Ž400. 205.

Non-steroidal anti-inflammatory drug (NSAID) Apoptosis; Ulcer; Colon cancer; Pentose phosphate pathway ŽPorter, S.N. Ž397. 1. Non-steroidal anti-inflammatory drug Neuroinflammation; Forebrain basal; Acetylcholine; Caspase; ŽRat. ŽWenk, G.L. Ž402. 77. Non-steroid anti-inflammatory drug Nitric oxide ŽNO.; Inflammation, intestinal ŽEvans, S.M. Ž388. 281. Nonvascular smooth muscle Mitogen-activated protein kinase; Contraction; Prostaglandin F2 a ; Carbachol ŽYousufzai, S.Y.K. Ž407. 17. Nootropic drug Movement disorder; Epilepsy; Anticonvulsant drug ŽLoscher, W. Ž391. ¨ 251. NOR3 Apoptosis; Nitric oxide ŽNO.; Nitric oxide ŽNO. donor; DAF-2 Ž4,5-diaminofluorescein.; Ascorbic acid ŽYamamoto, T. Ž397. 25. Noradrenaline Nasal mucosa vasculature; NS-49; a 1-Adrenoceptor subtype; Vasoconstrictor response ŽTanimitsu, N. Ž387. 73. Locus coeruleus; Cortex, prefrontal; Stress; NMDA receptor; GABA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279. Dopamine; Hypothalamus–pituitary–adrenocortical axis; Tolerance; Morphine; Paraventricular nucleus ŽFuertes, G. Ž388. 49. Cocaine; Potentiation; Blood pressure; Contractility; Chlorisondamine ŽSabra, R. Ž397. 139. 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HIAA Ž5-hydroxyindole-3acetic acid.; 5-Hydroxytryptophol; Dopamine; Ataxia, cerebellar ŽReader, T.A. Ž398. 41. Nandrolone decanoate; Deca durabolin; Cocaine; Radiotelemetry; Cardiac hypertrophy; ECG Želectrocardiogram. ŽPhillis, B.D. Ž398. 263. Anxiety; Stress; Hypothalamus; Amygdala; Locus coeruleus; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397.

NO (Nitric oxide) Capsaicin; Myenteric neuron; PPADS ŽPyridoxal-phosphate-6-azophenylX X 2 ,4 -disulphonic acid.; VIP ŽVasoactive intestinal polypeptide.; PACAP ŽPituitary adenylate cyclase activating peptide.; Small intestine ŽBartho, ´ L. Ž392. 183.

´ Ž407. Paroxetine; Desipramine; Microdialysis; 5-HT ŽHajos-Korcsok, E. ´ 101.

NO (nitric oxide) synthase, neuronal Hyperalgesia; Complete Freund adjuvant; NF-kB Žnuclear factor kappa B.; AP-1 Žactivator protein-1.; Octamer factor ŽChan, C.-F. Ž402. 61.

Noradrenaline release AMPA receptor; S18986-1; Hippocampus; Allosteric modulator ŽLockhart, B. Ž401. 145.

Non-linear dynamics Anabolic steroid; Pregnenolone sulfate; Ethylestrenol; Passive avoidance behavior; Memory; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177.

Coeliac ganglion; Nicotine; Stomach, rat; Nicotinic receptor ŽYokotani, K. Ž402. 223.

Non-peptide Antagonism; Bradykinin B 2 receptor; FR173657; FR190997; MEN 11270 ŽMeini, S. Ž409. 185. Nonpeptide angiotensin receptor agonist Angiotensin; DuP 532; PD123,319; ŽFeline. ŽDe Witt, B.J. Ž404. 213.

Endothelin; Nitric oxide ŽNO.; Smooth muscle, vascular ŽLui, A.H. Ž410. 25.

Noradrenaline reuptake site Meta-hydroxyephedrine; PET Žpositron emission tomography.; Tricyclic antidepressant; ŽHuman. ŽMalizia, A.L. Ž391. 263. Noradrenergic system a 2 -Adrenoceptor; Atipamezole; Ageing; Memory; Cholinergic system ŽHaapalinna, A. Ž387. 141.

Master keyword index to Õolumes 386–410 (2000) Risperidone; Microdialysis; Schizophrenia; Antipsychotic drug; Electrophysiology ŽNasif, F.J. Ž394. 67. FR140423; Antinociception; a 2 -Adrenoceptor; Spinal cord; ŽMouse. ŽOchi, T. Ž400. 199. Norbinaltorphimine Binding; k-Opioid receptor ŽJones, R.M. Ž396. 49.

99

NR2B subunit NMDA receptor; Receptor occupancy, in vivo; MK-801; Radioligand binding ŽMurray, F. Ž397. 263. NS-49 Nasal mucosa vasculature; Noradrenaline; a 1 -Adrenoceptor subtype; Vasoconstrictor response ŽTanimitsu, N. Ž387. 73.

Nor-binaltorphimine Dorsal periaqueductal gray; m-Opioid receptor; k-Opioid receptor; CTOP; Aversion; Elevated plus-maze ŽNobre, M.J. Ž404. 145.

NS-105 Glutamate receptor, metabotropic; Adenylyl cyclase; Antisense oligodeoxynucleotide, knockdown; Primary neuronal culture ŽHirouchi, M. Ž387. 9.

Norepinephrine Antidepressant; NMDA receptor; Glycine; DSP-4; Desipramine ŽHarkin, A. Ž389. 187.

NSAID (nonsteroidal anti-inflammatory drug) Helicobacter pylori; Prostaglandin; Cyclooxygenase; Gastric ulceration ŽTakahashi, S. Ž406. 461.

Acetylcholine; Choline; Cortex, medial prefrontal; Serotonin ŽHedou, G. Ž390. 127.

Alzheimer’s disease; Microglia; Aspirin; Interferon-g ŽOgawa, O. Ž408. 137.

5-HT2A receptor antagonist; Microdialysis; YM992; Venlafaxine; Antidepressant ŽHatanaka, K.-i. Ž395. 31.

OAT1 Žorganic anion transporter 1.; p-Aminohippurate; Methotrexate; Probenecid; Kidney; ŽRat. ŽUwai, Y. Ž409. 31.

Enteric nervous system; Submucous plexus; Small intestine; Synaptic transmission, inhibitory; Somatostatin ŽLiu, S. Ž397. 49.

NT(8–13) NT69L; Hot plate test ŽTyler-McMahon, B.M. Ž390. 107.

Self-administration; Catecholamine; Epinephrine; Corticosterone; Yoking; Nicotine ŽDonny, E.C. Ž402. 231.

NT69L NTŽ8–13.; Hot plate test ŽTyler-McMahon, B.M. Ž390. 107.

Organophosphate; Diisopropyl-flurophosphate; Aorta; Phentolamine; ŽRat. ŽLim, S.L. Ž404. 353.

Nuclear-factor-k B Phospholipase A 2 ; Mitogen-activated protein kinase; Interleukin-1; Inflammation ŽBurgermeister, E. Ž388. 195.

Vasopressin; Neuromodulation; Associative memory mechanism; Hippocampus ŽBrinton, R.D. Ž405. 73. Cocaine; Cerebellum; Purkinje cell; Microiontophoresis; Glutamate; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ CART Žcocaine- and amphetamine-regulated transcript.; TRH Žthyrotropin releasing hormone.; Dopamine; Synaptosome; Hypothalamus ŽBrunetti, L. Ž409. 103. Norepinephrine transporter Placenta, rat; Cocaine, chronic ŽShearman, L.P. Ž386. 1. Electrophysiology; Antidepressant; 5-HT1A receptor; a 2-Adrenoceptor; Tyramine; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. 211. ´ Noxious heat c-Fos; Racemic-flurbiprofen; S Žq.-flurbifrofen; Spinal dorsal horn ŽBuritova, J. Ž406. 59.

R Žy.-flurbifrofen;

[Nphe 1 ]nociceptin-(1–13)NH 2 Nociceptin; OP4 receptor; Ileum, rabbit ŽPheng, L.-H. Ž397. 383. NPPB (5-nitro-2-(3-phenylpropylamino)-benzoic acid) Patch clamp; Ca2q current; Ca2q current, Capacitative; Ca2q releaseactivated current; Jurkat cell; pH Modulation ŽLi, J.H. Ž394. 171. npr-1 G-protein coupled receptor; RNA-mediated interference ŽGomes, A.V. Ž397. R3. N-propyl analog Apomorphine; Dopamine; Microdialysis; Bioavailability; Striatum ŽRodenhuis, N. Ž387. 39.

Nucleotide Purine; Adenosine; ATP; Hippocampus; Suramin; Long-term potentiation ŽO’Kane, E.M. Ž409. 159. Nucleus accumben Dopamine; Nicotine; Ethanol; Microdialysis; Selected line ŽKiianmaa, K. Ž407. 293. Nucleus accumben, Core Nicotine sensitization; Nucleus accumben, Shell ŽCadoni, C. Ž387. R23. Nucleus accumbens NMDA receptors; Glutamate; Dizocilpine; Tail-flick ŽMillan, M.J. Ž388. 37. Addiction; Dependence; Dopamine; Nicotine; Prefrontal cortex ŽDi Chiara, G. Ž393. 295. Ethanol; Dopamine release; Stress of social defeat; Voltammetry in vivo; ŽMouse. ŽYavich, L. Ž401. 365. Glutamate receptor, metabotropic; Excitatory amino acid; Caudoputamen; Basal ganglia; Drug of abuse ŽMao, L. Ž404. 289. Dopamine; Subiculum; Fimbria-fornix; Microdialysis; ŽRat. ŽMitchell, S.N. Ž407. 131. Nucleus accumbens core Psychostimulants sensitization; Cocaine; Amphetamine; Nucleus accumbens shell ŽCadoni, C. Ž388. 69. Nucleus accumben, Shell Nicotine sensitization; Nucleus accumben, Core ŽCadoni, C. Ž387. R23.

100

Master keyword index to Õolumes 386–410 (2000)

Nucleus accumbens shell Psychostimulants sensitization; Cocaine; Amphetamine; Nucleus accumbens core ŽCadoni, C. Ž388. 69. Nucleus basalis, rat Cholinergic system; Cholinesterase inhibitor; Cerebral metabolism; Alzheimer’s disease ŽBassant, M.-H. Ž387. 151. Nucleus tractus solitarii Nitric oxide; Glutamate; Microdialysis ŽLin, H.-C. Ž407. 83.

Arthritis; Phosphodiesterase 4; Hyperalgesia; TNF-a Žtumor necrosis factor-a .; Rolipram ŽFrancischi, J.N. Ž399. 243. Ischemia–reperfusion; Neutrophil; Mesenteric artery; Inflammation ŽSouza, D.G. Ž403. 121. Oestrogen Phenytoin; Ovulation; Uterus ŽTamura, K. Ž398. 317. Aromatase inhibitor; Breast carcinoma; Androgen ŽPalma, C. Ž409. 93.

OAT1 (organic anion transporter 1) Renal tubular secretion; Xenopus oocytes; Sulfonylurea; Nateglinide; p-Aminohippurate ŽUwai, Y. Ž398. 193. p-Aminohippurate; Methotrexate; Probenecid; NSAID Žnonsteroidal antiinflammatory drug.; Kidney; ŽRat. ŽUwai, Y. Ž409. 31. Obese Zucker rat Oxidant stress; Endothelium; Nitric oxide ŽNO.; Insulin resistance ŽLaight, D.W. Ž402. 95. Obesity Sibutramine; Desmethylsibutramine; Didemethylsibutramine; Food intake; Locomotor activity; Antidepressant ŽGlick, S.D. Ž397. 93. Melanocortin; Feeding; Central nervous system; Behavior; Body weight homeostasis; Anorexia ŽVergoni, A.V. Ž405. 25. ß3-adrenoceptor agonist ŽForrest, M.J. Ž407. 175. Object recognition AMPA receptor; Memory; S 18986-1; ŽRat. ŽLebrun, C. Ž401. 205. Obsessive compulsive disorder 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1. Octamer factor Hyperalgesia; Complete Freund adjuvant; NF-kB Žnuclear factor kappa B.; AP-1 Žactivator protein-1.; NO Žnitric oxide. synthase, neuronal ŽChan, C.-F. Ž402. 61. Odor, cat MDMA ŽŽ".-3,4-Methylenedioxymethamphetamine.; Ecstasy; Anxiety; Social interaction; Ultrasonic vocalization ŽMorley, K.C. Ž408. 41. ODQ ([1-H-(1,2,4) Oxadiazole (4,3-a) quinoxalin-1-one]) Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; Temperature ŽTiritilli, A. Ž406. 79. ODQ (1 H-(1,2,4)-oxadiazolo(4,2-a )quinoxalin-1-one) Meloxicam; Nitric oxide ŽNO.; cGMP; N G -L-nitro-arginine methyl ester ŽL-NAME. ŽAguirre-Banuelos, P. Ž395. 9. ˜ ODQ (1 H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) Morphine; Sildenafil; cGMP; N G -L-nitro-arginine methyl ester ŽLNAME.; Naloxone ŽMixcoatl-Zecuatl, T. Ž400. 81. Hyperpolarization; Nitric oxide ŽNO.; Prostanoid; N v -nitro-L-arginine; Carotid artery; Femoral artery ŽCrauwels, H.M. Ž404. 341. Oedema Adenosine A 1 receptor; Adenosine A 2B receptor; Mast cell ŽSawynok, J. Ž395. 47.

Oestrogen receptor modulator; Nitric oxide ŽNO.; Blood pressure; Vasopressin; Enzyme regulation ŽPavo, ´ ´ I. Ž410. 101. Oestrogen receptor modulator Oestrogen; Nitric oxide ŽNO.; Blood pressure; Vasopressin; Enzyme regulation ŽPavo, ´ ´ I. Ž410. 101. 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin) 5-HT1A receptor; Naq channel; Ca2q channel; Neuroprotection; Ischemia ŽMelena, J. Ž406. 319. Cerebral ischemia; 5-HT receptor; Stereology; ŽRat. ŽTorup, L. Ž395. 137. Clozapine; Fos-protein; Tolerance; DOI ŽSebens, J.B. Ž408. 11. 8-OH-DPAT (8-hydroxy-2-di-n-(propylamino)tetralin) Nitric oxide ŽNO.; Food intake; 5-HT Ž5-hydroxytryptamine, serotonin.; N G -nitro-L-arginine methyl ester ŽL-NAME.; Hypothalamus ŽYamada, J. Ž402. 247. 8-OH-DPAT (8-hydroxy-N, N-dipropylaminotetralin) 5-HT Ž5-Hydroxytryptamine serotonin.; 5-HT receptor; FLIPR Žflourescent imaging plate reader.; Fluorescence; Meta-chlorophenylpiperazine ŽWood, M. Ž396. 1. 4OH-GTS-21 GTS-21; a7 Receptor-selective agonist ŽPapke, R.L. Ž393. 179. Okadaic acid Adrenomedullin; ERK Žextracellular signal-related kinase.; JNK Žjun amino-terminal kinase.; P38 MAPK ŽP38 mitogen-activated protein kinase. ŽParameswaran, N. Ž388. 133. Olanzapine Muscarinic receptor; Clozapine; Binding; Antipsychotic ŽBymaster, F.P. Ž390. 245. Dizocilpine ŽŽq.-MK-801.; NMDA receptor antagonist; Neurotoxicity; Retrosplenial cortex; Clozapine; Immediate early gene ŽFujimura, M. Ž398. 1. Olfactory bulb GABA A rbenzodiazepine receptor; Hippocampus; Ligand affinity; Receptor heterogeneity; a subunit ŽLameh, J. Ž400. 167. Oligomycin Naq,Kq-ATPase; Ca2q-ATPase; Naq occlusion; Chimeric ATPase ŽHomareda, H. Ž400. 177. Olprinone Radial artery; Phosphodiesterase 3; Phenylephrine ŽAdachi, H. Ž396. 43.

Master keyword index to Õolumes 386–410 (2000) Omeprazole Ischemia–reperfusion; Gastric secretion; Ranitidine; Ulcer healing; Gastric blood flow; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147. Ondansetron Ketamine; 5-HT Ž5-hydroxytryptamine, serotonin.; Heart rate; Electrocardiography; Fractal ŽDePetrillo, P.B. Ž391. 113. 5-HT3 receptor; Cocaine; Sensitization; ŽRat. ŽKing, G.R. Ž394. 97. ONO-5046 Hyperoxia; Lecithinized superoxide dismutase; Neutrophil elastase; Lung injury ŽYamamoto, H. Ž409. 179.

Enteropooling; Inflammation, peripheral; Intestine; Opioid receptor; Permeability ŽValle, L. Ž389. 235. Antinociception; Dizocilpine ŽMK-801.; NMDA receptor; Metabotropic glutamate receptor; Ž S .-4CPG ŽŽ S .-4-carboxyphenylglycine. ŽSuzuki, T. Ž396. 23. Respiration; Ca2q channel blocker; Rhesus monkey ŽKishioka, S. Ž397. 85. Neutral endopeptidase; Enkephalinase; Enkephalin; Knockout mouse; Alcohol consumption; Angiotensin-converting enzyme; Enkephalin-degrading peptidases ŽSiems, W.-E. Ž397. 327. Respiration; Tolerance; Dependence; ŽRhesus monkey. ŽKishioka, S. Ž398. 121.

Oocyte ATP receptor; Antagonist; Voltage clamp; Whole cell; NF279 Ž8,8X -ŽcarbonylbisŽimino-4,1-phenylenecarbonyl-imino-4,1-phenylenecarbonylimino..bisŽ1,3,5-naphthalenetrisulfonic acid.. ŽKlapperstuck, ¨ M. Ž387. 245.

Adenosine; Striatum ŽHalimi, G. Ž398. 217.

Alzheimer’s disease; Cholinergic; Exocytosis; Neuromuscular junction; Synaptic vesicle; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7.

Nociceptinrorphanin FQ; ORL1 receptor ŽOzaki, S. Ž402. 45.

OPC-21268 Vasopressin; Microvascular constriction; Mesenteric arteriole; Cremasteric arteriole; OPC-31260 ŽIshiguro, S. Ž400. 121. OPC-31260 Vasopressin; Microvascular constriction; Mesenteric arteriole; Cremasteric arteriole; OPC-21268 ŽIshiguro, S. Ž400. 121. Open field Antidepressant drug; Desipramine; Grooming; Locomotor activity; Mesolimbic dopamine system; Restraint stress; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43. Operant behavior THC Žtetrahydrocannabinol.; Dependence; Withdrawal; Behavioral dependence; SR141716A; ŽRat. ŽBeardsley, P.M. Ž387. 47. D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; SR 141716; Amphetamine; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251. Opiate Anxiety; Plus-maze; Benzodiazepine; Naloxone ŽBelzung, C. Ž394. 289. Dependence, acute; Gender difference; Cardiovascular system; Blood pressure; Heart rate; Rat, spinal ŽCruz, S.L. Ž397. 121. Heroin; Addiction; Genetic; Pharmacogenomics; Candidate gene ŽLichtermann, D. Ž410. 269.

101

Diabetes mellitus; Antinociception; G-protein; m-Opioid receptor; dOpioid receptor ŽPieper, G.M. Ž401. 375.

Opioid agent Anxiety; Stress; Noradrenaline; Hypothalamus; Amygdala; Locus coeruleus; Benzodiazepines; Anxiolytic drug ŽTanaka, M. Ž405. 397. Opioid analgesia U69,593; Hotplate; Sex differences; Lick latency; ŽRat. ŽVan Haaren, F. Ž408. 153. Opioid drug d-Opioid receptor; m-Opioid receptor; m-Opioid receptor-knockout mice; Antinociception; G protein ŽHosohata, Y. Ž388. 241. Opioid peptide AP-1 Žactivator protein-1.; Electrophoretic mobility shift assay; Transcriptional regulation; Uterus, rat; Hypothalamus, rat ŽOszter, A. Ž395. 103. Opioid receptor Nociceptin; Orphanin FQ; ORL1; Opioid; GTPgS ŽHawkinson, J.E. Ž389. 107. Enteropooling; Inflammation, peripheral; Intestine; Opioid; Permeability ŽValle, L. Ž389. 235. Crotalus durissus terrificus venom; Analgesia; Nitric oxide ŽNO. ŽPicolo, G. Ž391. 55. wMet 5 xenkephalin; Gender; T-lymphocyte; B-lymphocyte; Proliferation ŽGabrilovac, J. Ž392. 101. Gastroprotection; Clonidine; a 2B -Adrenoceptor ŽGyires, K. Ž396. 131.

Opiate withdrawal Morphine tolerance; Morphine dependence; Naloxone; Cerebral blood flow; Laser–Doppler flowmetry, ŽRat. ŽZamani, R. Ž408. 299.

Amphibian; w3 HxNaloxone; Antinociception ŽNewman, L.C. Ž397. 255.

Opioid Leukotriene; Nociception; LTD4 receptor antagonist; Naloxone ŽGok, ¨ S¸ . Ž386. 195.

Alcohol; Genetics; Alcoholism; Quantitative trait locus ŽTown, T. Ž410. 243.

Ligand selectivity; Mutagenesis; w35 SxGTPgS ŽBonner, G. Ž403. 37.

Nociceptinrorphanin FQ; ORL1 receptor ŽOzaki, S. Ž387. R17.

d-Opioid receptor Down-regulation; Carboxyl terminal tail ŽOkura, T. Ž387. R11.

Nociceptin; Orphanin FQ; ORL1; Opioid receptor; GTPgS ŽHawkinson, J.E. Ž389. 107.

m-Opioid receptor; m-Opioid receptor-knockout mice; Antinociception; G protein; Opioid drug ŽHosohata, Y. Ž388. 241.

Master keyword index to Õolumes 386–410 (2000)

102

CREB ŽcAMP responsive element binding protein.; DPDPE ŽwDPen2,5 xenkephalin., Morphine; NG108-15 neuroblastoma; Protein kinase ŽBilecki, W. Ž390. 1.

d-Opioid receptor agonist Tonazocine; SNC-80; Rotation; Parkinson’s disease ŽHudzik, T.J. Ž396. 101.

Short-circuit current; Endothelin-1; Intestine, large ŽGauthier, C. Ž390. 335.

k-Opioid receptor agonist Antinociceptive action; TRK-820; k-Opioid receptor subtype ŽEndoh, T. Ž387. 133.

Endomorphin-1; Endomorphin-2; Diabetes; Antinociception; m-Opioid receptor ŽKamei, J. Ž391. 91. 35

m-Opioid receptor; G-protein; w SxGTPgS binding; Collision-coupling model; Compartmentalization ŽRemmers, A.E. Ž396. 67. Opioid; Diabetes mellitus; Antinociception; G-protein; m-Opioid receptor ŽPieper, G.M. Ž401. 375. k-Opioid receptor Nocistatin; Naloxone benzoylhydrazone; Spontaneous alternation; Passive avoidance ŽHiramatsu, M. Ž395. 149. Norbinaltorphimine; Binding ŽJones, R.M. Ž396. 49. Dorsal periaqueductal gray; m-Opioid receptor; CTOP; Nor-binaltorphimine; Aversion; Elevated plus-maze ŽNobre, M.J. Ž404. 145. m-Opioid receptor Inflammation; Knockout mice ŽQiu, C. Ž387. 163. d-Opioid receptor; m-Opioid receptor-knockout mice; Antinociception; G protein; Opioid drug ŽHosohata, Y. Ž388. 241. Tolerance; Desensitization; cAMP-dependent protein kinase; Morphine; N-Ž2-aminoethyl.-5-isoquinolinesulfonamide ŽH8. ŽWang, Z. Ž389. 165. w35 SxGTPgS binding; Brain, human; a 2 -Adrenoceptor; 5-HT1A receptor; G-protein ŽGonzalez-Maeso, J. Ž390. 25. ´ Morphine withdrawal; Prostaglandin; Prostanoid EP3 receptor; c-fos; Locus coeruleus ŽNakagawa, T. Ž390. 257. Endomorphin-1; Endomorphin-2; Diabetes; Antinociception; d-Opioid receptor ŽKamei, J. Ž391. 91. Endomorphin-1; Endomorphin-2; Spontaneous alternation performance; ŽMouse. ŽUkai, M. Ž395. 211. d-Opioid receptor; G-protein; w35 SxGTPgS binding; Collision-coupling model; Compartmentalization ŽRemmers, A.E. Ž396. 67. G-protein; Antinociception; Ponsrmedulla; Diabetes ŽOhsawa, M. Ž401. 55. Opioid; Diabetes mellitus; Antinociception; G-protein; d-Opioid receptor ŽPieper, G.M. Ž401. 375. cAMP accumulation; Orphanin FQrnociceptin ŽMandyam, C.D. Ž402. 205. Dorsal periaqueductal gray; k-Opioid receptor; CTOP; Nor-binaltorphimine; Aversion; Elevated plus-maze ŽNobre, M.J. Ž404. 145. m 1 -Opioid receptor Dermorphin N-terminal tetrapeptide; Tail-flick test; Naloxonazine; bFunaltrexamine ŽSakurada, S. Ž395. 107. Opioid receptor agonist Respiration; Buprenorphine; Methoclocinnamox; Opioid receptor antagonist; ŽRhesus monkey. ŽKishioka, S. Ž391. 289.

Opioid receptor antagonist Respiration; Buprenorphine; Methoclocinnamox; Opioid receptor agonist; ŽRhesus monkey. ŽKishioka, S. Ž391. 289. m-Opioid receptor antagonist Lipopolysaccharide; Fever; Preoptic anterior hypothalamus ŽBenamar, K. Ž401. 161. m-Opioid receptor-knockout mice d-Opioid receptor; m-Opioid receptor; Antinociception; G protein; Opioid drug ŽHosohata, Y. Ž388. 241. k-Opioid receptors Allodynia; Antinociception; Diuresis; Dynorphin; Sedation ŽKo, M.C.H. Ž402. 69. Opioid receptor subtype Xylazine; DAMGO; DPDPE; Tyr-W-MIF-1; U50,488; a 2 adrenoceptor ŽWare, T.D. Ž389. 181. k-Opioid receptor subtype k-Opioid receptor agonist; Antinociceptive action; TRK-820 ŽEndoh, T. Ž387. 133. Opioid system Restraint stress; Adaptation; D-Amphetamine; Conditioned place preference; Dopamine D1 receptor; Dopamine D 2 receptor; Sensitization ŽCapriles, N. Ž386. 127. Nigella satiÕa oil; Thymoquinone; Antinociception; Formalin test ŽAbdel-Fattah, A.-F.M. Ž400. 89. Opioid system, endogenous Gene polymorphism; Single nucleotide polymorphism; Addiction; Pharmacogenetics; Physiogenetics ŽLaForge, K.S. Ž410. 249. OP4 receptor Nociceptin; wNphe1 xnociceptin-Ž1–13.NH 2 ; Ileum, rabbit ŽPheng, L.-H. Ž397. 383. Optical recording ATP; Hippocampal slice; Electrical signal; Adenosine receptor ŽSato, K. Ž399. 123. Optic nerve GABA Ž g-aminobutyric acid.; Anaesthetic; Benzodiazepine; Propofol ŽEmpson, R.M. Ž401. 339. Orexigenesis Neuropeptide Y receptor; Neuropeptide Y y6 receptor; Neuropeptide Y; 1229U91 ŽMullins, D.E. Ž395. 87. Organic nitrate Nitric oxide ŽNO.; S-Nitrosothiol; Tolerance; Blood vessel ŽMiller, M.R. Ž403. 111. Nitric oxide ŽNO.; S-Nitrosothiol; Tolerance; Blood vessel ŽMiller, M.R. Ž408. 335.

Master keyword index to Õolumes 386–410 (2000) Organophosphate Diisopropyl-flurophosphate; Aorta; Phentolamine; Norepinephrine; ŽRat. ŽLim, S.L. Ž404. 353. Organotypic slice culture s Receptor; Mesencephalon; N-methyl-D-aspartate ŽNMDA.; Dopaminergic neuron ŽShimazu, S. Ž388. 139. ORL1 receptor Nociceptinrorphanin FQ; Opioid ŽOzaki, S. Ž387. R17. Nociceptin; Colon, mouse, isolated; Nitric oxide ŽNO. ŽMenzies, J.R.W. Ž388. 183. Nociceptin; Orphanin FQ; Opioid; Opioid receptor; GTPgS ŽHawkinson, J.E. Ž389. 107. Nociceptinrorphanin FQ; Opioid ŽOzaki, S. Ž402. 45. Isolated lung, guinea pig; Nociceptinrorphanin FQ; ORL1 receptor antagonist ŽCorboz, M.R. Ž402. 171. Nociceptin; Orphanin FQ; Morphine; Conditioned place preference; Spatial learning; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. ORL1 receptor antagonist Isolated lung, guinea pig; ORL1 receptors; Nociceptinrorphanin FQ ŽCorboz, M.R. Ž402. 171. ORL 1 receptor Nociceptin; Inflammatory response; Histamine; Mast cell; G protein; ŽRat. ŽKimura, T. Ž407. 327. Orphanin FQ Micturition reflex; Tachykinin NK 1 receptor; Tachykinin NK 2 receptor; Tachykinin ŽLecci, A. Ž389. 99. Nociceptin; ORL1; Opioid; Opioid receptor; GTPgS ŽHawkinson, J.E. Ž389. 107. Nociceptin; ORL1 receptor; Morphine; Conditioned place preference; Spatial learning; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. Orphanin FQ r nociceptin m-Opioid receptor; cAMP accumulation ŽMandyam, C.D. Ž402. 205. Osteoarthritis X Rheumatoid arthritis; Aceclofenac; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 1; Pro-matrix metalloproteinase 3; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429. Osteoblast differentiation Nitric oxide ŽNO.; Nitric oxide ŽNO. synthases; Vanadium; Growth; Bone; Cytotoxicity ŽCortizo, A.M. Ž400. 279. Osteoblast, Human CGRP Žcalcitonin gene-related peptide.; CGRP-Ž8-37.; Amylin, AmylinŽ8-37.; Proliferation; cAMP ŽVilla, I. Ž409. 273. Osteoblast-like cell Nitric oxide ŽNO.; Stromal cell; Mineralization; Differentiation ŽKoyama, A. Ž391. 225. Osteopenia Cyclosporin A; Arginine; Pyridinoline; ŽRat. ŽFiore, C.E. Ž408. 323. (I)-OSU6162 6-Hydroxydopamine; Parkinson’s disease; Dopamine receptor agonist; Dyskinesia ŽEkesbo, A. Ž389. 193.

103

Ototoxicity Aminoglycoside; NMDA receptor; Dizocilpine ŽHarvey, S.C. Ž387. 1. Ouabain Endothelium-derived hyperpolarizing factor ŽEDHF.; 18a-Glycyrrhetinic acid; Gap junctions; Kq; Endothelium ŽHarris, D. Ž402. 119. Naq; Ca2q; Aldosterone; NaŽq. –KŽq. –exchanging ATPase ŽYingst, D.R. Ž406. 49. Diabetes; Naq,Kq-ATPase; Phenylephrine; Vascular reactivity; Streptozotocin; Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419. Histamine; Histamine release; Microdialysis; Veratrine ŽWashington, B. Ž407. 117. Astrocyte; Ca2q; LDH Žlactate dehydrogenase.; Mitochondrion; MTT; Naq,Kq-ATPase ŽTakahashi, S. Ž408. 127. Ovalbumin Hypersensitivity; Endothelial reactivity; Nitric oxide ŽNO.; Pulmonary artery ŽAkar, F. Ž395. 225. Phosphatidylinositol-3-kinase; Wortmannin; Adenosine; Methacholine; 5-HT; Bronchoconstriction; Active sensitisation; Brown Norway, rat ŽTigani, B. Ž406. 469. Ovarian function Dexamethasone; FSH Žfollicle-stimulating hormone.; Inhibin; ŽRat, female, immature. ŽTohei, A. Ž386. 69. Ovulation Phenytoin; Oestrogen; Uterus ŽTamura, K. Ž398. 317. Oxatomide Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Oxidant Protein kinase C; Phorbol ester; Cellular injury ŽTepperman, B.L. Ž389. 131. Oxidant stress Endothelium; Nitric oxide ŽNO.; Insulin resistance; Obese Zucker rat ŽLaight, D.W. Ž402. 95. Oxidative stress Diabetes; Smooth muscle, vascular; Hypertrophy, cell; Oxyhaemoglobin, glycosylated ŽPeiro, ´ C. Ž386. 317. Ischemia–reperfusion; Cyclopiazonic acid; Free radical; Reactive oxygen species ŽGrover, A.K. Ž387. 87. Kainate; Excitotoxicity; Cyclooxygenase-2; Nimesulide; Hippocampus ŽCandelario-Jalil, E. Ž390. 295. Isoprostane; Mammary artery; Vasoconstriction ŽCracowski, J.-L. Ž397. 161. Nerve conduction; Blood flow; Kq channel opener; Naq, Kq ATPase; Glutathione; Neuropathy; Diabetic rat ŽHohman, T.C. Ž397. 335. Streptozotocin-induced diabetic mouse; Corpus cavernosum; Nitric oxide ŽNO.; Antioxidant; Vitamin E; Sodium selenate ŽGoc ¨ ¸men, C. Ž398. 93. Methamphetamine; Glutathione ŽHarold, C. Ž400. 99.

104

Master keyword index to Õolumes 386–410 (2000)

Flow; Nitric oxide ŽNO.; Ischemia-reperfusion; Vascular ŽWalia, M. Ž400. 249. Free radical; Antioxidant; Cortical culture; Propofol; Vitamin E ŽBoland, A. Ž404. 21.

PACAP (Pituitary adenylate cyclase activating peptide) Capsaicin; Myenteric neuron; PPADS ŽPyridoxal-phosphate-6-azophenylX X 2 ,4 -disulphonic acid.; VIP ŽVasoactive intestinal polypeptide.; NO ŽNitric oxide.; Small intestine ŽBartho, ´ L. Ž392. 183.

Oxygen radical LY341122; Cerebral ischemia, focal; Neuroprotection; Stroke; ŽRat. ŽHuh, P.W. Ž389. 79.

PACAP (pituitary adenylate cyclase activating peptide) VIP Žvasoactive intestinal peptide.; Nitric oxide ŽNO.; Nonadrenergic noncholinergic ŽNANC. relaxation, inhibitory; Smooth muscle, tracheal; ŽCat. ŽYoshida, M. Ž395. 77.

Oxyhaemoglobin, glycosylated Diabetes; Smooth muscle, vascular; Hypertrophy, cell; Oxidative stress ŽPeiro, ´ C. Ž386. 317.

PAF acetylhydrolase PAF Žplatelet-activating factor.; Anaphylactic shock ŽFukuda, Y. Ž390. 203.

Oxyhemoglobin Cerebrovascular constriction; Tamoxifen; Protein kinase C ŽWickman, G. Ž390. 181.

PAF (platelet-activating factor) PAF acetylhydrolase; Anaphylactic shock ŽFukuda, Y. Ž390. 203.

Oxysterol Endothelium-dependent relaxation; Very low-density lipoprotein; Lowdensity lipoprotein; High-density lipoprotein ŽPersegol, L. Ž406. 429. ´

Colon, rat; Thromboxane A 2 ; Cly secretion ŽSuzuki, T. Ž400. 297. Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Thromboxanes; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193.

Oxytocin Penile erection; Hexarelin; EP 60761; EP 50885; Nitric oxide ŽNO.; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137.

FITC-dextran; Arteriole; Permeability; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS. inhibitor; Microcirculation ŽKlabunde, R.E. Ž404. 387.

Ozone Haemoxygenase; Carbon monoxide ŽCO.; Neutrophil; Bronchial hyperresponsiveness ŽHisada, T. Ž399. 229.

Pain Thalidomide; TNF-a Žtumor necrosis factor-a .; Hyperalgesia, inflammatory ŽRibeiro, R.A. Ž391. 97.

JTE-522; Cyclooxygenase-2; Prostaglandin E 2 ; Thromboxane A 2 ; U46619; Airway hyperresponsiveness; ŽGuinea pig. ŽNakano, H. Ž403. 267.

Protein kinase, cGMP-dependent; N-methyl-D-aspartate ŽNMDA.; Nitric oxide ŽNO.; Nociception; Spinal cord; Hyperalgesia ŽTao, Y.-X. Ž392. 141.

Ozone-exposure Neutrophil elastase inhibitor; Mucus score; Goblet cell hypersecretion ŽNogami, H. Ž390. 197. P38 CGRP Žcalcitonin gene-related peptide.; ERK Žextracellular signal-regulated kinase.; Forskolin; HEK 293 cell ŽParameswaran, N. Ž389. 125. p38 Mitogen-activated protein kinase Neutrophils, rat; Tyrosine kinase; Protein kinase C; Phospholipase C; Ca2q, cytosolic-free ŽChang, L.-C. Ž390. 61. p53 Glioma; Telomerase; Chemosensitivity; Penclomedine ŽVietor, M. Ž407. 27.

Antinociception; Sex difference; Gonadectomy, adult; b-Endorphin ŽKrzanowska, E.K. Ž392. 157. Cannabinoid; Capsaicin; Neuron; Afferent; Receptor; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39. ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Peptide– receptor interaction; Avoidance; Grooming; Food intake ŽAdan, R.A.H. Ž405. 13. Capsaicin; Nociception; Ricinoleic acid; Substance P; Tachykinin; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Analgesia; Antinociception; Neuropeptide FF; Spinal cord; Supraspinal ŽAltier, N. Ž407. 245.

Apoptosis; Smooth muscle cell, vascular; Gadd45; Troglitazone; Pioglitazone ŽOkura, T. Ž407. 227.

Adenosine; Adenosine kinase; Adenosine deaminase; Formalin; Microdialysis; Inflammation ŽLiu, X.J. Ž408. 143.

P7480 a 1-Adrenoceptor subtype; Methoxamine; Cirazoline; Mesenteric artery, rat; BMY 7378 ŽHussain, M.B. Ž395. 69.

Pain perception Histamine H 1 receptor; Histamine; Somatic pain; Visceral pain; Gene targeting ŽMobarakeh, J.I. Ž391. 81.

p160ROCK Polymorphonuclear leukocyte; Rho kinase; Superoxide production; Aggregation ŽKawaguchi, A. Ž403. 203.

PAK-104P Multidrug resistance; P-glycoprotein; MRP1 Žmultidrug resistance-associated protein.; Daunorubicin; Calcein-AM; Inhibitor ŽMarbeuf-Gueye, C. Ž391. 207.

PACAP-(6–38) PACAP Žpituitary adenylate cyclase-activating peptide.; VIP Žvasoactive intestinal peptide.; Apamin; Suramin; VIP-Ž10–28.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217. PACAP (pituitary adenylate cyclase-activating peptide) VIP Žvasoactive intestinal peptide.; Apamin; Suramin; PACAP-Ž6–38.; VIP-Ž10–28.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217.

Palatability Benzodiazepine; Dopamine; Licking behaviour; Bout structure ŽHiggs, S. Ž409. 73. Palmitoylation G protein-coupled receptor; Dopamine; Phosphorylation; Desensitization; Adenylyl cyclase ŽJin, H. Ž386. 305.

Master keyword index to Õolumes 386–410 (2000) Palmitoylethanolamide Cannabinoid CB1 receptor; Cannabinoid CB 2 receptor; Cannabinoid receptor antagonist; Hyperalgesia; Anandamide; 2-Arachidonylglycerol; Nociception; Inflammation ŽBeaulieu, P. Ž396. 85. Cannabinoid CB 2 receptor; WIN55212; Nitric oxide ŽNO.; RAW264.7; Macrophage; cAMP ŽRoss, R.A. Ž401. 121. p-Aminohippurate OAT1 Žorganic anion transporter 1.; Renal tubular secretion; Xenopus oocytes; Sulfonylurea; Nateglinide ŽUwai, Y. Ž398. 193. Pancreas 4-Hydroxyisoleucine; Insulin release; Structural analogue; Fenugreek seed; ŽRat. ŽBroca, C. Ž390. 339.

105

Paraventricular nucleus Noradrenaline; Dopamine; Hypothalamus–pituitary–adrenocortical axis; Tolerance; Morphine ŽFuertes, G. Ž388. 49. Excitatory amino acid; Cardiovascular regulation; Central; Microinjection; ŽRat. ŽGoren, M.Z. Ž388. 77. ¨ Penile erection; Hexarelin; EP 60761; EP 50885; Oxytocin; Nitric oxide ŽNO.; ŽRat. ŽMelis, M.R. Ž404. 137. Stressful stimuli; Neuropeptide; c-fos; Supraoptic nucleus; Amygdaloid nucleus, central ŽPalkovits, M. Ž405. 161. Parkinson’s disease Žy.-OSU6162; 6-Hydroxydopamine; Dopamine receptor agonist; Dyskinesia ŽEkesbo, A. Ž389. 193.

Pancreas, rat Sodium tungstate; Insulin; Glucagon ŽRodrıguez-Gallardo, J. Ž402. 199. ´

Deprenyl metabolism; Cytochrome P450; N-dealkylation pathway; C57BL mouse liver microsomal preparation ŽValoti, M. Ž391. 199.

Pancreastatin receptor Signaling; G protein; Phospholipase C; MAPK; HTC cell; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´

Alzheimer’s disease; a 3 subunit; a4 subunit; a7 subunit; b-Amyloidosis; Acetylcholinesterase; Tobacco exposure ŽPerry, E. Ž393. 215.

Pancreatic acinar cell Rebamipide; CCK 1 receptor; wCa2q x i oscillation ŽMoon, S.J. Ž388. 17. Pancreatic regeneration Pancreatitis; EGF Žepidermal growth factor.; Interleukin 1b ŽDembinski, ´ A. Ž398. 159. Pancreatitis EGF Žepidermal growth factor.; Pancreatic regeneration; Interleukin 1b ŽDembinski, A. Ž398. 159. ´ Panic Anxiety; Blood pressure; Glutamate; Heart rate; Kindling; Long-term potentiation; Social interaction; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

Nicotinic receptor; MPTP Ž1-methyl-4-phenyl-1,2,3,6-tetrahydropteridine.;Hybridization, in situ; Neuroprotection; ŽMonkey. ŽQuik, M. Ž393. 223. d-Opioid receptor agonist; Tonazocine; SNC-80; Rotation ŽHudzik, T.J. Ž396. 101. 6-Hydroxydopamine-lesioned rat; 5-HT2C receptor; SKF 82958 ŽFox, S.H. Ž398. 59. Dopamine D4 receptor; L-Dopa-induced dyskinesia; JL-18; MPTP Ž1methyl-4-phenyl-1,2,3,6-tetrahydropyridine. ŽTahar, A.H. Ž399. 183. L-DOPA

methylester; Daily rhythm; Chronopharmacology; Radiotelemetry; Infusion constant rate ŽSimon, N. Ž401. 79.

Glutamate; Dopamine uptake; NMDA receptor ŽPage, G. Ž403. 75. 1-propanamine-3-hydroxy-2-nitroso-1-propylhydrazino (PAPA NONOate) Phenylethanoid; Macrophage; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase; Inducible ŽXiong, Q. Ž400. 137. Papaverine Anococcygeus, mouse; Forskolin; Nitrergic; Nitric oxide ŽNO.; Sildenafil; Sodium nitroprusside ŽFrith, D. Ž400. 305. Papillary muscle Metoprolol; Ramipril; Myocardial infarction; Action potential ŽWagner, K.-D. Ž388. 263. Adrenomedullin; Contractility; cAMP ŽIhara, T. Ž390. 167. Adrenomedullin; Myocyte; Heart, isolated; Ca2q transient; ŽRat. ŽStangl, V. Ž408. 83. Parachlorophenylalanine D-Fenfluramine; Hypothermia; 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275. Parasitic nematode Patch-clamp; Anthelmintic resistance; Nicotinic receptor ŽRobertson, A.P. Ž394. 1.

KF17837 ŽŽ E .-1,3-dipropyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1 H-purine-2,6-dione.; KW-6002 ŽŽ E .-1,3-diethyl-8-Ž3,4-dimethoxystyryl.-7-methyl-3,7-dihydro-1H-purine-2,6-dione.; Adenosine A 2A receptor antagonist; 6-Hydroxydopamine ŽKoga, K. Ž408. 249. Paroxetine 5-HT Ž5-hydroxytryptamine, serotonin.; Tianeptine; Frontal cortex; Raphe nuclei; Microdialysis, in vivo ŽMalagie, ´ I. Ž403. 55.

´ Desipramine; Microdialysis; 5-HT; Noradrenaline ŽHajos-Korcsok, E. ´ Ž407. 101. Paroxysmal choreoathetosis Movement disorder; Dystonia; Barbiturate; GABA Ž g-aminobutyric acid. ŽRichter, A. Ž397. 343. Partial Nicotinic acetylcholine receptor; Acetylcholine; Choline; Agonist; Coagonist; Xenopus laeÕis oocyte ŽZwart, R. Ž393. 209. Partial agonist Constitutively-active receptor; Chimeric receptor; IP receptor; Prostacyclin ŽWise, H. Ž386. 89. Dopamine D 2 receptor; Dopamine synthesis; Locomotor activity; ŽRat. ŽAhlenius, S. Ž394. 247.

106

Master keyword index to Õolumes 386–410 (2000)

b-Adrenoceptor, atypical; b 3 -Adrenoceptor; Duodenum, guinea pig; Carteolol; Bupranolol ŽHorinouchi, T. Ž403. 133. Passive avoidance Nocistatin; Naloxone benzoylhydrazone; k-Opioid receptor; Spontaneous alternation ŽHiramatsu, M. Ž395. 149. Phosphatidylserine; Reserpine; Memory ŽAlves, C.S.D. Ž404. 161. 4-Aminopyridine; 3,4-Diaminopyridine; Apamin; ŽMouse. ŽInan, S.Y. Ž407. 159. Passive avoidance behavior Anabolic steroid; Pregnenolone sulfate; Ethylestrenol; Memory; Non-linear dynamics; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177. Patch clamp Anaesthetic volatile; Action potential; Arrhythmia; K AT P channel; Myocyte ŽTerrenoire, C. Ž390. 95. Ivermectin; GABA A receptors; Subunit composition ŽAdelsberger, H. Ž394. 163. NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Ca2q current; Ca2q current, Capacitative; Ca2q release-activated current; Jurkat cell; pH Modulation ŽLi, J.H. Ž394. 171. Kq channel; Calcium; Calmodulin; Antipsychotic; Dequalinium ŽDreixler, J.C. Ž401. 1. Patch-clamp l-cis-Diltiazem; d-cis-Diltiazem; Whole-cell; Ca2q overload; Naq current; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217. Anthelmintic resistance; Parasitic nematode; Nicotinic receptor ŽRobertson, A.P. Ž394. 1. Patch-clamp technique HERG; QT-prolongation; Fluoroquinolones ŽBischoff, U. Ž406. 341. Patch-clamp, whole-cell Acamprosate; Ethanol; Spermine; NMDA receptor; Primary cultured neuron ŽPopp, R.L. Ž394. 221. Patch clamp, Whole-cell Rabies virus; NG108-15 cell; Ca2q current; a-Adrenoceptor; Muscarinic receptor ŽIwata, M. Ž404. 79. Patient-pair studies Pharmacogenetic; Pharmacogenomic; Molecular epidemiology; Genotype; Phenotype; DNA sequence variants; Population genetic ŽNebert, D.W. Ž410. 107. Paw oedema Adenosine A 1 receptor; Adenosine A 2 receptor; Adenosine A 3 receptor; Plethysmometry; ŽRat. ŽSawynok, J. Ž386. 253. Benzodiazepine receptor, peripheral; Pleurisy ŽTorres, S.R. Ž408. 199. Paw pressure test 5-HT Ž5-hydroxytryptamine, serotonin.; Chronic pain; Spinal cord; ŽRat. ŽBardin, L. Ž409. 37. Paxilline InsP3 receptor; Ca2q signalling; Mycotoxin ŽLongland, C.L. Ž408. 219.

PC12 Nitric oxide ŽNO.; Hydrogen peroxide; Apoptosis; Neuroblastoma; NO donor; Annexin V ŽTerwel, D. Ž400. 19. PC12 cell Arachidonic acid; Cytosolic phospholipase A 2 ; S-Nitroso-cysteine; cGMP ŽThang, S.H. Ž395. 183. Flupirtine; Retigabine; Glutamate toxicity; Reactive oxygen intermediates; Glutathione ŽSeyfried, J. Ž400. 155. PC12D cell Picroside I; Picroside II; Neurite outgrowth activity; Nerve growth factor ŽNGF.; Mitogen-activated protein ŽMAP. kinase ŽLi, P. Ž406. 203. P19 cell Neurosteroid; Development ŽGrobin, A.C. Ž409. R1. p-Chloroamphetamine Hyperthermia; 5-HT2A receptor; 5-HT2Br2C receptor; ŽMouse. ŽSugimoto, Y. Ž403. 225. p-Chlorophenylalanine Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; 5-HT1A receptor; Nemonapride; Raclopride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. PD 155080 Endothelin-1; Endothelin ETA -receptor; Endothelin ETB -receptor; A192621; Endotoxaemia; Septic shock ŽWanecek, M. Ž386. 235. (H)-PD128,907 Dopamine; Dopamine D 3 receptor; Motor activity; Postnatal development ŽHeijtz, R.D. Ž392. 35. PD 123319 Angiotensin AT2 receptor; Losartan; Kinin; Nitric oxide ŽNO. synthase; Cyclo-oxygenase; Footshock ŽIsrael, A. Ž394. 103. PD98059 Ca2q reperfusion; T-588; NGF Žnerve growth factor.; MAP Žmitogenactivated protein. kinase; Astrocyte ŽTakuma, K. Ž399. 1. PD123,319 Angiotensin; Nonpeptide angiotensin receptor agonist; DuP 532; ŽFeline. ŽDe Witt, B.J. Ž404. 213. Penclomedine Glioma; Telomerase; Chemosensitivity; p53 ŽVietor, M. Ž407. 27. Penile erection Hexarelin; EP 60761; EP 50885; Oxytocin; Nitric oxide ŽNO.; Paraventricular nucleus; ŽRat. ŽMelis, M.R. Ž404. 137. [3 H](H)-Pentazocine s Receptor; Haloperidol; s1 Receptor mRNA; w3 HxDTG Žw3 Hx1,3-di Ž2-tolyl. guanidine.; Species difference ŽInoue, A. Ž401. 307. (H)Pentazocine s Receptor; Haloperidol; Cerebellum; GTPase; w35 SxGTPgS autoradiography ŽHong, W. Ž408. 117. Pentose phosphate pathway Non-steroidal anti-inflammatory drug ŽNSAID.; Apoptosis; Ulcer; Colon cancer ŽPorter, S.N. Ž397. 1. Peptide Rabbit; Artery; Phosphoinositide; Phospholipase C; Urotensin II ŽOpgaard, O.S. Ž406. 265.

Master keyword index to Õolumes 386–410 (2000) Peptide–receptor interaction ACTH Žadrenocorticotropic hormone.; MSH Žmelanocyte-stimulating hormone.; Melanocortin receptor; Brain melanocortin system; Avoidance; Grooming; Food intake; Pain ŽAdan, R.A.H. Ž405. 13. Peptide transporter Drug interaction; Hypoglycemic agent; Nateglinide; Noncompetitive inhibition ŽTerada, T. Ž392. 11. Perforant path–dentate gyrus pathway Clozapine-induced potentiation; NMDA receptor; MK-801; Haloperidol; Long-term potentiation ŽKubota, T. Ž395. 37. Perfusion cannula Dual coronary perfusion method; Coronary bed ŽCoetzee, W.A. Ž402. 263. Peripheral nervous system Acetylcholine receptor; Ligand-gated ion channel; RNA blot; In situ hybridization; Neural development ŽErkman, L. Ž393. 97. Peripheral tissue Donepezil hydrochloride; E2020; Tacrine; Cholinesterase inhibitor; Brain; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. Permeability Enteropooling; Inflammation, peripheral; Intestine; Opioid; Opioid receptor ŽValle, L. Ž389. 235. FITC-dextran; Arteriole; Nitric oxide ŽNO.; Platelet-activating factor ŽPAF.; Nitric oxide synthase ŽNOS. inhibitor; Microcirculation ŽKlabunde, R.E. Ž404. 387. Permeability transition pore Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADP-ribose. polymerase ŽRuiz, F. Ž404. 29. Peroxinitrite Cisplatin; Sensory neuropathy; Superoxide production ŽSzilvassy, J. Ž403. ´ 259. Peroxisome proliferator-activated receptor g Cardiac hypertrophy; Diabetes; Hyperglycaemia ŽBell, D. Ž390. 237. Peroxisome proliferator-activated receptor (PPAR) Retinoid X receptor ŽRXR.; Inflammation; Monocyte; Migration; Matrix metalloproteinase ŽKintscher, U. Ž401. 259. Peroxynitrite Carrageenan; Inflammation; Nitric oxide ŽNO.; Superoxide dismutase; Tempol ŽCuzzocrea, S. Ž390. 209. Transplantation; Nitric oxide ŽNO. synthase; Inducible; Macrophage ŽVos, I.H.C. Ž391. 31.

107

Pertussis toxin Acetylcholine release; Stomach; Histamine H 3 receptor ŽYokotani, K. Ž392. 23. Hypothalamo-pituitary-adrenal axis; Aggressive behavior; Monoamine; ŽMouse. ŽKim, D.-H. Ž409. 67. PET (positron emission tomography) Noradrenaline reuptake site; Meta-hydroxyephedrine; Tricyclic antidepressant; ŽHuman. ŽMalizia, A.L. Ž391. 263. P-Glycoprotein Bioflavonoid; Blood–brain barrier; Vincristine; Protein kinase C ŽMitsunaga, Y. Ž395. 193. P-Glycoprotein Placenta; BeWo cells; Blood–placental barrier; Drug disposition ŽUshigome, F. Ž408. 1. P-glycoprotein Multidrug resistance; MRP1 Žmultidrug resistance-associated protein.; Daunorubicin; Calcein-AM; Inhibitor; PAK-104P ŽMarbeuf-Gueye, C. Ž391. 207. P-glycoprotein 5-HT1A receptor; Positron Emission Tomography ŽPET. ŽPasschier, J. Ž407. 273. P-glycoprotein function, in vivo Renal failure, acute; P-glycoprotein level; P-glycoprotein-related compound endogenous; Rhodamine 123; Pharmacokinetics ŽHuang, Z.-H. Ž406. 453. P-glycoprotein level Renal failure, acute; P-glycoprotein function, in vivo; P-glycoprotein-related compound endogenous; Rhodamine 123; Pharmacokinetics ŽHuang, Z.-H. Ž406. 453. P-glycoprotein-related compound endogenous Renal failure, acute; P-glycoprotein level; P-glycoprotein function, in vivo; Rhodamine 123; Pharmacokinetics ŽHuang, Z.-H. Ž406. 453. pH Acidosis; ATP; P2X receptor; Purine; Mesenteric arterial bed; Vasoconstriction ŽRalevic, V. Ž406. 99. pH Modulation NPPB Ž5-nitro-2-Ž3-phenylpropylamino.-benzoic acid.; Patch clamp; Ca2q current; Ca2q current, Capacitative; Ca2q release-activated current; Jurkat cell ŽLi, J.H. Ž394. 171. Pharmacodynamics Acute tolerance; Clozapine, intravenous; Clozapine, oral; Pharmacokinetics; Pharmacokinetic–pharmacodynamic modeling; Potency, relative ŽSun, L. Ž398. 225. Pharmacoepidemiology Pharmacogenetics; Polymorphism; Pharmacotherapy van der Zee, A.H. Ž410. 121.

ŽMaitland-

Dinitrobenzene sulfonic acid; Inflammation; Nitric oxide ŽNO.; Poly ŽADP-ribose. synthetase; Colon damage; Free radical ŽCuzzocrea, S. Ž406. 127.

Pharmacogenetic Pharmacogenomic; Molecular epidemiology; Genotype; Phenotype; DNA sequence variants; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107.

Personality Genes; Neurotransmission; Polymorphism; Temperament; Abnormal behavior ŽEbstein, R.P. Ž410. 205.

Pharmacogenetics Polymorphism; Pharmacotherapy; Pharmacoepidemiology ŽMaitlandvan der Zee, A.H. Ž410. 121.

108

Master keyword index to Õolumes 386–410 (2000)

5-HT Ž5-hydroxytryptamine, serotonin.; Tryptophan hydroxylase; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. Dopamine receptor; Polymorphism; Mutation; Antipsychotic; Schizophrenia ŽWong, A.H.C. Ž410. 183. Schizophrenia; Single nucleotide polymorphism; Pharmacogenomics; Genome-wide scanning; DNA microarray ŽKawanishi, Y. Ž410. 227. Opioid system, endogenous; Gene polymorphism; Single nucleotide polymorphism; Addiction; Physiogenetics ŽLaForge, K.S. Ž410. 249.

Pharmacotherapy Pharmacogenetics; Polymorphism; Pharmacoepidemiology ŽMaitlandvan der Zee, A.H. Ž410. 121. Phenamil Ryanodine receptor; Skinned fiber; Dichlorobenzamil; Caffeine ŽPonte, C.G. Ž391. 11. Phencyclidine Scopolamine; Muscarinic acetylcholine receptor; Prepulse inhibition; Startle; Apomorphine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105.

Long QT syndrome; Kq channel; Heart ŽEscande, D. Ž410. 281.

Prepulse inhibition; Apomorphine; s1 Receptor ligand; MS-377 ŽYamada, S. Ž402. 251.

Pharmacogenomics Pharmacogenetic; Molecular epidemiology; Genotype; Phenotype; DNA sequence variants; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107.

Nitric oxide ŽNO.; N G -nitro-L-arginine methyl ester; Behaviour; c-fos; ŽRat. ŽBujas-Bobanovic, M. Ž409. 57.

Schizophrenia; Pharmacogenetics; Single nucleotide polymorphism; Genome-wide scanning; DNA microarray ŽKawanishi, Y. Ž410. 227. Opiate; Heroin; Addiction; Genetic; Candidate gene ŽLichtermann, D. Ž410. 269. Pharmacokinetic–pharmacodynamic modeling Acute tolerance; Clozapine, intravenous; Clozapine, oral; Pharmacodynamics; Pharmacokinetics; Potency, relative ŽSun, L. Ž398. 225. Pharmacokinetics Acute tolerance; Clozapine, intravenous; Clozapine, oral; Pharmacodynamics; Pharmacokinetic–pharmacodynamic modeling; Potency, relative ŽSun, L. Ž398. 225. Renal failure, acute; P-glycoprotein level; P-glycoprotein function, in vivo; P-glycoprotein-related compound endogenous; Rhodamine 123 ŽHuang, Z.-H. Ž406. 453. Pharmacological Acetylcholine receptor; Neuron; Property; Ligand binding domain; Physiological ŽCurtis, L. Ž393. 155. Pharmacological comparison Nicotinic acetylcholine receptor; Subunit null mutation; Binding; Activation ŽWhiteaker, P. Ž393. 123. Pharmacology a 1a -Adrenoceptor; a 1b-Adrenoceptor; a 1d-Adrenoceptor; Rabbit; Molecular cloning; Tissue distribution ŽPiao, H. Ž396. 9. Dopamine D4 receptor; G protein-coupled receptor; Structure; Signaling; Physiology; Genetics ŽOak, J.N. Ž405. 303. Ca2q channel; Recombinant; HEK293 cell ŽMcNaughton, N.C.L. Ž407. 53. Pharmacophore model mGlu8 receptor; mGlu4 receptor; ŽRat. ŽDe Colle, C. Ž394. 17. Glycine receptor; 5-HT3 receptor antagonist; Potentiation; Interaction; Selectivity ŽChesnoy-Marchais, D. Ž402. 205. Pharmacoresistant Antiepileptic drug; Vigabatrin; Epileptic activity; Temporal lobe epilepsy; Brain slice ŽMusshoff, U. Ž401. 167.

Phencyclidine receptor NMDA receptor; Gacyclidine; Gacyclidine enantiomer; Neuroprotection ŽHirbec, H. Ž388. 235. Phencyclidine site Glutamate; Neurotoxicity; s Receptor; Cortical culture ŽNishikawa, H. Ž404. 41. Phenobarbital Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenytoin; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Phenotype Pharmacogenetic; Pharmacogenomic; Molecular epidemiology; Genotype; DNA sequence variants; Population genetic; Patient-pair studies ŽNebert, D.W. Ž410. 107. Phentolamine Pulmonary arteries; Dexfenfluramine; Prazosin; Ketanserin; Indomethacin ŽPatnaude, L.A. Ž401. 229. Organophosphate; Diisopropyl-flurophosphate; Aorta; Norepinephrine; ŽRat. ŽLim, S.L. Ž404. 353. Phenylephrine Radial artery; Phosphodiesterase 3; Olprinone ŽAdachi, H. Ž396. 43. Diabetes; Ouabain; Naq,Kq-ATPase; Vascular reactivity; Streptozotocin; Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419. Phenylethanoid Macrophage; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase; Inducible; 1-propanam ine-3-hydroxy-2-nitroso-1-propylhydrazino Ž PA PA NONOate.ŽXiong, Q. Ž400. 137. Phenytoin Epilepsy; Topiramate; Carbamazepine; Valproate; Felbamate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Valproate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275. Ovulation; Oestrogen; Uterus ŽTamura, K. Ž398. 317.

Master keyword index to Õolumes 386–410 (2000) Phloacetophenone Acetophenone analogue; Choleretic; Cholesterol; Lithogenic index; Ž Curcuma comosa. ŽPiyachaturawat, P. Ž387. 221. Phlorizin Streptozotocin; T-1095; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Phobia Nicotine; 5-HT1A receptor; Anxiety; Septum, lateral; Hippocampus, dorsal ŽFile, S.E. Ž393. 231. Phoneutria nigrizenter venom Sensory nerve; Neurogenic plasma extravasation; Tachykinin NK 1 receptor agonist; Vanilloid receptor; Purinoceptor ŽCosta, S.K.P. Ž391. 305. Phorbol 12,13-diacetate Bronchus, human, isolated; Theophylline; Caffeine ŽSarria, ´ B. Ž399. 65. Phorbol-12, 13-dibutyrate Bradykinin; Thermal hyperalgesia; Protein kinase C; Calphostin C; Diabetes; ŽMouse. ŽKamei, J. Ž390. 113. [3 H]Phorbol 12,13-dibutyrate binding 5-HT Ž5-Hydroxytryptamine, serotonin.; Endothelial cell, rat; Protein kinase C; Trypsin-treated protein kinase C activity; cAMP; cGMP ŽLee, H.-Z. Ž403.195. Phorbol ester Dopamine release; Protein kinase C; Amphetamine; Cocaine; Transport, reverse ŽCowell, R.M. Ž389. 59.

109

Ethanol withdrawal; Adipose tissue; Hormone-sensitive lipase, cAMP ŽShih, M.-F. Ž409. 223. Phosphodiesterase 4 inhibitor RPR 73401; Allergic dermatitis; Ear swelling test, mouse; Interleukin-4 ŽEhinger, A.M. Ž392. 93. Glaucine; Sensitized, guinea pig; Airway hyperreactivity; Airway eosinophil infiltration; Airway microvascular leakage ŽPons, R. Ž397. 187. Phosphodiesterase inhibitor Matrix metalloproteinase; Tissue remodelling; Bronchoalveolar lavage; ŽMouse. ŽBelleguic, C. Ž404. 369. Streptozotocin-diabetic, rat; Cilostazol; Antiplatelet vasodilating agent ŽYamamoto, Y. Ž409. 1. Phosphoinositide Rabbit; Artery; Peptide; Phospholipase C; Urotensin II ŽOpgaard, O.S. Ž406. 265. Phosphoinositide breakdown HCL-31D, platelet aggregation; cAMP; Thromboxane B 2 ŽChou, T.-C. Ž387. 125. Phosphoinositide turnover Cholecystokinin; SR146131; wCa2q x i ; Binding; ŽHuman. ŽSchaeffer, P. Ž397. 303.

Protein kinase C; Oxidant; Cellular injury ŽTepperman, B.L. Ž389. 131.

Phospholipase A 2 Nuclear-factor-kB; Mitogen-activated protein kinase; Interleukin-1; Inflammation ŽBurgermeister, E. Ž388. 195.

Bradykinin; Inflammation; Neurogenic; Protein kinase C; Triterpenoid ŽHuguet, A.-I. Ž410. 69.

Cardiomyocyte; Ca2q channel; Arachidonic acid; Mepacrine ŽXiao, Y.-F. Ž399. 107.

Phorbol 12-myristate 13-acetate (PMA) Taxol; Polyploidization; Protein kinase C; Polymerization ŽZong, Z.-p. Ž394. 181.

Carrageenin-induced pleurisy, rat; Anti-inflammatory steroid; Dexamethasone; Prostaglandin H synthase-2 Žcyclooxygenase-2. ŽKawamura, M. Ž400. 127.

Phosphatidylcholine secretion Pneumocyte Žtype II.; Adrenomedullin; Surfactant; Protein kinase C ŽOkumura, M. Ž403. 189.

Melittin; Gap junction; Connexin; Endothelium-derived hyperpolarizing factor ŽEDHF.; Endothelium; Smooth muscle, vascular ŽHutcheson, I.R. Ž406. 239.

Phosphatidylinositol 3-kinase a 1-Adrenoceptor; Receptor phosphorylation; Protein kinase C; G protein receptor kinases; Desensitization ŽGarcıa-Sainz, J.A. Ž389. 1. ´ ´

Phospholipase C Neutrophils, rat; p38 Mitogen-activated protein kinase; Tyrosine kinase; Protein kinase C; Ca2q, cytosolic-free ŽChang, L.-C. Ž390. 61.

Phosphatidylinositol-3-kinase Wortmannin; Adenosine; Methacholine; 5-HT; Bronchoconstriction; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469.

Pancreastatin receptor; Signaling; G protein; MAPK; HTC cell; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´

Phosphatidylserine Reserpine; Memory; Passive avoidance ŽAlves, C.S.D. Ž404. 161.

Histamine; Chromaffin cell; Ca2q; Inositol phospholipid; Adrenal medulla ŽRoberts-Thomson, E.L. Ž398. 199.

Phosphodiesterase 3 Radial artery; Olprinone; Phenylephrine ŽAdachi, H. Ž396. 43.

Rabbit; Artery; Phosphoinositide; Peptide; Urotensin II ŽOpgaard, O.S. Ž406. 265.

Phosphodiesterase 4 Arthritis; Hyperalgesia; Oedema; TNF-a Žtumor necrosis factor-a .; Rolipram ŽFrancischi, J.N. Ž399. 243.

Phosphoramidon Endothelin-1; FR139317; BQ-788; Transmural electrical stimulation ŽNagayama, T. Ž406. 69.

Phosphodiesterase Pulmonary circulation; cAMP; cGMP; ŽPharmacology.; ŽCat. ŽDe Witt, B.J. Ž406. 233.

Phosphorylation G protein-coupled receptor; Dopamine; Palmitoylation; Desensitization; Adenylyl cyclase ŽJin, H. Ž386. 305.

110

Master keyword index to Õolumes 386–410 (2000)

Dopamine transporter; Cocaine; Cocaine analog; Chimera; Site-directed mutagenesis ŽChen, N. Ž405. 329. Photoaffinity labeling Nicotinic acetylcholine receptor; Antagonist, noncompetitive; Antagonist, competitive; 5-HT Ž5-hydroxytryptamine, serotonin. ŽBlanton, M.P. Ž389. 155. Physical dependence Dihydroetorphine; Morphine; Stereotypy; Continuous infusion; ŽRat. ŽAceto, M.D. Ž387. 31. Physiogenetics Opioid system, endogenous; Gene polymorphism; Single nucleotide polymorphism; Addiction; Pharmacogenetics ŽLaForge, K.S. Ž410. 249. Physiological Acetylcholine receptor; Neuron; Property; Ligand binding domain; Pharmacological ŽCurtis, L. Ž393. 155.

Place conditioning Naloxone; Morphine; Sensitization; NMDA receptor antagonist; Mice ŽBlokhina, E.A. Ž406. 227. Placenta P-Glycoprotein; BeWo cells; Blood–placental barrier; Drug disposition ŽUshigome, F. Ž408. 1. Placenta, rat Norepinephrine transporter; Cocaine, chronic ŽShearman, L.P. Ž386. 1. Planaria D2 receptor; UV light ŽRaffa, R.B. Ž406. R11. Plant alkaloid Cryptolepine; Neocryptolepine; Topoisomerase II; Cytotoxicity; Apoptosis ŽDassonneville, L. Ž409. 9.

Physiology Dopamine D4 receptor; G protein-coupled receptor; Structure; Pharmacology; Signaling; Genetics ŽOak, J.N. Ž405. 303.

Plaque Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Tau; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨

Physostigmine Donepezil hydrochloride ŽE2020.; Tacrine; ENA-713; TAK-147; NIK247; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173.

Plasma Kynurenine; 3-Hydroxyanthranilic acid; Inhibitor; Brain; ŽRat. ŽFornstedt-Wallin, B. Ž386. 15.

Picroliv Ischemia–reperfusion injury; Liver; Antioxidant ŽSingh, A.K. Ž395. 229.

Plasma extravasation Substance P; Vasodilatation; Knee joint, Rabbit ŽLam, F.F.Y. Ž400. 327.

Picroside I Picroside II; Neurite outgrowth activity; Nerve growth factor ŽNGF.; Mitogen-activated protein ŽMAP. kinase; PC12D cell ŽLi, P. Ž406. 203.

Platelet Valproate; Arachidonic acid cascade; Brain microvessel, rat ŽSzupera, Z. Ž387. 205.

Picroside II Picroside I; Neurite outgrowth activity; Nerve growth factor ŽNGF.; Mitogen-activated protein ŽMAP. kinase; PC12D cell ŽLi, P. Ž406. 203.

Aspirin; Dipyridamole; Nitric oxide ŽNO.; Polymorphonuclear leukocyte ŽDe La Cruz, J.P. Ž397. 35.

Pilsicainide Disopyramide; Cibenzoline; QTc; Adrenaline; ŽDog. ŽMiyamoto, S. Ž400. 263. Pimozide Kq channel; HERG Žhuman ether-a-go-go-related gene.; Arrhythmia; Antipsychotic agent ŽKang, J. Ž392. 137. Pineal gland X X Melatonin; N -acetyl-5-hydroxytryptamine Ž N -acetyl-5-HT.; Suramin; P2-receptor ŽMortani Barbosa Jr., E.J. Ž401. 59. Pioglitazone Apoptosis; Smooth muscle cell, vascular; p53; Gadd45; Troglitazone ŽOkura, T. Ž407. 227. 4-PIOL GABA A receptor subtype; Brain regional heterogeneity; w35 SxTBPS binding; Agonist coupling; Taurine; b-Alanine; Muscimol; 5-Ž4piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233. 5-(4-piperidine)isoxazol-3-ol GABA A receptor subtype; Brain regional heterogeneity; w35 SxTBPS binding; Agonist coupling; Taurine; b-Alanine; Muscimol; 4-PIOL ŽRabe, H. Ž409. 233. Pituitary adenylate cyclase activating polypeptide (PACAP) Atrium; cAMP ŽCui, X. Ž402. 129.

Endothelial factor; Hemostasis; Nitric oxide ŽNO.; Thrombosis ŽMomi, S. Ž397. 177. TA-993; Glycoprotein IIbrIIIa receptor; ADP; Actin polymerization; Ca2q, intracellular ŽKatoh, M. Ž399. 91. Alzheimer disease; Amyloid precursor protein ŽAPP.; Diagnosis ŽDi Luca, M. Ž405. 277. Platelet aggregation Angiotensin-converting enzyme; Angiotensin-converting enzyme inhibitor; Endothelial cells, cultured; Umbilical veins, human; Nitric oxide ŽNO. ŽPersson, K. Ž406. 15. Thrombin; Coagulation; Shear; Bifunctional inhibitor ŽTaka, T. Ž406. 181. (PDGF) Platelet-derived growth factor Biscoclaurine alkaloid; ŽTGF-b . Transforming growth factor-b; Mesangial cell, rat ŽHayama, M. Ž390. 37. Platelet-derived growth factor A-chain Methylene methylimino linkage; Antisense; Spontaneously hypertensive rat ŽSHR.; Smooth muscle cell, vascular ŽKishioka, H. Ž392. 129. Platelet, human Thrombin; Thromboxane; Protein kinase C; Protein kinase inhibitor ŽSamokhin, G.P. Ž386. 297.

Master keyword index to Õolumes 386–410 (2000)

111

Plethysmometry Paw oedema; Adenosine A 1 receptor; Adenosine A 2 receptor; Adenosine A 3 receptor; ŽRat. ŽSawynok, J. Ž386. 253.

Polyploidization Taxol; Phorbol 12-myristate 13-acetate ŽPMA.; Protein kinase C; Polymerization ŽZong, Z.-p. Ž394. 181.

Pleura Angiotensin II; Angiotensin II type 1 receptor; Ca2q, cytosolic; Mesothelial cell ŽKuwahara, M. Ž388. 21.

Pons r medulla m-Opioid receptor; G-protein; Antinociception; Diabetes ŽOhsawa, M. Ž401. 55.

Pleurisy Benzodiazepine receptor, peripheral; Paw oedema ŽTorres, S.R. Ž408. 199.

Population genetic Pharmacogenetic; Pharmacogenomic; Molecular epidemiology; Genotype; Phenotype; DNA sequence variants; Patient-pair studies ŽNebert, D.W. Ž410. 107.

Plus-maze Anxiety; Opiate; Benzodiazepine; Naloxone ŽBelzung, C. Ž394. 289. Nicotinic acetylcholine receptor; Sensitization; Disinhibition; Locomotor activity; ŽRat. ŽEricson, M. Ž397. 103. P38 MAPK (P38 mitogen-activated protein kinase) Okadaic acid; Adrenomedullin; ERK Žextracellular signal-related kinase.; JNK Žjun amino-terminal kinase. ŽParameswaran, N. Ž388. 133. Pneumocyte (type II) Phosphatidylcholine secretion; Adrenomedullin; Surfactant; Protein kinase C ŽOkumura, M. Ž403. 189. Poly(ADP-ribose)polymerase Glioma; Nitrosoureas; 3-Aminobenzamide ŽWinter, S. Ž398. 177. Poly (ADP-ribose) polymerase Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Reactive oxygen species; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide ŽRuiz, F. Ž404. 29. Poly (ADP-ribose) synthetase Dinitrobenzene sulfonic acid; Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Colon damage; Free radical ŽCuzzocrea, S. Ž406. 127. Polygodial Relaxation; Aorta, rabbit; Pulmonary artery, rabbit; Pulmonary artery, guinea-pig; Nitric oxide ŽNO. ŽAndre, ´ E. Ž386. 47. Polymerization Taxol; Polyploidization; Phorbol 12-myristate 13-acetate ŽPMA.; Protein kinase C ŽZong, Z.-p. Ž394. 181. Polymorphism Pharmacogenetics; Pharmacotherapy; Pharmacoepidemiology ŽMaitlandvan der Zee, A.H. Ž410. 121. Dopamine receptor; Pharmacogenetics; Mutation; Antipsychotic; Schizophrenia ŽWong, A.H.C. Ž410. 183. Personality; Genes; Neurotransmission; Temperament; Abnormal behavior ŽEbstein, R.P. Ž410. 205. Angiotensin; Angiotensin-converting enzyme; Angiotensinogen; Angiotensin AT1 receptor; Renin ŽDanser, A.H.J. Ž410. 303. Polymorphonuclear leukocyte Aspirin; Dipyridamole; Nitric oxide ŽNO.; Platelet ŽDe La Cruz, J.P. Ž397. 35. Rho kinase; p160ROCK; Superoxide production; Aggregation ŽKawaguchi, A. Ž403. 203.

Porigonum tinctorium Lour. Indirubin; Interferon-g; Delayed-type, hypersensitivity ŽKunikata, T. Ž410. 93. Positive inotropic effect Ventricular muscle, dog; Ca2q transient; Myofibrillar Ca2q sensitivity; cAMP; Levosimendan ŽTakahashi, R. Ž400. 103. Positron Emission Tomography (PET) 5-HT1A receptor; P-glycoprotein ŽPasschier, J. Ž407. 273. Postnatal development Dopamine; Dopamine D 3 receptor; Žq.-PD128,907; Motor activity ŽHeijtz, R.D. Ž392. 35. Post-operative ileus Gastrointestinal transit; Gastrointestinal motility; Interdigestive migrating contraction; SK-896; Prostaglandin F2 a ; ŽDog. ŽTsukamoto, K. Ž401. 97. Post-traumatic stress disorder (PTSD) Behaviour; Autonomic response; Endocrine response; Anxiety; Affective disorder; ŽRat. ŽStam, R. Ž405. 217. Potency, relative Acute tolerance; Clozapine, intravenous; Clozapine, oral; Pharmacodynamics; Pharmacokinetics; Pharmacokinetic–pharmacodynamic modeling ŽSun, L. Ž398. 225. Potent adenylate cyclase activator Protein kinase-A; Protein phosphatase-1rprotein phosphatase-2A ŽParameswaran, N. Ž407. 205. Potentiation Cocaine; Noradrenaline; Blood pressure; Contractility; Chlorisondamine ŽSabra, R. Ž397. 139. Glycine receptor; 5-HT3 receptor antagonist; Interaction; Pharmacophore model; Selectivity ŽChesnoy-Marchais, D. Ž402. 205. X X PPADS (Pyridoxal-phosphate-6-azophenyl-2 ,4 -disulphonic acid) Ž Capsaicin; Myenteric neuron; VIP Vasoactive intestinal polypeptide.; PACAP ŽPituitary adenylate cyclase activating peptide.; NO ŽNitric oxide.; Small intestine ŽBartho, ´ L. Ž392. 183. X

X

X

PPADS (pyridoxal-5 -phosphate-6-phenylazo-2 ,4 -disulfonate) X X P2 receptor antagonist; PPNDS Žpyridoxal-5 -phosphate-6-Ž2 -naphX X X thylazo-6 -nitro-4 ,8 -disulfonate.. ŽLambrecht, G. Ž387. R19. X

X

X

X

X

PPNDS (pyridoxal-5 -phosphate-6-(2 -naphthylazo-6 -nitro-4 ,8 -disulfonate)) X P2 receptor antagonist; PPADS Žpyridoxal-5 -phosphate-6-phenylazoX X . Ž Ž . . 2 ,4 -disulfonate Lambrecht, G. 387 R19

112

Master keyword index to Õolumes 386–410 (2000)

P2 purinoceptors ATP; Feeding behaviour ŽKittner, H. Ž406. R13. Pravastatin Monocyte; Inflammation; Lipid metabolism; Pro-inflammatory molecule ŽGrip, O. Ž410. 83. Prazosin Morphine withdrawal; Ventricle, right; Catecholaminergic activity; Yohimbine ŽMilanes, ´ M.V. Ž397. 311. Pulmonary arteries; Dexfenfluramine; Phentolamine; Ketanserin; Indomethacin ŽPatnaude, L.A. Ž401. 229. Preconditioning; Angiotensin; Ischaemia; Colchicine ŽSharma, A. Ž406. 85. P2 receptor EDHF Žendothelin-derived hyperpolarising factor.; Endothelium; Purine; Pyrimidine; Vasodilatation ŽMalmsjo, ¨ M. Ž390. 173. P2-receptor X X Pineal gland; Melatonin; N -acetyl-5-hydroxytryptamine Ž N -acetyl-5. Ž Ž . . HT ; Suramin Mortani Barbosa Jr., E.J. 401 59

Preoptic anterior hypothalamus Lipopolysaccharide; Fever; m-Opioid receptor antagonist ŽBenamar, K. Ž401. 161. Prepulse inhibition Scopolamine; Muscarinic acetylcholine receptor; Startle; Apomorphine; Phencyclidine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105. Apomorphine; Phencyclidine; s1 Receptor ligand; MS-377 ŽYamada, S. Ž402. 251. Pre-pulse inhibition Nicotine; Schizophrenia; Information processing; ŽRat. ŽMirza, N.R. Ž407. 73. Presynaptic modulation Basolateral amygdala; Synaptic g-aminobutyric acid ŽGABA. transmission; 5-HT1A receptors; Dissociated neuron and tandospirone ŽKishimoto, K. Ž407. 257. Primary culture DNA synthesis; Proliferation; Prostaglandin; Hepatocyte; ŽAdult rat. ŽKimura, M. Ž404. 259.

P2 receptor antagonist X X X X X PPNDS Žpyridoxal-5 -phosphate-6-Ž2 -naphthylazo-6 -nitro-4 ,8 -disX X X ulfonate..; PPADS Žpyridoxal-5 -phosphate-6-phenylazo-2 ,4 -disulfonate. ŽLambrecht, G. Ž387. R19.

Primary cultured neuron Acamprosate; Ethanol; Spermine; NMDA receptor; Patch-clamp, wholecell ŽPopp, R.L. Ž394. 221.

Preclinical study 5-HT1B r1D receptor agonist; Migraine; Almotriptan ŽGras, J. Ž410. 43.

Primary culture of hepatocyte Insulin; Tyrosine phosphorylation; cAMP phosphodiesterase; Microtubule; Wortmannin; Herbimycin A ŽIshibashi, K. Ž409. 109.

Preconditioning Brain; Cerebral ischemia; Ischemic tolerance; Lipopolysaccharide; Nitric oxide ŽNO.; Nitric oxide synthase ŽNOS.; Heat shock protein; Nitro-Larginine methyl ester; ŽRat. ŽPuisieux, F. Ž389. 71. Angiotensin; Ischaemia; Prazosin; Colchicine ŽSharma, A. Ž406. 85. CGRP Žcalcitonin gene-related peptide.; TNF-a Žtumor necrosis factor-a .; Glibenclamide; Heart, rat ŽPeng, J. Ž407. 303. Pre-eclampsia Histamine; Nitric oxide ŽNO.; Endothelium; ANP Žatrial natriuretic peptide.; ŽHuman. ŽSuzuki, Y. Ž410. 7. Prefrontal cortex Addiction; Dependence; Dopamine; Nicotine; Nucleus accumbens ŽDi Chiara, G. Ž393. 295. Dopamine; Microdialysis, In vivo; Shuttle-box; Working memory; ŽGerbil. ŽStark, H. Ž405. 263. Pregnenolone CO-induced amnesia; Neuroactive steroid; Dehydroepiandrosterone; Learning; Memory; ŽMouse. ŽMaurice, T. Ž390. 145. Pregnenolone sulfate Anabolic steroid; Ethylestrenol; Passive avoidance behavior; Memory; Non-linear dynamics; Chaos theory; Attractor ŽIsaacson, R.L. Ž405. 177. Prejunctional neuromodulation Adenosine; ATP; Mesentery, hamster; Purine receptor; Sympathetic neurotransmission ŽRalevic, V. Ž387. 287. Prenatal Androgen; Th1rTh2; Immune function; Estrogen; Autoimmunity ŽMartin, J.T. Ž405. 251.

Primary neuronal culture NS-105; Glutamate receptor, metabotropic; Adenylyl cyclase; Antisense oligodeoxynucleotide, knockdown ŽHirouchi, M. Ž387. 9. Primed-burst stimulation Synaptic plasticity; Long-term potentiation; Visual cortex; Ketamine ŽSalami, M. Ž390. 287. Proarrhythmia Antiarrhythmic; Class I; Myocardial ischaemia; Arrhythmia ŽBarrett, T.D. Ž398. 365. Probenecid OAT1 Žorganic anion transporter 1.; p-Aminohippurate; Methotrexate; NSAID Žnonsteroidal anti-inflammatory drug.; Kidney; ŽRat. ŽUwai, Y. Ž409. 31. Progesterone Diazepam; g-Aminobutyric acid ŽGABA.; Kq channel; Coronary ŽJacob, M.K. Ž403. 209. Pro-inflammatory molecule Pravastatin; Monocyte; Inflammation; Lipid metabolism ŽGrip, O. Ž410. 83. Prolactin Low dose; Grooming, Novelty-induced; Sexual behavior, Male; Sexual behavior, Female ŽDrago, F. Ž405. 131. Proliferation Ibuprofen; Cyclooxygenase; Smooth muscle cell ŽWeber, A.-A. Ž389. 67. wMet 5 xenkephalin; Gender; T-lymphocyte; B-lymphocyte; Opioid receptor ŽGabrilovac, J. Ž392. 101.

Master keyword index to Õolumes 386–410 (2000) Endothelial cell; Angiogenesis; Ca2q influx ŽKawasaki, J. Ž398. 19. Berberine; Nitric oxide ŽNO.; Kq channel; Ca2q channel; Vasorelaxation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187.

113

Airway; Leukotriene; Neuromediator; Endothelin; ŽMouse. ŽRichter, M. Ž389. 225. Morphine withdrawal; Prostanoid EP3 receptor; m-Opioid receptor; c-fos; Locus coeruleus ŽNakagawa, T. Ž390. 257.

Heparin; Intragastric administration; Gastric ulcer healing; Nitric oxide ŽNO. synthase, Constitutive; Regeneration; Angiogenesis ŽLi, Y. Ž399. 205.

Momordin Ic; Gastrointestinal transit; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT2 receptor ŽLi, Y. Ž392. 71.

Dermatan; Chondroitin sulfate; Fibroblast; Chondroitinase ŽDenholm, E.M. Ž400. 145.

Hyperosmolarity; Nitric oxide ŽNO.; Vasoactive intestinal peptide ŽVIP.; Tracheal perfusion; ŽGuinea-pig. ŽHjoberg, J. Ž398. 303.

DNA synthesis; Prostaglandin; Primary culture; Hepatocyte; ŽAdult rat. ŽKimura, M. Ž404. 259.

Thiazolidinedione; Hemodynamics; Heart; Coronary vasorelaxant ŽUchida, K. Ž400. 113.

Neuromedin B receptor antagonist, nonpeptide; Ca2q, cytosolic; c-fos mRNA; Focal adhesion kinase ŽMoody, T.W. Ž409. 133.

DNA synthesis; Proliferation; Primary culture; Hepatocyte; ŽAdult rat. ŽKimura, M. Ž404. 259.

Osteoblast, Human; CGRP Žcalcitonin gene-related peptide.; CGRP-Ž837.; Amylin, Amylin-Ž8-37.; cAMP ŽVilla, I. Ž409. 273.

Helicobacter pylori; NSAID; Cyclooxygenase; Gastric ulceration ŽTakahashi, S. Ž406. 461.

Pro-matrix metalloproteinase 1 X Osteoarthritis; Rheumatoid arthritis; Aceclofenac; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 3; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429.

Wogonin; Flavonoid; Cyclooxygenase; Macrophage ŽWakabayashi, I. Ž406. 477.

Pro-matrix metalloproteinase 3 X Osteoarthritis; Rheumatoid arthritis; Aceclofenac; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 1; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429. Promoter Nicotinic receptor; Transcription; Enhancer; Neuron ŽDeneris, E.S. Ž393. 69. Nicotinic receptor; Neuron, human; Gene; Transcriptional regulation ŽFlora, A. Ž393. 85. Property Acetylcholine receptor; Neuron; Ligand binding domain; Pharmacological; Physiological ŽCurtis, L. Ž393. 155. Propofol GABA A receptor; Anesthetic; Locus coeruleus ŽChen, C.-L. Ž386. 201. Arterial baroreceptor; Autonomic nervous system ŽXu, H. Ž387. 79. GABA Ž g-aminobutyric acid.; Anaesthetic; Benzodiazepine; Optic nerve ŽEmpson, R.M. Ž401. 339. Oxidative stress; Free radical; Antioxidant; Cortical culture; Vitamin E ŽBoland, A. Ž404. 21. Propranolol Zatebradine; Ischemia-induced arrhythmia; Reperfusion arrhythmia; ŽDog. ŽNaito, H. Ž388. 171. Prostacyclin Constitutively-active receptor; Chimeric receptor; IP receptor; Partial agonist ŽWise, H. Ž386. 89. Pulmonary artery, human; Contraction; Cysteinyl–leukotriene receptor; BAY u9773; MK 571 ŽBack, ¨ M. Ž401. 389. Prostaglandin Urinary bladder; Epithelium; Diabetes ŽPinna, C. Ž388. 267.

Tryptanthrin; Nitric oxide; Inducible NO synthase; Cyclooxygenase; Inflammation ŽIshihara, T. Ž407. 197. Prostaglandin E 2 Endothelin-1; Cyclooxygenase 2; Lipopolysaccharide; Macrophage ŽShimada, K. Ž388. 187. Bradykinin; Interleukin-1b; Ca2q mobilization; Gingival fibroblast, human ŽNakao, S. Ž395. 247. JTE-522; Cyclooxygenase-2; Thromboxane A 2 ; U-46619; Airway hyperresponsiveness; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267. Prostaglandin F2 a Gastrointestinal transit; Gastrointestinal motility; Interdigestive migrating contraction; Post-operative ileus; SK-896; ŽDog. ŽTsukamoto, K. Ž401. 97. Nitric oxide ŽNO.; Hypoxic pulmonary vasoconstriction; Pulmonary arterial tone; L-NAME; N-g-nitro-L-argine methyl ester ŽJones, R.D. Ž402. 111. Nonvascular smooth muscle; Mitogen-activated protein kinase; Contraction; Carbachol ŽYousufzai, S.Y.K. Ž407. 17. Prostaglandin H synthase-2 (cyclooxygenase-2) Carrageenin-induced pleurisy, rat; Anti-inflammatory steroid; Dexamethasone; Phospholipase A 2 ŽKawamura, M. Ž400. 127. Prostanoid wArg 8 xvasopressin; Smooth muscle cell; Cell proliferation ŽNagano, K. Ž389. 25. Hyperpolarization; Nitric oxide ŽNO.; N v -nitro-L-arginine; ODQ Ž1 Hw1,2,4xoxadiazolow4,3-axquinoxalin-1-one.; Carotid artery; Femoral artery ŽCrauwels, H.M. Ž404. 341. Purinergic neuromodulation; Endothelium; Bradykinin ŽThapaliya, S. Ž408. 313. Prostanoid EP3 receptor Morphine withdrawal; Prostaglandin; m-Opioid receptor; c-fos; Locus coeruleus ŽNakagawa, T. Ž390. 257.

Master keyword index to Õolumes 386–410 (2000)

114

Prostate a 1-Adrenoceptor; a 1L -Adrenoceptor; JTH-601; ŽDog. ŽSuzuki, Y. Ž394. 123.

P-Glycoprotein; Bioflavonoid; Blood–brain barrier; Vincristine ŽMitsunaga, Y. Ž395. 193. Endothelin-1; Cardiac muscle; wCa2q x i transient ŽIzumi, M. Ž396. 109.

Endothelin; Neuromuscular transmission; Endothelin ETA receptor; ŽRat. ŽSalamoussa, A. Ž403. 139. a 1A -Adrenoceptor antagonist; Adrenoceptor subtype ŽChang, R.S.L. Ž409. 301. Protection, delayed Myocardial infarction; Adenosine receptor agonist; ŽMinipig. ŽMeng, H. Ž387. 101. Protective effect Liver, rat; Ischemia–reperfusion; ATP; Bile flow; Glutathione; Antioxidant ŽSettaf, A. Ž406. 281. Protein kinase CREB ŽcAMP responsive element binding protein.; d-Opioid receptor; DPDPE ŽwD-Pen2,5 xenkephalin., Morphine; NG108-15 neuroblastoma ŽBilecki, W. Ž390. 1. Protein kinase A Rp-cAMPS; H-89; Mitogenesis ŽOsinski, M.T. Ž395. 173. Mesenteric artery, rat; cAMP; Levcromakalim; Forskolin; K AT P channels ŽOmar, R. Ž401. 85. q

2q

K channel, Ca -activated; Large conductance; Detrusor muscle; bAdrenoceptor ŽKobayashi, H. Ž404. 231. Protein kinase-A Potent adenylate cyclase activator; Protein phosphatase-1rprotein phosphatase-2A ŽParameswaran, N. Ž407. 205. Protein kinase C Thrombin; Thromboxane; Protein kinase inhibitor; Platelet, human ŽSamokhin, G.P. Ž386. 297. a 1-Adrenoceptor; Receptor phosphorylation; Phosphatidylinositol 3kinase; G protein receptor kinases; Desensitization ŽGarcıa-Sainz, J.A. ´ ´ Ž389. 1. Dopamine release; Amphetamine; Phorbol ester; Cocaine; Transport, reverse ŽCowell, R.M. Ž389. 59.

Nerve ligation; Chronic pain; TrkB receptor; Spinal cord; ŽMouse. ŽNarita, M. Ž401. 187. Hyperalgesia; Nerve ligation; Inflammation; Spinal cord; ŽMouse. ŽOhsawa, M. Ž403. 81. Taurine; Angiotensin II; Cell size; Fetal gene expression; Growth factor gene expression ŽAzuma, M. Ž403. 181. Pneumocyte Žtype II.; Phosphatidylcholine secretion; Adrenomedullin; Surfactant ŽOkumura, M. Ž403. 189. 5-HT Ž5-Hydroxytryptamine, serotonin.; Endothelial cell, rat; w3 HxPhorbol 12,13-dibutyrate binding; Trypsin-treated protein kinase C activity; cAMP; cGMP ŽLee, H.-Z. Ž403. 195. Differentiation; Atherosclerosis; Gene expression; a-tropomyosin; ŽRat. ŽHirano, K. Ž406. 209. Bradykinin; Inflammation; Neurogenic; Phorbol ester; Triterpenoid ŽHuguet, A.-I. Ž410. 69. Protein kinase, cAMP-dependent MAP Žmitogen-activated protein. kinase cascade; Regulation; Signal transduction ŽMizuno, K. Ž404. 63. Protein kinase, cGMP-dependent N-methyl-D-aspartate ŽNMDA.; Nitric oxide ŽNO.; Nociception; Spinal cord; Hyperalgesia; Pain ŽTao, Y.-X. Ž392. 141. Protein kinase C isoform Subarachnoid hemorrhage; Cerebral vasospasm ŽNishizawa, S. Ž398. 113. Protein kinase inhibitor Thrombin; Thromboxane; Protein kinase C; Platelet, human ŽSamokhin, G.P. Ž386. 297. Protein phosphatase Endothelial cell; Thrombin receptor ŽMizuno, O. Ž389. 13. Steroid; Dopamine D 2 receptor agonist; Dopamine D 2 receptor antagonist; Uptake ŽThompson, T.L. Ž401. 357.

Phorbol ester; Oxidant; Cellular injury ŽTepperman, B.L. Ž389. 131. Adenosine A 1 receptor; ATP; FRTL-5 thyroid cell; Signal transduction ŽVainio, M. Ž390. 43. Neutrophils, rat; p38 Mitogen-activated protein kinase; Tyrosine kinase; Phospholipase C; Ca2q, cytosolic-free ŽChang, L.-C. Ž390. 61. Bradykinin; Thermal hyperalgesia; Phorbol-12, 13-dibutyrate; Calphostin C; Diabetes; ŽMouse. ŽKamei, J. Ž390. 113. Cerebrovascular constriction; Tamoxifen; Oxyhemoglobin ŽWickman, G. Ž390. 181. UTP contraction; Aorta, rat; Smooth muscle; Vascular; Ca2q ŽLopez, C. ´ Ž391. 299. Taxol; Polyploidization; Phorbol 12-myristate 13-acetate ŽPMA.; Polymerization ŽZong, Z.-p. Ž394. 181.

r protein phosphatase-2A Protein phosphatase-1r Potent adenylate cyclase activator; Protein kinase-A ŽParameswaran, N. Ž407. 205. Protein SV-IV Hemophilia A; Blood coagulation control; Antithrombin consumption; Thrombin–antithrombin complex; Factor Xarantithrombin complex ŽDi Micco, B. Ž391. 1. Protoporphyrin IX Benzodiazepine receptor, mitochondrial; d-Aminolaevulinic acid; Zinc protoporphyrin IX; Aciflourfen; Protoporphyrinogen oxidase ŽMesenholler, M. Ž406. 171. ¨ Protoporphyrinogen oxidase Benzodiazepine receptor, mitochondrial; d-Aminolaevulinic acid; Protoporphyrin IX; Zinc protoporphyrin IX; Aciflourfen ŽMesenholler, M. ¨ Ž406. 171.

Master keyword index to Õolumes 386–410 (2000) Psychiatric disorder 5-HT1B rD receptor; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive; Target ŽMoret, C. Ž404. 1. Psychoneuroendocrinology Psychoneuroimmunoendocrinology; Genetic; Molecular biology ŽBrambilla, F. Ž405. 341. Psychoneuroimmunoendocrinology Psychoneuroendocrinology; Genetic; Molecular biology ŽBrambilla, F. Ž405. 341. Psychoneuroimmunology Conditioned response; Immunity; Stress ŽAder, R. Ž405. 167. Psychostimulant Dopamine trasporter; Amphetamine ŽFleckenstein, A.E. Ž406. 1.

115

Pulmonary supernumerary artery 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT1D -like receptor ŽShaw, A.M. Ž408. 69. Pulmonary vasoconstriction Chronic hypoxia; Lung; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. Pulmonary vasodilation Chronic hypoxia; Lung; Endothelin-1; Big-endothelin-1; Sarafotoxin-6C; Pulmonary vasoconstriction; Bronchoconstriction; Endothelin ET B receptor; ŽRat. ŽLal, H. Ž402. 101. Purine EDHF Žendothelin-derived hyperpolarising factor.; Endothelium; P2 receptor; Pyrimidine; Vasodilatation ŽMalmsjo, ¨ M. Ž390. 173. Acidosis; ATP; P2X receptor; pH; Mesenteric arterial bed; Vasoconstriction ŽRalevic, V. Ž406. 99.

Psychostimulants sensitization Cocaine; Amphetamine; Nucleus accumbens shell; Nucleus accumbens core ŽCadoni, C. Ž388. 69.

Adenosine; ATP; Nucleotide; Hippocampus; Suramin; Long-term potentiation ŽO’Kane, E.M. Ž409. 159.

Pulmonary arterial tone Nitric oxide ŽNO.; Hypoxic pulmonary vasoconstriction; L-NAME; N-gnitro-L-argine methyl ester; Prostaglandin F2 a ŽJones, R.D. Ž402. 111.

Purine receptor Adenosine; ATP; Mesentery, hamster; Prejunctional neuromodulation; Sympathetic neurotransmission ŽRalevic, V. Ž387. 287.

Pulmonary arteries Dexfenfluramine; Phentolamine; Prazosin; Ketanserin; Indomethacin ŽPatnaude, L.A. Ž401. 229.

Purinergic Vas deferens; Ectonucleotidase; ATP ŽTennant, J.P. Ž387. 107.

Pulmonary artery Stroke-prone spontaneously hypertensive rats ŽSHRSP.; a-Adrenoceptors; Nitric oxide ŽNO.; Endothelium ŽMatsuda, K. Ž392. 61. Hypersensitivity; Ovalbumin; Endothelial reactivity; Nitric oxide ŽNO. ŽAkar, F. Ž395. 225.

Purinergic neuromodulation Endothelium; Bradykinin; Prostanoid ŽThapaliya, S. Ž408. 313. Purinoceptor Phoneutria nigriÕenter venom; Sensory nerve; Neurogenic plasma extravasation; Tachykinin NK 1 receptor agonist; Vanilloid receptor ŽCosta, S.K.P. Ž391. 305.

Pulmonary artery, guinea-pig Polygodial; Relaxation; Aorta, rabbit; Pulmonary artery, rabbit; Nitric oxide ŽNO. ŽAndre, ´ E. Ž386. 47.

Neonate; Cardiac myocyte; Ca2q current, L-type; Adenosine; ATP ŽSuto, F. Ž409. 213.

Pulmonary artery, human Contraction; Cysteinyl–leukotriene receptor; Prostacyclin; BAY u9773; MK 571 ŽBack, ¨ M. Ž401. 389.

Hormonal control; Endothelial receptor, luminal; ATP; Endothelial mediator; Cardiac function control ŽZenteno-Savin, T. Ž410. 15.

Pulmonary artery, porcine Leukotriene; Contraction; CysLT receptor; ICI 204,219; BAY u9773 ŽBack, ¨ M. Ž401. 381. Pulmonary artery, rabbit Polygodial; Relaxation; Aorta, rabbit; Pulmonary artery, guinea-pig; Nitric oxide ŽNO. ŽAndre, ´ E. Ž386. 47. Pulmonary circulation Phosphodiesterase; cAMP; cGMP; ŽPharmacology.; ŽCat. ŽDe Witt, B.J. Ž406. 233. Pulmonary hypertension Chronic hypoxia; 5-HT Ž5-hydroxytryptamine, serotonin. uptake; Lung, rat ŽJeffery, T.K. Ž396. 137. Pulmonary neuroendocrine cell a 7 Nicotinic receptor; Nicotine; Nicotine-derived nitrosamine; Small cell lung carcinoma; Mitogenic signal transduction ŽSchuller, H.M. Ž393. 265.

Purkinje cell AMPA receptor; GYKI 53784; Aniracetam; Cyclothiazide; 1-BCP; BDP12 ŽKapus, G. Ž397. 43. Cocaine; Cerebellum; Norepinephrine; Microiontophoresis; Glutamate; ŽRat. ŽJimenez-Rivera, C.A. Ž407. 91. ´ Purkinje fibre Fluoroquinolones; Sparfloxacin; Moxifloxacin; Grepafloxacin; Ciprofloxacin; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449. P2X receptor Acidosis; ATP; pH; Purine; Mesenteric arterial bed; Vasoconstriction ŽRalevic, V. Ž406. 99. Enteric neuron; Submucosal neuron; ATP receptor; Ca2q; Receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´ P2X 3 receptor Ethanol; Trichloroethanol ŽKoles, L. Ž409. R3. ¨

116

Master keyword index to Õolumes 386–410 (2000)

P2Y receptor Sweat gland; Anionic secretion; Hyperhidrosis; Ca2q, intracellular; Ussing chamber ŽBovell, D.L. Ž403. 45.

Rabeprazole Histamine; Enterochromaffin-like cell; Mast cell; Mast cell-deficient, rat ŽNakamura, S. Ž394. 9.

Enteric neuron; Submucosal neuron; ATP receptor; Ca2q; Receptor; P2X receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´

Rabies virus NG108-15 cell; Ca2q current; a-Adrenoceptor; Muscarinic receptor; Patch clamp, Whole-cell ŽIwata, M. Ž404. 79.

Pyridinoline Cyclosporin A; Osteopenia; Arginine; ŽRat. ŽFiore, C.E. Ž408. 323. Pyridobenzoazepine Electrophysiology; Antidepressant; 5-HT1A receptor; a 2-Adrenoceptor; Tyramine; Norepinephrine transporter ŽLiegeois, J.-F. Ž386. 211. ´ Pyrimidine EDHF Žendothelin-derived hyperpolarising factor.; Endothelium; P2 receptor; Purine; Vasodilatation ŽMalmsjo, ¨ M. Ž390. 173. Pyruvate-oxidation b 3 -Adrenoceptor agonists; Thermogenesis; Glucose metabolism; Soleus muscle, isolated ŽBoard, M. Ž406. 33. QTc Disopyramide; Cibenzoline; Pilsicainide; Adrenaline; ŽDog. ŽMiyamoto, S. Ž400. 263. QT-prolongation HERG; Fluoroquinolones; Patch-clamp technique ŽBischoff, U. Ž406. 341. Quantitative trait locus Alcohol; Opioid receptor; Genetics; Alcoholism ŽTown, T. Ž410. 243. Quetiapine 5-HT1A receptor; GTPgw35 Sx; Brain, human; Antipsychotic drug; Clozapine ŽElliott, J. Ž386. 313. Quinolinic acid NMDA Ž N-methyl-D-aspartate.; Kynurenine; Long-term potentiation; Hippocampus; NMDA receptor subunit ŽYoussef, F. Ž398. 349. Quinpirole Baroreflex; Renal sympathetic nerve activity; Rabbit, conscious ŽVan den Buuse, M. Ž388. 85.

Racemic-flurbiprofen c-Fos; SŽq.-flurbifrofen; RŽy.-flurbifrofen; Noxious heat; Spinal dorsal horn ŽBuritova, J. Ž406. 59. Raclopride Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; WAY 100635 ŽPrinssen, E.P.M. Ž395. 143. Radial-arm maze SR141716A; Cannabinoid; Working memory ŽLichtman, A.H. Ž404. 175. Radial artery Phosphodiesterase 3; Olprinone; Phenylephrine ŽAdachi, H. Ž396. 43. Radical oxygen intermediate Endocannabinoid; Cytokine ŽGallily, R. Ž406. R5. Radicicol LL-Z1640-2; Mitogen-activated protein kinases; c-Jun N-terminal kinase; HgCl 2 ŽMatsuoka, M. Ž409. 155. Radiolabeled ligand binding MS-377; s Binding site; Brain membrane, rat ŽKarasawa, J.-i. Ž400. 51. Radioligand binding b-Adrenoceptor; Muscarinic acetylcholine receptor ŽManukhin, B.N. Ž386. 279. Muscarinic receptor; Gallbladder; Receptor heterogeneity; Kinetics; Ca2q, Intracellular; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. Maxi-Kq channel; Iberiotoxin; Urinary bladder ŽMolinari, E.J. Ž388. 155.

w35 SxGTPgS binding, agonist-stimulated; Dopamine D 2 -like receptor; Monoamine oxidase inhibitor; Striatum; ŽRat. ŽGilliland, S.L. Ž392. 125.

5-HT3 receptor; Zn2q; Cation, Divalent; Voltage-clamp, Whole-cell; Neuromodulation ŽHubbard, P.C. Ž394. 189.

Blood pressure; Spinal cord transection; Intrathecal domperidone; Dopamine D 2 receptor, spinal; Conscious, rat ŽLahlou, S. Ž408. 51.

NMDA receptor; Receptor occupancy, in vivo; NR2B subunit; MK-801 ŽMurray, F. Ž397. 263.

Quisqualic acid mGlu 1 receptor, Arg 78 ; Agonist binding; Glutamic acid; Mutagenesis ŽJensen, A.A. Ž397. 247.

Dopamine; D3 receptor; BP 897; Microphysiometry ŽWood, M.D. Ž407. 47.

Rabbit a 1a -Adrenoceptor; a 1b -Adrenoceptor; a 1d -Adrenoceptor; Molecular cloning; Pharmacology; Tissue distribution ŽPiao, H. Ž396. 9. Artery; Phosphoinositide; Peptide; Phospholipase C; Urotensin II ŽOpgaard, O.S. Ž406. 265. Rabbit, conscious Quinpirole; Baroreflex; Renal sympathetic nerve activity ŽVan den Buuse, M. Ž388. 85.

Radiotelemetry Abecarnil; Withdrawal, precipitated ŽElliot, E.E. Ž394. 237. Nandrolone decanoate; Deca durabolin; Cocaine; Cardiac hypertrophy; ECG Želectrocardiogram.; Noradrenaline ŽPhillis, B.D. Ž398. 263. Anxiety; Stress; 5-HT1A receptor; Tachycardia; Hyperthermia ŽBouwknecht, J.A. Ž400. 59. L-DOPA

methylester; Parkinson’s disease; Daily rhythm; Chronopharmacology; Infusion constant rate ŽSimon, N. Ž401. 79.

Master keyword index to Õolumes 386–410 (2000)

117

Raf-1 Ribavirin; Ras; Cell cycle; Heat shock; Extracellular signal-regulated protein kinase; GTP ŽVallee, ´ S. Ž404. 49.

Rebamipide CCK 1 receptor; wCa2q x i oscillation; Pancreatic acinar cell ŽMoon, S.J. Ž388. 17.

Ramipril Metoprolol; Myocardial infarction; Action potential; Papillary muscle ŽWagner, K.-D. Ž388. 263.

Rebeccamycin Indolocarbazole; Cell membrane; Cellular uptake; Carbohydrate ŽGoossens, J.-F. Ž389. 141.

RAMP (receptor activity-modifying protein) Lenticulostriate artery, human; RT-PCR; CGRP Žcalcitonin gene-related peptide.; Adrenomedullin; CRLR Žcalcitonin receptor-like receptor. ŽSams, A. Ž408. 183.

Receptor Cannabinoid; Capsaicin; Neuron; Afferent; Pain; Sensory; Vasodilation ŽZygmunt, P.M. Ž396. 39.

Ranitidine Ischemia–reperfusion; Gastric secretion; Omeprazole; Ulcer healing; Gastric blood flow; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147. Raphe nuclei 5-HT Ž5-hydroxytryptamine, serotonin.; Paroxetine; Tianeptine; Frontal cortex; Microdialysis, in vivo ŽMalagie, ´ I. Ž403. 55. Ras Ribavirin; Raf-1; Cell cycle; Heat shock; Extracellular signal-regulated protein kinase; GTP ŽVallee, ´ S. Ž404. 49.

Glutamate; Metabotropic; Antagonist; 2-Methyl-6-Žphenylethynyl.-pyridine ŽMPEP. ŽSpooren, W.P.J.M. Ž406. 403. Enteric neuron; Submucosal neuron; ATP receptor; Ca2q; P2X receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´ s Receptor Organotypic slice culture; Mesencephalon; N-methyl-D-aspartate ŽNMDA.; Dopaminergic neuron ŽShimazu, S. Ž388. 139. Glutamate release; GABA Ž g-aminobutyric acid. release; Synaptosome; Cerebellum ŽGarrone, B. Ž400. 35. Neuroleptic; Haloperidol; Dystonia; Extrapyramidal ŽMatsumoto, R.R. Ž401. 155.

Rat Ensaculin; Dopamine; DOPAC Ž3,4-dihydroxyphenylacetic acid.; Glutamate; Microdialysis ŽTeismann, P. Ž398. 247.

Haloperidol; s1 Receptor mRNA; w3 HxDTG Žw3 Hx1,3-di Ž2-tolyl. guanidine.; w3 HxŽq.-Pentazocine; Species difference ŽInoue, A. Ž401. 307.

Rat sino-atrial nodal cell Cibenzoline; Disopyramide; Ionic current; I Kr ; I Ks ŽSatoh, H. Ž407. 123.

Glutamate; Neurotoxicity; Phencyclidine site; Cortical culture ŽNishikawa, H. Ž404. 41.

Rat, spinal Opiate; Dependence, acute; Gender difference; Cardiovascular system; Blood pressure; Heart rate ŽCruz, S.L. Ž397. 121.

Žq.Pentazocine; Haloperidol; Cerebellum; GTPase; w35 SxGTPgS autoradiography ŽHong, W. Ž408. 117.

Rauwolscine a 2 -Adrenoceptor; Agonist, Inverse; G protein-coupled receptor; RX821002; MK-912; GTP ŽMurrin, L.C. Ž398. 185. RAW264.7 Cannabinoid CB 2 receptor; WIN55212; Palmitoylethanolamide; Nitric oxide ŽNO.; Macrophage; cAMP ŽRoss, R.A. Ž401. 121. RB 120 Fluoxetine; Conditioned place preference; Morphine; CI 988; CCK 2 receptor antagonist ŽSubhan, F. Ž390. 137. Enkephalin catabolism, mixed inhibitors; Enkephalin, endogenous; Drug discrimination; Morphine; CI 988; CCK 1 receptor antagonist ŽHutcheson, D.M. Ž401. 197. Reactive oxygen intermediates Flupirtine; Retigabine; Glutamate toxicity; PC12 cells; Glutathione ŽSeyfried, J. Ž400. 155. Reactive oxygen species Ischemia–reperfusion; Cyclopiazonic acid; Oxidative stress; Free radical ŽGrover, A.K. Ž387. 87. Cerebrocortical neuronal culture; Glutamate excitotoxicity; Mitochondrion; Permeability transition pore; Cyclophilin; Cyclosporin A; Calcineurin; Nitric oxide ŽNO. synthase; Adenine nucleotide; Poly ŽADPribose. polymerase ŽRuiz, F. Ž404. 29.

Receptor associated modifying protein (RAMP) Amylin; Adrenomedullin; Calcitonin gene-related peptide ŽCGRP.; Calcitonin receptor-like receptor; Myocardial contraction ŽSaetrum Opgaard, O. Ž397. 373. Receptor binding NMDA receptor; Glycine site; GV150526A ŽMugnaini, M. Ž391. 233. Receptor coupling Chemokine; G-protein coupled receptor; HIV Žhuman immunodeficiency virus. ŽDi Salvo, J. Ž409. 143. Receptor expression Ligand binding; cAMP; mRNA detection ŽDautzenberg, F.M. Ž390. 51. Receptor fragment Dopamine receptor; COS-7 cell; Adenylate cyclase ŽScarselli, M. Ž397. 291. Receptor heterogeneity Muscarinic receptor; Gallbladder; Radioligand binding; Kinetics; Ca2q, Intracellular; Ca2q, Extracellular; Sr 2q; ŽGuinea pig. ŽAkici, A. Ž388. 115. GABA A rbenzodiazepine receptor; Hippocampus; Olfactory bulb; Ligand affinity; a subunit ŽLameh, J. Ž400. 167. s1 Receptor ligand Prepulse inhibition; Apomorphine; Phencyclidine; MS-377 ŽYamada, S. Ž402. 251.

Master keyword index to Õolumes 386–410 (2000)

118

s 1 Receptor mRNA s Receptor; Haloperidol; w3 HxDTG Žw3 Hx1,3-di Ž2-tolyl. guanidine.; w3 HxŽq.-Pentazocine; Species difference ŽInoue, A. Ž401. 307. Receptor occupancy, in vivo NMDA receptor; NR2B subunit; MK-801; Radioligand binding ŽMurray, F. Ž397. 263.

Renal sympathetic nerve activity Quinpirole; Baroreflex; Rabbit, conscious ŽVan den Buuse, M. Ž388. 85. Renal tubular secretion OAT1 Žorganic anion transporter 1.; Xenopus oocytes; Sulfonylurea; Nateglinide; p-Aminohippurate ŽUwai, Y. Ž398. 193.

Receptor phosphorylation a 1-Adrenoceptor; Protein kinase C; Phosphatidylinositol 3-kinase; G protein receptor kinases; Desensitization ŽGarcıa-Sainz, J.A. Ž389. 1. ´ ´

Renal vasculature, rat Bradykinin; Bradykinin B 2 receptor; Carboxypeptidase; Neutral endopeptidase; Angiotensin I converting enzyme; Aminopeptidase P ŽBagate, ´ K. Ž407. 317.

Receptor regulation GEPR Žgenetically epilepsy-prone rat.; Electroshock; Convulsion; a 1 Adrenoceptor; b-Adrenoceptor ŽSeo, D.O. Ž396. 53.

Renin Angiotensin; Angiotensin-converting enzyme; Angiotensinogen; Angiotensin AT1 receptor; Polymorphism ŽDanser, A.H.J. Ž410. 303.

Receptor reserve 5-HT1A receptor; EEDQ; w35 SxGTPgS binding assay; Hippocampus; Cortex; Spare receptor ŽAlper, R.H. Ž390. 67.

Renin–angiotensin system Guanylyl cyclase, soluble; Superoxide anion; Aorta; Hypertension ŽJacke, K. Ž403. 27.

a 7 Receptor-selective agonist GTS-21; 4OH-GTS-21 ŽPapke, R.L. Ž393. 179.

Repaglinide Exocytosis; Glucagon; K AT P channel; Nateglinide ŽBokvist, K. Ž386. 105.

Recombinant Ca2q channel; HEK293 cell; Pharmacology ŽMcNaughton, N.C.L. Ž407. 53. Recovery a 2 -Adrenoceptor antagonist; Focal cerebral ischemia; Sensorimotor functions; ŽRat. ŽJolkkonen, J. Ž400. 211. Redox L-S-Nitrosocysteine;

Nitric oxide ŽNO.; Vasodilation; ŽRat. ŽHoque, A.

Reperfusion Angiotensin-converting enzyme inhibitor; Bradykinin; Ischemia; Ventricular function, dog ŽHosoya, K. Ž390. 157. K AT P channel; Hypertension; Arrhythmias; Myocardial ischemia ŽLee, Y.-M. Ž397. 151. Diltiazem; Coronary flow; Heart, isolated, rat; Ischemia; Microsphere ŽKatsumata, N. Ž398. 83.

Ž408. 195. Regeneration Heparin; Intragastric administration; Gastric ulcer healing; Nitric oxide ŽNO. synthase, Constitutive; Proliferation; Angiogenesis ŽLi, Y. Ž399. 205.

TY-12533; NaqrHq exchanger; Ischemia; Arrhythmia; Myocardial infarction ŽAihara, K. Ž404. 221. Reperfusion arrhythmia Zatebradine; Ischemia-induced arrhythmia; Propranolol; ŽDog. ŽNaito, H. Ž388. 171.

Development; Melanocortin ŽStrand, F.L. Ž405. 3. Regulation Bradykinin B1 receptor; Bradykinin B 2 receptor; w3 Hxdes-Arg 10 -kallidin; w3 HxBradykinin; WI-38 cell; Cytokine ŽPhagoo, S.B. Ž397. 237. MAP Žmitogen-activated protein. kinase cascade; Protein kinase, cAMPdependent; Signal transduction ŽMizuno, K. Ž404. 63.

Antiarrhythmic drug; Action potential duration; Vma x ŽBaczko, ´ I. Ž404. 181. Reperfusion injury Apoptosis; Cardiac ischemia; Infarct; Caspase inhibitor ŽHuang, J.-Q. Ž402. 139. Amrinone; Ischaemia; ŽRat. ŽRechtman, M.P. Ž402. 255.

Relaxation Polygodial; Aorta, rabbit; Pulmonary artery, rabbit; Pulmonary artery, guinea-pig; Nitric oxide ŽNO. ŽAndre, ´ E. Ž386. 47. Thapsigargin; Nitric oxide ŽNO.; Endothelium; Kq channel; Aorta; ŽRat. ŽHuang, Y. Ž392. 51. b-Adrenoceptor; Age; Endothelium; Isoprenaline; K q ŽVan der Zypp, A. Ž397. 129.

channel

Renal failure Gentamicin; Nitric oxide ŽNO.; L-arginine; L-NAME Ž N v -nitro-L-arginine methyl ester.; ŽRat. ŽCan, C. Ž390. 327. Renal failure, acute P-glycoprotein level; P-glycoprotein function, in vivo; P-glycoprotein-related compound endogenous; Rhodamine 123; Pharmacokinetics ŽHuang, Z.-H. Ž406. 453.

NaqrHq exchange; Myocardial ischemia ŽYamada, K. Ž404. 201. Reporter gene assay Melatonin receptor; cAMP response element; Luciferase; HEK293 cell ŽConway, S. Ž390. 15. Reserpine Bafilomycin A 1 ; a-Fluoromethylhistidine; Histidine decarboxylase; Vacuolar-type ATPase; Vesicular monoamine transporter ŽLindstrom, ¨ E. Ž387. 19. Phosphatidylserine; Memory; Passive avoidance ŽAlves, C.S.D. Ž404. 161. Respiration Buprenorphine; Methoclocinnamox; Opioid receptor agonist; Opioid receptor antagonist; ŽRhesus monkey. ŽKishioka, S. Ž391. 289.

Master keyword index to Õolumes 386–410 (2000) Ca2q channel blocker; Opioid; Rhesus monkey ŽKishioka, S. Ž397. 85. Opioid; Tolerance; Dependence; ŽRhesus monkey. ŽKishioka, S. Ž398. 121. Respiratory mechanics Endothelin; Endothelin ETA rETB receptor antagonist bifunctional; IRL 3630A ŽMakatani, M. Ž406. 139. Restraint stress Adaptation; D-Amphetamine; Conditioned place preference; Dopamine D1 receptor; Dopamine D 2 receptor; Opioid system; Sensitization ŽCapriles, N. Ž386. 127. Antidepressant drug; Desipramine; Grooming; Locomotor activity; Mesolimbic dopamine system; Open field; Chronic mild stress ŽD’Aquila, P.S. Ž399. 43. Retigabine Anticonvulsant; Entorhinal cortex; Spike frequency habituation; EPSP Žexcitatory postsynaptic potential.; IPSP Žinhibitory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165. Flupirtine; Glutamate toxicity; PC12 cells; Reactive oxygen intermediates; Glutathione ŽSeyfried, J. Ž400. 155. Retinoid Bradykinin B1 receptor; Umbilical vein, human ŽSardi, S.P. Ž407. 313. Retinoid X receptor (RXR) Peroxisome proliferator-activated receptor ŽPPAR.; Inflammation; Monocyte; Migration; Matrix metalloproteinase ŽKintscher, U. Ž401. 259. Retrosplenial cortex Dizocilpine ŽŽq.-MK-801.; NMDA receptor antagonist; Neurotoxicity; Clozapine; Olanzapine; Immediate early gene ŽFujimura, M. Ž398. 1. Reverse phase HPLC Clonidine-displacing substance; NG108-15 cell; Imidazoline binding site ŽParker, C.A. Ž387. 27. Reward Endogenous opoid; Addiction; Brain stimulation reward; Self-administration; Sexual behaviour; Social behaviour ŽVan Ree, J.M. Ž405. 89. R(I)-flurbifrofen c-Fos; Racemic-flurbiprofen; SŽq.-flurbifrofen; Noxious heat; Spinal dorsal horn ŽBuritova, J. Ž406. 59. Rhesus Lipolysis; Tachycardia ŽForrest, M.J. Ž407. 175.

119

Rho-associated coiled coil-forming protein kinase Airway; Bronchodilation; Rho; Smooth muscle ŽNakahara, T. Ž389. 103. Rhodamine 123 Renal failure, acute; P-glycoprotein level; P-glycoprotein function, in vivo; P-glycoprotein-related compound endogenous; Pharmacokinetics ŽHuang, Z.-H. Ž406. 453. Rho kinase Polymorphonuclear leukocyte; p160ROCK; Superoxide production; Aggregation ŽKawaguchi, A. Ž403. 203. Rho-kinase Bronchodilator; Y-27632 ŽIizuka, K. Ž406. 273. Ribavirin Ras; Raf-1; Cell cycle; Heat shock; Extracellular signal-regulated protein kinase; GTP ŽVallee, ´ S. Ž404. 49. Ribozyme Dopamine D 2 receptor; Stereotypy ŽSalmi, P. Ž388. R1. Ricinoleic acid Capsaicin; Nociception; Pain; Substance P; Tachykinin; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Riluzole Hyperalgesia; Ventral posterolateral nucleus; Excitatory amino acid; Morphine; Dizocilpine ŽAbarca, C. Ž403. 67. Epilepsy; Audiogenic seizure; AMPA Ž a-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid.; GlycinerNMDA receptor; DBAr2 mouse ŽDe Sarro, G. Ž408. 25. Risperidone Microdialysis; Schizophrenia; Antipsychotic drug; Electrophysiology; Noradrenergic system ŽNasif, F.J. Ž394. 67. Ritanserin Clozapine; Haloperidol; Ascorbic acid; Ethanol; Microdialysis; ŽRat. ŽLiu, W. Ž398. 333. RNA blot Acetylcholine receptor; Ligand-gated ion channel; In situ hybridization; Peripheral nervous system; Neural development ŽErkman, L. Ž393. 97. RNA-mediated interference G-protein coupled receptor; npr-1 ŽGomes, A.V. Ž397. R3. RO 43-0440 D-Fenfluramine; Hypothermia; 5-HT1A

Rhesus monkey Respiration; Ca2q channel blocker; Opioid ŽKishioka, S. Ž397. 85. Rheumatoid arthritis Synoviocyte; Cyclooxygenase-1; Cyclooxygenase-2; Meloxicam ŽTsubouchi, Y. Ž395. 255.

receptor; Sertraline; WAY 100635; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275. Ro 32-0432 CGRP receptor, porcine, cloned; G protein-coupled receptor kinase; Homologous desensitization; CGRP Žcalcitonin gene-related peptide.; Antisense oligonucleotide ŽAiyar, N. Ž403. 1.

X

Osteoarthritis; Aceclofenac; 4 -Hydroxy aceclofenac; Pro-matrix metalloproteinase 1; Pro-matrix metalloproteinase 3; Articular chondrocyte, rabbit ŽAkimoto, H. Ž401. 429. Rho Airway; Bronchodilation; Rho-associated coiled coil-forming protein kinase; Smooth muscle ŽNakahara, T. Ž389. 103.

Rolipram Arthritis; Phosphodiesterase 4; Hyperalgesia; Oedema; TNF-a Žtumor necrosis factor-a . ŽFrancischi, J.N. Ž399. 243. Ropivacaine Inflammation; Leukocyte ŽZhang, X.W. Ž392. R1.

120

Master keyword index to Õolumes 386–410 (2000)

Rosiglitazone Thiazolidinedione; Troglitazone; BRL 49653; K AT P current; Glibenclamide; Kq channel ŽMishra, S.K. Ž386. 121.

Salivary flow rate Desipramine; Gingivitis; Microbiota; Salivary protein; Tricyclic antidepressant ŽKoller, M.M. Ž408. 91.

Rostral ventromedial medulla C-fibre; Flexor reflex; Wind-up; Spino-bulbo-spinal; Inhibitory feedback mechanism; Morphine ŽGozariu, M. Ž394. 75.

Salivary protein Desipramine; Gingivitis; Microbiota; Salivary flow rate; Tricyclic antidepressant ŽKoller, M.M. Ž408. 91.

Rotarod Dopamine D1 receptor; Dopamine D 3 receptor; Knockout mice; Locomotor activity; Exploratory behaviour; Elevated plus maze; Spatial learning ŽKarasinska, J.M. Ž399. 171.

Intestinal motility; Lipopolysaccharide ŽTan, D. Ž409. 203.

Rotation d-Opioid receptor agonist; Tonazocine; SNC-80; Parkinson’s disease ŽHudzik, T.J. Ž396. 101. Rp-cAMPS Protein kinase A; H-89; Mitogenesis ŽOsinski, M.T. Ž395. 173. RPR 73401 Phosphodiesterase 4 inhibitor; Allergic dermatitis; Ear swelling test, mouse; Interleukin-4 ŽEhinger, A.M. Ž392. 93. RPR 118723 Glycine antagonist; Glutamate; N-methyl-D-aspartate ŽNMDA . receptor–channel complex; TCP binding; Dopamine release ŽBoireau, A. Ž401. 131. r1 subunit GABA Ž g-aminobutyric acid.; GABA C receptor; Loreclezole ŽThomet, U. Ž408. R1. RT-PCR Lenticulostriate artery, human; CGRP Žcalcitonin gene-related peptide.; Adrenomedullin; CRLR Žcalcitonin receptor-like receptor.; RAMP Žreceptor activity-modifying protein. ŽSams, A. Ž408. 183. RT-PCR (reverse transcription-polymerase chain reaction) Dysmotility; Ischemia–reperfusion; Colon; Adenosine A 1 receptor antagonist; ŽRat. ŽKadowaki, M. Ž409. 319. RX821002 Imidazoline I 2 receptor ligand; Idazoxan; Metrazoline; Benazoline; Tracizoline; Food intake; Water intake ŽPolidori, C. Ž392. 41. a 2-Adrenoceptor; Agonist, Inverse; G protein-coupled receptor; MK-912; GTP; Rauwolscine ŽMurrin, L.C. Ž398. 185. Ryanodine receptor Skinned fiber; Dichlorobenzamil; Phenamil; Caffeine ŽPonte, C.G. Ž391. 11. S-0139 Endothelin receptor subtype; Antagonist activity; Blood vessel, rabbit; Blood vessel, canine ŽIwasaki, T. Ž400. 255. S-14506 Affinity; Intrinsic activity; Efficacy; GppŽNH.p shift; 5-HT1A receptor ligand; Dihydroergotamine ŽAssie, ´ M.-B. Ž386. 97. S18986-1 AMPA receptor; Hippocampus; Noradrenaline release; Allosteric modulator ŽLockhart, B. Ž401. 145. S 18986-1 AMPA receptor; Object recognition; Memory; ŽRat. ŽLebrun, C. Ž401. 205.

Salmeterol Benzalkonium chloride; Mast cell; G-protein; b 2-Adrenoceptor; Asthma ŽSeebeck, J. Ž397. 19. Saphenous vein Thromboxane A 2 ; TP receptor; Forskolin; cAMP; Mammary artery, internal ŽCracowski, J.-L. Ž387. 295. Coronary artery; Eletriptan; GR125743; Middle meningeal artery; Migraine; Serotonin; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. In vivo; Adrenoceptor; 5-HT receptor; ŽRabbit. ŽVayssettes-Courchay, C. Ž408. 277. Sarafotoxin-6C Chronic hypoxia; Lung; Endothelin-1; Big-endothelin-1; Pulmonary vasoconstriction; Pulmonary vasodilation; Bronchoconstriction; Endothelin ETB receptor; ŽRat. ŽLal, H. Ž402. 101. Sarafotoxin S6c Cytokine; Endothelin ETB receptor; Interleukin-1b; Interleukin-6; Interferon-g; TNF-a Žtumour necrosis factor-a .; Vasoactivity ŽWhite, L.R. Ž406. 117. Sarcoplasmic reticulum Ca2q-ATPase, Sarcoplasmic reticulum; Ca2q uptake function; Superficial buffer barrier hypothesis; Ca2q influx; Ca2q channel, L-type; Arterial contraction ŽNomura, Y. Ž404. 315. Superficial buffer barrier hypothesis; Ca2q-induced Ca2q release channels; Ca2q movement; Ca2q influx; Ca2q channel, L-type ŽAsano. M. Ž404. 327. Sarpogrelate 5-HT2A receptor antagonist; Antinociception; Formalin test; ŽRat. ŽObata, H. Ž404. 95. SB 204070A Forced swim test; 5-HT4 receptor; Fluoxetine; Antidepressant ŽCryan, J.F. Ž409. 295. SC17599 Antinociception; Locomotor activity; Straub tail; Morphine; ŽMouse. ŽHoushyar, H. Ž395. 121. SCH 39166 Dopamine; Dopamine D1 receptor agonist; Drug discrimination; SKF82958; Cocaine; ŽRat. ŽHaile, C.N. Ž388. 125. SCH 23390 Catalepsy; Dopamine D 2 receptor; Dopamine D 3 receptor; Haloperidol; Knock-out mice ŽBoulay, D. Ž391. 63. Eticlopride; Species-specificity; Monoamine ŽSandoval, V. Ž409. 265. SCH 58261 Adenosine A 2A receptor; ZM 241385; CGS 21680; Motor activity; Knockout, mouse ŽEl Yacoubi, M. Ž401. 63.

Master keyword index to Õolumes 386–410 (2000) Schizophrenia Dopamine; Dopamine D 2 receptor, extrastriatal; w123 IxEpidepride; SPECT ŽSingle photon emission computed tomography.; a-Methyl-para-tyrosine; Binding, in vivo ŽFujita, M. Ž387. 179. Drug discrimination; Glutamate receptor, Metabotropic ŽSchreiber, R. Ž388. R3. Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Nicotinic agent; Dementia; Ageing; Epilepsy; Tobacco addiction ŽClementi, F. Ž393. 3. Nicotinic receptor; Nicotine; Smoking; Gene duplication; Neutrophil ŽLeonard, S. Ž393. 237. Risperidone; Microdialysis; Antipsychotic drug; Electrophysiology; Noradrenergic system ŽNasif, F.J. Ž394. 67. Stress; Cognition; Coping; Hypothalamic–pituitary–adrenal system; Immune system ŽGispen-de Wied, C.C. Ž405. 375. Bipolar disorder; Depression; Memory; Synaptic plasticity; Ventricle enlargement; Neurocognitive impairment ŽVawter, M.P. Ž405. 385. Nicotine; Pre-pulse inhibition; Information processing; ŽRat. ŽMirza, N.R. Ž407. 73. Dopamine receptor; Pharmacogenetics; Polymorphism; Mutation; Antipsychotic ŽWong, A.H.C. Ž410. 183. Pharmacogenetics; Single nucleotide polymorphism; Pharmacogenomics; Genome-wide scanning; DNA microarray ŽKawanishi, Y. Ž410. 227. Sciatic nerve Nicotinic receptor; Acetylcholine receptor; a-Bungarotoxin; Ciliary ganglion; Neuronal ŽRoth, A.L. Ž393. 105. Scinderin Cytoskeleton; Exocytosis; Insulin ŽBruun, T.Z. Ž403. 221. Scopolamine Muscarinic acetylcholine receptor; Prepulse inhibition; Startle; Apomorphine; Phencyclidine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105. Scratching behavior Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Scropolioside A Anti-inflammatory activity; Verbascosaponin A; Verbascosaponin; Scrovalentinoside; Ž Scrophularia auriculata ssp. pseudoauriculata. ŽGiner, R.-M. Ž389. 243. Scrovalentinoside Anti-inflammatory activity; Verbascosaponin A; Verbascosaponin; Scropolioside A; Ž Scrophularia auriculata ssp. pseudoauriculata. ŽGiner, R.-M. Ž389. 243. SDZ CPI 975 Carnitine palmitoyltransferase; Etomoxir; Hypertrophy ŽYotsumoto, T. Ž398. 297. Second messenger Signal transduction; G protein; a 2 -Adrenoceptor; G protein coupled receptor; 5-HT receptor; 5-HT1A receptor ŽHappe, H.K. Ž399. 17.

121

Secretory vesicle a-Fluoromethylhistidine; Gastrin; Histamine; Histidine decarboxylase; Microdialysis in vivo; ECL cell; Stomach ŽNorlen, ´ P. Ž400. 1. Sedation GABA A rbenzodiazepine receptor; 3D pharmacophore ŽHarris, D.L. Ž401. 271. Allodynia; Antinociception; Diuresis; Dynorphin; k-Opioid receptors ŽKo, M.C.H. Ž402. 69. Seizure Lethality; Sensitization ŽGasior, M. Ž387. R15. 5-HT Ž5-hydroxytryptamine, serotonin.; Kindling; Hippocampus ŽWatanabe, K.-i. Ž398. 239. Topiramate; Antiepileptic drug; Electroshock, maximal; Drug interaction ´ ˛der, M. Ž399. 35. ŽSwia 3-Nitropropionic acid; Mitochondrial toxin; GABA Ž g-aminobutyric acid.; 4-Aminopyridine; Electroconvulsion ŽHaberek, G. Ž403. 229. SEK-1005 Wound healing accelerator; Healing-impaired, mouse; Cyclic peptide; TGF-b1 Žtransforming growth factor-b1. inducer ŽAbe, Y. Ž408. 213. Selected line Dopamine; Nicotine; Ethanol; Microdialysis; Nucleus accumben ŽKiianmaa, K. Ž407. 293. Selectin Sialyl Lewis X; Acute lung injury; Lipopolysaccharide ŽHayashi, H. Ž392. 109. Selective serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibitor Microdialysis; Serotonin Ž5-hydroxytryptamine, 5-HT.; Venlafaxine; YM992; Antidepressant ŽHatanaka, K.-i. Ž395. 23. Selectivity Glycine receptor; 5-HT3 receptor antagonist; Potentiation; Interaction; Pharmacophore model ŽChesnoy-Marchais, D. Ž402. 205. Self-administration Cocaine; Corticosterone; Neuroendocrine; Hypothalamo pituitary–adrenal axis; Stress ŽGalici, R. Ž387. 59. Catecholamine; Epinephrine; Norepinephrine; Corticosterone; Yoking; Nicotine ŽDonny, E.C. Ž402. 231. Muscarinic receptor agonist; Cocaine; Drug-naive; ŽMouse. ŽRasmussen, T. Ž402. 241. Endogenous opoid; Addiction; Reward; Brain stimulation reward; Sexual behaviour; Social behaviour ŽVan Ree, J.M. Ž405. 89. Sensitization Restraint stress; Adaptation; D-Amphetamine; Conditioned place preference; Dopamine D1 receptor; Dopamine D 2 receptor; Opioid system ŽCapriles, N. Ž386. 127. Seizure; Lethality ŽGasior, M. Ž387. R15. Methamphetamine; Adenosine; Adenosine A 1 receptor; Adenosine A 2A receptor ŽShimazoe, T. Ž388. 249. 5-HT3 receptor; Cocaine; Ondansetron; ŽRat. ŽKing, G.R. Ž394. 97.

122

Master keyword index to Õolumes 386–410 (2000)

Nicotinic acetylcholine receptor; Disinhibition; Locomotor activity; Plusmaze; ŽRat. ŽEricson, M. Ž397. 103. Ibogaine; Cocaine; Dopamine; Stereotypy; Drug addiction ŽSzumlinski, K.K. Ž398. 259. Naloxone; Morphine; Place conditioning; NMDA receptor antagonist; Mice ŽBlokhina, E.A. Ž406. 227.

Coronary artery; Eletriptan; GR125743; Middle meningeal artery; Migraine; Saphenous vein; Sumatriptan; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Serotonin (5-hydroxytryptamine, 5-HT) Microdialysis; Selective serotonin Ž5-hydroxytryptamine, 5-HT. reuptake inhibitor; Venlafaxine; YM992; Antidepressant ŽHatanaka, K.-i. Ž395. 23. Sertraline

Sensitized, guinea pig Glaucine; Phosphodiesterase 4 inhibitor; Airway hyperreactivity; Airway eosinophil infiltration; Airway microvascular leakage ŽPons, R. Ž397. 187. Sensorimotor functions a 2 -Adrenoceptor antagonist; Focal cerebral ischemia; Recovery; ŽRat. ŽJolkkonen, J. Ž400. 211. Sensory Cannabinoid; Capsaicin; Neuron; Afferent; Pain; Receptor; Vasodilation ŽZygmunt, P.M. Ž396. 39. Sensory–motor test g-Hydroxybutyrate; Cerebral ischemia; Hippocampus; Immunochemistry; Spatial learning ŽVergoni, A.V. Ž397. 75. Sensory nerve Phoneutria nigriÕenter venom; Neurogenic plasma extravasation; Tachykinin NK 1 receptor agonist; Vanilloid receptor; Purinoceptor ŽCosta, S.K.P. Ž391. 305. Sensory nerve fibre Vasodilation; CGRP Žcalcitonin-gene-related peptide.; Migraine ŽOlivar, T. Ž395. 61.

D-Fenfluramine;

Hypothermia; 5-HT1A receptor; WAY 100635; RO 430440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275. Serum 5-Hydroxytryptamine Ž5-HT, serotonin.; Desensitization; T84 cell ŽBurleigh, D. Ž390. 103. Sesquiterpene Herbal drug; Ca2q channel blocker; Smooth muscle ŽIrie, K. Ž403. 235. Sex difference Pain; Antinociception; Gonadectomy, adult; b-Endorphin ŽKrzanowska, E.K. Ž392. 157. Melatonin; Forced-swim test; Antidepressant; Depression ŽBrotto, L.A. Ž402. 87. Sex differences Opioid analgesia; U69,593; Hotplate; Lick latency; ŽRat. ŽVan Haaren, F. Ž408. 153. Sexual behavior, female Low dose; Prolactin; Grooming, Novelty-induced; Sexual behavior, Male ŽDrago, F. Ž405. 131.

Sensory neuropathy Cisplatin; Superoxide production; Peroxinitrite ŽSzilvassy, J. Ž403. 259. ´

Sexual behavior, male Low dose; Prolactin; Grooming, Novelty-induced; Sexual behavior, Female ŽDrago, F. Ž405. 131.

Septic shock Endothelin-1; Endothelin ETA -receptor; Endothelin ETB -receptor; A192621; PD 155080; Endotoxaemia ŽWanecek, M. Ž386. 235.

Sexual behaviour Endogenous opoid; Addiction; Reward; Brain stimulation reward; Selfadministration; Social behaviour ŽVan Ree, J.M. Ž405. 89.

Endothelin-1; Endothelin receptor antagonism; Endotoxin ŽWanecek, M. Ž407. 1.

S(H)-flurbifrofen c-Fos; Racemic-flurbiprofen; RŽy.-flurbifrofen; Noxious heat; Spinal dorsal horn ŽBuritova, J. Ž406. 59.

Septum, Epilepsy Clonidine; BAY K 8644; GABA Ž g-aminobutyric acid.; Ca2q channel, L-type; Limbic system ŽBaran, H. Ž401. 31.

[35 S]GTPgS Opioid receptor; Ligand selectivity; Mutagenesis ŽBonner, G. Ž403. 37.

Septum, lateral Nicotine; 5-HT1A receptor; Anxiety; Phobia; Hippocampus, dorsal ŽFile, S.E. Ž393. 231.

[35 S]GTPgS autoradiography G-protein; 5-HT1 A receptor; GABA B receptor; Anxiolytic; Antidepressant ŽSim-Selley, L.J. Ž389. 147.

Serine protease inhibitor Chloromethyl ketone; Stroke; Focal ischemia; Apoptosis; Nitric oxide ŽNO. ŽLeBlanc, M.H. Ž390. 249.

s Receptor; Žq.Pentazocine; Haloperidol; Cerebellum; GTPase ŽHong, W. Ž408. 117.

Serotonergic system FR140423; Antinociception; 5-HT2A receptor; 5-HT3 receptor; Spinal cord; ŽMice. ŽOchi, T. Ž409. 167. Serotonin Acetylcholine; Choline; Cortex, medial prefrontal; Norepinephrine ŽHedou, G. Ž390. 127.

[35 S]GTPgS binding Brain, human; a 2-Adrenoceptor; 5-HT1A receptor; m-Opioid receptor; G-protein ŽGonzalez-Maeso, J. Ž390. 25. ´ m-Opioid receptor; d-Opioid receptor; G-protein; Collision-coupling model; Compartmentalization ŽRemmers, A.E. Ž396. 67. 5-HT1A receptor; Inverse agonist; WAY 100635 ŽCosi, C. Ž401. 9.

Master keyword index to Õolumes 386–410 (2000) [35 S]GTPgS binding, agonist-stimulated Dopamine D 2 -like receptor; Quinpirole; Monoamine oxidase inhibitor; Striatum; ŽRat. ŽGilliland, S.L. Ž392. 125. [35 S]GTPgS binding assay 5-HT1A receptor; EEDQ; Hippocampus; Cortex; Receptor reserve; Spare receptor ŽAlper, R.H. Ž390. 67. Shear Thrombin; Platelet aggregation; Coagulation; Bifunctional inhibitor ŽTaka, T. Ž406. 181. Short-circuit current d-Opioid receptor; Endothelin-1; Intestine, large ŽGauthier, C. Ž390. 335. Short-circuit current, rat Cannabinoid receptor agonist; WIN 55212-2; Cannabinoid receptor antagonist; SR14716A; Ileum; Electrical field stimulation ŽTyler, K. Ž409. 207. Shortening velocity Malignant hyperthermia; Skeletal muscle ŽEtchrivi, T.S. Ž388. 107. Short-term memory Acetycholine; Cannabinoid; Glutamate; Learning ŽHan, C.J. Ž403. 87. SH-SY5Y neuroblastoma cell Muscarinic receptor; Sphingosine 1-phosphate; Dimethylsphingosine; InsŽ1,4,5.P3 ; Ca2q mobilisation ŽYoung, K.W. Ž402. 55. Shuttle-box Dopamine; Microdialysis, In vivo; Prefrontal cortex; Working memory; ŽGerbil. ŽStark, H. Ž405. 263. Sialyl Lewis X Selectin; Acute lung injury; Lipopolysaccharide ŽHayashi, H. Ž392. 109. Sibutramine Desmethylsibutramine; Didemethylsibutramine; Food intake; Obesity; Locomotor activity; Antidepressant ŽGlick, S.D. Ž397. 93.

123

Anococcygeus, mouse; Forskolin; Nitrergic; Nitric oxide ŽNO.; Papaverine; Sodium nitroprusside ŽFrith, D. Ž400. 305. Single nephron filtration rate Cyclosporine; Tacrolimus; Glomerulo-tubular balance; Tubulo-glomerular feed-back; Tubular reabsorption ŽRomano, G. Ž399. 215. Single nucleotide polymorphism Schizophrenia; Pharmacogenetics; Pharmacogenomics; Genome-wide scanning; DNA microarray ŽKawanishi, Y. Ž410. 227. Opioid system, endogenous; Gene polymorphism; Addiction; Pharmacogenetics; Physiogenetics ŽLaForge, K.S. Ž410. 249. SIN-1 (3-Morpholinosydnonimine) Endothelium-derived hyperpolarizing factor ŽEDHF.; Kq channel, Ca2q-activated; Kq channel, ATP-sensitive; Membrane potential ŽQuignard, J.-F. Ž399. 9. Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79. Sinoatrial node Kq current, Delayed rectifier; Atrioventricular node; Antiarrhythmic agent, Class III ŽSato, N. Ž404. 281. Sinus node cell Mibefradil; Ca2q current ŽProtas, L. Ž401. 27. Site-directed mutagenesis Dopamine transporter; Cocaine; Cocaine analog; Phosphorylation; Chimera ŽChen, N. Ž405. 329. SK-896 Gastrointestinal transit; Gastrointestinal motility; Interdigestive migrating contraction; Post-operative ileus; Prostaglandin F2 a ; ŽDog. ŽTsukamoto, K. Ž401. 97. Skeletal muscle Malignant hyperthermia; Shortening velocity ŽEtchrivi, T.S. Ž388. 107.

Sick sinus syndrome MF 10058; Muscarinic M 2 receptor antagonist; Cardioselective muscarinic receptor antagonist; Antibradycardic agent; Bradycardia ŽLamperti, G. Ž406. 93.

Ca2q channel; Anandamide ŽOz, M. Ž404. 13.

Signaling Pancreastatin receptor; G protein; Phospholipase C; MAPK; HTC cell; Insulin resistance ŽSanchez-Margalet, V. Ž397. 229. ´

SKF 82958 Dopamine; Dopamine D1 receptor agonist; Drug discrimination; SCH39166; Cocaine; ŽRat. ŽHaile, C.N. Ž388. 125.

Dopamine D4 receptor; G protein-coupled receptor; Structure; Pharmacology; Physiology; Genetics ŽOak, J.N. Ž405. 303.

Parkinson’s disease; 6-Hydroxydopamine-lesioned rat; 5-HT2C receptor ŽFox, S.H. Ž398. 59.

Signal transduction Adenosine A 1 receptor; ATP; FRTL-5 thyroid cell; Protein kinase C ŽVainio, M. Ž390. 43.

SKF 99101H 5-HT1B rD receptor; Locomotor activity; GR127935; WAY100635; ŽGuinea pig. ŽO’Neill, M.F. Ž399. 49.

G protein; a 2 -Adrenoceptor; G protein coupled receptor; Second messenger; 5-HT receptor; 5-HT1A receptor ŽHappe, H.K. Ž399. 17.

Skin Nicotine; Nicotinic receptor, Non-neuronal; Lung; Blood vessel ŽContiFine, B.M. Ž393. 279.

MAP Žmitogen-activated protein. kinase cascade; Regulation; Protein kinase, cAMP-dependent ŽMizuno, K. Ž404. 63. Sildenafil Morphine; cGMP; N G -L-nitro-arginine methyl ester ŽL-NAME.; ODQ Ž1 H-w1,2,4x-oxadiazolow4,3-axquinoxalin-1-one.; Naloxone ŽMixcoatlZecuatl, T. Ž400. 81.

Substance P; TNF-a Žtumor necrosis factor-a .; Histamine; Dexamethasone; MAP Žmitogen-activated protein. kinase ŽOkabe, T. Ž398. 309. Skinned fiber Ryanodine receptor; Dichlorobenzamil; Phenamil; Caffeine ŽPonte, C.G. Ž391. 11.

124

Master keyword index to Õolumes 386–410 (2000)

SL 65.0472 Vasoconstriction; 5-HT1B receptor; 5-HT2A receptor ŽGalzin, A.-M. Ž404. 361.

Methylene methylimino linkage; Antisense; Platelet-derived growth factor A-chain; Spontaneously hypertensive rat ŽSHR. ŽKishioka, H. Ž392. 129.

Sleep deprivation Glutathione; Antioxidant; Melatonin; Hypothalamus ŽD’Almeida, V. Ž390. 299.

Apoptosis; p53; Gadd45; Troglitazone; Pioglitazone ŽOkura, T. Ž407. 227.

Small cell lung carcinoma a 7 Nicotinic receptor; Nicotine; Nicotine-derived nitrosamine; Pulmonary neuroendocrine cell; Mitogenic signal transduction ŽSchuller, H.M. Ž393. 265. Small intestine Capsaicin; Myenteric neuron; PPADS ŽPyridoxal-phosphate-6-azophenylX X 2 ,4 -disulphonic acid.; VIP ŽVasoactive intestinal polypeptide.; PACAP ŽPituitary adenylate cyclase activating peptide.; NO ŽNitric oxide. ŽBartho, ´ L. Ž392. 183. Enteric nervous system; Submucous plexus; Synaptic transmission, inhibitory; Norepinephrine; Somatostatin ŽLiu, S. Ž397. 49.

Smooth muscle relaxation Kq channel opener; Detrusor smooth muscle; Kq channels, ATP-sensitive; Sulfonylurea receptor ŽBuckner, S.A. Ž400. 287. Smooth muscle, tracheal Cromakalim; Kq channel, ATP-sensitive; Tyrosine kinase inhibitor ŽMatsushita, Y. Ž389. 51. PACAP Žpituitary adenylate cyclase activating peptide.; VIP Žvasoactive intestinal peptide.; Nitric oxide ŽNO.; Nonadrenergic noncholinergic ŽNANC. relaxation, inhibitory; ŽCat. ŽYoshida, M. Ž395. 77. Smooth muscle, vascular Diabetes; Hypertrophy, cell; Oxyhaemoglobin, glycosylated; Oxidative stress ŽPeiro, ´ C. Ž386. 317.

Smoking Nicotinic receptor; Schizophrenia; Nicotine; Gene duplication; Neutrophil ŽLeonard, S. Ž393. 237.

Adenosine; Kq channel, Ca2q-dependent ŽLi, G. Ž394. 35.

Genetic polymorphism; Neurotransmitter; Association; Linkage ŽArinami, T. Ž410. 215.

b-Adrenoceptor; b-Adrenoceptor, atypical; Endothelium; Nitric oxide ŽNO.; Guanylyl cyclase ŽBrawley, L. Ž398. 285.

Smooth muscle X Monosodium glutamate; Adenosine-5 -triphosphate; Acetylcholine; Bradykinin; Angiotensin II ŽSukhanov, S.N. Ž386. 247.

Cly channel; Vasoconstriction; Stilbene derivative ŽLamb, F.S. Ž401. 403.

Airway; Bronchodilation; Rho-associated coiled coil-forming protein kinase; Rho ŽNakahara, T. Ž389. 103.

Melittin; Phospholipase A 2 ; Gap junction; Connexin; Endothelium-derived hyperpolarizing factor ŽEDHF.; Endothelium ŽHutcheson, I.R. Ž406. 239.

UTP contraction; Aorta, rat; Vascular; Protein kinase C; Ca2q ŽLopez, C. ´ Ž391. 299. Nitric oxide ŽNO.; b 2 -Adrenoceptor agonist; cGMP; cAMP; Iberiotoxin ŽVaali, K. Ž399. 75. Urinary bladder; Urethra; Nitric oxide ŽNO.; cGMP ŽFujiwara, M. Ž401. 241. Antiarrhythmic drug; Inward rectifier Kq channel; Maxi-Kq channel; ŽBovine. ŽNakahara, T. Ž402. 143. Herbal drug; Sesquiterpene; Ca2q channel blocker ŽIrie, K. Ž403. 235. Smooth muscle, airway Acetylcholine; Airway epithelium; Nitric oxide ŽNO.; Indomethacin; Airway segment ŽMcParland, B.E. Ž402. 151. Smooth muscle, aortic, rat Sphingomyelinase; Ca2q concentration; Intracellular, free ŽZheng, T. Ž391. 127. Smooth muscle cell wArg 8 xvasopressin; Prostanoid; Cell proliferation ŽNagano, K. Ž389. 25. Ibuprofen; Cyclooxygenase; Proliferation ŽWeber, A.-A. Ž389. 67. Smooth muscle cell, vascular Endothelial cell; Integrin; Vitronectin; Glycoprotein IIbrIIIa-inhibitor; ŽHuman. ŽKintscher, U. Ž390. 75.

Endothelin; Nitric oxide ŽNO.; Noradrenaline ŽLui, A.H. Ž410. 25. SNC-80 d-Opioid receptor agonist; Tonazocine; Rotation; Parkinson’s disease ŽHudzik, T.J. Ž396. 101. S-nitrosocaptopril Angiogenesis; Captopril; Nitric oxide ŽNO.; Capillary endothelium; Chorioallantoic membrane; Chick embryo; Hemoglobin ŽJia, L. Ž391. 137. S-Nitroso-cysteine Arachidonic acid; Cytosolic phospholipase A 2 ; cGMP; PC12 cell ŽThang, S.H. Ž395. 183. L-S-Nitrosocysteine

Nitric oxide ŽNO.; Redox; Vasodilation; ŽRat. ŽHoque, A. Ž408. 195. S-Nitrosoglutathione Neocuproine; Bathocuproine; Corpus cavernosum; Non-adrenergic noncholinergic ŽNANC. nerve; Nitrergic relaxation ŽGoc ¨ ¸men, C. Ž406. 293. S-Nitrosothiol Nitric oxide ŽNO.; Organic nitrate; Tolerance; Blood vessel ŽMiller, M.R. Ž403. 111. Nitric oxide ŽNO.; Organic nitrate; Tolerance; Blood vessel ŽMiller, M.R. Ž408. 335.

Master keyword index to Õolumes 386–410 (2000) S-Nitrosothiol N-Methyl-D-aspartate receptor; Nitric oxide ŽTravis, M.D. Ž407. 309. Nitric oxide ŽNO.; EDRF Žendothelium-derived relaxing factor.; Ca2qchannel, voltage-sensitive; Vasodilation ŽTravis, M.D. Ž408. 289. Social Corticosterone; ACTH Žadrenocorticotropin.; CRH Žcorticotropin-releasing hormone.; Coping; Maternal behavior ŽLevine, S. Ž405. 149. Social behaviour Endogenous opoid; Addiction; Reward; Brain stimulation reward; Selfadministration; Sexual behaviour ŽVan Ree, J.M. Ž405. 89.

125

Ischemia–reperfusion; Gastric secretion; Omeprazole; Ranitidine; Ulcer healing; Gastric blood flow; Interleukin-1b; Gastrin ŽBrzozowski, T. Ž398. 147. Vagal afferent; Capsaicin; Mustard oil; Antidromic stimulation; Anti-inflammatory effect ŽThan, ´ M. Ž399. 251. Somatostatin sst2 receptor Somatostatin; Subiculum; Dopamine; Microdialysis ŽMitchell, S.N. Ž395. 43. Sox protein Acetylcholine receptor; Sp1; Transcriptional regulation; hnRNP K ŽMelnikova, I.N. Ž393. 75.

Social interaction Anxiety; Blood pressure; Glutamate; Heart rate; Kindling; Long-term potentiation; Panic; Sodium lactate ŽSajdyk, T.J. Ž394. 265.

Soyasapogenol A Alanine aminotransferase; Concanavalin A; Apoptosis; Interferon-g; Tumor necrosis factor-a ŽTNF-a . ŽKuzuhara, H. Ž391. 175.

MDMA ŽŽ".-3,4-Methylenedioxymethamphetamine.; Ecstasy; Anxiety; Odor, cat; Ultrasonic vocalization ŽMorley, K.C. Ž408. 41.

Sp1 Acetylcholine receptor; Sox protein; Transcriptional regulation; hnRNP K ŽMelnikova, I.N. Ž393. 75.

Sodium lactate Anxiety; Blood pressure; Glutamate; Heart rate; Kindling; Long-term potentiation; Panic; Social interaction ŽSajdyk, T.J. Ž394. 265. Sodium nitroprusside cGMP; Kq channel; Antinociception ŽSoares, A.C. Ž400. 67. Anococcygeus, mouse; Forskolin; Nitrergic; Nitric oxide ŽNO.; Papaverine; Sildenafil ŽFrith, D. Ž400. 305. Sodium selenate Streptozotocin-induced diabetic mouse; Corpus cavernosum; Nitric oxide ŽNO.; Antioxidant; Vitamin E; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93. Sodium tungstate Insulin; Glucagon; Pancreas, rat ŽRodrıguez-Gallardo, J. Ž402. 199. ´ Soleus muscle, isolated b 3 -Adrenoceptor agonists; Thermogenesis; Pyruvate-oxidation; Glucose metabolism ŽBoard, M. Ž406. 33. Somatic pain Histamine H 1 receptor; Pain perception; Histamine; Visceral pain; Gene targeting ŽMobarakeh, J.I. Ž391. 81. Somatodendritic Nicotinic receptor; Epibatidine; Substantia nigra; Ventral tegmental area; Dendrosome ŽReuben, M. Ž393. 39. Somatostatin Diabetic rat; Neurogenic inflammation; Inflammatory preconditioning ŽNemeth, J. Ž386. 83. ´ TGF-a Žtransforming growth factor-a .; TGF-b1 Žtransforming growth factor-b1.; 2,4-Dideoxyadenosine; H-89; Hepatocyte proliferation ŽKimura, M. Ž386. 271. Aorta; Mesenteric artery; Ca2q ŽRuiz, E. Ž388. 255. Subiculum; Somatostatin sst2 receptor; Dopamine; Microdialysis ŽMitchell, S.N. Ž395. 43. Enteric nervous system; Submucous plexus; Small intestine; Synaptic transmission, inhibitory; Norepinephrine ŽLiu, S. Ž397. 49.

Spare receptor 5-HT1A receptor; EEDQ; w35 SxGTPgS binding assay; Hippocampus; Cortex; Receptor reserve ŽAlper, R.H. Ž390. 67. Sparfloxacin Fluoroquinolones; Moxifloxacin; Grepafloxacin; Ciprofloxacin; Purkinje fibre; Cardiac action potential; ŽCanine. ŽPatmore, L. Ž406. 449. Spatial learning g-Hydroxybutyrate; Cerebral ischemia; Hippocampus; Immunochemistry; Sensory–motor test ŽVergoni, A.V. Ž397. 75. Dopamine D1 receptor; Dopamine D 3 receptor; Knockout mice; Locomotor activity; Exploratory behaviour; Elevated plus maze; Rotarod ŽKarasinska, J.M. Ž399. 171. Nociceptin; Orphanin FQ; ORL1 receptor; Morphine; Conditioned place preference; Locomotor sensitization ŽCiccocioppo, R. Ž404. 153. Species difference s Receptor; Haloperidol; s1 Receptor mRNA; w3 HxDTG Žw3 Hx1,3-di Ž2-tolyl. guanidine.; w3 HxŽq.-Pentazocine ŽInoue, A. Ž401. 307. Species selectivity Molecule antagonist; CCR1 ŽLiang, M. Ž389. 41. Species-specificity SCH23390; Eticlopride; Monoamine ŽSandoval, V. Ž409. 265. Spectral analysis Valsartan; Catecholamine; Isoprenaline; Arterial pressure ŽBlanc, J. Ž394. 311. SPECT (Single photon emission computed tomography) Dopamine; Dopamine D 2 receptor, extrastriatal; w123 IxEpidepride; aMethyl-para-tyrosine; Schizophrenia; Binding, in vivo ŽFujita, M. Ž387. 179. Spermine Acamprosate; Ethanol; NMDA receptor; Primary cultured neuron; Patchclamp, whole-cell ŽPopp, R.L. Ž394. 221. Sphingomyelinase Smooth muscle, Aortic, rat; Ca2q concentration; Intracellular, free ŽZheng, T. Ž391. 127.

126

Master keyword index to Õolumes 386–410 (2000)

Sphingosine 1-phosphate Muscarinic receptor; Dimethylsphingosine; InsŽ1,4,5.P3 ; Ca2q mobilisation; SH-SY5Y neuroblastoma cell ŽYoung, K.W. Ž402. 55.

Spontaneous alternation performance Endomorphin-1; Endomorphin-2; m-Opioid receptor; ŽMouse. ŽUkai, M. Ž395. 211.

Spike frequency habituation Retigabine; Anticonvulsant; Entorhinal cortex; EPSP Žexcitatory postsynaptic potential.; IPSP Žinhibitory postsynaptic potential.; Kq channel opener ŽHetka, R. Ž386. 165.

Spontaneously hypertensive rat (SHR) Methylene methylimino linkage; Antisense; Platelet-derived growth factor A-chain; Smooth muscle cell, vascular ŽKishioka, H. Ž392. 129.

Spike-wave discharge Generalized absence epilepsy; Ca2q channel; WAGrRij rat; Nimodipine; BAY K8644; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381.

MAP Žmitogen-activated protein. kinase; Angiotensin; Endothelin; Aorta; DOCA-salt hypertensive rat ŽKubo, T. Ž400. 231. Spontaneously hypertensive, rat (SHR) Thiazide; Methyclothiazide; Endothelium; Ca2q; Hypertension ŽColas, B. Ž408. 63.

Spinal cord Protein kinase, cGMP-dependent; N-methyl-D-aspartate ŽNMDA.; Nitric oxide ŽNO.; Nociception; Hyperalgesia; Pain ŽTao, Y.-X. Ž392. 141.

Spreading depression Clomethiazole; Chlormethiazole; Hippocampus; Hypoxia; Neuroprotection ŽStone, T.W. Ž399. 29.

Analgesia; NMDA receptor; AMPA receptor; Morphine; ŽRat. ŽNishiyama, T. Ž395. 203.

SP1 (stimulatory protein-1) gene transcription factor NF-kB Žnuclear factor-kB. gene transcription factor; Brain; Ethanol tolerance; Ethanol dependence ŽMittal, N. Ž386. 113.

FR140423; Antinociception; Noradrenergic system; a 2 -Adrenoceptor; ŽMouse. ŽOchi, T. Ž400. 199. Nerve ligation; Chronic pain; Protein kinase C; TrkB receptor; ŽMouse. ŽNarita, M. Ž401. 187. TAK-637; Tachykinin NK 1 receptor antagonist, non-peptide; Micturition reflex; Electrical stimulation ŽKamo, I. Ž401. 235.

SR 141716 D 9-Tetrahydrocannabinol; SR 144528; Natural killer cell cytolytic activity; Interferon g ŽMassi, P. Ž387. 343. D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; Amphetamine; Operant behavior; Tolerance; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251.

Hyperalgesia; Nerve ligation; Inflammation; Protein kinase C; ŽMouse. ŽOhsawa, M. Ž403. 81.

SR 144528 D 9-Tetrahydrocannabinol; SR 141716; Natural killer cell cytolytic activity; Interferon g ŽMassi, P. Ž387. 343.

Neuropeptide FF; Morphine; Adenosine; Antinociception ŽGouarderes, ` C. Ž406. 391.

Cannabinoid CB1 receptor; D9-Tetrahydrocannabinol; CP 55,940; Anandamide; SR 141716A; Sympathetic neurotransmission ŽLay, L. Ž391. 151.

Analgesia; Antinociception; Pain; Neuropeptide FF; Supraspinal ŽAltier, N. Ž407. 245. 5-HT Ž5-hydroxytryptamine, serotonin.; Chronic pain; Paw pressure test; ŽRat. ŽBardin, L. Ž409. 37. FR140423; Antinociception; Serotonergic system; 5-HT2A receptor; 5-HT3 receptor; ŽMice. ŽOchi, T. Ž409. 167. Spinal cord transection Quinpirole; Blood pressure; Intrathecal domperidone; Dopamine D 2 receptor, spinal; Conscious, rat ŽLahlou, S. Ž408. 51. Spinal dorsal horn c-Fos; Racemic-flurbiprofen; SŽq.-flurbifrofen; RŽy.-flurbifrofen; Noxious heat ŽBuritova, J. Ž406. 59. Spino-bulbo-spinal C-fibre; Flexor reflex; Rostral ventromedial medulla; Wind-up; Inhibitory feedback mechanism; Morphine ŽGozariu, M. Ž394. 75.

Cannabinoid receptor; WIN 55212-2; Mutagenesis; Ligand docking; Molecular model ŽGouldson, P. Ž401. 17. CCK 1 receptor; Binding site; Modelling; SR 27897 ŽGouldson, P. Ž400. 185. Sr 2H Muscarinic receptor; Gallbladder; Receptor heterogeneity; Radioligand binding; Kinetics; Ca2q, Intracellular; Ca2q, Extracellular; ŽGuinea pig. ŽAkici, A. Ž388. 115. CCK 1 receptor; Binding site; Modelling; SR 146131 ŽGouldson, P. Ž400. 185. SR 27897 Cholecystokinin CCK 1 receptor; Mutagenesis; Charged residue; SR 146131 ŽGouldson, P. Ž389. 115. SR 48692 Neurotensin; Neurotensin receptor; Cly current; Dorsal root ganglion ŽKawarada, S. Ž404. 69.

Splanchnic nerve stimulation Endothelin ETA receptor; Endothelin ETB receptor; FR139317; BQ-788 ŽHosokawa, A. Ž397. 55.

SR 48968 Trachea; Acetylcholine release; Tachykinin NK 2 receptor; wbAla8 xNeurokinin A-Ž4–10. ŽD’Agostino, G. Ž396. 29.

Spontaneous alternation Nocistatin; Naloxone benzoylhydrazone; k-Opioid receptor; Passive avoidance ŽHiramatsu, M. Ž395. 149.

SR121463 Vasopressin V2 receptor antagonist; Aquaretic effect ŽLacour, C. Ž394. 131.

Master keyword index to Õolumes 386–410 (2000)

127

SR146131 Cholecystokinin; wCa2q x i ; Phosphoinositide turnover; Binding; ŽHuman. ŽSchaeffer, P. Ž397. 303.

Stereotypy Dihydroetorphine; Morphine; Physical dependence; Continuous infusion; ŽRat. ŽAceto, M.D. Ž387. 31.

SR 146131 Cholecystokinin CCK 1 receptor; Mutagenesis; Charged residue; SR 27897 ŽGouldson, P. Ž389. 115.

Ribozyme; Dopamine D 2 receptor ŽSalmi, P. Ž388. R1.

SR14716A Cannabinoid receptor agonist; WIN 55212-2; Cannabinoid receptor antagonist; Ileum; Electrical field stimulation; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207. SR141716A THC Žtetrahydrocannabinol.; Dependence; Withdrawal; Operant behavior; Behavioral dependence; ŽRat. ŽBeardsley, P.M. Ž387. 47.

Ibogaine; Cocaine; Sensitization; Dopamine; Drug addiction ŽSzumlinski, K.K. Ž398. 259. Glutamate receptor, metabotropic; Amphetamine; LY379268; Motor activity ŽCartmell, J. Ž400. 221. Steroid Protein phosphatase; Dopamine D 2 receptor agonist; Dopamine D 2 receptor antagonist; Uptake ŽThompson, T.L. Ž401. 357.

Radial-arm maze; Cannabinoid; Working memory ŽLichtman, A.H. Ž404. 175.

Steroid-like anti-inflammatory action Inflammation; Cyclic peptide; Streptomyce product ŽKuriyama, K. Ž390. 223.

SR 141716A Cannabinoid CB1 receptor; D9-Tetrahydrocannabinol; CP 55,940; Anandamide; SR 144528; Sympathetic neurotransmission ŽLay, L. Ž391. 151.

Steroid, synthetic Dienogest; Angiogenesis inhibition; Angiostatic therapy; Angiogenic disease ŽNakamura, M. Ž386. 33.

Cannabinoid; D9 -THC Ž D9 -tetrahydrocannabinol.; Antinociception; Marijuana, medical; Aerosol; Nebulizer ŽLichtman, A.H. Ž399. 141.

Stilbene derivative Cly channel; Vasoconstriction; Smooth muscle, vascular ŽLamb, F.S. Ž401. 403.

Acetylcholine; Hippocampus; HU 210; Microdialysis; Cortex, prefrontal; WIN 55, 212-2 ŽAcquas, E. Ž401. 179. SR 27897B L-365,260; Cholecystokinin; Dopamine; CCK A receptor; CCK B receptor ŽTieppo, C.A. Ž387. 189. s site NMDA receptor; w3 HxIfenprodil; w3 HxMK-801; Hippocampal brain membrane, porcine ŽHofner, G. Ž394. 211. ¨

Stimulus pattern Ca2q channel blocker; Thapsigargin; Acetylcholine release; Neuromuscular junction ŽCorreia-de-Sa, ´ P. Ž406. 355. Stomach Acetylcholine release; Histamine H 3 receptor; Pertussis toxin ŽYokotani, K. Ž392. 23. a-Fluoromethylhistidine; Gastrin; Histamine; Histidine decarboxylase; Microdialysis in vivo; ECL cell; Secretory vesicle ŽNorlen, ´ P. Ž400. 1.

Staphylococcal enterotoxin B Kinin; Mast cell; Neurogenic inflammation; Tachykinin NK 1 receptor; Vanilloid receptor ŽLinardi, A. Ž399. 235.

Stomach, rat Coeliac ganglion; Nicotine; Noradrenaline release; Nicotinic receptor ŽYokotani, K. Ž402. 223.

Startle Scopolamine; Muscarinic acetylcholine receptor; Prepulse inhibition; Apomorphine; Phencyclidine; Dopamine receptor; Glutamate receptor; ŽRat. ŽJones, C.K. Ž391. 105.

Strain difference NANC Žnonadrenergic, noncholinergic. relaxation; Colon, distal; Nitric oxide ŽNO.; VIP Žvasoactive intestinal peptide. ŽOkishio, Y. Ž388. 97.

[35 S]TBPS binding GABA A receptor subtype; Brain regional heterogeneity; Agonist coupling; Taurine; b-Alanine; Muscimol; 4-PIOL; 5-Ž4-piperidine.isoxazol3-ol ŽRabe, H. Ž409. 233. Stellate cell Cirrhosis; Endothelin; Liver; Fibrosis, rat ŽGandhi, C.R. Ž406. 311. Stem cell ´ Ž405. Differentiation; Hematopoietic; Central nervous system ŽMezey, E. 297. Stereology N v-nitro-L-arginine methyl ester; Heart lesion; Ventricular hypertrophy ŽDe Oliveira, C.F. Ž391. 121. Cerebral ischemia; 5-HT receptor; 8-OH-DPAT Ž8-hydroxy-2-Ždi-n-propylamino.tetralin.; ŽRat. ŽTorup, L. Ž395. 137.

Straub tail Antinociception; Locomotor activity; Morphine; SC17599; ŽMouse. ŽHoushyar, H. Ž395. 121. Streptomyce product Inflammation; Steroid-like anti-inflammatory action; Cyclic peptide ŽKuriyama, K. Ž390. 223. Streptozotocin Allodynia; Endothelin; Diabetic neuropathy ŽJarvis, M.F. Ž388. 29. T-1095; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. Aldose reductase; Autonomic neuropathy; Diabetes; Non-adrenergic non-cholinergic; Gastric fundus, rat ŽJenkinson, K.M. Ž401. 251. Diabetes; Ouabain; Naq,Kq-ATPase; Phenylephrine; Vascular reactivity;

128

Master keyword index to Õolumes 386–410 (2000)

Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419.

Stress; Nicotine; Dopamine; Hippocampus; ŽRat. ŽPawlak, R. Ž387. 171.

Streptozotocin-diabetes Aorta; Endothelium-dependent relaxation; Endothelium-independent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163.

w35 SxGTPgS binding, agonist-stimulated; Dopamine D 2 -like receptor; Quinpirole; Monoamine oxidase inhibitor; ŽRat. ŽGilliland, S.L. Ž392. 125.

Streptozotocin-diabetic, rat Cilostazol; Antiplatelet vasodilating agent; Phosphodiesterase inhibitor ŽYamamoto, Y. Ž409. 1. Streptozotocin-induced diabetic mouse Corpus cavernosum; Nitric oxide ŽNO.; Antioxidant; Vitamin E; Sodium selenate; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93. Stress Cocaine; Corticosterone; Neuroendocrine; Hypothalamo pituitary–adrenal axis; Self-administration ŽGalici, R. Ž387. 59. Nicotine; Dopamine; Striatum; Hippocampus; ŽRat. ŽPawlak, R. Ž387. 171. Locus coeruleus; Noradrenaline; Cortex, prefrontal; NMDA receptor; GABA receptor; CRF receptor; Microdialysis ŽKawahara, H. Ž387. 279. Neuropeptide-Y; Depression ŽStogner, K.A. Ž387. R9. Behaviour; Autonomic nervous system ŽNijsen, M.J.M.A. Ž389. 89. Anxiety; 5-HT1A receptor; Tachycardia; Hyperthermia; Radiotelemetry ŽBouwknecht, J.A. Ž400. 59. Glucocorticoid; Cytokine; Ageing; Alzheimer’s disease ŽAngelucci, L. Ž405. 139. Conditioned response; Immunity; Psychoneuroimmunology ŽAder, R. Ž405. 167. Corticosteroid; Hypothalamus–pituitary–adrenal activity ŽDe Kloet, E.R. Ž405. 187.

Dopamine receptor agonist; Microdialysis; Bioavailability; Bioisosteric replacement; Thiophene analog ŽRodenhuis, N. Ž394. 255. Adenosine; Opioid ŽHalimi, G. Ž398. 217. Dopamine; Acetylcholine; GABA Ž g-aminobutyric acid.; Substantia niP. Ž399. 151. gra; Antimuscarinic drug; L-Dopa ŽIzurieta-Sanchez, ´ c-fos; zif268; 6-Hydroxydopamine; N-methyl-D-aspartate ŽNMDA.; 3,4-dihydroxyphenylalanine ŽL-DOPA. ŽAdams, A.C. Ž404. 303.

L-

Striatum, rat Domoic acid; DNQX; MK-801; Dopamine; Microdialysis ŽQuintela, B.A. Ž401. 173. Stroke LY341122; Cerebral ischemia, focal; Neuroprotection; Oxygen radical; ŽRat. ŽHuh, P.W. Ž389. 79. Chloromethyl ketone; Focal ischemia; Apoptosis; Serine protease inhibitor; Nitric oxide ŽNO. ŽLeBlanc, M.H. Ž390. 249. NAALADase inhibition Ž N-acetylated-a-linked-acidic dipeptidase.; Neuroprotection; ŽRat. ŽTortella, F.C. Ž402. 31. Stroke-prone spontaneously hypertensive rats (SHRSP) Pulmonary artery; a-Adrenoceptors; Nitric oxide ŽNO.; Endothelium ŽMatsuda, K. Ž392. 61. Stromal cell Nitric oxide ŽNO.; Osteoblast-like cell; Mineralization; Differentiation ŽKoyama, A. Ž391. 225.

CRF Žcorticotropin-releasing factor.; Urocortin; CRF receptor; Antisense; Behaviour; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Structural analogue 4-Hydroxyisoleucine; Insulin release; Fenugreek seed; Pancreas; ŽRat. ŽBroca, C. Ž390. 339.

Mineralocorticoid receptor; Glucocorticoid receptor; Hypothalamic–pituitary–adrenocortical axis; Antidepressants; Major depression ŽReul, J.M.H.M. Ž405. 235.

Structure Dopamine D4 receptor; G protein-coupled receptor; Pharmacology; Signaling; Physiology; Genetics ŽOak, J.N. Ž405. 303.

Schizophrenia; Cognition; Coping; Hypothalamic–pituitary–adrenal system; Immune system ŽGispen-de Wied, C.C. Ž405. 375.

Structure–activity relationship Antinociception; Cannabinoid; Intrahecal; Intraventricular; Tetrahydrocannabinol ŽWiley, J.L. Ž397. 319.

Anxiety; Noradrenaline; Hypothalamus; Amygdala; Locus coeruleus; Benzodiazepines; Opioid agent; Anxiolytic drug ŽTanaka, M. Ž405. 397. Stressful stimuli Neuropeptide; c-fos; Paraventricular nucleus; Supraoptic nucleus; Amygdaloid nucleus, central ŽPalkovits, M. Ž405. 161. Stress of social defeat Ethanol; Dopamine release; Voltammetry in vivo; Nucleus accumbens; ŽMouse. ŽYavich, L. Ž401. 365.

Stunning Ca2q-responsiveness; Ca2q-sensitizer; Myocardial contractility; End-systolic elastance ŽDe Zeeuw, S. Ž403. 99. Subarachnoid hemorrhage Erythropoietin; Brain ŽBuemi, M. Ž392. 31. Protein kinase C isoform; Cerebral vasospasm ŽNishizawa, S. Ž398. 113. Brain ischemia; Erythropoietin ŽAlafaci, C. Ž406. 219.

Stretch receptor Calmodulin antagonist; Mechanosensitive channel; Voltage clamp ŽLin, J.-H. Ž397. 11. Striatum Apomorphine; Dopamine; N-propyl analog; Microdialysis; Bioavailability ŽRodenhuis, N. Ž387. 39.

Subiculum Somatostatin; Somatostatin sst2 receptor; Dopamine; Microdialysis ŽMitchell, S.N. Ž395. 43. Dopamine; Nucleus accumbens; Fimbria-fornix; Microdialysis; ŽRat. ŽMitchell, S.N. Ž407. 131.

Master keyword index to Õolumes 386–410 (2000) Submucosal neuron Enteric neuron; ATP receptor; Ca2q; Receptor; P2X receptor; P2Y receptor; Ligand-gated channel ŽBarajas-Lopez, C. Ž409. 243. ´ Submucous plexus Enteric nervous system; Small intestine; Synaptic transmission, inhibitory; Norepinephrine; Somatostatin ŽLiu, S. Ž397. 49. Substance P Neurotensin; Dopamine; Ibogaine; Cocaine; Methamphetamine; Drug abuse ŽAlburges, M.E. Ž390. 119. TNF-a Žtumor necrosis factor-a .; Histamine; Dexamethasone; MAP Žmitogen-activated protein. kinase; Skin ŽOkabe, T. Ž398. 309. Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; Terfenadine; ŽMouse. ŽInagaki, N. Ž400. 73. Vasodilatation; Plasma extravasation; Knee joint, Rabbit ŽLam, F.F.Y. Ž400. 327. Tachykinin NK 1 receptor; Inflammation; Hypertension genetic; GH Žgenetically hypertensive. rat; Nitric oxide ŽNO. ŽCampbell, V.A. Ž401. 109. Emedastine difumarate; Itch-associated response; Histamine; Leukotriene B 4 ; 5-HT Ž5-hydroxytryptamine, Serotonin. ŽAndoh, T. Ž406. 149. Capsaicin; Nociception; Pain; Ricinoleic acid; Tachykinin; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Cough; C-fibre; Tachykinin; Citric acid ŽMoreaux, B. Ž408. 305. Substantia nigra 6-Hydroxydopamine; Ligand binding autoradiography; Neostriatum ŽVasiliadis, H.-M. Ž386. 155. Nicotinic receptor; Epibatidine; Somatodendritic; Ventral tegmental area; Dendrosome ŽReuben, M. Ž393. 39. Dopamine; Acetylcholine; GABA Ž g-aminobutyric acid.; Striatum; AnP. Ž399. 151. timuscarinic drug; L-Dopa ŽIzurieta-Sanchez, ´ Tyrosine hydroxylase; Haloperidol; Immunohistochemistry; Antioxidant; ŽRat. ŽBesret, L. Ž408. 35. Substantia nigra reticulata Gabapentin; g-Aminobutyric acid; Microdialysis ŽTimmerman, W. Ž398. 53. Subunit composition Ivermectin; GABA A receptors; Patch clamp ŽAdelsberger, H. Ž394. 163. Subunit null mutation Nicotinic acetylcholine receptor; Pharmacological comparison; Binding; Activation ŽWhiteaker, P. Ž393. 123. Sulfonylurea Dopamine; Tyrosine hydroxylase; Glipizide; DOPAC Ž3,4-dihydroxyphenylacetic acid.; HVA Žhomovalinic acid. ŽLamensdorf, I. Ž388. 147.

129

I K.ATP ; Glibenclamide; HMR1883; Sulfonylurea; Cardiac ischemia; Dispersion; Arrhythmia ŽDhein, S. Ž398. 273. Sulfonylurea compound Ž R .-ACX; Insulin releasing effect; Hypoglycemic effect ŽSeri, K. Ž389. 253. Sulfonylurea receptor Kq channel opener; Detrusor smooth muscle; Smooth muscle relaxation; Kq channels, ATP-sensitive ŽBuckner, S.A. Ž400. 287. Sulpiride D-Fenfluramine; Hypothermia; 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Yohimbine ŽCryan, J.F. Ž390. 275. Sumatriptan Eletriptan; Carotid artery blood flow; Femoral artery blood flow; Neurogenic inflammation; Coronary artery diameter ŽGupta, P. Ž398. 73. Coronary artery; Eletriptan; GR125743; Middle meningeal artery; Migraine; Saphenous vein; Serotonin; ŽHuman. ŽVan den Broek, R.W.M. Ž407. 165. Superficial buffer barrier hypothesis Sarcoplasmic reticulum; Ca2q-ATPase, Sarcoplasmic reticulum; Ca2q uptake function; Ca2q influx; Ca2q channel, L-type; Arterial contraction ŽNomura, Y. Ž404. 315. Sarcoplasmic reticulum; Ca2q-induced Ca2q release channels; Ca2q movement; Ca2q influx; Ca2q channel, L-type ŽAsano, M. Ž404. 327. Superior cervical ganglion Ca2q channel, N-type; v-Conotoxin GVIA; v-Conotoxin MVIIA; vConotoxin MVIIC; Vas deferens; Intestine; ŽHuman.; ŽRat.; ŽGuinea-pig. ŽSanger, G.J. Ž388. 89. Superior cervical ganglion, rat ATP; Ecto-nucleotidase; Dipyridamole; Ecto-ATPase; UTP ŽConnolly, G.P. Ž397. 271. Superoxide Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Endothelium-independent relaxation; Nitric oxide ŽNO.; Hydrogen peroxide; Superoxide dismutase; Catalase ŽKarasu, C¸ . Ž392. 163. Insulin resistance; Nitric oxide ŽNO.; Isometric tension study ŽShinozaki, K. Ž394. 295. Superoxide anion AMP579; Coronary artery endothelium; Neutrophil degranulation; Neutrophil adherence ŽNakamura, M. Ž397. 197. Guanylyl cyclase, soluble; Aorta; Renin–angiotensin system; Hypertension ŽJacke, K. Ž403. 27. Superoxide dismutase Carrageenan; Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Tempol ŽCuzzocrea, S. Ž390. 209.

OAT1 Žorganic anion transporter 1.; Renal tubular secretion; Xenopus oocytes; Nateglinide; p-Aminohippurate ŽUwai, Y. Ž398. 193.

Aorta; Streptozotocin-diabetes; Endothelium-dependent relaxation; Endothelium-independent relaxation; Nitric oxide ŽNO.; Superoxide; Hydrogen peroxide; Catalase ŽKarasu, C¸ . Ž392. 163.

I K.ATP ; Glibenclamide; HMR1883; Cardiac ischemia; Dispersion; Arrhythmia; Sulfonylurea ŽDhein, S. Ž398. 273.

Antioxidant; Diabetic retinopathy; Glutathione; Lipid peroxidation ŽObrosova, I.G. Ž398. 139.

130

Master keyword index to Õolumes 386–410 (2000)

Superoxide production Polymorphonuclear leukocyte; Rho kinase; p160ROCK; Aggregation ŽKawaguchi, A. Ž403. 203.

Sympathetic neurotransmission Adenosine; ATP; Mesentery, hamster; Prejunctional neuromodulation; Purine receptor ŽRalevic, V. Ž387. 287.

Cisplatin; Sensory neuropathy; Peroxinitrite ŽSzilvassy, J. Ž403. 259. ´

Cannabinoid CB1 receptor; D9-Tetrahydrocannabinol; CP 55,940; Anandamide; SR 141716A; SR 144528 ŽLay, L. Ž391. 151.

Supersensitive 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Target ŽMoret, C. Ž404. 1. Supraoptic nucleus Stressful stimuli; Neuropeptide; c-fos; Paraventricular nucleus; Amygdaloid nucleus, central ŽPalkovits, M. Ž405. 161. Supraspinal Analgesia; Antinociception; Pain; Neuropeptide FF; Spinal cord ŽAltier, N. Ž407. 245. Sural nerve Neuropathy; Colorectal cancer; Dorsal root ganglia; Hippocampal neuron ŽAdelsberger, H. Ž406. 25. Suramin PACAP Žpituitary adenylate cyclase-activating peptide.; VIP Žvasoactive intestinal peptide.; Apamin; PACAP-Ž6–38.; VIP-Ž10–28.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217. Eriochrome Black T; Endothelial cell; Cyclin; Cell cycle ŽLanger, I. Ž399. 85. X X Pineal gland; Melatonin; N -acetyl-5-hydroxytryptamine Ž N -acetyl-5HT.; P2-receptor ŽMortani Barbosa Jr., E.J. Ž401. 59.

Purine; Adenosine; ATP; Nucleotide; Hippocampus; Long-term potentiation ŽO’Kane, E.M. Ž409. 159.

Sympathetic vasodilation Choroidal blood flow; Laser-Doppler flowmetry; b-Adrenoceptor activation; b-Adrenoceptor antagonist; L-NAME Ž N G -nitro-L-arginine methyl ester.; Indomethacin; ŽRat. ŽKawarai, M. Ž386. 227. Sympatho-adrenomedullary outflow, central Brain phospholipase A 2 ; Catecholamines, plasma; Melittin; Mepacrine ŽYokotani, K. Ž398. 341. Synaptic g-aminobutyric acid (GABA) transmission Basolateral amygdala; 5-HT1A receptors; Presynaptic modulation; Dissociated neuron and tandospirone ŽKishimoto, K. Ž407. 257. Synaptic inhibition GABA Ž g-aminobutyrate.; Caged compound; Hippocampus; Granule cell; GABA A receptor ŽMolnar, ´ P. Ž391. 255. Synaptic plasticity Long-term potentiation; Primed-burst stimulation; Visual cortex; Ketamine ŽSalami, M. Ž390. 287. Schizophrenia; Bipolar disorder; Depression; Memory; Ventricle enlargement; Neurocognitive impairment ŽVawter, M.P. Ž405. 385. Synaptic transmission, inhibitory Enteric nervous system; Submucous plexus; Small intestine; Norepinephrine; Somatostatin ŽLiu, S. Ž397. 49.

Surfactant Pneumocyte Žtype II.; Phosphatidylcholine secretion; Adrenomedullin; Protein kinase C ŽOkumura, M. Ž403. 189.

Synaptic vesicle Alzheimer’s disease; Cholinergic; Exocytosis; Neuromuscular junction; Oocyte; Tacrine; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7.

Surgery Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Vasopressin ŽPavo, ´ ´ I. Ž402. 193.

Synaptosome Nicotinic receptor, presynaptic; Glutamate receptor antagonist; Nicotine; Anatoxin-a; Immunogold electron microscopy ŽWonnacott, S. Ž393. 51.

Survival rate g-Butyrobetaine hydroxylase inhibitor; Heart failure; Ventricular remodeling; Cardiac functional adaptability; High-energy phosphate ŽHayashi, Y. Ž395. 217. Susceptibility Gene polymorphism; Cardiovascular disease; Angiotensin-converting enzyme; Angiotensinogen; Angiotensin II type 1 receptor ŽWang, J.-G. Ž410. 289. Sweat gland P2Y receptor; Anionic secretion; Hyperhidrosis; Ca2q, intracellular; Ussing chamber ŽBovell, D.L. Ž403. 45. Swelling Hippocampal neuron; Veratridine; Death; Naq channel; Ca2q channel ŽOkuyama, K. Ž398. 209. Sympathetic activation Collagen; Heart failure; Hypertrophy; Moxonidine; ŽRat. ŽVan Kerckhoven, R. Ž397. 113.

v-Agatoxin IVA-sensitive Ca2q channel; a-Eudesmol; Glutamate release; Microdialysis; Focal ischemia ŽAsakura, K. Ž394. 57. s Receptor; Glutamate release; GABA Ž g-aminobutyric acid. release; Cerebellum ŽGarrone, B. Ž400. 35. CART Žcocaine- and amphetamine-regulated transcript.; TRH Žthyrotropin releasing hormone.; Dopamine; Norepinephrine; Hypothalamus ŽBrunetti, L. Ž409. 103. Synoviocyte Rheumatoid arthritis; Cyclooxygenase-1; Cyclooxygenase-2; Meloxicam ŽTsubouchi, Y. Ž395. 255. Systemic haemodynamics Ca2q sensitizer; Myocardial oxygen consumption; Diastolic function, regional; Systolic shortening, regional ŽSoei, L.K. Ž386. 55. Systemic toxicity Convulsion; Central nervous system ŽSugimoto, M. Ž401. 329.

Master keyword index to Õolumes 386–410 (2000) Systolic shortening, regional Ca2q sensitizer; Myocardial oxygen consumption; Diastolic function, regional; Systemic haemodynamics ŽSoei, L.K. Ž386. 55. T-588 Ca2q reperfusion; NGF Žnerve growth factor.; PD98059; MAP Žmitogen-activated protein. kinase; Astrocyte ŽTakuma, K. Ž399. 1. T-1095 Streptozotocin; Phlorizin; Naq-glucose cotransporter; Glucose clamp; Glucose tolerance test; Glucose transporter; Insulin sensitivity; Insulin secretion ŽOku, A. Ž391. 183. TA-270 Asthmatic response; Bronchoalveolar eosinophilia; Airway hyperresponsiveness ŽAoki, Y. Ž409. 325. TA-993 Platelet; Glycoprotein IIbrIIIa receptor; ADP; Actin polymerization; Ca2q, intracellular ŽKatoh, M. Ž399. 91. Tachycardia Anxiety; Stress; 5-HT1A receptor; Hyperthermia; Radiotelemetry ŽBouwknecht, J.A. Ž400. 59. Lipolysis; Rhesus ŽForrest, M.J. Ž407. 175. Tachykinin Micturition reflex; Tachykinin NK 1 receptor; Tachykinin NK 2 receptor; Orphanin FQ ŽLecci, A. Ž389. 99. Capsaicin; Nociception; Pain; Ricinoleic acid; Substance P; ŽGuinea pig.; ŽMouse. ŽVieira, C. Ž407. 109. Cough; Substance P; C-fibre; Citric acid ŽMoreaux, B. Ž408. 305. Tachykinin NK 1 receptor Micturition reflex; Tachykinin NK 2 receptor; Orphanin FQ; Tachykinin ŽLecci, A. Ž389. 99. Wood smoke; CP-96,345; Tachykinin NK 2 receptor ŽLin, Y.S. Ž394. 139. Tachykinin NK 2 receptor Micturition reflex; Tachykinin NK 1 receptor; Orphanin FQ; Tachykinin ŽLecci, A. Ž389. 99. Wood smoke; CP-96,345; Tachykinin NK 1 receptor ŽLin, Y.S. Ž394. 139. Staphylococcal enterotoxin B; Kinin; Mast cell; Neurogenic inflammation; Vanilloid receptor ŽLinardi, A. Ž399. 235. Trachea; Acetylcholine release; wbAla8 xNeurokinin A-Ž4–10.; SR 48968 ŽD’Agostino, G. Ž396. 29. Substance P; Inflammation; Hypertension genetic; GH Žgenetically hypertensive. rat; Nitric oxide ŽNO. ŽCampbell, V.A. Ž401. 109. Tachykinin NK 1 receptor agonist Phoneutria nigriÕenter venom; Sensory nerve; Neurogenic plasma extravasation; Vanilloid receptor; Purinoceptor ŽCosta, S.K.P. Ž391. 305. Tachykinin NK 1 receptor antagonist, non-peptide TAK-637; Micturition reflex; Urinary tract, lower ŽDoi, T. Ž395. 241.

131

TAK-637; Micturition reflex; Spinal cord; Electrical stimulation ŽKamo, I. Ž401. 235. Tachykinin receptor Nepadutant; Tachykinin receptor antagonist; Intestine, human; Urinary bladder, human ŽPatacchini, R. Ž398. 389. Tachykinin receptor antagonist Nepadutant; Tachykinin receptor; Intestine, human; Urinary bladder, human ŽPatacchini, R. Ž398. 389. Diabetic, rat; Allodynia, tactile; Allodynia, thermal ŽCoudore-Civiale, ´ M.-A. Ž401. 47. Tacrine Donepezil hydrochloride; E2020; Cholinesterase inhibitor; Brain; Peripheral tissue; ŽRat, young.; ŽRat, Aged. ŽKosasa, T. Ž386. 7. Donepezil hydrochloride ŽE2020.; Physostigmine; ENA-713; TAK-147; NIK-247; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173. Alzheimer’s disease; Cholinergic; Exocytosis; Neuromuscular junction; Oocyte; Synaptic vesicle; ŽTorpedo marmorata.; Ž Xenopus laeÕis . ŽRos, E. Ž390. 7. Tacrolimus Cyclosporine; Glomerulo-tubular balance; Tubulo-glomerular feed-back; Tubular reabsorption; Single nephron filtration rate ŽRomano, G. Ž399. 215. Tail-flick NMDA receptors; Glutamate; Dizocilpine; Nucleus accumbens ŽMillan, M.J. Ž388. 37. Tail-flick latency Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Withdrawal jump ŽRaghavendra, V. Ž409. 279. Tail-flick test Dermorphin N-terminal tetrapeptide; Naloxonazine; b-Funaltrexamine; m1-Opioid receptor ŽSakurada, S. Ž395. 107. Tail tremor Nicotine; 5-HT1A receptor; ŽRat. ŽSuemaru, K. Ž408. 19. TAK-147 Donepezil hydrochloride ŽE2020.; Tacrine; Physostigmine; ENA-713; NIK-247; Cholinesterase inhibitor; Cholinesterase ŽKosasa, T. Ž389. 173. TAK-637 Tachykinin NK 1 receptor antagonist, non-peptide; Micturition reflex; Urinary tract, lower ŽDoi, T. Ž395. 241. Tachykinin NK 1 receptor antagonist, non-peptide; Micturition reflex; Spinal cord; Electrical stimulation ŽKamo, I. Ž401. 235. Tamoxifen Cerebrovascular constriction; Oxyhemoglobin; Protein kinase C ŽWickman, G. Ž390. 181. Tangle Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tau; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨

132

Master keyword index to Õolumes 386–410 (2000)

Target 5-HT1B rD receptor; Psychiatric disorder; 5-HT Ž5-hydroxytryptamine, serotonin. release; 5-HT Ž5-hydroxytryptamine, serotonin. synthesis; Depression; Anxiety; Obsessive compulsive disorder; Desensitisation; Supersensitive ŽMoret, C. Ž404. 1. Tau Alzheimer’s disease; Amyloid precursor protein; Amyloid-b peptide; Plaque; Tangle; Nicotine; Muscarinic receptor; Nicotinic receptor; Cholinesterase inhibitor ŽHellstrom-Lindahl, E. Ž393. 255. ¨ Taurine Angiotensin II; Cell size; Fetal gene expression; Growth factor gene expression; Protein kinase C ŽAzuma, M. Ž403. 181. 35

GABA A receptor subtype; Brain regional heterogeneity; w SxTBPS binding; Agonist coupling; b-Alanine; Muscimol; 4-PIOL; 5-Ž4piperidine.isoxazol-3-ol ŽRabe, H. Ž409. 233. Taxol Polyploidization; Phorbol 12-myristate 13-acetate ŽPMA.; Protein kinase C; Polymerization ŽZong, Z.-p. Ž394. 181. TC-2559 Nicotinic receptor; Cognition; Central nervous system ŽBencherif, M. Ž409. 45. T84 cell 5-Hydroxytryptamine Ž5-HT, serotonin.; Desensitization; Serum ŽBurleigh, D. Ž390. 103.

Terfenadine Scratching behavior; Immunoglobulin E; Anaphylaxis, passive cutaneous; Substance P; Histamine; Histamine H 1 receptor; Oxatomide; Epinastine; Cetirizine; ŽMouse. ŽInagaki, N. Ž400. 73. Testis, rat w3 HxAdenosine; Adenosine uptake; Mitochondrion; Benzodiazepine receptor ligand, mitochondrial ŽJimenez, A. Ž398. 31. ´ Tetrahydrocannabinol Dependence; Withdrawal; Operant behavior; Behavioral dependence; SR141716A; ŽRat. ŽBeardsley, P.M. Ž387. 47. Antinociception; Cannabinoid; Intrahecal; Intraventricular; Structure–activity relationship ŽWiley, J.L. Ž397. 319.

D 9-Tetrahydrocannabinol SR 141716; SR 144528; Natural killer cell cytolytic activity; Interferon g ŽMassi, P. Ž387. 343. D9-Tetrahydrocannabinol Cannabinoid CB1 receptor; CP 55,940; Anandamide; SR 141716A; SR 144528; Sympathetic neurotransmission ŽLay, L. Ž391. 151. Activity; Cannabinoid; Biphasic effect; Movement ŽSanudo-Pena, ˜ ˜ M.C. Ž391. 269. ( D9 -Tetrahydrocannabinol) D9 -THC Cannabinoid; SR 141716A; Antinociception; Marijuana, medical; Aerosol; Nebulizer ŽLichtman, A.H. Ž399. 141.

TCP binding RPR 118723; Glycine antagonist; Glutamate; N-methyl-D-aspartate ŽNMDA. receptor–channel complex; Dopamine release ŽBoireau, A. Ž401. 131.

Tetrodotoxin-resistant Amitriptyline; Antidepressant; Tetrodotoxin-sensitive; Naq channel; Dorsal root ganglion ŽSong, J.-H. Ž401. 297.

TDPA EAAT; Ž RS .-2-Amino-3-Ž3-hydroxy-1,2,5-thiadiazol-4-yl.propionic acid; EAAT2 inhibitor, selective ŽBrauner-Osborne, H. Ž406. 41. ¨

Tetrodotoxin-sensitive Amitriptyline; Antidepressant; Tetrodotoxin-resistant; Naq channel; Dorsal root ganglion ŽSong, J.-H. Ž401. 297.

TEI-9874 Asthma; Immunoglobulin E ŽNonaka, T. Ž402. 287.

TGF-a (transforming growth factor-a ) TGF-b1 Žtransforming growth factor-b1.; 2,4-Dideoxyadenosine; Somatostatin; H-89; Hepatocyte proliferation ŽKimura, M. Ž386. 271.

Tele-methylhistamine Food intake; Histamine; Hypothalamus; Leptin; ŽIntracereboventricular infusion. ŽLecklin, A. Ž395. 113. Telomerase Glioma; Chemosensitivity; Penclomedine; p53 ŽVietor, M. Ž407. 27. Temperament Personality; Genes; Neurotransmission; Polymorphism; Abnormal behavior ŽEbstein, R.P. Ž410. 205. Temperature Umbilical artery, human; 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex. ŽTiritilli, A. Ž406. 79. Tempol Carrageenan; Inflammation; Nitric oxide ŽNO.; Peroxynitrite; Superoxide dismutase ŽCuzzocrea, S. Ž390. 209. Temporal lobe epilepsy Antiepileptic drug; Vigabatrin; Epileptic activity; Pharmacoresistant; Brain slice ŽMusshoff, U. Ž401. 167.

TGF-b1 (transforming growth factor-b1) TGF-a Žtransforming growth factor-a .; 2,4-Dideoxyadenosine; Somatostatin; H-89; Hepatocyte proliferation ŽKimura, M. Ž386. 271. TGF-b (transforming growth factor b ) CTGF Žconnective tissue growth factor.; Apoptosis; Caspase; Atherosclerosis ŽHishikawa, K. Ž392. 19. TGF-b1 (transforming growth factor-b1) inducer Wound healing accelerator; Healing-impaired, mouse; Cyclic peptide; SEK-1005 ŽAbe, Y. Ž408. 213. Thalidomide TNF-a Žtumor necrosis factor-a .; Hyperalgesia, inflammatory; Pain ŽRibeiro, R.A. Ž391. 97. Thapsigargin Antisense oligodeoxynucleotide; NaqrCa2q exchange; Ca2q pump; Ca2q concentration, Intracellular ŽNakao, M. Ž387. 273. Nitric oxide ŽNO.; Endothelium; Kq channel; Relaxation; Aorta; ŽRat. ŽHuang, Y. Ž392. 51.

Master keyword index to Õolumes 386–410 (2000) Ca2q channel blocker; Stimulus pattern; Acetylcholine release; Neuromuscular junction ŽCorreia-de-Sa, ´ P. Ž406. 355. Betulinic acid; Ca2q; Ca2q store; Fura-2; MDCK cell ŽChou, K.-J. Ž408. 99.

133

Thromboxane Thrombin; Protein kinase C; Protein kinase inhibitor; Platelet, human ŽSamokhin, G.P. Ž386. 297. Blood pressure; Endothelin receptor antagonist; Nicotine; ŽRat. ŽTanusSantos, J.E. Ž396. 33.

Ca2q-ATPase inhibitor; Ca2q store, EpDRF Žepithelium-dependent relaxing factor.; Airway epithelial cell; ŽGuinea pig. ŽTakahashi, N. Ž410. 61.

Leukotriene; YM158; Asthma ŽArakida, Y. Ž403. 169.

Theophylline Bronchus, human, isolated; Phorbol 12,13-diacetate; Caffeine ŽSarria, ´ B. Ž399. 65.

Thromboxane A 2 TP receptor; Forskolin; cAMP; Mammary artery, internal; Saphenous vein ŽCracowski, J.-L. Ž387. 295.

Thermal hyperalgesia Bradykinin; Protein kinase C; Phorbol-12, 13-dibutyrate; Calphostin C; Diabetes; ŽMouse. ŽKamei, J. Ž390. 113.

Colon, rat; PAF Žplatelet-activating factor.; Cly secretion ŽSuzuki, T. Ž400. 297.

Amitriptyline; Caffeine; Neuropathic pain ŽEsser, M.J. Ž399. 131. Thermogenesis b 3 -Adrenoceptor agonists; Pyruvate-oxidation; Glucose metabolism; Soleus muscle, isolated ŽBoard, M. Ž406. 33. Thiazide Methyclothiazide; Endothelium; Ca2q; Spontaneously hypertensive, rat ŽSHR.; Hypertension ŽColas, B. Ž408. 63. Thiazolidinedione Troglitazone; Rosiglitazone; BRL 49653; K AT P current; Glibenclamide; Kq channel ŽMishra, S.K. Ž386. 121. Hemodynamics; Heart; Coronary vasorelaxant; Prostaglandin ŽUchida, K. Ž400. 113. Troglitazone; Fructose 2,6-bisphosphate; Hepatocyte; Insulin ŽRaman, P. Ž409. 19. Thiophene analog Dopamine receptor agonist; Microdialysis; Bioavailability; Striatum; Bioisosteric replacement ŽRodenhuis, N. Ž394. 255. Thrombin Thromboxane; Protein kinase C; Protein kinase inhibitor; Platelet, human ŽSamokhin, G.P. Ž386. 297. Antithrombotic; Coagulation factor Xa; Heparin; ŽIn vivo. ŽHeran, C. Ž389. 201. Thrombosis; Factor Xa; Coagulation inhibitor ŽSinha, U. Ž395. 51.

Arterial thrombosis; Z-335; Cilostazol ŽTanaka, T. Ž401. 413. JTE-522; Cyclooxygenase-2; Prostaglandin E 2 ; U-46619; Airway hyperresponsiveness; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267. Thromboxane B 2 HCL-31D, platelet aggregation; cAMP; Phosphoinositide breakdown ŽChou, T.-C. Ž387. 125. Thromboxanes Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193. Th1 r Th2 Androgen; Immune function; Prenatal; Estrogen; Autoimmunity ŽMartin, J.T. Ž405. 251. Thymoquinone Nigella satiÕa oil; Antinociception; Opioid system; Formalin test ŽAbdel-Fattah, A.-F.M. Ž400. 89. Tianeptine 5-HT Ž5-hydroxytryptamine, serotonin.; Paroxetine; Frontal cortex; Raphe nuclei; Microdialysis, in vivo ŽMalagie, ´ I. Ž403. 55. Tissue culture Amyotrophic lateral sclerosis ŽALS.; Motor neuron; Apoptosis; Cell culture; Neurodegenerative disease ŽBar, ¨ P.R. Ž405. 285. Tissue distribution a 1a -Adrenoceptor; a 1b-Adrenoceptor; a 1d-Adrenoceptor; Rabbit; Molecular cloning; Pharmacology ŽPiao, H. Ž396. 9.

Coronary artery disease; Coagulation; ŽHuman. ŽPothula, A. Ž402. 1. Platelet aggregation; Coagulation; Shear; Bifunctional inhibitor ŽTaka, T. Ž406. 181.

Tissue remodelling Phosphodiesterase inhibitor; Matrix metalloproteinase; Bronchoalveolar lavage; ŽMouse. ŽBelleguic, C. Ž404. 369.

Thrombin–antithrombin complex Hemophilia A; Blood coagulation control; Antithrombin consumption; Factor Xarantithrombin complex; Protein SV-IV ŽDi Micco, B. Ž391. 1.

T-lymphocyte wMet 5 xenkephalin; Gender; B-lymphocyte; Proliferation; Opioid receptor ŽGabrilovac, J. Ž392. 101.

Thrombin receptor Endothelial cell; Protein phosphatase ŽMizuno, O. Ž389. 13.

TNF-a Nociception; Interleukin 1b; Interleukin 8; Macrophage; Mast cell; ŽTumour necrosis factor-a . ŽRibeiro, R.A. Ž387. 111.

Thrombosis Factor Xa; Thrombin; Coagulation inhibitor ŽSinha, U. Ž395. 51. Endothelial factor; Hemostasis; Nitric oxide ŽNO.; Platelet ŽMomi, S. Ž397. 177.

TNF-alpha (tumor necrosis factor-a ) Lead; Hepatocyte, rat; Lipopolysaccharide; Kupffer cell; Coculture; Nitric oxide ŽNO.; Nitric oxide ŽNO. synthase, inducible ŽMilosevic, N. Ž401. 317.

134

Master keyword index to Õolumes 386–410 (2000)

TNF-a (tumor necrosis factor-a ) Thalidomide; Hyperalgesia, inflammatory; Pain ŽRibeiro, R.A. Ž391. 97.

Nitric oxide ŽNO.; S-Nitrosothiol; Organic nitrate; Blood vessel ŽMiller, M.R. Ž403. 111.

Substance P; Histamine; Dexamethasone; MAP Žmitogen-activated protein. kinase; Skin ŽOkabe, T. Ž398. 309.

GABA Ž g-aminobutyric acid.; Esophageal sphincter relaxation, transient, lower; Baclofen ŽLehmann, A. Ž403. 163.

Cynaropicrin; Anti-inflammatory effect; Nitric oxide ŽNO. release; Lymphocyte proliferation; Immunosuppressive effect ŽCho, J.Y. Ž398. 399.

Morphine; Zn2q; Intrathecal; Antinociception; Dependence ŽLarson, A.A. Ž407. 267.

Arthritis; Phosphodiesterase 4; Hyperalgesia; Oedema; Rolipram ŽFrancischi, J.N. Ž399. 243.

Clozapine; Fos-protein; DOI; 8-OH-DPAT ŽSebens, J.B. Ž408. 11.

Neutrophil; Caspase; Apoptosis inhibitory protein; Transcription factor; NF-kB Žnuclear factor-kB. ŽNiwa, M. Ž407. 211. Preconditioning; CGRP Žcalcitonin gene-related peptide.; Glibenclamide; Heart, rat ŽPeng, J. Ž407. 303. TNF-a , tumor necrosis factor-a Interleukin-10; Lipopolysaccharide ŽFukuda, T. Ž391. 317. TNF-a (Tumor necrosis factor-a ) Y-39041; Arthritis; Interleukin-10; Lipopolysaccharide ŽHisadome, M. Ž409. 331. TNF-a (tumor neocrisis factor-a ) Lipopolysacharide; Melatonin; Dexamethasone; Naltrexone; Nitric oxide ŽNO.; Hyperalgesia, centralrperipheral ŽRaghavendra, V. Ž395. 15. TNF-a (tumour necrosis factor-a ) Cytokine; Endothelin ETB receptor; Interleukin-1b; Interleukin-6; Interferon-g; Sarafotoxin S6c; Vasoactivity ŽWhite, L.R. Ž406. 117. TNF (tumor necrosis factor) receptor Endothelin; Endothelial cell; Epithelial cell; Inflammation; Atherosclerosis ŽLees, D.M. Ž390. 89. Tobacco Nicotine; Activation; Cholinergic; Addiction; Ventral tegmental area ŽDani, J.A. Ž393. 31. Tobacco addiction Neuronal nicotinic receptor; Nicotinic receptor distribution; Nicotine; Nicotinic agent; Schizophrenia; Dementia; Ageing; Epilepsy ŽClementi, F. Ž393. 3. Tobacco exposure Alzheimer’s disease; Parkinson’s disease; a 3 subunit; a4 subunit; a7 subunit; b-Amyloidosis; Acetylcholinesterase ŽPerry, E. Ž393. 215. Tolbutamide Glibenclamide; Desensitization; Clonal pancreatic b-cell; Insulin release; K AT P channel ŽBall, A.J. Ž408. 327. Tolerance Noradrenaline; Dopamine; Hypothalamus–pituitary–adrenocortical axis; Morphine; Paraventricular nucleus ŽFuertes, G. Ž388. 49. m-Opioid receptor; Desensitization; cAMP-dependent protein kinase; Morphine; N-Ž2-aminoethyl.-5-isoquinolinesulfonamide ŽH8. ŽWang, Z. Ž389. 165.

Nitric oxide ŽNO.; S-Nitrosothiol; Organic nitrate; Blood vessel ŽMiller, M.R. Ž408. 335. Tonazocine d-Opioid receptor agonist; SNC-80; Rotation; Parkinson’s disease ŽHudzik, T.J. Ž396. 101. Tone Circumferential stretch; Axial stretch; Impedance planimetry; Coronary artery, large; Ca2q-channel, voltage-gated; ŽPig. ŽTanko, ´ L.B. Ž387. 303. Topiramate Epilepsy; Carbamazepine; Phenytoin; Valproate; Felbamate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163. Antiepileptic drug; Electroshock, maximal; Drug interaction; Seizure ´ ˛der, M. Ž399. 35. ŽSwia Topoisomerase II Cryptolepine; Neocryptolepine; Plant alkaloid; Cytotoxicity; Apoptosis ŽDassonneville, L. Ž409. 9. Toxicity Cocaine; Convulsion; AMPA receptor; Kainate receptor; NMDA receptor ŽPouw, B. Ž386. 181. TP receptor Thromboxane A 2 ; Forskolin; cAMP; Mammary artery, internal; Saphenous vein ŽCracowski, J.-L. Ž387. 295. Trachea Niflumic acid; Cly channel; ICl ŽCa. ŽTeixeira, M.C.L. Ž394. 117. Acetylcholine release; Tachykinin NK 2 receptor; wbAla8 xNeurokinin AŽ4–10.; SR 48968 ŽD’Agostino, G. Ž396. 29. Tracheal contraction Compound 48r80; Connective tissue mast cell; Mast cell-deficient ŽWsrWs. rat; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽIkawati, Z. Ž420. 297. Tracheal perfusion Hyperosmolarity; Prostaglandin; Nitric oxide ŽNO.; Vasoactive intestinal peptide ŽVIP.; ŽGuinea-pig. ŽHjoberg, J. Ž398. 303. Trachea, rat Nitric oxide ŽNO.; cGMP-dependent protein kinase; Naq,Kq-ATPase; Aging ŽScavone, C. Ž388. 1.

Respiration; Opioid; Dependence; ŽRhesus monkey. ŽKishioka, S. Ž398. 121.

Tracizoline Imidazoline I 2 receptor ligand; Idazoxan; RX821002; Metrazoline; Benazoline; Food intake; Water intake ŽPolidori, C. Ž392. 41.

D9-Tetrahydrocannabinol; Ž R .-Methanandamide; Anandamide; SR 141716; Amphetamine; Operant behavior; Cross-tolerance; Dependence; ŽRat. ŽLamb, R.J. Ž398. 251.

Trandolapril Angiotensin-converting enzyme inhibitor; Cholesterol-fed, rabbit; Aorta; Coronary artery; Mesenteric, 5th branch ŽSanz, M. Ž397. 359.

Master keyword index to Õolumes 386–410 (2000) Transcription Nicotinic receptor; Enhancer; Promoter; Neuron ŽDeneris, E.S. Ž393. 69. Transcriptional regulation Acetylcholine receptor; Sox protein; Sp1; hnRNP K ŽMelnikova, I.N. Ž393. 75. Nicotinic receptor; Neuron, human; Gene; Promoter ŽFlora, A. Ž393. 85. Opioid peptide; AP-1 Žactivator protein-1.; Electrophoretic mobility shift assay; Uterus, rat; Hypothalamus, rat ŽOszter, A. Ž395. 103. Transcription factor Antidepressant; Mechanism of action; Monoamine; Neuropeptide; Intracellular signaling ŽVetulani, J. Ž405. 351. Neutrophil; Caspase; Apoptosis inhibitory protein; NF-kB Žnuclear factor-kB.; TNF-a Žtumor necrosis factor-a . ŽNiwa, M. Ž407. 211. Transcription factors Neuropeptide; Vasopressin; Corticotropin-releasing hormone; Dopamine; Homeobox gene; Development ŽBurbach, J.P.H. Ž405. 55. (TGF-b ) Transforming growth factor-b Biscoclaurine alkaloid; ŽPDGF. Platelet-derived growth factor; Mesangial cell, rat ŽHayama, M. Ž390. 37. Transmission disequilibrium 5-HT2A receptor; Association; Genome screening; Dopamine; Estrogen b receptor; Leptin ŽHinney, A. Ž410. 147. Transmural electrical stimulation Endothelin-1; FR139317; BQ-788; Phosphoramidon ŽNagayama, T. Ž406. 69. Transplantation Nitric oxide ŽNO. synthase; Inducible; Macrophage; Peroxynitrite ŽVos, I.H.C. Ž391. 31. Transport, reverse Dopamine release; Protein kinase C; Amphetamine; Phorbol ester; Cocaine ŽCowell, R.M. Ž389. 59. TRH (thyrotropin releasing hormone) CART Žcocaine- and amphetamine-regulated transcript.; Dopamine; Norepinephrine; Synaptosome; Hypothalamus ŽBrunetti, L. Ž409. 103. Trichloroethanol AMPA receptor; Cortical neurone, cultured; Chloral hydrate; Ca2q concentration, intracellular; Fura-2 microfluorimetry ŽFischer, W. Ž394. 41.

135

TRK-820 k-Opioid receptor agonist; Antinociceptive action; k-Opioid receptor subtype ŽEndoh, T. Ž387. 133. Morphine; U-50,488H; Antinociceptive tolerance; ŽMouse. ŽTsuji, M. Ž394. 91. TrkB receptor Nerve ligation; Chronic pain; Protein kinase C; Spinal cord; ŽMouse. ŽNarita, M. Ž401. 187. Troglitazone Thiazolidinedione; Rosiglitazone; BRL 49653; K AT P current; Glibenclamide; Kq channel ŽMishra, S.K. Ž386. 121. Apoptosis; Smooth muscle cell, vascular; p53; Gadd45; Pioglitazone ŽOkura, T. Ž407. 227. Fructose 2,6-bisphosphate; Hepatocyte; Insulin; Thiazolidinedione ŽRaman, P. Ž409. 19. Trypsin-treated protein kinase C activity 5-HT Ž5-Hydroxytryptamine, serotonin.; Endothelial cell, rat; Protein kinase C; w3 HxPhorbol 12,13-dibutyrate binding; cAMP; cGMP ŽLee, H.-Z. Ž403. 195. Tryptanthrin Nitric oxide; Inducible NO synthase; Prostaglandin; Cyclooxygenase; Inflammation ŽIshihara, T. Ž407. 197. Tryptophan hydroxylase Pharmacogenetics; 5-HT Ž5-hydroxytryptamine, serotonin.; 5-HT receptor; 5-HT Ž5-hydroxytryptamine, serotonin. transporter; Monoamine oxidase; 5-HT Ž5-hydroxytryptamine, serotonin. reuptake inhibitor, selective; Clozapine ŽVeenstra-VanderWeele, J. Ž410. 165. Tubular reabsorption Cyclosporine; Tacrolimus; Glomerulo-tubular balance; Tubulo-glomerular feed-back; Single nephron filtration rate ŽRomano, G. Ž399. 215. Tubulo-glomerular feed-back Cyclosporine; Tacrolimus; Glomerulo-tubular balance; Tubular reabsorption; Single nephron filtration rate ŽRomano, G. Ž399. 215. Tumor necrosis factor-a (TNF-a ) Alanine aminotransferase; Concanavalin A; Apoptosis; Interferon-g; Soyasapogenol A ŽKuzuhara, H. Ž391. 175. Turning behavior Dopamine D1 receptor; 6-Hydroxydopamine; Behavioral tolerance ŽCasas, M. Ž396. 93.

P2X 3 receptor; Ethanol ŽKoles, L. Ž409. R3. ¨ Tricyclic antidepressant Noradrenaline reuptake site; Meta-hydroxyephedrine; PET Žpositron emission tomography.; ŽHuman. ŽMalizia, A.L. Ž391. 263. Desipramine; Gingivitis; Microbiota; Salivary protein; Salivary flow rate ŽKoller, M.M. Ž408. 91. Triiodothyronine Amiodarone; b-Adrenoceptor turnover; Cardiomyocyte ŽVassy, R. Ž408. 227. Triterpenoid Bradykinin; Inflammation; Neurogenic; Phorbol ester; Protein kinase C ŽHuguet, A.-I. Ž410. 69.

TY-12533 NaqrHq exchanger; Ischemia; Reperfusion; Arrhythmia; Myocardial infarction ŽAihara, K. Ž404. 221. Tyramine Electrophysiology; Antidepressant; 5-HT1A receptor; a 2 -Adrenoceptor; Norepinephrine transporter; Pyridobenzoazepine ŽLiegeois, J.-F. Ž386. ´ 211. Tyrosine hydroxylase Dopamine; Sulfonylurea; Glipizide; DOPAC Ž3,4-dihydroxyphenylacetic acid.; HVA Žhomovalinic acid. ŽLamensdorf, I. Ž388. 147. Haloperidol; Substantia nigra; Immunohistochemistry; Antioxidant; ŽRat. ŽBesret, L. Ž408. 35.

136

Master keyword index to Õolumes 386–410 (2000)

Tyrosine kinase Damnacanthal; Dermal fibroblast; Ca2q, intracellular ŽAoki, K. Ž387. 119. Ca2q entry, capacitative; Ca2q store, internal; Fura-2; Cation channel, non-selective ŽOhta, T. Ž387. 211.

Umbilical artery, human 5-HT Ž5-hydroxytryptamine, serotonine.; Nicorandil; ATP-sensitive, Kq channels; SIN-1 Ž3-Morpholinosydnonimine.; Guanylate cyclase; Glibenclamide; ODQ Žw1-H-Ž1,2,4. Oxadiazole Ž4,3-a. quinoxalin-1-onex.; Temperature ŽTiritilli, A. Ž406. 79.

Ca2q; Adrenoceptor; Inositol phosphate; Fura-2 ŽBerts, A. Ž389. 35.

Umbilical vein, human Fractalkine; Chemokine; Chemotaxis; Adhesion; Endothelial cell ŽChapman, G.A. Ž392. 189.

Neutrophils, rat; p38 Mitogen-activated protein kinase; Protein kinase C; Phospholipase C; Ca2q, cytosolic-free ŽChang, L.-C. Ž390. 61.

Bradykinin B1 receptor; Retinoid ŽSardi, S.P. Ž407. 313.

Tyrosine kinase inhibitor Smooth muscle, Tracheal; Cromakalim; Kq channel, ATP-sensitive ŽMatsushita, Y. Ž389. 51.

Umbilical veins, human Angiotensin-converting enzyme; Angiotensin-converting enzyme inhibitor; Endothelial cells, cultured; Nitric oxide ŽNO.; Platelet aggregation ŽPersson, K. Ž406. 15.

Tyrosine phosphorylation Insulin; Primary culture of hepatocyte; cAMP phosphodiesterase; Microtubule; Wortmannin; Herbimycin A ŽIshibashi, K. Ž409. 109.

Uptake Steroid; Protein phosphatase; Dopamine D 2 receptor agonist; Dopamine D 2 receptor antagonist ŽThompson, T.L. Ž401. 357.

Tyr-W-MIF-1 Opioid receptor subtype; Xylazine; DAMGO; DPDPE; U50,488; a 2 adrenoceptor ŽWare, T.D. Ž389. 181.

Urate uptake E3040; Brush border membrane vesicle; ŽRat. ŽYamada, H. Ž406. 45.

U50,488 Opioid receptor subtype; Xylazine; DAMGO; DPDPE; Tyr-W-MIF-1; a 2 adrenoceptor ŽWare, T.D. Ž389. 181. U-50,488H Morphine; TRK-820; Antinociceptive tolerance; ŽMouse. ŽTsuji, M. Ž394. 91. 1229U91 Neuropeptide Y receptor; Neuropeptide Y y6 receptor; Neuropeptide Y; Orexigenesis ŽMullins, D.E. Ž395. 87. U-46619 JTE-522; Cyclooxygenase-2; Prostaglandin E 2 ; Thromboxane A 2 ; Airway hyperresponsiveness; Ozone; ŽGuinea pig. ŽNakano, H. Ž403. 267. U69,593 Opioid analgesia; Hotplate; Sex differences; Lick latency; ŽRat. ŽVan Haaren, F. Ž408. 153. Ulcer Non-steroidal anti-inflammatory drug ŽNSAID.; Apoptosis; Colon cancer; Pentose phosphate pathway ŽPorter, S.N. Ž397. 1. Ulcer healing Ischemia–reperfusion; Gastric secretion; Omeprazole; Ranitidine; Gastric blood flow; Interleukin-1b; Gastrin; Somatostatin ŽBrzozowski, T. Ž398. 147. Ultrasonic vocalization MDMA ŽŽ".-3,4-Methylenedioxymethamphetamine.; Ecstasy; Anxiety; Odor, cat; Social interaction ŽMorley, K.C. Ž408. 41. Nitric oxide ŽNO.; NMDA Ž N-methyl-D-aspartate.; Anxiety; Motor behavior; ŽRat. ŽPodhorna, J. Ž408. 265. Ultrastructure 2,3-Butanedione monoxime; Ca2i q transient; Fura 2-acetoxymethyl ŽAM. ester; Long-term culture; Contractility; ŽGuinea pig. ŽHorackova, M. Ž404. 247.

Urethra Nitric oxide ŽNO.; Adrenoceptor; Nitrergic nerve; ŽRabbit. ŽSeshita, H. Ž400. 271. Urinary bladder; Nitric oxide ŽNO.; cGMP; Smooth muscle ŽFujiwara, M. Ž401. 241. Urethra relaxation Nitric oxide ŽNO.; Carbon monoxide ŽCO.; Hydrogen peroxide; Corpus cavernosa ŽNaseem, K.M. Ž387. 329. Urinary albumin excretion Angiotensin-converting enzyme inhibitor; Diabetes; Nephropathy; Immunohistochemistry ŽKatoh, M. Ž398. 381. Urinary bladder Endothelin receptor; Diabetes ŽSaito, M. Ž387. 253. Maxi-Kq channel; Radioligand binding; Iberiotoxin ŽMolinari, E.J. Ž388. 155. Epithelium; Prostaglandin; Diabetes ŽPinna, C. Ž388. 267. Urethra; Nitric oxide ŽNO.; cGMP; Smooth muscle ŽFujiwara, M. Ž401. 241. Epithelial Naq channel; cAMP ŽBurton, T.J. Ž404. 273. Urinary bladder, human Bradykinin B 2 receptor; Bradykinin receptor antagonist; Cystitis; MEN 11270; Urinary bladder, rat ŽMeini, S. Ž388. 177. Nepadutant; Tachykinin receptor; Tachykinin receptor antagonist; Intestine, human ŽPatacchini, R. Ž398. 389. Urinary bladder, rat Bradykinin B 2 receptor; Bradykinin receptor antagonist; Cystitis; MEN 11270; Urinary bladder, human ŽMeini, S. Ž388. 177. Urinary incontinence b 2-Adrenoceptor; ATP-sensitive Kq channel; Detrusor muscle; Clenbuterol ŽHudman, D. Ž397. 169.

Master keyword index to Õolumes 386–410 (2000)

137

Urinary tract, lower TAK-637; Tachykinin NK 1 receptor antagonist, non-peptide; Micturition reflex ŽDoi, T. Ž395. 241.

Nitric oxide ŽNO.; Epilepsy; 7-Nitroindazole; Carbamazepine; Diazepam; Lamotrigine; Phenobarbital; Phenytoin; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž394. 275.

Urocanic acid GABA A receptor; UV-induced immunosuppression ŽUusi-Oukari, M. Ž400. 11.

Valsartan Spectral analysis; Catecholamine; Isoprenaline; Arterial pressure ŽBlanc, J. Ž394. 311.

Urocortin CRF Žcorticotropin-releasing factor.; CRF receptor; Antisense; Stress; Behaviour; ŽAntagonist. ŽSmagin, G.N. Ž405. 199.

Cyclosporine A; Naq; Enalapril; Angiotensin II; Vascular response ŽLassila, M. Ž398. 99.

Urotensin II Coronary artery; Vasodilatation ŽKatano, Y. Ž402. 209. Rabbit; Artery; Phosphoinositide; Peptide; Phospholipase C ŽOpgaard, O.S. Ž406. 265. Ussing chamber P2Y receptor; Sweat gland; Anionic secretion; Hyperhidrosis; Ca2q, intracellular ŽBovell, D.L. Ž403. 45. Uterus Phenytoin; Ovulation; Oestrogen ŽTamura, K. Ž398. 317. Uterus, rat Opioid peptide; AP-1 Žactivator protein-1.; Electrophoretic mobility shift assay; Transcriptional regulation; Hypothalamus, rat ŽOszter, A. Ž395. 103. UTP ATP; Ecto-nucleotidase; Dipyridamole; Ecto-ATPase; Superior cervical ganglion, rat ŽConnolly, G.P. Ž397. 271.

Vanadium Nitric oxide ŽNO.; Nitric oxide ŽNO. synthases; Growth; Osteoblast differentiation; Bone; Cytotoxicity ŽCortizo, A.M. Ž400. 279. Vanadyl sulfate Aging; Insulin action; Insulin release; Islet, isolated ŽDe Tata, V. Ž398. 169. Vanilloid receptor Phoneutria nigriÕenter venom; Sensory nerve; Neurogenic plasma extravasation; Tachykinin NK 1 receptor agonist; Purinoceptor ŽCosta, S.K.P. Ž391. 305. Staphylococcal enterotoxin B; Kinin; Mast cell; Neurogenic inflammation; Tachykinin NK 1 receptor ŽLinardi, A. Ž399. 235. Cannabinoid receptor; Anandamide; Capsaicin; Anti-nociception; Behavior; ŽMouse. ŽDi Marzo, V. Ž406. 363. Vascular UTP contraction; Aorta, rat; Smooth muscle; Protein kinase C; Ca2q ŽLopez, C. Ž391. 299. ´

UTP contraction Aorta, rat; Smooth muscle; Vascular; Protein kinase C; Ca2q ŽLopez, C. ´ Ž391. 299.

Flow; Nitric oxide ŽNO.; Oxidative stress; Ischemia-reperfusion ŽWalia, M. Ž400. 249.

UV-induced immunosuppression Urocanic acid; GABA A receptor ŽUusi-Oukari, M. Ž400. 11.

Vascular endothelial cell Diarylheptanoid; Leukocyte adhesion molecule; Anti-inflammation; 5Lipoxygenase ŽYamazaki, R. Ž404. 375.

UV light D2 receptor; Planaria ŽRaffa, R.B. Ž406. R11. Vma x Antiarrhythmic drug; Reperfusion arrhythmia; Action potential duration ŽBaczko, ´ I. Ž404. 181. Vacuolar-type ATPase Bafilomycin A 1; a-Fluoromethylhistidine; Histidine decarboxylase; Reserpine; Vesicular monoamine transporter ŽLindstrom, ¨ E. Ž387. 19. Vagal afferent Somatostatin; Capsaicin; Mustard oil; Antidromic stimulation; Anti-inflammatory effect ŽThan, ´ M. Ž399. 251. Vagus nerve C-fiber; Cholinergic nerve; Acetylcholine; Neurokinin-A ŽMatsumoto, K. Ž403. 157. Valproate Arachidonic acid cascade; Platelet; Brain microvessel, rat ŽSzupera, Z. Ž387. 205. Epilepsy; Topiramate; Carbamazepine; Phenytoin; Felbamate; Anticonvulsant; Audiogenic seizure; DBAr2 mouse ŽDe Sarro, G. Ž388. 163.

Vascular endothelium Nitric oxide ŽNO.; Vascular permeability; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193. Vascular hyporeactivity Lipopolysaccharide; Ventricular myocyte; Ca2q transient; b-adrenergic stimulation; Nitric oxide ŽNO. ŽShan, Q. Ž406. 257. Vascular permeability Nitric oxide ŽNO.; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Vasopressin; Surgery ŽPavo, ´ ´ I. Ž402. 193. Allergic conjunctivitis; Histamine H 1 receptors; 5-HT Ž5-hydroxytryptamine, serotonin.; Histamine ŽNakahara, H. Ž409. 313. Vascular reactivity Diabetes; Ouabain; Naq,Kq-ATPase; Phenylephrine; Streptozotocin; Nitric oxide; ŽRat. ŽDavel, A.P.C. Ž406. 419. Vascular response Cyclosporine A; Naq; Enalapril; Valsartan; Angiotensin II ŽLassila, M. Ž398. 99.

138

Master keyword index to Õolumes 386–410 (2000)

Vas deferens Ectonucleotidase; ATP; Purinergic ŽTennant, J.P. Ž387. 107.

S-Nitrosothiol; Nitric oxide ŽNO.; EDRF Žendothelium-derived relaxing factor.; Ca2q-channel, voltage-sensitive ŽTravis, M.D. Ž408. 289.

Ca2q channel, N-type; v-Conotoxin GVIA; v-Conotoxin MVIIA; vConotoxin MVIIC; Intestine; Superior cervical ganglion; ŽHuman.; ŽRat.; ŽGuinea-pig. ŽSanger, G.J. Ž388. 89.

Vasopressin Vasopressin V1A receptor; Vasopressin V2 receptor; Hypertrophy; Myocyte; Cell culture ŽNakamura, Y. Ž391. 39.

Vas deferens, rat Bradykinin; Bradykinin receptor; Hoe 140; Antagonism, insurmountable ŽAsghar, A.U.R. Ž398. 131.

Microvascular constriction; Mesenteric arteriole; Cremasteric arteriole; OPC-21268; OPC-31260 ŽIshiguro, S. Ž400. 121.

Calcitonin gene-related peptide ŽCGRP.; BIBN4096BS; CGRP Ž8-38.; CGRP receptor subtypes; Left atrium, rat ŽWu, D. Ž400. 313.

Vasopressin receptor; Vasopressin V1B receptor; Vasopressin V2 receptor, CHO ŽChinese hamster ovary. cell; Medullary collecting duct, inner ŽSaito, M. Ž401. 289.

Vasoactive intestinal peptide (VIP) Hyperosmolarity; Prostaglandin; Nitric oxide ŽNO.; Tracheal perfusion; ŽGuinea-pig. ŽHjoberg, J. Ž398. 303.

Nitric oxide ŽNO.; Vascular permeability; Vascular endothelium; Neutrophil granulocytes; Platelet-activating factor ŽPAF.; Thromboxanes; Leukotrienes; Surgery ŽPavo, ´ ´ I. Ž402. 193.

Vasoactivity Cytokine; Endothelin ETB receptor; Interleukin-1b; Interleukin-6; Interferon-g; TNF-a Žtumour necrosis factor-a .; Sarafotoxin S6c ŽWhite, L.R. Ž406. 117. Vasoconstriction Carotid artery, rat; Endothelial injury; Angiotensin I-converting enzyme; Angiotensin I-converting enzyme inhibitor ŽLemay, J. Ž394. 301. Isoprostane; Oxidative stress; Mammary artery ŽCracowski, J.-L. Ž397. 161. Cly channel; Stilbene derivative; Smooth muscle, vascular ŽLamb, F.S. Ž401. 403. SL 65.0472; 5-HT1B receptor; 5-HT2A receptor ŽGalzin, A.-M. Ž404. 361. Acidosis; ATP; P2X receptor; pH; Purine; Mesenteric arterial bed ŽRalevic, V. Ž406. 99. 5-HT receptor; cAMP accumulation ŽBou, J. Ž410. 33. Vasoconstrictor effect 5-HT Ž5-hydroxytryptamine, serotonin.; a-Methyl-5-hydroxytryptamine; Mesenteric blood flow; 5-HT2B r2C receptor ŽFernandez, M.M. Ž401. 221. ´ Vasoconstrictor response Nasal mucosa vasculature; Noradrenaline; NS-49; a 1 -Adrenoceptor subtype ŽTanimitsu, N. Ž387. 73. Vasodilatation EDHF Žendothelin-derived hyperpolarising factor.; Endothelium; P2 receptor; Purine; Pyrimidine ŽMalmsjo, ¨ M. Ž390. 173. Substance P; Plasma extravasation; Knee joint, Rabbit ŽLam, F.F.Y. Ž400. 327. Urotensin II; Coronary artery ŽKatano, Y. Ž402. 209. Vasodilation Sensory nerve fibre; CGRP Žcalcitonin-gene-related peptide.; Migraine ŽOlivar, T. Ž395. 61. Cannabinoid; Capsaicin; Neuron; Afferent; Pain; Receptor; Sensory ŽZygmunt, P.M. Ž396. 39. L-S-Nitrosocysteine;

195.

Nitric oxide ŽNO.; Redox; ŽRat. ŽHoque, A. Ž408.

Neuropeptide; Intranasal administration; Insulin; Melanocortin; Cognition ŽFehm, H.L. Ž405. 43. Neuropeptide; Corticotropin-releasing hormone; Dopamine; Homeobox gene; Transcription factors; Development ŽBurbach, J.P.H. Ž405. 55. Hippocampus; Memory process ŽAlescio-Lautier, B. Ž405. 63. Norepinephrine; Neuromodulation; Associative memory mechanism; Hippocampus ŽBrinton, R.D. Ž405. 73. Corticosterone; Firing pattern; Ion channel; Neurotransmitter ŽJoels, ¨ M. Ž405. 207. Corticotropin-releasing factor ŽCRF.; Autonomic nervous system; Learning; Memory ŽCroiset, G. Ž405. 225. Oestrogen receptor modulator; Oestrogen; Nitric oxide ŽNO.; Blood pressure; Enzyme regulation ŽPavo, ´ ´ I. Ž410. 101. Vasopressin receptor Vasopressin; Vasopressin V1B receptor; Vasopressin V2 receptor, CHO ŽChinese hamster ovary. cell; Medullary collecting duct, inner ŽSaito, M. Ž401. 289. Vasopressin V1A receptor Vasopressin; Vasopressin V2 receptor; Hypertrophy; Myocyte; Cell culture ŽNakamura, Y. Ž391. 39. Vasopressin V2 receptor Vasopressin; Vasopressin V1A receptor; Hypertrophy; Myocyte; Cell culture ŽNakamura, Y. Ž391. 39. Vasopressin V1B receptor Vasopressin; Vasopressin receptor; Vasopressin V2 receptor, CHO ŽChinese hamster ovary. cell; Medullary collecting duct, inner ŽSaito, M. Ž401. 289. Vasopressin V2 receptor antagonist Aquaretic effect; SR121463 ŽLacour, C. Ž394. 131. Vasopressin V2 receptor, CHO (Chinese hamster ovary) cell Vasopressin; Vasopressin receptor; Vasopressin V1B receptor; Medullary collecting duct, inner ŽSaito, M. Ž401. 289. Vasorelaxant Harman; Endothelium; Nitric oxide ŽNO. ŽShi, C.-C. Ž390. 319. Vasorelaxation Flavonoid; Dioclein; Endothelium; Nitric oxide ŽNO.; Aorta ŽLemos, V.S. Ž386. 41.

Master keyword index to Õolumes 386–410 (2000) Berberine; Nitric oxide ŽNO.; Kq channel; Ca2q channel; Proliferation; Mesenteric artery; ŽRat. ŽKo, W.-H. Ž399. 187. Venlafaxine Microdialysis; Serotonin Ž5-hydroxytryptamine, 5-HT.; Selective serotonin Ž5-hydroxytryptamine, 5-HT. reuptake inhibitor; YM992; Antidepressant ŽHatanaka, K.-i. Ž395. 23. Norepinephrine; 5-HT2A receptor antagonist; Microdialysis; YM992; Antidepressant ŽHatanaka, K.-i. Ž395. 31. WAY 100635; 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT1A autoreceptor; Dorsal raphe nucleus; 5-HT syndrome; ŽCat. ŽBjorvatn, B. Ž404. 121.

139

Veratridine Hippocampal neuron; Swelling; Death; Naq channel; Ca2q channel ŽOkuyama, K. Ž398. 209. Veratrine Histamine; Histamine release; Microdialysis; Ouabain ŽWashington, B. Ž407. 117. Verbascosaponin Anti-inflammatory activity; Verbascosaponin A; Scropolioside A; Scrovalentinoside; Ž Scrophularia auriculata ssp. pseudoauriculata. ŽGiner, R.-M. Ž389. 243.

Ventral posterolateral nucleus Hyperalgesia; Excitatory amino acid; Morphine; Riluzole; Dizocilpine ŽAbarca, C. Ž403. 67.

Verbascosaponin A Anti-inflammatory activity; Verbascosaponin; Scropolioside A; Scrovalentinoside; Ž Scrophularia auriculata ssp. pseudoauriculata. ŽGiner, R.-M. Ž389. 243.

Ventral tegmental area Nicotine; Activation; Cholinergic; Tobacco; Addiction ŽDani, J.A. Ž393. 31.

Very low-density lipoprotein Endothelium-dependent relaxation; Low-density lipoprotein; High-density lipoprotein; Oxysterol ŽPersegol, L. Ž406. 429. ´

Nicotinic receptor; Epibatidine; Somatodendritic; Substantia nigra; Dendrosome ŽReuben, M. Ž393. 39.

Vesicular monoamine transporter Bafilomycin A 1; a-Fluoromethylhistidine; Histidine decarboxylase; Reserpine; Vacuolar-type ATPase ŽLindstrom, ¨ E. Ž387. 19.

Nicotine; Neurofilament; NF-68; NF-160; NF-200; Immunohistochemistry ŽBunnemann, B. Ž393. 249. Ventricle enlargement Schizophrenia; Bipolar disorder; Depression; Memory; Synaptic plasticity; Neurocognitive impairment ŽVawter, M.P. Ž405. 385. Ventricle, right Morphine withdrawal; Catecholaminergic activity; Yohimbine; Prazosin ŽMilanes, ´ M.V. Ž397. 311. Ventricular arrhythmia AH-1058; Ca2q channel blocker ŽTakahara, A. Ž398. 107. Ventricular cardiomyocyte, rat Contractile function; Ca2q channel, L-type; Nitric oxide ŽNO.; Myoglobin ŽVulcu, S.D. Ž406. 247. Ventricular function, dog Angiotensin-converting enzyme inhibitor; Bradykinin; Ischemia; Reperfusion ŽHosoya, K. Ž390. 157. Ventricular hypertrophy N v -nitro-L-arginine methyl ester; Heart lesion; Stereology ŽDe Oliveira, C.F. Ž391. 121. Ventricular muscle, dog Positive inotropic effect; Ca2q transient; Myofibrillar Ca2q sensitivity; cAMP; Levosimendan ŽTakahashi, R. Ž400. 103. Ventricular myocyte Lipopolysaccharide; Vascular hyporeactivity; Ca2q transient; b-adrenergic stimulation; Nitric oxide ŽNO. ŽShan, Q. Ž406. 257. Ventricular myocyte, guinea-pig Nifedipine; Kq current, inward-rectifier; Kq current, delayed-rectifier ŽZhabyeyev, P. Ž401. 137. Ventricular remodeling g-Butyrobetaine hydroxylase inhibitor; Heart failure; Survival rate; Cardiac functional adaptability; High-energy phosphate ŽHayashi, Y. Ž395. 217.

Vessel, isolated Bradykinin B 2 receptor; Antagonist; ŽHuman.; ŽPig.; ŽRabbit. ŽRizzi, C. Ž386. 25. Vigabatrin Antiepileptic drug; Epileptic activity; Temporal lobe epilepsy; Pharmacoresistant; Brain slice ŽMusshoff, U. Ž401. 167. Vincristine P-Glycoprotein; Bioflavonoid; Blood–brain barrier; Protein kinase C ŽMitsunaga, Y. Ž395. 193. g-Vinyl GABA (vigabatrin) g-Aminobutyric acid ŽGABA.; Dopamine; Microdialysis; Cocaine; gAminobutyric acid ŽGABA. reuptake inhibitor ŽGerasimov, M.R. Ž395. 129. VIP-(10–28) PACAP Žpituitary adenylate cyclase-activating peptide.; VIP Žvasoactive intestinal peptide.; Apamin; Suramin; PACAP-Ž6–38.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217. VIP (vasoactive intestinal peptide) NANC Žnonadrenergic, noncholinergic. relaxation; Strain difference; Colon, distal; Nitric oxide ŽNO. ŽOkishio, Y. Ž388. 97. PACAP Žpituitary adenylate cyclase-activating peptide.; Apamin; Suramin; PACAP-Ž6–38.; VIP-Ž10–28.; Colon; ŽRat. ŽPluja, ` L. Ž389. 217. PACAP Žpituitary adenylate cyclase activating peptide.; Nitric oxide ŽNO.; Nonadrenergic noncholinergic ŽNANC. relaxation, inhibitory; Smooth muscle, tracheal; ŽCat. ŽYoshida, M. Ž395. 77. VIP (Vasoactive intestinal polypeptide) Capsaicin; Myenteric neuron; PPADS ŽPyridoxal-phosphate-6-azophenylX X 2 ,4 -disulphonic acid.; PACAP ŽPituitary adenylate cyclase activating peptide.; NO ŽNitric oxide.; Small intestine ŽBartho, ´ L. Ž392. 183. VIP (vasoactive intestinal polypeptide) Nitric oxide ŽNO.; Gastric fundus, Pig ŽDick, J.M.C. Ž397. 389.

140

Master keyword index to Õolumes 386–410 (2000)

Visceral pain Histamine H 1 receptor; Pain perception; Histamine; Somatic pain; Gene targeting ŽMobarakeh, J.I. Ž391. 81. Visual cortex Synaptic plasticity; Long-term potentiation; Primed-burst stimulation; Ketamine ŽSalami, M. Ž390. 287. Vitamin E Streptozotocin-induced diabetic mouse; Corpus cavernosum; Nitric oxide ŽNO.; Antioxidant; Sodium selenate; Oxidative stress ŽGoc ¨ ¸men, C. Ž398. 93. Oxidative stress; Free radical; Antioxidant; Cortical culture; Propofol ŽBoland, A. Ž404. 21. Atherosclerosis; Alzheimer’s disease; Apolipoprotein E ŽPeroutka, S.J. Ž410. 161. Vitronectin Smooth muscle cell, Vascular; Endothelial cell; Integrin; Glycoprotein IIbrIIIa-inhibitor; ŽHuman. ŽKintscher, U. Ž390. 75. Volatile Anesthetic; Kq channel; Ca2q-activated; Xenopus oocyte ŽNamba, T. Ž395. 95. Voltage clamp X ATP receptor; Oocyte; Antagonist; Whole cell; NF279 Ž8,8 -ŽcarbonylbisŽimi no- 4,1-phenylenecarbonylimino- 4,1-phenylenecarbonylimino..bisŽ1, 3,5-naphthalenetrisulfonic acid.. ŽKlapperstuck, ¨ M. Ž387. 245. Calmodulin antagonist; Mechanosensitive channel; Stretch receptor ŽLin, J.-H. Ž397. 11. Voltage-clamp, Whole-cell 5-HT3 receptor; Zn2q; Cation, Divalent; Radioligand binding; Neuromodulation ŽHubbard, P.C. Ž394. 189. Voltammetry in vivo Ethanol; Dopamine release; Stress of social defeat; Nucleus accumbens; ŽMouse. ŽYavich, L. Ž401. 365. Volume and fluid regulation Alcohol withdrawal, human; Delirium tremens; ANP Žatrial natriuretic peptide. secretion; Withdrawal hyperexcitability, mouse; NMDA Ž Nmethyl-D-aspartate. seizure; Glutamate ŽKovacs, ´ G.L. Ž405. 103. WAGr r Rij rat Generalized absence epilepsy; Ca2q channel; Spike-wave discharge; Nimodipine; BAY K8644; Ethosuximide; Genetic model ŽVan Luijtelaar, G. Ž406. 381. Water intake Imidazoline I 2 receptor ligand; Idazoxan; RX821002; Metrazoline; Benazoline; Tracizoline; Food intake ŽPolidori, C. Ž392. 41.

Neuroleptic; Antipsychotic; Catalepsy; Extrapyramidal side-effect; 5-HT Ž5-hydroxytryptamine, Serotonin. depletion; Dopamine D 2-like receptor; 5-HT1A receptor; p-Chlorophenylalanine; Nemonapride; Raclopride ŽPrinssen, E.P.M. Ž395. 143. w35 SxGTPgS binding; 5-HT1A receptor; Inverse agonist ŽCosi, C. Ž401. 9. Venlafaxine; 5-HTŽ5-hydroxytryptamine, serotonin.; 5-HT1A autoreceptor; Dorsal raphe nucleus; 5-HT syndrome; ŽCat. ŽBjorvatn, B. Ž404. 121. Microdialysis, in vivo; 5-HT1A receptor; 5-HT Ž5-hydroxytryptamine, serotonin. release ŽAssie, ´ M.-B. Ž409. 173. WAY100635 5-HT1BrD receptor; Locomotor activity; SKF99101H; GR127935; ŽGuinea pig. ŽO’Neill, M.F. Ž399. 49. WAY-100635 Ipsapirone; 5-HT1A receptor agonist; Food intake ŽArkle, M. Ž408. 273. Whole cell X ATP receptor; Oocyte; Antagonist; Voltage clamp; NF279 Ž8,8 -ŽcarboŽ nylbis imino-4,1-phenylenecarbonylimino- 4,1-phenylenecarbonylimino..bisŽ1,3,5-naphthalenetrisulfonic acid.. ŽKlapperstuck, ¨ M. Ž387. 245. Whole-cell l-cis-Diltiazem; d-cis-Diltiazem; Patch-clamp; Ca2q overload; Naq current; Lysophosphatidylcholine ŽHashimoto, Y. Ž391. 217. WI-38 cell Bradykinin B1 receptor; Bradykinin B 2 receptor; Regulation; w3 HxdesArg 10 -kallidin; w3 HxBradykinin; Cytokine ŽPhagoo, S.B. Ž397. 237. WIN55212 Cannabinoid CB 2 receptor; Palmitoylethanolamide; Nitric oxide ŽNO.; RAW264.7; Macrophage; cAMP ŽRoss, R.A. Ž401. 121. WIN 55212-2 Cannabinoid receptor; SR 144528; Mutagenesis; Ligand docking; Molecular model ŽGouldson, P. Ž401. 17. Cannabinoid receptor agonist; Cannabinoid receptor antagonist; SR14716A; Ileum; Electrical field stimulation; Short-circuit current, ŽRat. ŽTyler, K. Ž409. 207. WIN 55, 212-2 Acetylcholine; Hippocampus; HU 210; Microdialysis; Cortex, prefrontal; SR 141716A ŽAcquas, E. Ž401. 179. Wind-up C-fibre; Flexor reflex; Rostral ventromedial medulla; Spino-bulbo-spinal; Inhibitory feedback mechanism; Morphine ŽGozariu, M. Ž394. 75. Withdrawal THC Žtetrahydrocannabinol.; Dependence; Operant behavior; Behavioral dependence; SR141716A; ŽRat. ŽBeardsley, P.M. Ž387. 47.

5-HT1B receptor; Knockout mouse; Ethanol intake; Food intake ŽBouwknecht, J.A. Ž403. 95.

Ethanol tolerance; Ethanol dependence; NMDA Ž N-methyl-D-aspartate.; ANP Žatrial natriuretic peptide.; Antiserum against atrial natriuretic peptide ŽKovacs, ´ G.L. Ž401. 343.

WAY 100635 D-Fenfluramine; Hypothermia; 5-HT1A receptor; Sertraline; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride; Yohimbine ŽCryan, J.F. Ž390. 275.

Withdrawal hyperexcitability, mouse Alcohol withdrawal, human; Delirium tremens; Volume and fluid regulation; ANP Žatrial natriuretic peptide. secretion; NMDA Ž N-methyl-Daspartate. seizure; Glutamate ŽKovacs, ´ G.L. Ž405. 103.

Master keyword index to Õolumes 386–410 (2000) Withdrawal jump Morphine tolerance; Morphine dependence; Melatonin MT1 receptor; Melatonin MT2 receptor; Melatonin MT3 receptor; Benzodiazepine receptor; Centralrperipheral; Nitric oxide ŽNO.; Tail-flick latency ŽRaghavendra, V. Ž409. 279. Withdrawal, precipitated Radiotelemetry; Abecarnil ŽElliot, E.E. Ž394. 237. Wogonin Flavonoid; Cyclooxygenase; Prostaglandin; Macrophage ŽWakabayashi, I. Ž406. 477.

141

Norepinephrine; 5-HT2A receptor antagonist; Microdialysis; Venlafaxine; Antidepressant ŽHatanaka, K.-i. Ž395. 31. YM-31636 5-HT3 receptor agonist; Colon, distal; Atrium, right; ŽGuinea pig. ŽIto, H. Ž409. 195. YM-126414 C2C12 cell; Glucose transporter isotype 4; Insulin resistance ŽShimokawa, T. Ž410. 1.

Wood smoke CP-96,345; Tachykinin NK 1 receptor; Tachykinin NK 2 receptor ŽLin, Y.S. Ž394. 139.

Yohimbine D-Fenfluramine; Hypothermia; 5-HT1A receptor; Sertraline; WAY 100635; RO 43-0440; Ketanserin; Parachlorophenylalanine; Haloperidol; Sulpiride ŽCryan, J.F. Ž390. 275.

Working memory Radial-arm maze; SR141716A; Cannabinoid ŽLichtman, A.H. Ž404. 175.

Morphine withdrawal; Ventricle, right; Catecholaminergic activity; Prazosin ŽMilanes, ´ M.V. Ž397. 311.

Dopamine; Microdialysis, In vivo; Prefrontal cortex; Shuttle-box; ŽGerbil. ŽStark, H. Ž405. 263. Wortmannin Phosphatidylinositol-3-kinase; Adenosine; Methacholine; 5-HT; Bronchoconstriction; Active sensitisation; Ovalbumin; Brown Norway, rat ŽTigani, B. Ž406. 469. Insulin; Primary culture of hepatocyte; Tyrosine phosphorylation; cAMP phosphodiesterase; Microtubule; Herbimycin A ŽIshibashi, K. Ž409. 109. Wound healing accelerator Healing-impaired, mouse; Cyclic peptide; SEK-1005; TGF-b1 Žtransforming growth factor-b1. inducer ŽAbe, Y. Ž408. 213. Xanthine oxidase Iodonium; NADPH oxidase; Nitric oxidase ŽNO. synthase; NADH– ubiquinone reductase ŽMoulton, P. Ž401. 115. Xenopus laezis oocyte Nicotinic acetylcholine receptor; Acetylcholine; Choline; Agonist; Partial; Co-agonist ŽZwart, R. Ž393. 209. Xenopus oocyte Anesthetic; volatile; Kq channel; Ca2q-activated ŽNamba, T. Ž395. 95. Xenopus oocytes OAT1 Žorganic anion transporter 1.; Renal tubular secretion; Sulfonylurea; Nateglinide; p-Aminohippurate ŽUwai, Y. Ž398. 193. Xylazine Opioid receptor subtype; DAMGO; DPDPE; Tyr-W-MIF-1; U50,488; a 2 adrenoceptor ŽWare, T.D. Ž389. 181. Y-27632 Bronchodilator; Rho-kinase ŽIizuka, K. Ž406. 273. Y-39041 Arthritis; TNF-a ŽTumor necrosis factor-a .; Interleukin-10; Lipopolysaccharide ŽHisadome, M. Ž409. 331. YM158 Leukotriene; Thromboxane; Asthma ŽArakida, Y. Ž403. 169. YM992 Microdialysis; Serotonin Ž5-hydroxytryptamine, 5-HT.; Selective serotonin Ž5-hydroxytryptamine, 5-HT. reuptake inhibitor; Venlafaxine; Antidepressant ŽHatanaka, K.-i. Ž395. 23.

Yoking Self-administration; Catecholamine; Epinephrine; Norepinephrine; Corticosterone; Nicotine ŽDonny, E.C. Ž402. 231. Z-335 Thromboxane A 2 ; Arterial thrombosis; Cilostazol ŽTanaka, T. Ž401. 413. Zaldaride maleate Calmodulin; Adenylate cyclase; Guanylate cyclase; Ion secretion ŽAikawa, N. Ž394. 233. Zatebradine Ischemia-induced arrhythmia; Reperfusion arrhythmia; Propranolol; ŽDog. ŽNaito, H. Ž388. 171. zif268 c-fos; 6-Hydroxydopamine; N-methyl-D-aspartate ŽNMDA.; L-3,4-dihydroxyphenylalanine ŽL-DOPA.; Striatum ŽAdams, A.C. Ž404. 303. Zinc protoporphyrin IX Benzodiazepine receptor, mitochondrial; d-Aminolaevulinic acid; Protoporphyrin IX; Aciflourfen; Protoporphyrinogen oxidase ŽMesenholler, M. ¨ Ž406. 171. ZM 241385 Adenosine A 2A receptor; SCH 58261; CGS 21680; Motor activity; Knockout, mouse ŽEl Yacoubi, M. Ž401. 63. Zn 2H Cerebral endothelial cell; Dithiocarbamate; NF-kB Žnuclear factor-kB.; ŽBovine. ŽKim, C.H. Ž392. 133. 5-HT3 receptor; Cation, Divalent; Voltage-clamp, Whole-cell; Radioligand binding; Neuromodulation ŽHubbard, P.C. Ž394. 189. Morphine; Intrathecal; Antinociception; Tolerance; Dependence ŽLarson, A.A. Ž407. 267. Zolmitriptan 5-HT1B receptor, human; Kq channel, Ca2q-dependent; C6 glioma cell ŽLe Grand, B. Ž397. 297. Zolpidem Benzodiazepine; Drug discrimination ŽRowlett, J.K. Ž406. R9.